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Summary 
Microbial fuel cells (MFCs) are a fascinating green technology with potential to 
simultaneously degrade waste organic material, reducing the chemical oxygen demand 
(COD) of the effluent and generate harvestable energy in the form of electrons.  A key 
element in the function of this potentially powerful technology is the microorganisms 
that make this all possible – dissimilatory metal reducing bacteria (DMRB). These 
ancient organisms are able to generate their energy through interactions with 
insoluble terminal electron acceptors such as Iron (III), Manganese (IV) and Uranium 
(VI) but are also able to interact with anodes within MFCs. These interactions occur 
due to the ability of the cells to transfer electrons extracellularly through complex 
protein pathways. Understanding the mechanisms by which they are able to do this 
presents opportunities to further tune or enhance this capability in order to generate 
greater power outputs. This thesis aims to make use of the engineering paradigm of 
“measure, model, manipulate , make” in order to generate obtain and generate 
results.  
 Through the use of modern molecular biology techniques, the mechanisms of 
extracellular electron transfer have been transferred into an organism 
previously incapable of this activity (manipulate and make – being based 
heavily upon previous research detailing previous electrochemical 
measurements and models). Through these methods a 60% increase in power 
generation was noted compared to the wild type host organism. This was also a 
64% power output of the model, naturally electrogenic organism. 
 A proteomic analysis was carried out in order to try and elucidate the 
underlying proteomic profile of a dissimilatory metal reducing bacterium 
(DMRB) within an MFC compared to controlled aerobic growth (measure and 
model – with the intention to manipulate and make). The study found 
differential regulation of several proteins outside the “classical Mtr pathway”, 
including upregulation of TolC within anode bound cells. 
 In order to try and reduce the metabolic burden of the exoelectrogenic system 
and increase the potential power density, it was attempted to be based on the 
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chromosome of E. coli (manipulate and make). A variety of techniques were 
applied to attempt this, and although the transfer of the genetic constructs 
onto the genome was unsuccessful, a wide range of important things to avoid 
are noted. In the second part of this chapter, an attempt to try and understand 
the native cellular components the recombinant system was interacting with a 
tandem affinity purification study was attempted (measure and model). 
 
This thesis therefore hopes to demonstrate comprehensive use of the engineering 
paradigm to help develop understanding of current generation by a biological 
organism, and the functional transfer of this activity to from a model organism to E. 
coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 | P a g e  
 
Chapter	1:	Introduction	
“Water and air, the two essential fluids on which all life depends, have become global 
garbage cans”  
Jacques Yves Cousteau 
Although my view of the world may not be quite as bleak as Monsieur Cousteau’s 
statement, I felt that in order to set the scene for this project it was apt to start not 
only with a quote but with some startling figures of the state of things as they 
currently stand. 
The Earth is in bad shape: 
 Currently roughly 7.2 billion people are on the planet and we are racing 
towards a total of approximately 10 billion in 2050 (1). 
 With increasing populations and development of economies come increasing 
demands for food, water and energy. 
 People are using increasingly desperate ways of harvesting fossil fuels using 
techniques such as the highly controversial fracking technique to the incredibly 
toxic harvesting of hydrocarbons from tar sands. 
 In 2009, the UN estimated the number of undernourished people to be roughly 
1 billion (2). This is all at a time when between 30-40% of food is approximately 
wasted in both the developed and developing world, albeit due to very 
different reasons (3) (4).  
 More food requires more water and around 1.8 billion people were estimated 
to have used unsafe drinking water in 2010 (5). 
 Although the world is two thirds covered in water, only 3% of the water on the 
planet is freshwater, with only 0.3% of that 3% being surface water (6) as 
shown in Figure 1.1: 
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Figure 1.1 Distribution of the Earth’s water, showing the minute 
amount of easily accessible fresh water on the planet  
In order to be able to deal with the increasing global demands there are many issues, 
such as the ones stated above that need to be tackled. Being able to develop 
technology that is able to deal with any of these is a great challenge. 
A technology that is able to effectively detoxify and or desalinate water, degrade waste 
organic material, generate energy in a variety of forms and potentially produce high 
value products, all simultaneously is highly desirable. This technology exists, albeit in a 
relatively immature form, in bioelectrochemical systems (BES). These systems are able 
to harness the capabilities of metabolically diverse microorganisms known as 
dissimilatory metal reducing bacteria (DMRB) to degrade organic material and transfer 
the released electrons to an extracellular acceptor for desired use elsewhere (7–9). 
As with a great many biological systems, the discovery of the organism producing the 
desired chemical molecule or trait is not the one that is economically viable for further 
use due (often) to inabilities to meet demands. This may be due to growth limitations, 
cost issues or potentially due to a lack of tools for simple and timely genetic 
manipulation. As previously inferred, the ability of BES to degrade waste organic 
material and generate energy or high value products is currently very limited (10).  The 
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systems suffer from a range of multi-disciplinary issues that encompass the biological 
and engineering aspects. Relatively low power density (11) and incomplete 
degradation of waste organics (12), all within currently lengthy timeframes (13) are 
some of the factors currently preventing this technology from gaining wider 
acceptance.  
Gaining an understanding of the mechanisms by which DMRB are able to perform 
these actions, provides a great opportunity to tune and further enhance their abilities.  
As argued in this thesis, discovering the genetic basis behind these traits requires the 
use of techniques such as genetic manipulation, transcriptomics analysis and 
quantitative proteomics. Although a relatively new field, a great deal of research has 
been put into this type of experimentation with a significant increase in the level of 
knowledge. 
In an attempt to try and alleviate some of the biological issues, a favoured 
microbiology workhorse, Escherichia coli, was employed in this thesis as a suitable host 
for genetic manipulation. This was done not only to help determine the basic genetic 
elements required for extracellular electron transfer, but also to be able to transfer 
this ability to a non DMRB – in this case referring specifically to the inability of E. coli to 
perform extracellular electron transfer. All of this was done with a view to transferring 
released electrons to a bioelectrochemical system (BES), with the potential for further 
manipulation to enhance the maximum power density. 
1.1 Chapter breakdown and Aims 
The main aims of this thesis, divided into each of the research chapters (4, 5 and 6) 
were therefore: 
 The focus of chapter 4 is the use of modern genetic and protein analysis 
techniques to integrate a functional extracellular electron transfer pathway 
into E. coli and test the success of the heterologous pathway within a BES, with 
the centre of attention being microbial fuel cells (MFCs).  
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 The focus of chapter 5 was to gain a proteomic understanding of the model 
DMRB organism, Shewanella oneidensis MR-1 under current generating 
conditions within an MFC. 
 Chapter 6 is broken down into two subsections with distinct aims: 
o The first section is directed towards streamlining the recombinant 
exoelectrogenic system and alleviating the metabolic burden by shifting 
away from large multi plasmid systems by incorporating the required 
genes into the host genome. 
o The second part is focussed on determining the interacting partners of 
this heterologous pathway within a non native system with an intended 
aim of forward engineering for further enhancement of power output. 
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Chapter	2:	General	Background	and	
Review	
2. Introduction 
The increasing demand for energy in a world with diminishing supplies requires not 
only more efficient energy usage but also the development of renewable energy 
technology. The water sector consumes a vast amount of energy yet possesses huge, 
largely untapped energy resources that could be utilised by emerging technologies 
such as BESs including, MFCs. In order to be able to make full use of this synergy 
between biology and engineering technology, there are a great deal of biological 
challenges that must be tackled. The literature review in this chapter provides an 
overview of the available technologies, discussion about the challenges at hand and 
some ideas about potential ways for these to be overcome. 
2.1 Background and Literature Review   
2.1.1 End of fossil fuels, beginning of a new renewable age 
The use of fossil fuels, especially gas and oil has accelerated due to the economic 
development of countries such as China, India and Brazil and the increased energy 
demand that has come with it (14–17). The natural stores of fossil fuels compounds 
are being rapidly depleted throughout the world, leading to high prices due to demand 
that is soon expected to go beyond peak production levels (18,19). The price of oil 
increased from a long steady period of around $20/barrel in the 1980’s and early 90’s 
to around $50/barrel in 2007 and then shot up to $150/barrel in spring 2008 (20).  This 
did not last but there have been (admittedly difficult) predictions that the price of oil 
per barrel could reach as high as $270 by 2020 (21,22).  The increase in requirement 
has led to more drastic and dangerous ways of extracting these compounds. This deep 
drilling for oil and gas has led to events such as that recently seen with BP in the Gulf 
of Mexico. 
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Even without disasters like this, the age of fossil fuels has caused immense damage to 
the environment as seen with the advent of global warming due to the highest CO2 
levels in human existence (23). This has led to the decision to reduce global CO2 
emissions significantly by 2050 with the UK aiming for a 60% decrease and Germany, 
France and the Netherlands aiming for 80%, 75% and 80% reduction respectively (24). 
These reductions in carbon emissions aim to be achieved when there will be the 
highest energy demand in history as the world population is expected to be around 9 
billion by 2050 (25). This energy demand must therefore come from the development 
of clean, renewable sources with the largest focus on renewable energies seen in solar, 
tidal and wind energy. All of these energies are intermittent and in order for the 
energy produced to be efficiently harnessed requires the development of a more 
advanced smart grid (26). This would be one which is capable of handling sporadically 
high levels of energy production that can be stored away for further use and be able to 
regulate the flow of energy. 
In order to be able to provide a westernised country with enough energy, it must come 
from a variety of different sources (Table 2.1). 
Table 2.1 – Comparison of different potential energy sources 
Energy 
source Renewable Pros Cons 
Nuclear Potentially No CO2, Cheap Very dangerous, Toxic waste 
(27) 
Wind Yes No CO2, Low siting 
costs, Take place 
alongside farming 
Unpredictable energy, Eye 
sore (28) 
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Apart from nuclear power, none of these energy sources are likely to be able to 
individually power an entire nation and must instead be combined in order to deal 
with demand. 
A large proportion of a developed country’s energy expenditure comes from the water 
industry (37) where there is a constant demand for clean, fresh water that must be 
treated and transported. In the USA, the treatment of wastewater to a safe level 
through the removal of toxic compounds is believed to require 1.5% of the total 
Solar Yes No CO2, Remote 
usage, Suited for 
developing countries, 
Integrate with 
buildings, More 
efficient than biofuel 
Weather dependent, Reliant 
on storage, 
DC to AC conversion losses   
(29,30) 
 
                                                                                                
Tidal Yes Reliable, No CO2 Environmental impact (31,32), 
transmission lines 
Biomass Yes Burn organic by-
products, Carbon 
neutral, Abundant 
Possible net energy loss in 
production, Competition with 
food use. Unable to replace 
current gasoline and diesel 
levels (33) (34)  
Geothermal Yes Low deployment 
costs, Continuous 
energy, No CO2 
Very location dependent 
(35) 
Hydroelectric Yes Constant energy,  No 
primary pollution, 
Relies on gravity 
Serious environmental impact, 
Long transmission lines (36) 
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energy produced, with the whole industry being responsible for between 4-5% (37). 
The high levels of organic compounds present in the wastewater are believed to hold 
9.3 times the energy currently required for the operation of this sector (37). According 
to Logan’s calculations (24), if even 50% of the energy stated by Logan could be 
harnessed it has the potential to provide around 20% of the country’s energy 
requirements. Methods for simultaneous energy production and degradation of 
organic compounds in wastewater can be seen with anaerobic digesters, and the 
development of microbial fuel cells (MFCs).  
2.1.1.1 Anaerobic digesters – This system makes use of different types of 
microorganisms to degrade organic material under anaerobic conditions to produce 
methane. This is done through 4 different steps (38,39): 
I. Hydrolysis – Degradation of matter into its constituents compounds such as 
long chain carbohydrates like starch down to sugars, and proteins to amino 
acids. 
II. Acidogenesis – The sugars and amino acids are then converted into the desired 
organic acids but by products such as ammonia, hydrogen and carbon dioxide 
are also produced. This is all done by acidogenic bacteria. 
III. Acetogenesis – The organic acids are converted into acetic acid along with the 
limited amounts of ammonia, hydrogen and carbon dioxide by acetogenic 
bacteria. 
IV. Methanogenesis – The organic acids and the derivatives such as acetic acid are 
converted into methane and carbon dioxide at roughly 60% and 40%, 
respectively. 
The methane can then be used to heat water, peoples’ homes or even used as a 
replacement fuel in transportation (40). However the conversion of this methane into 
electricity that can be used to power a wide range of appliances is highly inefficient 
with more than 60% of the energy being lost in the process (41). There are further 
limitations to this technology as the containers must be kept under certain conditions 
in order to efficiently produce methane. The most common example being the 
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requirement to keep the tanks at a temperature of either 35°C (mesophilic) or 55°C 
(thermophilic) (41) in order to provide the required environment for the microbial 
species to be most effective. There are many different steps that occur throughout this 
procedure where energy is expended and which require the transportation of the 
media through different containment tanks to provide the desired conditions. The 
methane that is produced needs to be burned in order for the energy to be released as 
heat or used in a combustion engine and is therefore limited by the Carnot cycle (42). 
The anaerobic digester system is instead more reliant on heating and proper mixing of 
the feedstock to ensure an even distribution within the container and provide optimal 
conditions for methane production. 
An alternative to this technology can be seen in MFCs, which are the focus of this 
study. 
2.1.2 Microbial fuel cells – Principles, potential and drawbacks 
MFCs provide an alternative to anaerobic digesters and present several advantages. 
They are in essence living batteries in which organic material is degraded to its 
smallest constituent compounds in the anode so that the energy stored in the 
chemical bonds within the compounds is released when they are oxidised (43). This is 
an exploitation of all organisms’ requirement to dispose of high energy electrons 
released following the catabolism of a substrate to create a proton gradient (44). 
Instead of utilising a standard terminal electron acceptor (TEA) such as oxygen to pass 
these electrons to, the bacteria make use of the anode. These electrons are then 
harnessed and can be used to power electrical equipment (45) (46). This was first 
discovered to be possible by Potter (47) although the power output achieved was 
incredibly small due to a number of limiting factors: (I) An inability to effectively 
transfer the electrons produced by the bacteria to the anode and (II) The use of a 
strain that lacked metabolic versatility, preventing the complete oxidation of the 
organic compounds leading to a loss in the number of electrons that could be 
extracted (48). 
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Potter’s discovery was unnoticed until the 1980’s when interest in the use of MFCs for 
the degradation of organic material and electricity production drew attention. At this 
point there was no knowledge of the ability of dissimilatory metal reducing bacteria 
(DMRB) to transfer electrons to an anode within an MFC and so strains incapable of 
extracellular electron transfer such as Escherichia coli were used in association with 
artificial electron mediators like methyl viologen and neutral red (49). These soluble 
mediators were able to greatly accelerate the transfer of electrons from the cells to 
the anode (50). There are however many problems with the use of such mediators. 
They are often expensive, toxic compounds that degrade over time and therefore 
require continual replenishment for effective activity (51). This makes them highly 
unfavourable for long term use within a MFC used to treat water that will later go on 
to be used for human consumption as it would require further treatment to remove 
these compounds. 
An example of a two chamber MFC can be seen in Figure 2.1. Recent developments in 
MFCs have made use of metabolically versatile dissimilatory metal reducing bacteria 
that are able to degrade a wide range of organic materials under a large variety of 
conditions. 
 
 
 
 
 
 
 
 
Figure 2.1 – Example of a two chamber MFC 
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Figure 2.1 illustrates the setup of a two chamber MFC. The microbes and organic 
material are stored in the anaerobic anode chamber, where the biological oxidation is 
allowed to take place and the electrons are transferred to the anode electrode (52): 
Anode:     Starch→ C 6 H 12 O 6 + 6 H 2 O→ 6 CO 2 + 24 H + + 24 e –   (1) 
The polysaccharide is enzymatically degraded to its monomer, glucose and is then 
oxidised to CO2 yielding 24 protons and 24 electrons. The thin line that can be seen in 
the middle of Figure 2.1 that divides the two chambers is known as the proton 
exchange membrane (PEM). This selectively permeable membrane limits the transfer 
of oxygen present in the water in the cathode from transferring into the anode and 
acting as a terminal electron acceptor (TEA). It also permits the transfer of protons 
released from the oxidation of the organic material from the anode to the cathode 
where they can then be used to reduce oxygen to water.  
 Cathode:  24 H+ + 24 e– + 6 O2 → 12 H2O     (2) 
The electrons that are released must travel through the anode and along the circuit 
where they can be harvested for use in electrical circuits. The organisms must be kept 
under anaerobic conditions so that the only available TEA is the anode. 
The combination of the reactions (1) and (2) can be seen in reaction (3), theoretically 
yielding a high power output. 
C6H12O6 + 6 O2 → 6 CO2 + 6H2O + electrical energy     (3) 
(theoretically approaching – 2840 kJ/mol) (53) 
The example MFC shown in Figure 2.1 presents the use of an added soluble mediator 
such as methyl viologen to the anode chamber to allow for electron transfer. This 
setup is now considered obsolete due to the number of issues that arise from their use 
such as the need to be frequently replenished, their cost and their toxicity. This lead to 
a search for organisms that were capable of transferring their electrons to the anode 
without the need for mediators. These were eventually found in the form of DMRB 
such as Geobacter and Shewanella as discussed in section 2.1.4. 
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2.1.3 Advantages over anaerobic digesters 
There are several advantages of using MFCs over anaerobic digesters (AD) and other 
methods of organic waste to energy conversion. Unlike anaerobic digesters, MFCs are 
not greatly inhibited by limited substrate concentrations and are still able to produce 
electricity at temperatures below 20°C (53). The limited heating required provides an 
opportunity to save significant amounts of energy compared to AD. The other major 
consideration is the further combustion of the methane that is required, which limits 
the achievable efficiency (54). This is not necessary for MFCs as the electricity 
produced is available for usage without conversion. The methane that is produced 
from AD requires drying to remove the steam and purification from other gases that 
are also expelled. Although ADs are able to use a wide range of substrates in order to 
be able to produce methane, they are still not able to utilise quite as many energy 
sources as MFCs. MFCs are able to use complex polysaccharides such as starch and 
cellulose and have even shown potential with light (55,56). With the theoretical 
maximum conversion rate of 100% coulombic efficiency, an MFC can produce 3kWh 
for every kg of organic matter compared to the 1 kWh of electricity and 2 kWh of heat 
produced during biomethanation (57). 
There are many different types of MFCs that have been developed, but there is 
currently a large amount of work that must be done in order for the technology to be 
able to be applied on a realistic scale for wastewater treatment (an example of a Pilot 
scale MFC has been demonstrated at Foster’s brewer in Queensland, Australia). There 
are obviously other opportunities in which MFCs can be utilised, but there is no 
standard model that can be applied to all situations, as no one setup will likely be able 
to provide the greatest output and efficiency under a variety of environments. Not all 
of these issues are specifically to do with the engineering side of the MFC. 
The most obvious disadvantage of this technology at present is the inability to upscale. 
It is not simply a task of increasing the size of each of the chambers as this brings with 
it a wide range of problems such as increasing resistance and proton transfer issues 
(58,59). One possible option can be seen with stacking technology as shown in Figure 
2.2. The energy output that can be achieved from a single MFC is not particularly 
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useful but the voltage that can be obtained through stacking MFCs can allow for a yield 
of over 100 V (53).  The use of single chamber and continuous flow MFCs for 
wastewater treatment can remove up to 80% COD meaning much less energy is then 
needed to remove the rest. This is all proposed to be done at a CE of ~80% (59,60).  
Figure 2.2 – Example of potential MFC stacking for increased 
power output (modified from Ieropoulos et al (61)) A) 
Demonstrates a parallel setup B) Demonstrates series 
The use of PEMs within MFCs creates a wide range of problems such as increasing the 
internal resistance due to the difficulty that protons often have diffusing through the 
membrane. This is further complicated by the direct competition that is seen between 
the protons and other cations present in the media.   
This is not the only issue to be noted with the MFCs as there are significant problems 
with slow kinetics of electrochemical reactions occurring at the electrode surface that 
can be a limiting step (62). This can be affected by the ability of the bacterial culture to 
adhere not only to the electrode but also in the formation of biofilms. The macro and 
microstructure of the electrode can play a large role as this needs to provide a large 
surface area for the cells, with high reaction kinetics and also be designed for 
adsorption of the cells (63). The inability of the cells to transfer their electrons through 
the cell membrane is often a major cause of poor power output. All of these are often 
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referred to as activation polarisation, where the activation energy must be overcome 
by the cellular components in order for the reaction to occur (63). With non 
electrogenic strains used in the past, this was overcome through the use of added 
mediators (49). Rare metals such as platinum are added to the electrodes to provide 
an efficient electrocatalyst (64) and redox reagents such as ferricyanide can be added 
to the cathode. Graphite is poorly suited for use as a catalyst for oxygen reduction in 
the cathode as the saturation value for dissolved oxygen is more than 6.6 mg/l (65). In 
air-saturated water this value is approximately 80% of the oxygen present.  This is very 
often the rate limiting step in the reaction, as the oxygen content can quickly reduce 
below 6.6 mg/l. The reaction in the cathode may then become suppressed. This can be 
aided by the addition of catalysts such as platinum that can reduce the oxygen level 
required down to 2.0 mg/l (65) as platinum has a lower energy barrier. The change 
from graphite to platinum cathode has also been shown to permit a maximum current 
three to four times higher than a standard carbon electrode (49). Potassium 
ferricyanide is often used in the cathode chamber to increase the reducing potential 
(compared to oxygen) and therefore the power output (66). This however is not a 
standard catalyst as although it can reduce oxygen, over time this occurs less 
frequently resulting in the need for replenishment of ferricyanide, making it expensive 
and infeasible for long term runs. The need to increase the dissolved oxygen content 
through the use of inexpensive means could possibly be accomplished through the use 
of microbubble technology which is capable of transferring gases at a greater rate (67). 
The power output that is achieved can vary due to a vast number of influences. In the 
context of this study these can be seen in the complex nature of the respiratory chain 
of the organism, which varies between organisms and also under differing conditions 
due to regulated metabolism and protein expression levels (62). It is the reduced 
potential of the terminal cytochrome transferring the electrons to the terminal 
electron accepting anode that determines the power achieved from the anode 
compartment. There are also always losses that occur within the system that in certain 
setups can cause a significant decrease in the power output achieved (61). These 
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losses can occur through internal resistances encountered within certain areas of the 
fuel cell, such as in the electrolyte and the electrode. 
There are a wide number of sources in which losses can occur as shown in Figure 2.3. 
This study is concerned with the first two stages in the process and the issues with 
bacterial metabolism and the transport of electrons to electrodes. The transfer of 
electrons through the electrolyte can also be impeded due to internal resistances. This 
can be overcome through reducing the distance between the two electrodes and also 
increasing the ionic conductivity of the electrolytes (68). This however produces its 
own problems as reducing the spacing distance between the electrodes too far can 
itself reduce the power output achieved (68) whilst the natural occurrence of salts 
within the media for proton transfer can also interfere with the PEM (due to blocking). 
The PEMs used are designed for use within standard chemical fuel cells and are 
therefore unsuited for use within MFCs. The use of salts within the growth media of 
the bacteria causes high levels of interference with the current PEMs (65). Up to 74% 
of the sulfonated residues on the PEM can be occupied by Na+ or K+ instead of being 
free for the transportation of protons. This then disrupts the conditions within the 
MFC as the anode chamber can become more acidic due to inefficient transfer of 
protons  and the cathode become alkaline which limits oxygen reduction (65) (69). The 
decrease of pH within the anode means that the enzymes required for oxidation of the 
organic compounds are not able to operate under optimum condition, which in turn 
limits electron flow and power output (65) (69). 
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Figure 2.3 – The potential losses during electron transfer within an 
MFC – 1) Losses due to bacterial metabolism 2) Losses due to 
bacterial electron transfer 3) Losses at the anode. 4) Losses due to 
MFC resistance including membrane resistance. 5) Losses at the 
cathode. 6) Losses owing to electron acceptor reduction. 
As shown in Figure 2.3, the potential gradient between the two chambers in the MFC 
allows for the transfer between the anode and the cathode. The greater the 
difference, the higher the voltage achieved is. 
Whilst MFC technology is still being developed, there is potential for the use of MFCs 
alongside AD. The effluent that is released from the digested organic material passed 
through the AD following methane production, could then be transferred to an MFC 
setup, once the concentration of organic material has potentially dropped. As the 
oxidation of the organic compounds is still incomplete this provides an opportunity for 
electricity production. The typical chemical oxygen demand (COD) of the wastewater 
released from an AD is a few kg/m3 and this still provides ample opportunity for highly 
efficient electricity production (57).  
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There have also been developments in other types of BESs such as microbial 
electrolysis cells (MEC) (70,71), microbial desalination cell (MDC) (72,73) and microbial 
electrolysis desalination cell (MEDC) (74). All of these are variants of the regular MFC 
that provide different advantages depending on the situation. The MEC for example, is 
instead capable of producing hydrogen as a final product in order to keep up with the 
proposed hydrogen economy of the future. This is apparently a more efficient method 
of hydrogen production than that achieved from fermentation or from the electrolysis 
of water (70). The production of hydrogen within a standard MFC is 
thermodynamically unfavourable, but with the application of an external voltage of 
only 110 mV (75) this was possible to achieve. The application of this small external 
voltage to the cathode chamber of the MEC meant that instead of oxygen being 
reduced to water, hydrogen gas is produced (70). This is a much lower energy input 
than that required for standard electrolysis, which needs 1210 mV (75), and also 
provides the potential to yield 8-9 mol H2/ mol glucose compared to the 4 mol H2/ mol 
glucose yielded from fermentation (75).  
Compared to other forms of renewable energy, there is a constant stream of 
wastewater production with the highest levels of wastewater occurring during times of 
the highest human activity. The energy produced from the degradation of organic 
compounds can then be fed to the national grid where it can be used to power 
electrical appliances, power transportation or with sufficient infrastructure 
development, stored for later use. The use of this directly converted electricity has 
already been used to power autonomous robotic experiments (76,77). The use of 
MFCs over anaerobic digesters allows for higher energy levels to be produced 
alongside a more useful energy product in the form of electricity over methane. This 
can then be used to power turbines required for the distribution of clean water to the 
consumer, making the water industry self sufficient. 
There is still a substantial amount of research that must be carried out in MFC 
technology as  there is uncertainty with respect to engineering, electrochemistry and 
biology of MFCs. Research into all of these areas is required due to the lack of 
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understanding of how the different microbial electron transfer mechanisms affect 
current output and hence, MFC performance (78).  
The type of MFC that is used can determine the type of environment within the 
chambers and therefore the organisms best suited to growth under those conditions. 
The use of a system that is highly anoxic, has been shown to result in the enrichment 
of Geobacter species within the anode, whereas an MFC type that permits oxygen 
leakage into the anode, allows for facultative anaerobic organisms to excel (45).   
The bacterial culture that is present within the anodic chamber can have a vast impact 
on the achievable power output. In general, the use of pure bacterial cultures within 
the anode for the degradation of waste organic material, limits the rate at which this 
can occur (79). This is due to the complex mix of compounds present within the 
mixture that requires metabolic versatility for efficient catabolic activity. Using a mixed 
microbial culture, provides a wide range of metabolic pathways that can allow for 
faster breakdown of compounds and may encourage the development of symbiotic 
relationships, whereby electrons are transferred from a non electrogenic strain to an 
electrogenic one which is then capable of transferring the electrons to the anode (80). 
The use of a mixed culture also appears to reduce the internal resistance within the 
MFC (81) and has also demonstrated the ability that mixed cultures are capable of 
producing between 68 and 480% more power than pure S. oneidensis MR-1 (81). For 
the greatest power output, the microbial community would need to be tailored in for 
the conditions in which it would be used i.e. pH, temperature and compound 
concentrations within the waste matter. The mixed microbial community would be 
more capable of withstanding and adapting to changes in conditions. Over a period of 
time, the bacteria best suited to the specific conditions imposed upon them, would 
dominate the community. When assessing the bacteria within a MFC following the 
inoculation with a wide range of waste sources, there is one class of bacteria that tend 
to prevail. Proteobacteria are the most commonly found bacteria within analysed MFC 
communities, although no single species has been found to be ubiquitous (41). The 
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fact that proteobacteria are seen throughout is not that surprising considering that 
Shewanella, Geobacter, Arcobacter and even Escherichia are found within this phylum.  
2.1.4 Dissimilatory Metal Reducing Bacteria  
Dissimilatory metal reducing bacteria (DMRB) such as Geobacter and Shewanella have 
been studied closely since the discovery of the first Geobacter strain GS-15 (82,83). 
This is due to the fact that these bacteria are highly metabolically versatile with the 
ability to degrade a wide range of organic compounds (84,85) decontaminate oil 
polluted soils and waters (86,87) and oxidise toxic uranium to a less soluble form (88). 
However, it is the capacity of these bacteria to reduce Fe (III) extracellularly that has 
been the subject of most attention.  
The discovery of these bacteria revolutionised MFC technology, as devices were able 
to be operated without the use of expensive and toxic additional mediators as the 
bacteria were able to produce their own extracellular transport mechanisms. These 
bacteria are far from sparsely distributed throughout the planet. Rich sources of these 
DMRB and electrogenic organisms can be seen in marine sediment, soil, wastewater, 
fresh water sediment and activated sludge (62). Several publications have called for 
the production of a genetic library containing the chromosomal information of known 
electrogenic species (62,89).  
The choice of substrate available within the anodic chamber can have a vast impact 
upon the strains that develop there and can therefore greatly affect the achievable 
power output. Electrochemically active microorganisms are able to out compete 
methanogens when non fermentable substrates such as acetate are used (44). This is 
however a different case when fermentable substrates such as glucose and ethanol are 
used, as they can lead to notable amounts of methane production. This is due to the 
inability of many DMRB such as Geobacter and Shewanella to fully oxidise glucose and 
ethanol (44). The use of a strain capable of doing this would out compete the 
methanogens due to the higher redox potential capable through the use of the anode. 
If this was infeasible, then the methanogens convert the glucose and ethanol to 
compounds that can then be oxidised by the DMRB and there would still be 
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harvestable methane produced. There is a significant decrease in the power output 
achieved when using complex organic substrates such as those seen in wastewater 
when compared to pure substrates such as acetate. This has been shown to decrease 
the power output to as little as 10 % of the value seen with pure substrate (57). This is 
not particularly surprising considering that the wastewater will contain complex 
organic molecules that will need a variety of enzymes in order to fully oxidise them. 
The effect that the variety of the substrate has upon the microbial community has yet 
to be elucidated, but the ability of an organism to fully oxidise a substrate can 
determine how successful it is within an MFC. Although Shewanella species are DMRB 
and able to transfer their electrons to a variety of electron acceptors including the 
anode, they cannot fully oxidise a variety of substrates to CO2. So, although they are 
classified as electrogenic bacteria due to their ability to generate current, they are not 
classed as electricigens under the criteria established by Lovley and colleagues  
(whereby full oxidation of substrates to CO2 is required) (45).  These criteria state that 
electricigens must be able to fully oxidise organic compounds to CO2 and transfer the 
released electrons to the anode (45). Shewanella is only capable of converting lactate 
to acetate, but is incapable of full oxidation to CO2 meaning that only a third of the 
electrons available are converted to electricity (90). This is, however, a hazy definition 
as Geobacter is itself, alongside Shewanella, unable to reduce glucose as stated above 
(44). The bacteria rely on more oxidised substrates such as acetate, produced by 
fermentative organisms (52).  
The most widely used method of expressing the efficiency of a MFC is to describe its 
coulombic efficiency (CE).  This is the percentage of the electrons released from the 
oxidation of a substrate that are collected as current (91). This value does not relate 
solely to any particular part of the MFC as it can be affected by the design, such as 
increased leakage of oxygen into the anode chamber, which could lead to the use of 
oxygen as the TEA and reduce the number of electrons moving to the anode. It has 
been shown to be resistance dependant, whereby applying an increased load upon the 
circuit decreases the achievable CE (92). In order to decipher the coulombic efficiency 
of the system (both BES and culture setup combined), the amount of substrate added 
46 | P a g e  
 
must be known. The choice of substrate and the metabolic versatility of the anodic 
organisms which provide higher CE values are obtained from the use of non 
fermentable substrates such as acetate compared to fermentable substrates, such as 
glucose. In general, the more complex the organic matter, the lower the CE due to the 
energy required in the construction of enzymes for its degradation (7,62). This again 
leads back to the fact that, to this date, mixed cultures provide a significant number of 
advantages over single strains as they are as a community much more metabolically 
versatile and therefore able to degrade a wide range of compounds. Versatility within 
the culture provides them with the ability to survive under changing conditions within 
the anode, where the substrate concentration and makeup may alter. Overall, this 
leads to a greater power output and greater CE (7). This demonstrates that alongside 
the electrogenic activities of an organism, its metabolic capabilities must also be 
considered, as this can have a great impact upon the energy conversion percentage. 
The electrons released from the degradation of the organic material are not directly 
used by respiring bacteria and are instead used to create a proton gradient and 
therefore regenerate ATP supplies (93). The bacteria are searching for a TEA with the 
highest potential difference between their electron donor redox protein and the 
acceptor, as this will provide the greatest energy return. An acceptor that is able to 
provide the greatest return will be preferentially used where possible and is the main 
reason why oxygen must be kept out of the anode chamber. The anode potential can 
determine the electron transport pathway that is used by the bacterium, but this is 
also very dependent on the strain (7). 
The ideal conditions within an MFC would be for a highly negative redox potential 
compound such as glucose to be completely oxidised in the anode and a highly positive 
compound such as oxygen to be reduced in the cathode (94). A setup such as this 
would provide the greatest power output due to the large difference in potential, but 
this is not easily achieved as although these compounds are easily obtained, there are 
very slow reaction kinetics when used with pure carbon electrodes (95). It is for this 
reason that compounds such as platinum and ferricyanide are used to speed the 
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reaction up. The final amount of voltage that is generated within the MFC is 
dependent on the difference between redox potential of the substrate and the redox 
couple within the bacterial metabolism. The potential difference between the host 
metabolism and the terminal electron acceptor then determines how much potential 
is utilised within the system (124).  
In order for the anodic electrode to be used as the TEA, the bacteria must not only be 
capable of interacting with it, but it must also have a sufficiently high positive redox 
potential. This is to ensure that in the absence of oxygen this is the TEA that provides 
the greatest energetic gain (7). Any minimal amounts of oxygen that are able to diffuse 
through the PEM will be used up very quickly by facultative anaerobes but will kill strict 
anaerobes and must therefore be limited (96). The electron transfer of NADH to NAD+ 
using oxygen as a terminal electron acceptor provides a high potential difference as 
shown by using the values stated in Table 2.2 and the calculations in reaction 4: 
    ΔE = O2/H2O (+0.820V) - NAD+/NADH (-0.320V) = 1.14 V   (4) 
1.14 V is obviously a very high redox potential, meaning that oxygen will be used by 
facultative anaerobes if it is present. The anode potential needs to be high enough to 
prevent the bacteria from using alternative sources of TEAs or even resort to 
fermentation. 
The use of sulphate for example provides a very low potential difference (although SO4 
can be used as an effective mediator): 
ΔE = SO42- (-0.220V) - NAD+/NADH (-0.320V) = 0.1 V    (5) 
The comparison between the energy released from the complete oxidation of glucose 
to CO2 compared to that achieved through its fermentation to high energy compounds 
such as butyrate and acetate can be seen in reaction 6 to 8 (44,97) 
Glucose fully oxidised to CO2 provides a high energetic gain: 
 C6H12O6 + 6 O2            6 H2O + 6 CO2  ΔG= 2895 kJ mol    (6) 
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Glucose to butyrate provides a low energy gain due to the vast majority of the energy 
being contained within the end product: 
C6H12O6           C3H7COOH + 2 CO2 + 2 H2                 ΔG0 = 225 kJ mol (7) 
Glucose to acetate provides an even lower energy gain 
C6H12O6 + 2 H2O          2CH3COOH + 2 CO2 + 4 H2    ΔG0 = 206 kJ mol (8) 
Table 2.2 also demonstrates the major advantage of being able to reduce Fe (III), as 
this has a redox potential second only to oxygen.  
       ΔE = Fe3/Fe2 (+771) - NAD+/NADH (-0.320V) = 1.09 V             (9) 
 
The energy gain provided from this is much greater than that seen with the reduction 
of sulphate or even nitrate.  
Table 2.2 – MFC electrode reactions and corresponding redox 
potentials (Modified from Fan et al (46)) 
Oxidation/reduction pairs E0 (mV) 
H+/H2 -420 
NAD+/NADH -320 
S0/HS- -270 
SO2-4/H2S -220 
Pyruvate2-/Lactate2- -185 
2,6-AQDS/2,6-AHQDS -184 
FAD/FADH2 -180 
Menaquinone ox/red -75 
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Pyocyanin ox/red -34 
Humic substances ox/red -200 to +300 
Methylene blue ox/red +11 
Fumarate2-/Succinate2- +31 
Thionine ox/red +64 
Cytochrome b(Fe3+)/Cytochrome b(Fe2+) +75 
Fe(III) EDTA/Fe(II) EDTA +96 
Ubiquinone ox/red +113 
Cytochrome c(Fe3+)/Cytochrome c (Fe2+) +254 
O2/H2O2 +275 
Fe(III) citrate/Fe(II) citrate +372 
Fe(III)NTA/Fe(II) NTA +385 
NO3-/NO2- +421 
Fe(CN)3-6/ Fe(CN)4-6 +430 
NO2/NH4+ +440 
Fe3/Fe2 +771 
O2/H2O +820 
 
If the substrate is fermented, then a much lower energy output may be generated 
within the MFC. This is highly inefficient as the substrate is a long way from being fully 
oxidised, leaving the vast majority of the energy stored in the fermentation compound 
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(97). This will depend upon the microbial community present on the anode and 
whether there are organisms that are able to further break down these compounds. 
As shown above, the anode must have a higher redox potential than other TEAs 
present within the media otherwise the electrons will not be transferred to it. The 
bacteria must however also be able to interact with the anode. This interaction is 
currently one of many rate limiting steps within MFCs. If it is to be resolved, then a 
deeper understanding of how extracellular electron transfer occurs in nature must be 
gained. 
2.1.5 Understanding of mechanisms of electrogenicity and synthetic biology’s 
potential role in increasing activity. 
Most bacterial strains are unable to directly transfer their electrons to the anode due 
to the lack of conductivity seen in the lipid membrane, peptidoglycans and 
lipopolysaccharides (62). They therefore require soluble TEAs such as oxygen or nitrate 
that are able to permeate the outer membrane and move into the cytoplasm where it 
is enzymatically reduced to provide a high energy return (98). DMRB do not require 
soluble electron acceptors in order to be able to respire; they are capable of reducing 
insoluble extracellular compounds such as Mn(IV),U(VI) and Fe(III) (88,99).  
The rise of synthetic biology within recent years holds significant potential in this field. 
Synthetic biology is not simply the development of molecular biology into the 21st 
century, but also encompasses engineering and design of novel biological systems. The 
ability to chemically synthesise genomes (100) now allows for the production of 
completely unique organisms that have been designed to serve a specific purpose. 
In order to be able to develop a highly electrogenic bacterium using modern synthetic 
biology techniques, a better understanding of the proposed methods in which this 
occurs in naturally electrogenic bacteria must first be obtained. The exact method in 
which this occurs is yet to be deciphered, although there are 3 known ways in which 
the electrons are transferred: 
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 Direct contact – The bacteria make use of a series of c-type cytochromes such 
as MtrA and OmcA in Shewanella oneidensis MR-1 (101) or OmcS and OmcE in 
Geobacter sulferreducens (102). These cytochromes provide a connection 
between the cells inner membrane through the periplasm to the outer 
membrane. 
 Nanowires – These are electrically conductive appendages that do not require 
direct contact of the cell body with the extracellular acceptor (103). They 
instead use pili like structures to transfer electrons to the TEA. These 
appendages are normally seen in conjunction with the direct contact method. 
 Endogenous mediators – Some DMRB such as Shewanella excrete mediators 
that are able to accept electrons and can then pass them to a TEA outside of 
the cell (78). This has been shown to be the dominant method of extracellular 
electron transport in Shewanella species (104). Within this category, 
synthetic/artificial mediators can also be considered, as they perform the same 
function as the naturally occurring molecules. 
The uppermost cluster of cells in Figure 2.4 present the most well documented method 
of electron transfer. The cells adhere directly to the anode and transfer their electrons 
through the cell membrane and straight to the electrode using multi haem c-type 
cytochromes (37,44). The expression of these cytochromes in S. oneidensis MR-1 is 
dependent on anaerobic growth, where they provide a route for extracellular 
reduction of metals such as Fe (III) oxide Mn (IV) (105). This regulated expression limits 
the metabolic load on the cells when the cytochromes are not necessary. The c-type 
cytochromes believed to be responsible for this are found widely within DMRB, with G. 
sulferreducens and S. oneidensis thought to possess roughly 100 and 42 of these 
proteins respectively (45,85,106). Analysis of the literature only indicates the predicted 
use of around 7 of these to be required for metal reduction or current production 
(107,108). This is shown here by the comparison of the predicted extracellular electron 
transfer pathways of two of the most highly documented DMRB, S. oneidensis MR-1 
and G. sulferreducens shown in Figure 2.5.  The high level of potential redundancy seen 
within the system has meant that the exact method in which the electrons are 
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transferred had until recently remained elusive (109). The elucidation of the structure 
of the Shewanella outer membrane cytochrome, MtrF (110) provided the first insight 
into a proposed electron transfer pathway through the 10 haems spread across the 
protein in a cross conformation (111).  
 
Figure 2.4 - Method of electron transfer to the anode. A) Direct 
contact of bacterial cells with the anode. Electrons transferred 
through the use of proteins such as those contained within the S. 
oneidensis MTR pathway. B) Electrons are transferred through the 
use of electrically conductive appendages known as nanowires. C) 
Mediators, either generated by the cells or added to the media are 
used to transfer electrons to the anode.  
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Figure 2.5 – Predicted extracellular electron transport pathways in 
two DMRB strains. OM – Outer membrane, Peri – Periplasm, IM – 
Inner membrane, Cyt – Cytoplasm. A) S. oneidensis MR-1, 
demonstrating the transfer of electrons from quinol to CymA, 
through MtrCAB an OmcA complex to a terminal electron acceptor. 
Pseudopilus from the type II secretion pathway (GspF involvement) 
transfers OmcA and MtrC through the periplasm and through GspD 
to cellular surface. B) G. sulferreducens, demonstrating transfer of 
electrons from quinol to OmcE/OmcS in the OM. 
This redundancy is also further documented in an analysis of a variety of strains from 
the Shewanella species carried out by Fredrickson et al. (108). This revealed that a 
number of  strains such as S. frigidimarina were capable of metal reduction with only 4 
c-type cytochromes compared to the 7 (plus 2 iron binding proteins) S. oneidensis is 
believed to use and were all contained within a single locus. This can be seen in Figure 
2.6 along with the even greater numbers seen by strains such as S. halifaxensis. 
Analysis of the genomes of both S. oneidensis MR-1 and G. sulferreducens allowed the 
determination of the position of the genes encoding these c-type cytochromes within 
the organisms’ chromosome. From the data available through the National Centre for 
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Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/) it was noted that 
the predicted genes required for metal reduction within S. oneidensis MR-1 were 
within a single locus (Figure 2.6), whereas the genes in G. sulfurreducens were 
distributed throughout its genome.   
 
Figure 2.6 – Predicted metal reducing c-type cytochromes from a variety of 
Shewanella species including S. oneidensis MR-1 (Highlighted). Different 
colours are used to represent different components of the Mtr pathway 
(and extension to Feo components). Green arrows represent beta barrels, 
blue denotes periplasmic c-type cytochromes, purple and yellow are outer 
membrane cytochromes (yellow are lesser known). Red arrows relate to 
genes involved in ferrous iron transport. 
This then raises the question as to whether all of these proteins are necessary for full 
activity or if some are presenting an unrequired metabolic burden. This has led to 
many studies conducted to try to determine the exact genes, or at least the most 
essentially required for activity (48,109,112,113).This type of analysis was first 
conducted by Holmes et al. (48) on G. sulfurreducens presenting the difference in the 
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regulation of transcript levels for a wide range of genes following growth on electrodes 
compared to using Fe (III) as the TEA. The greatest upregulation seen was 19-fold,       
7-fold and 2-fold increase in the transcript levels of the genes coding for the outer 
membrane proteins OmcS, OmcT and OmcE, respectively (48). These were not the only 
changes noted, as there were a total of 474 genes with significantly different transcript 
levels when grown on an electrode compared to Fe (III) (48). Mutant strains deficient 
in each of the most highly upregulated cytochromes were made, with unsurprisingly 
the biggest decrease in current production of more than 50%, seen with the removal 
of OmcS (48).  
A further Geobacter study (114) was carried out in which a pure culture of Geobacter 
sulfurreducens DL-1 was added to a MFC with a poised anode potential of -400 mV, 
thereby making the transfer of electrons from it much harder. Through the challenge 
of surviving within this environment within a 5 month period, the strain adapted to the 
situation, resulting in a substantial increase in the achievable power output. The 
adapted strain named KN400 had a power density of 3.9 W/m2 compared to 0.5 W/ m2 
achieved by the WT strain (114). 
An example of potential redundancy within the genome of S. oneidensis MR-1 can be 
seen with the deletion of MtrB, the beta-barrel sheath protein. Removal of this protein 
is known to knock out dissimilatory iron reduction (115) but in this case, 
complementation with two S. oneidensis genes SO4359 and SO4360 was enough to 
restore activity. This suggests a level of genomic plasticity which confers the ability to 
replace the function of one protein for another. This study was however, conducted 
using ferric citrate which is capable of permeating the cell membrane, allowing for 
reduction at locations other than the outer membrane (107). 
A more in depth study into the functional involvement of certain genes was carried out 
by Bretschger et al (109) with the use of wild type S. oneidensis MR-1 and a wide 
variety of single gene knockout mutants (apart from OmcA and MtrC which was 
studied as a complex). This study provided a real insight into the genes required for 
current production and the reduction of Fe (III) and Mn (IV). There were a number of 
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these mutants in which the removal had caused a significant impact on the cells ability 
to produce current. The most evident of these could be seen in the deletions shown in 
Table 2.3. 
Table 2.3 – S. oneidensis MR-1 mutants that showed severe 
decrease in current production (Produced using data from 
Bretschger et al. (109)) 
MR-1 Strain/Mutant 
Current output (µA/cm2) 
with 10 Ω resistor Percentage of Wild Type 
Wild Type 13.8 N/A 
ΔMtrA 0.35 2.5 
ΔMtrB 0.35 2.5 
ΔOmcA/MtrC 2.3 16.7 
ΔCymA 0.4 2.9 
ΔPilD 0.68 4.9 
ΔGspD 0.7 5.1 
ΔGspG 0.35 2.5 
 
It is evident from Table 2.3 that only the top 4 mutants are deficient in the 
cytochromes that are typically shown to have a predicted involvement in metal 
reduction (The use of CymA is shown in Figure 2.5). Each of these genes is believed to 
play a pivotal role in extracellular electron transfer, as MtrB is required for proper 
localisation and incorporation of OmcA and MtrC into the outer membrane in the 
highly similar strain Shewanella putrefaciens MR-1 (112). The deletion of CymA has 
been shown to inhibit the ability of S. oneidensis MR-1 to reduce Fe (III), Manganese 
(IV) and nitrate demonstrating the necessity of this inner membrane periplasmic 
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cytochrome (116). Mutants in other c-type cytochromes that were predicted to have 
an involvement in activity such as MtrD and MtrF did not have any negative effect in 
activity. There was even a slight increase in activity noted with the removal of MtrF. 
This further demonstrates the redundancy within the c-type cytochromes within these 
defined conditions, as these genes may well be required for electron transfer to other 
insoluble metals. The bottom 3 mutants in Table 3 have other functions within the 
protein secretion ability of the cell and come into effect with the expression of 
nanowires (109).   
There were a number of gene deletions that caused significant increases in activity as 
shown in Table 2.4. The highest power increase was seen in the removal of NrfA, a 
gene involved in the nitrate reduction function of the cell as is NapB. The other genes 
are believed to play a role in redox reactions involving suphur. 
Table 2.4 – S. oneidensis MR-1 mutants that showed significant 
increase in activity (produced using data from Bretschger, et al. 
(109)) 
MR-1 Strain/Mutant Current output (µA/cm2) Percentage of Wild Type 
Wild Type 13.8 N/A 
ΔNrfA 31.2 226.1 
ΔSO0717 24.3 176.1 
ΔSorB 24.0 173.9 
ΔNapB 24.2 175.4 
ΔDmsC 23.1 167.4 
During the course of Bretschger et al’s study an attempt to increase the expression of 
MtrC resulted in a significant increase in the activity but not as much as the removal of 
NrfA. The other complement strains were made through firstly deleting the noted gene 
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and then reintroducing it and determining its activity. The results from this can be seen 
in Table 2.5. 
Table 2.5 - S. oneidensis MR-1 complement mutants and their 
activities (produced using data from (Bretschger et al. (109)) 
MR-1 Strain/Mutant Current output (µA/cm2) Percentage of Wild Type 
Wild Type 13.8 N/A 
WT + MtrC 21.3 154.3 
ΔMtrB complement 16.9 122.5 
ΔMtrA complement 13.9 100.7 
ΔMtrC complement 14.8 107.2 
ΔOmcA complement 10.8 78.3 
 
Although the experiment provided information on the changes seen by the removal of 
individual cytochromes, it also highlighted the highly complex nature of electron flow 
through MR-1 cytochromes.  
All of this demonstrates potential for the development of a genetically modified strain 
in which a combination of different genes could be knocked out in order to reduce the 
metabolic load and increase electron transfer to the anode. This is however all 
conducted within the bacterial strain that these proteins are native to and therefore 
does not show how the use of a combination of these proteins would act if transferred 
into a foreign strain such as E. coli. 
2.1.6 Transfer of iron reduction capability into E. coli using cytochromes 
From the predicted activities of some of these c-type cytochromes there have been 
attempts made to transfer the extracellular iron reduction capabilities of S. oneidensis 
MR-1 into various E. coli strains. This was first seen through the introduction of the 
periplasmic cytochrome MtrA into E. coli JM109 (DE3) by Pitts et al. (105). This gene 
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was inserted into the host organism along with cytochrome maturation genes required 
for proper insertion of the haem groups into the protein and correct protein 
localisation (shown in Figure 2.7) (117). Through this the E. coli strain was shown to be 
able to reduce Fe (III) EDTA, Fe (III) Maltol and Fe (III) benzohydroxamic acid through 
the pathway proposed in Figure 2.7. There are however several issues with this as all of 
these forms of iron are soluble and therefore able to pass into the periplasmic space 
where MtrA is being expressed. 
 
 
Figure 2.7 - Predicted method of extracellular electron transfer in S. 
oneidensis MR-1 (A) and E. coli heterologously expressing MtrA (B) - 
(Modified from Pitts et al (105)).OM – Outer membrane, Peri – Periplasm, 
IM – Inner membrane, Cyt - Cytoplasm 
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Figure 2.8 – The cytochrome maturation genes required for proper 
expression of c-type cytochromes. Holocytochromes are 
transferred from the cytoplasm to the periplasm where insertion 
of the haem group into the target cytochrome is carried out 
through the use of the cytochrome maturation genes ccmA-H and 
DsbD/DipZ. PP – Periplasm, IM – Inner membrane, Cyt – 
Cytoplasm. 
There is, however, another way in which this could be explained. E. coli only has 7 
naturally occurring c-type cytochromes, but NapC is one of these. It is a native 
tetrahaem cytochrome present in the inner periplasmic membrane, the same as CymA 
and has a very similar overall amino acid sequence (107). Both CymA and NapC are 
involved in electron transfer from menaquinol to NapAB – a periplasmic terminal 
reductase complex (119). It not only shares sequence homology with CymA, but it is 
also capable of reducing soluble Fe (III) on its own. Reduction occurs at a rate 2.6 fold 
lower than the strain containing CymA (107). The ability of this cytochrome to reduce 
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Fe (III) is not of real concern to this study but instead the rate in which it is capable of 
transferring its electrons to the next available cytochrome in the pathway (through the 
cell membrane).  
Another attempt at transferring iron reducing capabilities into E. coli was also 
attempted by Donald et al. (120). This experiment was carried out using the outer 
membrane decahaem cytochrome OmcA, with the intention of being able to reduce 
insoluble Fe (III). This was again conducted with the simultaneous use of cytochrome 
maturation genes for the same reason as stated in the MtrA study. It was shown that 
E. coli K-12 was not capable of expressing this protein correctly due to the cryptic 
nature of the type-II secretion (in MC4100) pathway seen in this strain. The expression 
system is expressed in BL21 and this was then used to show that the recombinant 
strain was able to reduce insoluble Fe (III). 
A more recent development along the same experimental path was the introduction of 
a “more complete” exoelectrogenic pathway through the introduction of 3 c-type 
cytochromes from S. oneidensis MR-1 into an E. coli strain. The chosen cytochromes 
were MtrA, B and C, as the proposed localisation of the proteins would permit a 
protein to interact with an inner membrane quinone reductase MtrA (to interact with 
NapC). The electrons would then be transferred to decahaem cytochrome, MtrC 
through the membrane spanning beta barrel protein MtrB, which acts as a sheath 
(121), covering transition space between MtrA and C. A diagrammatic representation 
of the proposed transfer is shown in Figure 2.9. 
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Figure 2.9 – The genes and proteins proposed to be involved in extracellular 
electron transfer to an insoluble metal. A) Proposed mechanism in 
Shewanella. B) MtrA expressed in E. coli to allow for reduction of soluble 
iron C) MtrCAB genes from Shewanella oneidensis MR-1 expressed within E. 
coli allow for extracellular reduction of iron. OM – Outer membrane, Peri – 
Periplasm, IM – Inner membrane, Cyt – Cytoplasm. 
All of these experiments provide evidence for the ability to functionally express foreign 
c-type cytochromes in E. coli and suggest that extracellular electron transfer is possible 
in a non DMRB strain through the addition of a single outer membrane cytochrome. 
This experiment however does not demonstrate that the cells would be capable of 
producing current, as shown by the case of Pelobacter carbinolicus, which is able to 
reduce Fe (III) but is incapable of power output in an MFC (122).  
A study carried out by White et al. (123) took a novel approach and introduced the 
same meta reduction pathway (MtrCAB) into a proteoliposome, effectively creating an 
artificial cell membrane. With the internal portion of the “cell” containing electron 
transporters, the artificial system with MtrA focussed internally and MtrC externally, 
with MtrB acting as a sheath between the two being tested for electron transfer. Not 
only was this shown to be possible, but electron transfer rates to oxide minerals such 
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as goethite were shown to be at levels similar to those seen by Shewanella cultures 
(123). 
More evidence for transfer of exoelectrogenic activity into a non DMRB for current 
generation within a BES came from a paper by Goldbeck et al (124). This paper, from 
the same group that produced the metal reducing E. coli (125), presented the same 
exoelectrogenic transport chain but further engineered the plasmid setup to aid in 
current production. In order to do this, a degree of synthetic biology methodology was 
implemented through promoter tuning. The generated library was shown to have 
vastly different levels of MtrA and C between the different promoter sets. The cells 
producing the greatest level of MtrA and C were however not found to produce the 
greatest current output or be the “healthiest”. An optimal expression level was 
reached, which provided the most morphologically typical E. coli but also the greatest 
current output. The exact mechanisms behind these observations have yet to be 
explained. 
The purple cells shown in Figure 2.4 may make use of electrically conductive 
appendages known as nanowires. These appendages allow the bacteria to transport 
their electrons extracellularly without having to have direct contact with the anode. 
This morphological feature has been noted in both Geobacter and Shewanella where 
the expression of these pili is dependent on the absence of soluble electron acceptors 
(126). Once all soluble electron acceptors have been exhausted, the bacteria then 
synthesise pili and flagella to allow them to migrate towards Fe (III) oxides for electron 
transfer (126). This feature is however not unique to DMRB as it has also been 
observed in the oxygenic phototrophic cyanobacterium Synechocystis sp. PCC6803 and 
the thermophilic, fermentative bacterium Pelotomaculum thermopropionicum (127) 
and may therefore be a feature of a variety of species to allow for electron transfer. 
The appendages produced by these species only occur under certain nutrient limiting 
conditions which are different for each species but lower the metabolic load on the 
strain as needed. The appendages produced by these strains were highly electrically 
conductive and very similar in appearance and structure to those seen in MR-1 (127). 
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The production of electrically conductive nanowires is different to the production of 
standard pilus like appendages that generally do not permit electron transfer. It is 
believed that the production of these nanowires not only allows for the efficient 
transfer of electrons, but increases the surface area of the cells, providing them with a 
greater chance of binding to a TEA such as Fe (III) oxide or an anode (128). The deletion 
of the S. oneidensis MR-1 cytochromes MtrC and OmcA resulted in significantly 
impaired nanowires compared to the wild type, thereby highlighting the importance of 
these outer membrane proteins (127). As shown in Table 2.3, the deletion of PilD, 
GspD and GspG has a significant impact on the achievable power output in MR-1. 
These genes are responsible for type IV prepilin peptidase (PilD) and type II secretion 
pathway (GspD and GspG) (109). The type IV preplilin peptidase is a cytoplasmic 
membrane protein that cleaves signal sequences on the cytoplasmic side for transport 
towards the outer membrane (129). This is essential for the production of type IV pili 
within a number of species, including E. coli, although this appears to be within 
pathogenic strains (130,131).  These type IV pili are not, however, expressed in E. coli 
under standard laboratory conditions. The type IV prepilin peptidase role makes them 
seem essential for the production of nanowires and may mean that expression of 
conductive pili within E. coli is possible. The type II secretion pathway is partially coded 
for by GspD and GspG and is one of 5 secretion pathways available to gram negative 
bacteria, but it appears to be essential for the proper expression of outer membrane 
cytochromes and nanowires (127,132). The type II secretion pathway appears to be 
cryptic within E. coli K-12, but is expressed under laboratory conditions in B type 
strains (120). The use of nanowires in MFCs has been shown to be very important, 
especially for DMRB strains such as Geobacter, which are incapable of producing 
endogenous mediators (44,133) and reported a 10-fold increase in power output when 
expressing nanowires. Lovley has postulated that if Geobacter were able to transfer 
electrons to the anode at the same rate as it is able to transport to its natural electron 
acceptor, ferric iron, it would be capable of producing a current four orders of 
magnitude higher than presently seen (62). The importance of pili and nanowires in S. 
oneidensis has in some cases been reported to be detrimental to the power output. 
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The construction of a mutant strain that was deficient in PilD was shown have very low 
power outputs due to the added effect that this has on the type II secretion system 
(109). A subsequent strain with the secretion system intact, but PilD deficient, 
produced greater power output than the wild type. This strain was capable of 
producing c-type cytochromes, but unable to produce pili or flagella (134). 
The blue cells shown in Figure 2.4 illustrate the use of endogenous mediators that 
allow the cells to transfer their electrons to an intermediate molecule before being 
transported to the anode without having any contact with it. This has not been as 
thoroughly documented as the other methods of electron transfer, but several 
Shewanella species have been recognised as secreting electron shuttles in the form of 
flavin mononucleotide and riboflavin, which can then reduce Fe (III) (135–137).  
Good mediators are capable of easily passing through the cell membrane and 
interacting with the electron transport chain of the cells and as well as other oxidising 
reducing agents such as NADH and reduced cytochromes(76). The reduced mediator is 
then able to move out of the cell, transfer its electrons to the anode and pass back 
through the cell membrane to harvest more (76). The mediators should also be stable 
within the anolyte, resist degradation and transfer the electrons to the anode at a high 
rate whilst also being non toxic to the cells. 
The use of these mediators has allowed for much greater power outputs to occur in 
certain situations. Velasquez-Orta et al. (78) showed that the addition of mediators to 
an MFC inoculated with Shewanella cells allowed for a peak current four times higher 
than that noted when only Shewanella’s self produced mediators were present. The 
levels of mediators required for this increased current output were almost 10 times 
higher (4.5-5.5 µM) than those normally produced by Shewanella (0.2-0.6 µM) (78). 
The removal of these naturally occurring flavins from a developed anodic Shewanella 
culture has been shown to reduce the power output by more than 70% (136). This 
does however have a significantly detrimental effect on the coulombic efficiency that 
can be achieved, as CE values tend to range between 35 and 5% (138–140). 
66 | P a g e  
 
As this is highly concentration dependent, the analysis of the proteins involved could 
provide an opportunity for their upregulation to allow for greater production of these 
mediators to increase the power output.  
There are other mediators that are naturally produced by a wide range of organisms 
and are found within wastewater. Some of these are humic acids, sulphate and 
thiosulphate, which  are naturally occurring and have the ability to act as mediators 
(141) as shown in Figure 2.10. Pseudomonas aeruginosa can produce the secondary 
metabolite pyocyanin that can act both as an electron shuttle but also as an antibiotic 
that can kill off other microbes thereby helping to keep the culture pure (37). 
Endogenous mediators are not as limited by the direct contact of the cell with the 
anode. The mediators are soluble and capable of diffusing through the culture and 
media allowing them to be reduced in the cell membrane and then travel to the anode 
where they are oxidised.  
The use of the increased levels of flavins within the MFC anode provides the 
opportunity for much higher electron transfer rates compared to those seen in a 
biofilm. Velasquez-Orta et al. (78) claim to have rates 20 times higher than those seen 
in a MFC biofilm setup carried out by (136). This would of course be highly dependent 
on the experimental methodology used. 
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Figure 2.10 - Showing a variety of substances that can be used as 
endogenous mediators. AQDS – Anthraquinone-2,6-disulfonate, 
AHQDS - Anthrahydroquinone-2,6-disulfonate. 
Naturally electrogenic bacteria have evolved to survive under conditions, where only 
insoluble electron acceptors are present and be able to reduce them. In order to 
achieve higher power densities from these bacteria, they will most likely require a 
mixture of synthetic biology and metabolic engineering. This will allow for the 
development of a strain or strains that have been engineered to remove undesired 
electron pools that prevent maximum electron transfer. The cells should also be able 
to express the most redox active proteins from a variety of organisms allowing for 
maximum transfer of electrons to the anode. 
Although Shewanella may possess the three stated methods of electron transfer, the 
strain is not an ideal electrogenic bacterium, as it is not able to fully oxidise all organic 
compounds to carbon dioxide and then transfer the electrons to the anode (90). This 
can be seen with the example of lactate, which is incompletely oxidised to acetate by 
Shewanella but can be fully degraded by Geobacter and Rhodoferax, which are 
considered to be electricigens (90). This inability results in only a third of the electrons 
from lactate being harvested and transferred to the anode (90). This does however 
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present an opportunity to develop mixed communities “designed” for operation under 
specific circumstances. 
There is no direct link between the ability of a bacterium to reduce Fe (III) and its 
ability to produce a current within an MFC. There are many examples where these 
abilities are seen together such as in Shewanella (96), Geobacter (102), 
Desulfuromonas (142) and Pseudomonas (143,144), but the exact link between these 
abilities has not been deciphered. It would seem reasonable to presume that the 
transfer of electrons to insoluble Fe (III) would also allow for the transfer of electrons 
to an insoluble electron acceptor in the form of an anode. This, however, has proven 
not to always be the case as shown with the example of Pelobacter carbinolicus (122). 
This is the first documented example of an organism that is capable of insoluble Fe (III) 
reduction yet unable to produce current within a MFC. 
The use of only a single method of extracellular electron transfer will greatly limit both 
the achievable power density and also the coulombic efficiency. Direct contact 
methods tend to have high efficiency, but when used as the sole transfer method 
provide a limited power output (44). As the cells must make contact with the anode, or 
at least form a biofilm for this method, it is necessary to have an anodic electrode with 
a large surface area. The reverse tends to be true of endogenous mediators, as they 
are capable of producing high power outputs, but are done at a reduced efficiency due 
to the production of electrochemically inactive side products (44). 
2.1.7 Biofilm development 
Although not directly involved with electron transfer, the development of a healthy 
anodic biofilm has been shown to greatly increase the achievable power output 
(138,145,146). This may be the most important factor in the biological side of the MFC 
electron transfer. Hou et al. (145) demonstrated that the development of a mature 
biofilm allowed for over an order of magnitude difference in power output. A 30 day 
biofilm provided a power density of 594 mW/m2 compared to 33.4 mW/m2 seen in the 
MFC on day 5. In nature, the biofilm provides protection from the environment and 
allows for transfer of nutrients between cells. In MFCs the full colonisation of the 
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anode allows for maximum contact with the electrode, therefore increasing the 
amount of electrons that are transferred.  As direct contact is a significant method of 
electron transfer (although not the main method of electron transfer in Shewanella - 
(104)) biofilm formation is an important factor to consider. This means that the choice 
of anodic electrode is important as it needs to have a large surface area and allow for 
proper adherence. A carbon brush anode, is one design that is well suited to this 
requirement (94). Figure 2.11 provides an example of the 3 main stages that occur in 
the life cycle of a biofilm although these can be further subdivided. The initial stage 
can be the deposition of a conditioning film on the surface to provide an opportunity 
for the cells to bind. The cells undergo reversible attachment to the surface and then 
through quorum sensing the cells are able to detect a change in environment (147). 
They alter their gene expression to suit their new environment and begin production 
of extracellular polymeric substance (EPS) (148). This allows them to bind more tightly 
to not only the anode surface but also to other cells. This is referred to as irreversible 
adherence. The biofilm then develops into a three dimensional structure of cells and 
EPS and once it reaches a certain size begins to disperse cells into the surrounding 
environment (149–151). A developed biofilm is able to transfer compounds between 
the cells contained within it and permits the transfer of electrons between cells to 
allow terminal transfer to the anode (152).
 
Figure 2.11 – Biofilm life cycle. Illustrates attachment, growth and 
dispersal/detachment stages of cycle. 
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The genetic factors involved in the development of biofilms are different for each 
species and this becomes more complex when a mixed microbial community is 
present. Biofilms use what is known as quorum sensing in order to be able to 
communicate with each other and also the secondary metabolite cyclic-di-GMP (153). 
Quorum sensing makes use of hormone like molecules known as auto-inducers (154) 
that allow the cells within the biofilm to regulate expression of proteins in order to suit 
their current environment.  
The ease with which the bacteria are able to bind to the anode and form a biofilm 
depends on a variety of conditions. These range from the microstructure of the anode 
to the pH, temperature, hydrophobicity of the cell membrane and the substrates 
available to the bacteria (153,155). Gram negative bacteria such as E. coli have a 
lipopolysaccharide outer membrane, which imbues the cell with a negative charge. 
This allows the cells to more easily bind to positively charged structures. As the anode 
has a negative charge, this could make it harder for the cells to bind. The use of 
fimbraie and flagella increase the ability of the bacteria to adhere to a surface 
(156,157) and has even been reported to be essential for early attachment in E. coli 
along with the outer membrane protein Ag43 (158). The necessity of these 
appendages ties in with the results seen in Table 2.3, where the removal of PilD in MR-
1 reduced the current production and greatly impacted upon biofilm production as 
seen in Figure 2.12. The deletion of a flagellar specific sigma factor (FliA) involved in 
the development of bacterial flagella has been shown to greatly decrease the ability of 
E. coli K-12 to form a biofilm (155). The same study however showed that the deletion 
of the master regulator in flagella biogenesis (FlhD/FlhC) resulted in a much smaller 
reduction in ability. The overexpression of this FlhD/FlhC complex, resulted in bacteria 
becoming overly motile and not settling to form a biofilm and therefore suggests that 
the overexpression of flagellar protein does not appear to be a suitable method for 
increasing biofilm formation. It may be possible that the over expression of nanowires 
within E. coli could allow for an increased biofilm forming capability although this is 
purely speculative. If this is not found to be sufficient, the addition of other factors 
that have been identified in biofilm development could be cloned into E. coli. It has 
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been reported that E. coli K-12 will not form a biofilm in minimal media unless supplied 
with amino acids (158) and that growth in media that contains substrates that are 
metabolised to acetyl phosphate and acetate, are highly supportive of biofilm 
formation (155). Staphylococcus epidermidis produces autolysin E in order to allow it 
to bind to bare surfaces (159). These factors could potentially be employed to increase 
the rate in which biofilm formation is initiated. The molecules responsible for quorum 
sensing have been identified in a number of species including E. coli, but the exact 
information that is sent by these molecules is yet to be determined (160). The 
concentration of the auto-inducer must reach a certain threshold before the cells alter 
their gene regulation (161), with the production of EPS being a direct result of the 
change in gene regulation following the detection of threshold levels of auto-inducers. 
The biofilm is believed to consist of 75-90% extracellular polymeric substances (EPS) 
and only 10-25% organisms although the specific makeup of this is dependent on 
environmental conditions (161). This demonstrates the importance of EPS in order to 
create a developed biofilm. There are a number of factors, which have been identified 
as important within biofilms formed by E. coli such as colonic acid and β-1,6-GlcNac 
polymer (162). The conductivity of the EPS is not very easily analysed, as there is a 
wide variety of compounds that are used to make it up and which can vary under 
different environmental conditions (163). The composition of EPS from a mixed 
bacterial culture studied within wastewater was shown to be mostly protein, then 
polysaccharide and finally DNA (163). However, when more complex organic 
substrates were contained within the wastewater, the protein levels decreased and 
DNA became the predominant factor in the EPS (163,164).  
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Figure 2.12 – SEM images of wild type S. oneidensis MR-1 and 
mutants. A) ΔpilD mutant B) ΔomcA/ΔmtrC mutant C) Wild type 
MR-1 (reproduced from Bretschger et al. (109)) 
Beloin & Ghigo (162) provide an analysis of regulatory genes within bacterial species 
looking for possible genetic factors that are activated under different environmental 
conditions in a biofilm. Table 2.6 presents a list of regulatory genes within biofilms and 
describes the role that each of them play in their host. There are a number of factors 
listed that are shown to repress the formation of a biofilm such as crp, csrAB and hns. 
These are unlikely to be the only genes involved in these actions, but the removal of 
them may increase biofilm formation. Production of the opposite effect, i.e. increasing 
the biofilm formation, could possibly be achieved through the overexpression of genes 
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such as barA and uvrY. The analysis of transcriptome studies of biofilm formation, has 
shown that a high number of stress related genes are expressed when biofilms are 
undergoing development (165–167). 
Table 2.6 – Presents regulatory genes and their role in biofilm 
development (Modified from Beloin & Ghigo, (162)) 
Regulatory gene (s) Bacterial species Function in biofilm formation 
Gram-negative bacteria 
barA/uvrY E. coli Activates biofilm formation 
cpxRA E. coli Senses surface perturbation and required for optimal 
cell-to-cell interactions 
crp E. coli Represses biofilm formation (catabolite repression) 
csrAB E. coli Represses biofilm formation and activates detachment 
hns E. coli Reduces adhesion in anoxic conditions 
ompR/envZ E. coli Increases attachment via curli and cellulose gene 
activation 
rcsB-yojN=rscC E. coli Activates biofilm formation via remodelling of cell 
surface composition 
rpoS E. coli Reduces or increases depth of the biofilm 
 P. aeruginosa Reduces depth of the biofilm 
crc P. aeruginosa Required for normal biofilm development (activation 
of type IV motility) 
gacAS P. aeruginosa Required for microcolonies formation 
mvaT P. aeruginosa Reduces adhesion to abiotic surfaces via cup gene 
repression 
rpoN P. aeruginosa Role in initial adhesion and biofilm architecture 
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 V. fisheri Role in biofilm architecture 
Gram-positive bacteria 
abrB B. subtilis Represses biofilm formation 
ccpA B. subtilis Reduces depth of the biofilm (catabolite repression) 
 S. mutans Necessary for full biofilm maturation 
spo0A B. subtilis Required for mature biofilm development (represses 
abrB) 
spo0H B. subtilis Required for mature biofilm development 
artRS S. aureus Reduces primary adherence to polystyrene 
rbf S. aureus Required for mature biofilm formation of abiotic 
surfaces 
SarA S. aureus Activates biofilm formation via PIA/PNAG activation 
SigmaB S. epidermidis Activates biofilm formation 
bfrAB S. gordonii Activates PVC and saliva-coated hydroxyapatite 
biofilm formation 
hk11/rr11 S. mutans Role in biofilm architecture 
brpA S. mutans Required for mature biofilm formation on abiotic 
surfaces 
 
All of these factors discussed are important in the development of a biofilm to allow 
for efficient electron transfer in a high power density MFC. 
2.1.8 Constructing electrogenic activity in a non electrogenic strain 
In order to create a fully electrogenic organism capable of completely oxidising a wide 
range of substrates to CO2, efficiently transferring these to the anode, whilst still 
producing a high power output, will require the use of a wide variety of techniques. 
This includes the use of synthetic biology but will also necessitate the use of 
techniques such as metabolic engineering. 
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Alfonta (128) described the possible methods that could be applied in order to create 
an electrogenic organism, although some methods appear less feasible than others 
whilst also appearing to disregard other possibly simpler methods. The use of methods 
such as directed evolution of redox enzymes present within the non electrogenic strain 
such as E. coli seems like a potentially lengthy procedure due to the lack of redox 
proteins present within the periplasm and outer membrane. The only potential redox 
protein present within the inner membrane of E. coli is NapC which is capable of 
reducing soluble Fe (III) but at a third of the rate seen by its homologues CymA from S. 
oneidensis MR-1 (107). This idea of directed evolution on pathway components from 
an already electrogenic organism could allow it to be better suited to the new 
environment within a host organism such as E. coli and also provide better affinity for 
the anode. The use of random mutagenesis on outer membrane proteins and those 
associated with the pathway through the use of techniques such as error prone PCR 
and high throughput analysis, could allow for increased transfer rate through greater 
binding with the target TEA. 
The use of gold coated bacteria to provide higher transfer efficiency stated in the 
discussed paper (128) is the same as coating the electrodes in platinum. These will 
both increase productivity but come at a significant cost, especially when considered 
for up scaling the systems. There are methods to allow the biosynthesis of gold 
nanoparticles that can coat the surface of the cells, but this appears an undesirable 
method due to the associated costs. 
A further method for developing an increasingly electrogenic cell line has been 
proposed through the use of bacterial surface display of redox proteins. A promising 
method for doing this is through the attachment of a signal peptide recognised by the 
host cell to a heterologously expressed protein. An example is the AIDA-I based 
autodisplay system that allows more than 105 recombinant proteins to be transported 
to the outer membrane of the cell where they could allow electron transfer to an 
anode (168). This method is illustrated in Figure 2.13 and could possibly be used to 
export a redox protein to the membrane to oxidise substrates.  
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Figure 2.13 - AIDA-I based autodisplay system showing the 
transport of the heterologously expressed protein through the cell 
membrane. Dark Grey is recombinant protein, black is native 
membrane protein, light grey is peptide linker sequence. OM – 
Outer membrane. PP – Periplasm. IM – Inner membrane. SP – 
Signal peptide. 
A similar system has already been applied for use within MFCs where a glucose oxidase 
enzyme was expressed on the outer membrane of Saccharomyces cerevisiae to 
increase the power output (169). The noted increase in this case was only from an 
open circuit value of 700 mV to 884 mV in the modified strain within a setup that also 
made heavy use of added mediators. This method also seems relatively unfeasible as 
the electrons released are not being directed towards the anode in anyway. A more 
practical method for increasing the power output could instead be to express a greater 
number of outer membrane cytochromes in a cell to allow it to transport its electrons 
directly to the anode. The overexpression of these outer membrane cytochromes has 
however been demonstrated to be a delicate balance between cellular fitness and the 
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correct expression and localisation of functional c-type cytochromes in order to obtain 
the greatest power output (124).  
Developments in recent years have shown that the transfer of exoelectrogenic activity 
to an organism without this capability, can be achieved through the introduction of the 
functional Mtr pathway from Shewanella oneidensis MR-1 alongside upregulated 
native cytochrome maturation proteins (124,125). The first study to conclusively 
demonstrate the ability of E. coli to be able to produce exoelectrogenic activity was 
Jensen et al (125). The expression of MtrA, B and C, expressed functionally and 
correctly localised, allowed for the reduction of insoluble iron particles residing outside 
the cell. 
The second, and perhaps more relevant study, was the demonstrated interaction of a 
genetically modified E. coli strain with an electrode within a MFC (124). This system 
again made use of the same section of the Shewanella Mtr pathway alongside 
overexpressed cytochrome maturation genes. In this case, however, the 
experimentalists strove to optimise the system through the use of a synthetic biology 
styled promoter screening system. The overexpression of the outer membrane Mtr 
cytochromes was demonstrated to be a delicate balance between cellular fitness and 
the correct expression and localisation of functional c-type cytochromes in order to 
obtain the greatest power output.  
2.1.9 – Strain activation  
There is a method for increasing the electrogenic activity of a microbial strain, without 
requiring any genetic or metabolic modifications. This technique makes use of the 
strict anaerobic environment seen within the anode chamber of an MFC. Due to the 
lack of TEA seen in the anode of an MFC, the bacteria must be able to make use of the 
carbon electrode as the TEA. As all organisms require a TEA of some sort, the bacteria 
that are best able to transfer their electrons to the anode will be most likely to survive 
there. 
The first example of this can be seen in the development of an electrogenic E. coli 
strain through the use of this technique. The bacteria were grown in an operating MFC 
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under strict anaerobic conditions until the voltage had decreased to below 10% of that 
seen initially. A sample of these cells were then grown anaerobically in fresh media 
and then re-inserted into the MFC for further development (170). This provides the 
opportunity to develop an electrogenic organism that is capable of metabolising a 
wide range of compounds that many DMRB are unable to do. An example can be seen 
with the development of an electrogenic strain of the highly metabolically versatile 
purple photosynthetic Rhodopseudomonas species (171).  This could well be an 
important part in the development of MFCs as the ability to degrade a wide array of 
compounds is one of the methods that allows for the higher power densities achieved 
by mixed cultures.  
2.1.10 – Metabolic engineering 
In order to be able to develop a cell strain capable of fully committing to the required 
need, the use of synthetic biology except in the case of simply building from scratch 
(100) is not sufficient (172). There must also be the use of metabolic engineering to 
allow for metabolic pathways to be upregulated, enhanced or even re-designed to 
provide the best opportunity for efficient electron transfer where it is required (172). 
In this case, this would be the transfer of electrons from the complete degradation of 
organic compounds in the cytoplasm, through the periplasm and exported through the 
outer membrane. As molecular and synthetic biology consider using the best individual 
components to make up an organism, metabolic engineering and systems biology 
consider the organism as a whole and how these components interact (172–174). This 
can then be used to determine how the energy can be channelled in the desired 
direction instead of it being used for the formation of undesired compounds. The first 
defined example of metabolic engineering can be seen with the use of glutamate 
dehydrogenase from E. coli to replace glutamate synthase in Methylophilus 
methylotrophus and allow for greater conversion efficiency of methanol into cellular 
carbon (175). The researchers identified the limiting junction (branching point or node) 
within the pathway and acknowledged that there was an alternative to this method 
which would allow for greater yields.  In order to reduce the amount of time taken for 
79 | P a g e  
 
a suitable modification to be deciphered, the type of alteration required must be 
known (174).  
Uses of metabolic engineering can be directly applied to microbial strains that are to 
be adapted for high efficiency within an MFC.  This is expressed within MFC results as 
the coulombic efficiency of an organism, and refers to the energy percentage 
transferred to the anode from the oxidation of a certain organic compound. As pure, 
relatively simple substrates such as acetate and lactate require the use of commonly 
expressed enzymes for their oxidation, there is a higher coulombic efficiency achieved 
from these compared to using wastewater. This is due to the fact that wastewater 
contains a wide variety of organic compounds, which will be of a more complex nature 
than acetate and lactate and therefore require the production of a broad range of 
enzymes for their degradation. The expression of these enzymes comes at a price and 
means that a proportion of the electrons produced from the oxidation of substrates 
will be siphoned into this process. Cameron & Tong (176) discussed extending the 
range of substrates that an organism can metabolise whilst also elaborating on the 
modification of the cells catabolic activities to help degrade toxic compounds.  
There are also inherent control mechanisms within biological systems that ensure 
growth within the cells is balanced. This prevents the transfer of all the energy through 
a certain pathway that could be detrimental to the organism and prevent the cells 
from developing in their natural environment. The resistance of these pathways 
against a change in the energy flux is described as its metabolic rigidity (174). Within 
an MFC, the cells are under artificial conditions that will be different to their natural 
environment. The cells will therefore not require some of the functions coded for in its 
genome that may only limit the rate in which the cells are able to release electrons for 
transfer. An example of reduced genome organisms that provide a more stable cell line 
can be seen in the strains produced by companies such as Scarab Genomics. Scarab 
Genomics have developed rationally designed E. coli genomes that take into account 
the genomic code for a variety of E. coli strains to determine the core genome 
common to all. The K-12 genome is 4.6 Mb (177) but the core genome of E. coli 
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continues to reduce as more genomes are sequenced (178). This has allowed Scarab 
genomics to remove over 15% of the E. coli genome, which includes non-essential 
genes, potential pathogenicity genes and many K-islands (179). Although 87.8% of the 
genome consists of protein coding genes and 11% regulatory functions, there are 
claims that this reduced genome provides substantial advantages over common E. coli 
strains (180). These include robust cell growth in minimal media, increased 
transformation efficiency and increased plasmid stability. Through continued 
development, they have managed to reduce the genome of the parental strain K-12 
MG1655 genome of 4.7 Mb to 3.9 Mb in strain MDS42 and further down to 3.2 Mb in 
MDS73 (179). 
It is vital within the metabolic engineering of organisms that all the branch points 
within a metabolic network are identified to determine where the energy flow may be 
directed and will therefore also provide an idea of how to redirect it. This allows the 
determination of the various desired pathways that may occur within a cell and also 
those that may produce undesired side products as shown in Figure 2.14. The 
degradation pathway for the oxidation of organic compounds can vary depending on 
the environmental conditions the cells are under and also the substrate conditions. As 
certain products will provide a better energy output and an less complex catabolic 
pathway using common enzyme mechanisms, there is a tendency for the cells to move 
towards this pathway (181). Under varying conditions, the cells may however choose 
to produce different compounds and secondary metabolites (182) that will decrease 
power output and as this may occur within an MFC, the removal of one of these 
enzymes may allow for complete oxidation of compounds and increase the energy 
yield. An example of metabolic engineering methods outperforming synthetic biology 
techniques, can be seen in the development of a lycopene producing E. coli (183,184). 
The use of synthetic biology techniques to introduce a wide variety of foreign genes 
into E. coli resulted in a maximum lycopene production of 9000 ppm. This was dwarfed 
by the 18000 ppm obtained through metabolic engineering by characterising the 
metabolic landscape and removing competing pathways (172). In the branch example 
shown in Figure 2.14 the inhibition of the undesired enzyme will allow for a greater 
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yield of the desired product as long as the enzyme is capable of dealing with the 
increased substrate yield. There may therefore be a need to increase the expression of 
the enzyme, seek out a similar enzyme from another organism with increased activity 
or perform random or directed mutagenesis on the gene, in order to try and increase 
its activity (172). 
 
 
 
 
 
 
 
 
 
Figure 2.14 – Example of a branch point within a metabolic 
pathway. The substrate or intermediate (I) can either be 
converted to the desired product (P) or an undesired side product 
(S) 
As discussed earlier, Shewanella species are unable to completely oxidise lactate to 
carbon dioxide and are instead only able to produce acetate from it (90). This means 
that in order to construct an electrogenic strain that is able to completely oxidise all 
the organic matter provided, and also produce a high rate of electron transfer, it will 
most likely require the acquisition of genes and pathways from a variety of organisms. 
The use of synthetic biology makes this process much easier due to the ability to 
rapidly construct a wide variety of gene variants in different strains and then test the 
efficiency of each system using high throughput analysis (172). Although the 
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introduction of a heterologous pathway into the host organism may provide certain 
enzymes with increased specificity or activity, the pathway is unlikely to harmonise 
with the pathways already present within the organism. The best option may instead 
be to refine the current pathways within the host organism in order to streamline its 
operation and increase activity (172).The mapping of a cells metabolic landscape, 
which has been documented in several strains of E. coli as well as a number of 
Shewanella, Geobacter and Rhodoferax strains (185–187), is a vital starting point. This 
will then allow for the identification and sequential removal of competing enzymatic 
pathways (172). As analysed in the MR-1 mutants study conducted by Bretschger, et al. 
(109), the removal of some of the other terminal reductase genes within MR-1 
increased its power output. This principle could, in theory also work effectively for E. 
coli as this has a number of terminal reductase genes. The ones that are involved in 
electron transfer under anaerobic conditions would be in direct competition with the 
c-type cytochromes transformed in from S. oneidensis MR-1. These enzymes can be 
seen in Table 2.7, where there are a number of nitrate reductases present. The 
removal of a number of these could allow for increased electron transfer to outer 
membrane MR-1 c-type cytochromes, although this may affect the delicate balance 
within the cell. The most obvious periplasmic nitrate reductases to remove would be 
the periplasmic reductases such as NapC, which would be in direct competition with 
the CymA inserted. This is due to the fact that NapC normally transfers electrons to a 
periplasmic nitrate reductase, in the presence of a NapC-F gene cluster in E. coli. 
Bretschger et al. (109) suggests that a deletion of napB in MR-1 leads to an increase in 
power output (188) making it a suitable candidate for removal as a competing 
pathway. Further studies looking into the proteins interacting with CymA and MtrA 
have shown transient protein interaction between most abundant periplasmic 
cytochromes STC, FccA and ScyA (189) to be highly important. These proteins may well 
have homologous partners in E. coli providing further targets for metabolic 
engineering. 
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Table 2.7 – Oxido – reductases of the respiratory chains of E. coli 
(Modified from Unden & Bongaerts (190)) 
 
Enzyme Redox couple 
Pair                       Em (V) 
Genes Map 
position 
(min) 
Signal sequence subunit 
(AA residues) 
Primary 
dehydrogenases 
(DH): 
Formate DHN HCO3/HCO2 -0.43 fdnGHI 33.0 FdnG (1-33) (pot.) 
Formate DHO HCO3/HCO2 -0.43 fdoGHI 88.03 FdoG (1-33) (pot.) 
Formate hydrogen-
lyase 
  fdhF, hycA-H 92.6; 61.35 n.s. 
Hydrogenase 1 H+/H2 -0.42 hyaABCDEF 22.26 HyaA (1-45) 
Hydrogenase 2 H+/H2 -0.42 hybABCDEFG 68.53 HybA (1-26/27) 
NADH DH I NAD+/NADH -0.32 nuoA-N 51.64 n.s. 
NADH DH II NAD+/NADH -0.32 ndh 25.17 n.s. 
Glycerol-3-P DHO DHAP/Gly-3-P -0.19 glpD 76.89 n.s. 
Glycerol-3-P DHN DHAP/Gly-3-P -0.19 glpACB 50.76 n.s. 
Pyruvate oxidase Acetate + CO2/Pyruvate  poxB 19.42 n.s. 
D-Lactate DH Pyruvate/D-lactate -0.19 dld 47.80 n.s. 
L-Lactate DH Pyruvate/L-lactate -0.19 lctD 81.55 n.s. 
D-amino acid DH 2-Oxoacid + NH4/Amino 
acid 
 dadA 26.64 n.s. 
Glucose 
dehydrogenase 
Glucose/gluconate -0.14 gcd 2.97 n.s. 
Succinate DH Fumarate/succinate +0.03 sdhCDAB 16.37 n.s. 
Terminal 
reductases: 
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Quinol oxidase bo3 O2/H2O +0.82 cyoABCDE 9.78 CyoA (1-24) (pot.) 
Quinol oxidase bd O2/H2O +0.82 cydAB 16.67 n.s. 
Quinol oxidase III 
(Cyx) 
O2/H2O +0.82 appBC (=cyxAB) 22.42 n.s. 
Nitrate reductase A NO3/NO2 +0.42 narGHJI 27.53 n.s. 
Nitrate reductase Z NO3/NO2 +0.42 narZYWV 33.09 n.s. 
Nitrate reductase, 
periplasmic 
NO3/NO2 +0.42 napFDAGHBC 49.5 NapB (1-34)(pot.) 
Nitrate reductase NO3/NH4 +0.36 nrfABCDEFG 92.42 NrfA (1-26)  
NrfB (1-31) (pot.) 
DMSO reductase DMSO/DMS +0.16 dmsABC 20.32 DmsA (1-16) 
TMAO reductase TMAO/TMA +0.13 torCAD 21.61 TorA (1-39) 
Fumarate reductase Fumarate/succinate +0.03 frdABCD 94.4 n.s. 
 
If more reductase genes were to be removed, especially those expressing signal 
peptides that are therefore likely expressed in the membrane, the heterologously 
expressed proteins from MR-1 would need to be able to cope with the increased load 
of electrons. There may need to be modifications made in order to increase the 
transfer kinetics between these proteins and ensure efficient transfer to the anode. 
In order for a host organism to be able to degrade a wider range of substrates to 
produce energy, it may only require the addition of a few enzymes from other 
organisms. These enzymes will then allow the previously indigestible compound to be 
converted to a product that is readily degraded by the host organism’s inherent 
metabolic pathways (173). 
The addition of individual foreign enzymes into a host organism is unlikely to provide 
the same activity as seen within the species of origin unless they are optimally 
expressed or structurally modified to allow them to adapt to the new environment 
(172). This infers that the development of metabolic engineering relies heavily upon 
systems biology for a whole cell understanding. 
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Systems biology is a combination of a wide variety of subject groups including biology, 
computer science and biophysics in order to determine interactions within a cell. This 
type of analysis views the cell from a holistic viewpoint instead of individual 
components. Knowing what each particular part is responsible for has largely been 
established but the interactions of these components within a system provides much 
more valuable information. Data collected detailing all the cellular transcripts 
(transcriptome), proteins (proteome) and also the cell metabolism (metabolome) 
under a given set of conditions are required for the most effective construction of 
these models (191). These data can then be used to construct computer models of cell 
types to help determine how cellular components will vary. These models can be 
applied for metabolic engineering to help predict how the modification of a particular 
protein or pathway will affect the overall balance within the cell. 
2.1.11 Inverse metabolic engineering 
This method was first termed by Bailey et al. (192) as ‘‘The elucidation of a metabolic 
engineering strategy by: first, identifying, constructing, or calculating a desired 
phenotype; second, determining the genetic or the particular environmental factors 
conferring that phenotype; and third, endowing that phenotype on another strain or 
organism by directed genetic or environmental manipulation.”. Inverse metabolic 
engineering (IME) was proposed by Bailey et al. (192), as a solution to the limited 
success by earlier metabolic engineering methods. In early IME methods, the 
identification of the genes responsible for the given phenotype firstly needs to be 
made through sequencing and 2D gel electrophoresis, but this was a lengthy 
procedure. The development of advanced sequencing technology that permits the 
elucidation of a genome sequence within a vastly reduced timeframe, use of DNA 
microarrays and expansion of –omics studies, has allowed for the rapid identification 
of cell components that are involved in desired phenotypes (193). Gill et al. (194) 
developed a method of deciphering the genetic components of the desired phenotype. 
This was done through digesting the genome into a variety of different sized fragments 
and inserting them into a plasmid thereby, creating a genomic library. Through the 
transformation of these plasmids into E. coli strains, they were able to identify the 
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ones expressing the desirable phenotype.  Examination of the strains expressing the 
desired phenotype then allowed for further analysis of the genes required, and 
permitted opportunities for further genetic tuning for upregulation. This technique 
also has its downsides, one of them being that it can be hugely time consuming. The 
use of DNA microarray technology to analyse the difference in transcript levels of 
genes under varying conditions allows for the identification of the relevant genes, 
which can then be modified or transferred onto plasmids allowing increased 
expression rates (195). This methodology has been successfully used in other cases to 
increase the efficiency of the less well studied Saccharomyces pastorianus (196) and 
also to increase solvent tolerance (197). The use of IME has significant potential within 
MFC strain development, especially in order to be able to produce patentable 
opportunities following the isolation of electrogenically active strains following 
enhancement of sewage sludge using an MFC. The challenge of high throughput 
analysis of a large number of cell types could be accomplished through the use of one 
of the multiwell MFC devices that will be discussed following discussion of the issues 
surrounding codon optimisation. 
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Figure 2.15 – Comparison between rational engineering and IME – 
(Modified from Saerens et al. (196))  
Once the proteins responsible for the increase in activity have been identified through 
MS analysis they can then be codon optimised for the host organism to aid in the 
recombinant production of the desired proteins. 
This literature review has illustrated that in order for the use of MFCs to be 
economically viable, replace the use of inefficient anaerobic digesters and create a 
water industry that can move closer to becoming self sufficient there is still a wide 
range of research required. 
2.1.12 Codon optimisation 
For the optimal expression of foreign proteins within E. coli, the protein will most likely 
need to have the codons altered to allow for proper interaction with the most 
common tRNA molecules present within the host. This can be done when planning the 
construction of a synthetic gene. This allows for the insertion and deletion of 
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restriction sites within the sequence to reduce the chance of digestion by the host cell 
and provides the researchers involved with greater cloning flexibility. The traditional 
method of codon optimising a sequence was to analyse the amino acid sequence of 
the protein and alter the codons in order to fit in with the most common codons seen 
within the host organism. Although this method of codon optimisation made sense, 
there was no experimental work conducted to support it. With an increase in the level 
of synthetic genes being produced, a study was conducted in order to test this in an 
attempt to further optimise heterologous protein production (198,199). It was noted 
from this study that expression of proteins within E. coli, was highly dependent on the 
codons used but not as classically predicted. Instead of using the most abundant 
codons seen in E. coli proteins, it was seen that the most favourable codons were 
those that were read by tRNAs that are highly charged (amino acetylated) during 
amino acid starvation (199). Through this information, the researchers were able to 
develop a model for the optimisation of the proteins and showed that differences in 
the codons used can result in up to a 40-fold difference in the amount of protein 
expressed (Welch et al. 2009).  
2.1.13 Strain development 
All of the above mentioned techniques require a high throughput analysis technique 
that is able to provide information about the developed strain and allow a rapid 
comparison between variants to determine those with the greatest current production 
potential. The use of colorimetric iron reduction assays is insufficient due to the 
inability to distinguish between the current production ability of a strain and merely its 
capability to transfer electrons to insoluble iron (122). A multiwell MFC as shown in 
Figures 2.16 and 2.17 would allow for the analysis of a large number of strains in a 
much quicker time than capable using a single twin chamber MFC setup. This is, 
however dependent on the analysis wanting to be undertaken, with it realistically 
being focussed on short term analysis. 
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Figure 2.16– Provides an example of a simple mutliwell MFC – 
here shown with 9 separate compartments. This provides a 
graphical, cross sectional illustration of the multiwell MFC. 
 
Figure 2.17 - A further example of multiwell chamber MFC that 
allows for the simultaneous analysis of 24 different strains.  
The analysis of strains using such minute volumes of cells would require multiple 
replicates due to the chance of false results. As the strain being tested would need to 
be grown within a separate container beforehand, this allows for the development of 
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subpopulations within the culture (200). This refers to the fact that although the cells 
may all be genetically identical, there is often a wide degree of heterogeneity seen 
between the phenotypes in a culture (200). Using small volumes may result in the 
acquisition of one abnormal phenotype. The only real method of rectifying this is to 
ensure that the culture is fully mixed before use, to allow for homogeneity and also 
carry out multiple replicates. 
2.1.14 Proteomic analysis 
Following the introduction of foreign genes into a host organism, they and the proteins 
they express will need to be identified. This can be done in a number of ways such as 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE), which allows 
for the proteins to be identified according to their molecular weight (201). The use of 
gel based analysis for the identification of proteins has largely been superseded due to 
the developments in mass spectrometric analysis. This latter type of analysis is coupled 
with protein labelling techniques that allow for not only the identification but also 
accurate quantitation of the identified proteins (202,203). Examples of protein 
labelling techniques can be seen with stable isotope labelling by amino acids in cell 
culture (SILAC) (202), isotope-coded affinity tags (ICATs) and the more recently 
developed isobaric tag for relative and absolute quantitation (iTRAQ) (204).  
The use of iTRAQ provides an advantage over other quantitative proteomic analysis 
methods such as ICAT, as it is possible to use either a 4- or 8-plex setup compared to 
ICAT’s 2-plex (203). This allows the user to analyse a multitude of phenotypes 
simultaneously without having to do numerous 2-plex analysis, where the data could 
be compiled at a later date. The use of multiple 2-plex analysis can introduce variance 
into the results due to the differential treatment of the samples. Although all the 
samples used in iTRAQ are combined before analysis, the quantitation of individual 
peptides, and the relevant sample group they were derived from, can be identified due 
to the reporter ions released (205). The ability to quantify the regulation in protein 
levels is incredibly useful within biological studies, providing a powerful insight into the 
workings of the cells under different conditions (205). 
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2.1.15 Conclusions 
The developments within the field over the course of this study are significant, with 
the major developments with the closest relevance to this study being surmised by a 
few choice papers: 
The work carried out by the Caroline Ajo-Franklin’s group within the University of 
California, Berkeley has produced two papers (124,125) that are in direct competition 
with the work that has been carried out during the course of this project. 
The first of the papers published by this research group, in many respects built upon 
the work by Pitts et al (105) and Donald et al (120). The work carried out by Pitts et al 
was the first known use of heterologously expressed c-type cytochromes within E. coli. 
During this study, they demonstrated that it was possible for E. coli to reduce iron, 
even though in this case it was in its soluble form as Fe (III) citrate. Further studies 
have shown that the native E. coli protein, NapC, that was believed to supply MtrA, 
when expressed in E. coli, was also capable of reducing soluble Fe (III) in the absence of 
heterologous MtrA(107). 
The work carried out by Donald et al (120) was a further addition to this thread of 
experiments whereby an outer membrane c-type cytochrome in the form of OmcA 
from S. oneidensis MR-1 was expressed in a B-type E. coli strain. This work showed that 
the protein was both functional and correctly localised, and capable of reducing 
insoluble Fe (III). 
Work within this area was subsequently carried out by the Ajo-Franklin group in the 
form of the paper by Jensen et al (125). This paper built on the work done by Donald et 
al and Pitts et al, although Jensen et al used a larger, “more complete” extracellular 
electron transfer pathway comprising of MtrA, B and C. The experiments further 
confirmed the capability of utilising E. coli as a DMRB with the addition of minimal 
genetic modifications to allow it to reduce insoluble iron. The study also highlighted 
the fact (through knocking out native NapC) that there are multiple inner membrane 
proteins in E. coli that are able to interact with the quinone pool and donate electrons 
to the recombinant Mtr pathway. 
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The second paper in this thread (124) produced by the Ajo-Franklin group was a 
further extension of the work carried out in the last paper. Although there is no direct 
link between insoluble metal reduction (especially iron) and current generation within 
a BES, these two capabilities are still relatively suggestive that an organism that can do 
one, can do the other. In order for extracellular electron transfer to occur within S. 
oneidensis MR-1, it relies upon the transcript being copied from the genome, 
component parts of the Mtr pathway (namely MtrCAB being produced), proper 
expression of the cytochrome maturation gene system within the membrane, 
localisation of the haem groups within the c-type cytochromes and the correct folding, 
localisation and ratios of the Mtr proteins. This is a delicate balance between a large 
number of elements within the complexity of the whole cell, made even harder due to 
the fact that the vast majority of the work is done in the membrane. Trying to replicate 
this activity artificially through a recombinant DNA expression system has numerous 
potential complications due to the high level of complexity in the system.  
The recombinant extracellular electron transport system is coded with the sec signal 
peptide attached to ensure localisation towards the membrane along with the 
essential CXXCH sequence (206) to allow for the apocytochromes to interact with the 
cytochrome maturation protein machinery (124). There is a limit to the amount of 
protein that the sec secretion pathway is able to deal with before being overloaded, 
resulting in a proportion of the proteins remaining without haem groups. Relying upon 
high level expression systems such as T7, where huge transcript levels are being 
produced and protein translated, resulted in the cell being unable to cope. This 
appeared to show a massive metabolic burden upon the cell, potentially with the sec 
system unable to cope with the huge amount of protein trying to be transferred 
through it and the Ccm proteins being overloaded.  Through the creation of a 
promoter library, the group was able to test a large number of tuning permutations to 
help determine the one that would yield the highest number of functional c-type 
cytochromes, but also the greatest current density.  
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Previous work carried out has demonstrated that the overexpression of membrane 
proteins within E. coli leads to the formation of aggregates within the cytoplasm 
alongside the required chaperones and precursors (207). All of this resulted in low 
level accumulation of the proteins within the membrane compared to overexpressed 
soluble proteins. This is possibly expectedly due to the saturation of the translocation 
machinery (207). 
During this thesis, there was however no attempt at potentially alleviating this issue of 
overexpressed membrane proteins through the upregulation of the translocation 
machinery. This would indeed have added another level of complexity and depending 
on the design of experiments, may have resulted in a far greater number of genetic 
permutations from promoter set tuning, but may have yielded some interesting results 
with greater current densities. This assumes that the translocation machinery is the 
limiting factor and there may well be other, quicker and better ways of increasing 
yields. 
With all this being said, this literature review has identified significant areas of 
potential development for the construction of a fully electrogenic E. coli. The areas 
that would need to be addressed primarily would be the transfer of c-type 
cytochromes such as CymA (knockout NapC), MtrA, MtrB, MtrC and OmcA in an 
attempt to create a functional high level transfer of electrons to the anode. Increasing 
the biofilm forming capacity of E. coli, to allow for greater colonisation of the anode 
should then hopefully increase this capacity further. The next steps would require a 
more thorough metabolic engineering strategy and analysis of activity changes, 
following the rational modification or removal of cell proteins and pathways. The 
removal of genes encoding proteins responsible for the reduction of other terminal 
electron acceptors such as nitrate and sulphur, could allow for greater electron 
transfer to the anode reducing pathway as seen in S. oneidensis MR-1. 
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Chapter	3:	Materials	and	Methods	
3.1 Bioinformatic analysis  
As detailed in chapter 2, analysis of the literature revealed that the genes encoding c-
type cytochromes believed to be responsible for electrogenic activity in S. oneidensis 
MR-1 were shown to be located on a single gene cluster (108). 
In order to be able to clone the electrogenic gene cluster, a bioinformatic analysis of 
the genes had to be carried out. This was done in order to determine the feasibility of 
amplifying the fragment from the Shewanella genome, ligating into a suitable plasmid 
and then expressing the proteins within a compatible E. coli strain. 
The first step for this was to determine the sequence of the gene cluster including all 
spacer regions which was collected from NCBI (http://www.ncbi.nlm.nih.gov/). As the 
entire gene cluster amounted to over 13 kb and there may well be redundancy within 
the genome, it was decided that it would be advantageous to try the simultaneous 
production of several plasmids using different fragments of the cluster. Following 
consideration of the literature it was decided that the minimum gene cluster 
(Fragment 1) should consist of the genes from OmcA to MtrB since this would contain 
the outer membrane cytochrome OmcA and the periplasmic cytochrome MtrA that 
had already demonstrated functional heterologous expression in E. coli strains 
(105,120) (Figure 3.1). This also provided the cytochrome MtrB that has been stated to 
be required for proper incorporation of OmcA and MtrC into the outer membrane of 
Shewanella putrefaciens (112). This fragment was designed in consideration of the fact 
that the full gene cluster may well be very difficult to amplify in a single PCR reaction. 
As this was roughly half of the gene cluster, it provided the option to potentially try 
and join this and a fragment containing MtrDEF together to make the full gene cluster 
following their individual amplification.  
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Figure 3.1 – S. oneidensis MR-1 electrogenic gene cluster 
(modified from Fredrickson et al (108)) 
The overall fragment sizes were as follows: 
OmcA, MtrC, MtrA and MtrB – 7,728 bp 
MtrC, MtrA and MtrB – 5,192 bp 
OmcA, MtrA and MtrB – 5,713 bp 
MtrD, E, F, OmcA, MtrC, A, B – 13,003 bp 
Several bioinformatic tools were used to try and determine more about the proteins 
that were to be expressed: 
3.1.1 Signal P  
This program (http://www.cbs.dtu.dk/services/SignalP/) allowed for the identification 
of predicted signal peptides within the proteins that would show whether they would 
be transported to the outer membrane. Inserting the amino acid sequence of the 
protein in FASTA format into the program provided details of the location and length 
of the signal protein. As all of the proteins being considered were thought to reside in 
the membrane of S. oneidensis MR-1, they were all expected to contain signal 
peptides. 
3.1.2 TMHMM  
This tool (http://www.cbs.dtu.dk/services/TMHMM/) provided an opportunity to 
determine the location of predicted transmembrane regions within the protein. This 
would show whether the protein was thought to reside in the membrane of the cell.  
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3.1.3 Webcutter  
Inserting the nucleotide sequence of the gene into webcutter 2.0 
(http://rna.lundberg.gu.se/cutter2/) and NEBcutter 2.0 
(http://tools.neb.com/NEBcutter2/) allowed for the identification of all the restriction 
sites that cut the sequence and provided the details of where these sites were. This 
allowed restriction sites that were present within the MCS of the pACYCDuet-1 vector 
to be chosen that did not cut the sequence of the desired fragment. This allowed for 
insertion of the fragment into the vector. 
Figure 3.2 – Multiple cloning sites within pACYCDuet-1 
3.1.4 Molecular weight/pI  
The molecular weight and pI of the proteins were predicted by inserting the amino 
acid of the protein into the ExPASY compute mW/pI tool 
(http://expasy.org/tools/pi_tool.html). 
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3.1.5 Primer design 
Primer design was carried out using the program SnapGene (GSL biotech LLC, IL,USA). 
Inserting the nucleotide sequence of the gene into the program allowed for the design 
of primers for PCR that would allow the desired fragment to be amplified. After the 
primers had been designed, they then had the additional restriction sites added to the 
3’ end, to allow for insertion of the fragments into the plasmid. Primers were 
synthesised by Invitrogen (Paisley, UK). 
3.1.6 – Theoretical plasmid construction 
Theoretical construction of plasmids for identification of restriction sites, details of 
origins of replication, resistance cassettes and selected ORFs were carried out using 
SnapGene (Biotech LLC – Chicago, IL, USA). 
3.2 Molecular biology 
3.2.1 Sterilisation and aseptic technique 
Unless stated otherwise, all solutions and apparatus were sterilised by autoclaving at 
121 °C, with a pressure of 1.05 bar for 20 min. The benches were regularly washed 
down with 1% Virkon, followed by 70% ethanol. A blue flame Bunsen was kept on 
throughout experiments where contamination was an issue. Lab coat, goggles and 
gloves were worn in the lab at all times to ensure that health and safety rules were 
adhered to, and therefore reduced the risk of injury from chemicals. 
3.2.2 Preparation of genomic DNA 
For amplification of Mtr genes to occur the genomic DNA firstly needed to be 
extracted. This came from the DMRB organism S. oneidensis MR-1. Before this 
amplification could occur the genomic DNA needed to be prepared to allow for 
Polymerase Chain Reactions (PCR). Frozen aliquots of spun down cell cultures that had 
the supernatant removed were used to extract the genomic DNA from. The protocol 
for this was followed exactly as stated in the Qiagen DNeasy® Blood and tissue 
Handbook (July 2006 edition). The only step that was modified slightly was after the 
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addition of the proteinase K, as the protocol only states to leave the sample at 56°C for 
30 min to allow the cells to lyse. The samples were instead left for roughly 6 h. 
3.2.3 Agarose gel (1%w/v) 
Agarose gels were made by using either 0.3g of agarose and 30 mL of 1 x TAE (recipe in 
appendix) (for small gels) or 1.2 g of agarose and 120 mL of 1 x TAE (for large gels) 
mixed together in a conical flask. The solution was heated up using a microwave 
making sure that it was removed as soon as the solution began to bubble. This was 
done until all the agarose had dissolved.  
Once the solution had cooled down to around 60°C, 10 µL of ethidium bromide was 
added, mixed, then poured into the gel casting tray of the desired size with the 
corresponding comb in place. The gel was given around 20 min to allow it to set and 
could be seen to become slightly opaque on setting. The gel was then placed into the 
running position and was covered with 1 x TAE buffer. The comb was removed 
carefully and 5 µL of Hyperladder I DNA size standard (Bioline, London, UK) (10.0, 8.0, 
6.0, 5.0, 4.0, 3.0, 2.5, 2.0, 1.5, 1.0, 0.8, 0.6, 0.4, 0.2 kb) was added to the first well of 
the gel and then the remaining samples were added. All gels were run at a constant 
current of 120 mA, with the small gels being run for 35 min and large gels being run for 
60 min for PCR samples and 4 h when gel purification of a vector was being done. 
After the gels had run sufficiently they were removed from their tanks and then 
viewed using a UVP GelDoc-It TS. The images of the gels were saved onto a memory 
stick, transferred to a computer and printed off. 
3.2.4 Plasmid preparation of pACYC-Duet-1 
Glycerol stocks of E. coli TOP10 carrying intact plasmids were frozen at -80°C. In order 
to make up a new batch of the plasmid vector a 2 µL aliquot of the glycerol stock was 
taken and put into 100 mL of Luria-Bertani (LB) media (appendix) in a 250 mL conical 
flask and then put into an incubator at 200 rpm at 37°C for 16 hrs. The solution was 
split into 2 separate 50 mL falcon tubes and the pellet was then used in a maxiprep (as 
described in section 3.2.18). 
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3.2.5 PCR 
Polymerase chain reaction was used to amplify the DNA of the desired gene. This was 
done using Phusion Hot Start II High-Fidelity DNA Polymerase kit (provided by New 
England Biolabs, Hitchin, UK). The advantages of using this polymerase is that it is 
highly specific and also contains an Affibody ® molecule supposedly allowing for 
removal of any annealing temperature limitations.  
An example PCR reaction set up is shown in Table 3.1: 
Table 3.1 - PCR reagents 
 
This set up is designed to produce the best result from the enzyme. The buffer is used 
to maintain the optimum conditions for the enzymes throughout the procedure. The 
order in which the components were added was done to prevent any reactions 
occurring before all the components were present within the PCR grade 0.2 mL 
microcentrifuge tubes. The Phusion Hot Start enzyme was the last component added, 
as this ensured that the reaction did not begin prematurely. The 200 µL 
microcentrifuge tubes that the samples were loaded in were spun down quickly before 
being put into the PCR thermocycler so that the components were properly mixed. 
The annealing temperatures that had been determined were used to set up the PCR 
program used for the amplification procedure. As there are 2 primers used in each 
 Reactant Volume/µL Final Concentration 
5X HF Buffer for Phusion DNA polymerase* 10 1X 
dNTPs (2mM each) 1 0.2mM (each) 
PCR Grade Water 35 - 
Sense (5’) Primer /10µM 1 0.3µM 
Anti-Sense (3’) Primer/10µM 1 0.3µM 
Template DNA 1 (1 in 10 dilution) - 
Phusion Hot Start II DNA Polymerase (2U/µL) 1 0.04U/µL 
Total reaction volume 
* 1X Buffer provides 1.5 mM MgCl2 
50 µL - 
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reaction and each one has a separate defined annealing temperature the higher of the 
2 annealing temperatures was used in each case. 
The PCR procedure was set up as shown in Table 3.2: 
Table 3.2 – PCR set up 
3.2.6 PCR overlap 
As the project developed, more advanced polymerase techniques were employed. One 
of these was the use of PCR overlap. This technique allows for the addition or removal 
of genetic sequences using PCR, followed by the removal of the initial template 
plasmid, yielding purely recombinant vector.  This technique was employed for the 
construction of the SPA-tagged (208) Mtr vectors in chapter 6. 
An example methodology, with the addition of a SPA-tag to pACYCOmcA is as follows, 
with full detailed description found in (209): 
1. SPA-tag nucleotide sequence was identified within pJL148 
2. Primers designed to amplify sequence using 30 bp on FP and RP. 
3. Addition of nucleotides to the 5’ region of the FP to allow for 3’ reading into 
OmcA. This was designed to remove the stop codon of OmcA and allow for the 
3’ attachment of the SPA-tag to OmcA. 
1.      T = 98°C  2 min 
2.      T = 98°C 15 s 
                    3.   T = Calculated 1° Annealing Temperature 30 s 
Ramping speed = 3.0             
Gradient across heating block = 10.0°C    
4.      T = 72°C (1kb/30s)   
5.      GO TO 2 – REPEAT 4   
6.      T = 98°C  15 s 
7.      T = calculated 2° Annealing Temperature                   30 s 
8.      T = 72°C (1kb/30s)   
9.      GO TO 6 – REPEAT 29 TIMES   
10.  T = 72°C  10 min 
11.  Hold 4°C   
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4. Addition of nucleotides to the 5’ region of the RP to allow for reading into 
region downstream of the GOI. The gap between the FP and RP binding regions 
wants to ideally be roughly 50 bp. 
5. Amplify the SPA-tag from pJL148 using a standard PCR protocol, taking into 
consideration primer annealing temperatures and allowing for sufficient 
extension time depending on polymerase used. 
6. Purify the correct band (roughly 200bp) using gel purification. 
7. Use the purified PCR product alongside desired template for modification (In 
this case pACYCOmcA) in a PCR reaction. The purified PCR product from step 6 
acts as FP and RP to the desired template allowing for simultaneous 
introduction of additional genetic material (SPA-tag) and then amplification of 
the remaining plasmid. Use standard PCR procedure as described in section 
3.2.5. 
8. Add DpnI to the mixture following PCR amplification to selectively digest dam 
methylated template DNA. Leave at 37 °C for 2 hrs. This leaves only 
recombinant, modified plasmid in a nicked form. 
9. Transform mixture into competent cloning strain such as DH5alpha and select 
based on original resistance of plasmid (Cm). 
10. Purify plasmid from culture, PCR amplify for detection of correct insertion and 
sequence for full verification. 
11. Plasmid is now ready for use and expression in desired strain. 
3.2.7 PCR for recombination 
An additional method of modifying either plasmid of chromosomal genetic sequences 
is through the use of recombination. In the method, a lambda red recombination 
method, widely popularised by Datsenko and Wanner (210) is described. The 
technique was originally specified as a deletion tool using a single PCR reaction but can 
be modified to allow for more complicated insertion events or with careful design, 
even simultaneous deletion and insertion. 
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An example of recombination used within this thesis was for the modification of 
pUC19 to replace the Ampicillin resistance cassette with that of the Chloramphenicol 
resistance cassette from pACYCDuet-1. This was done to help provide a 2 plasmid 
system of chromosomal insertion as described in chapter 6. 
In order to be able to do this, PCR primers were designed to amplify the 
Chloramphenicol cassette from pACYCDuet-1 that would also be homologous to the 
region immediately upstream and downstream of the Ampicillin resistance cassette in 
pUC19. This would involve an initial amplification of the Chloramphenicol resistance 
cassette from pACYCDuet-1 and electroporation into a strain harbouring pUC19 and an 
induced pKD46 Kan. 
An example is shown below: 
1. Primers were designed to the Chloramphenicol cassette: 
2. The region immediately upstream and downstream of the Ampicillin cassette 
was identified: 
Upstream of Amp – aaaaggaagagt 
Downstream of Amp – aagtatatatgagtaaacttggtctgacag 
3. The sequences were combined to allow for the initial amplification of Cm from 
pACYCDuet-1 with extensions for insertion into pUC19: 
Duet Cm lambda Amp FP – aaaaggaagagtttacgccccgccctgc 
103 | P a g e  
 
Duet Cm lambda Amp both RP - 
aagtatatatgagtaaacttggtctgacagatggagaaaaaaatcactggatataccaccg  
Bold section is from Amp, as shown above. Underlined sequence is from Cm cassette. 
4. PCR is setup as described in section 3.2.5 
5. Recombination event is described in section 3.2.27 
3.2.8 Restriction enzyme digest of vector and PCR products 
The digestion of the vector depended upon which type of restriction endonuclease was 
being used to digest it. All restriction enzymes and buffers were purchased from New 
England Biolabs (Hitchin, UK) apart from multicore buffer, which was purchased from 
Promega (Southampton, UK). 
The reaction was setup with the least reactive solutions first (i.e. 18.2 MΩ water), 
gradually building up to the most reactive (restriction enzymes). The solution was 
pulse spun in a micro centrifuge and then stored in a water bath at 37°C for at least 2 
hrs.  In order to prevent re-ligation of the cleaved vector fragment, 2µL of alkaline 
phosphatase was added to the solution to remove the terminal phosphate groups 
from the DNA strands. To inactivate the restriction enzymes and alkaline phosphatase, 
the temperature of the water bath was increased to 42°C for 10 mins and then stored 
in the freezer for later use. 
Table 3.3 - Example AscI and NotI digest of pACYCDuet-1 
 
Reactant Volume used 
18.2 MΩ/cm water 6 µL 
10 x Buffer 4 17 µL 
BSA (10mg/mL) 17 µL 
Uncut pACYCDuet-1 (10 µg) 120 µL 
AscI enzyme (20U/µL) 5 µL 
NotI enzyme (20U/µL) 5 µL 
Total volume 160 µL 
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Restriction enzyme digest also needed to be carried out on PCR products but this was 
normally done following gel purification (as detailed in section 3.2.7) to remove any 
other DNA fragments that had been unintentionally amplified during PCR. Following 
gel purification the PCR products could then be digested as shown in Table 3.4. 
Table 3.4 - Example PCR digest 
3.2.9 Gel purification 
Qiagen gel purification kits were used for all DNA purification following transfer 
through an agarose gel. The procedure used for this technique was as detailed in the 
manufacturer’s instructions. 
3.2.10 PCR cleanup – SURECLEAN 
As gel purification often results in a large loss of DNA, this step is considered 
unnecessary for PCR products following enzymatic digestion and instead have the 
enzymes and unwanted DNA removed using a PCR cleanup procedure. The version was 
used in this thesis was Sureclean from Bioline (London, UK). The procedure use was as 
detailed in the manufacturers protocol 
3.2.11 Ligation 
Ligation reactions were set up in 3 different ways where the ratio of ligation to vector 
was altered. All the reactions contained 1 µL of T4 DNA ligase (purchased from 
Promega, Madison, WI, USA) and were made up to a total volume of 10 µL. The 3 
different ratios used were: 
1:3, 1:1 and a 3:1 ratio of vector to insert 
Reactant Volume used 
18.2 MΩ/cm water 8 µL 
10 x Multicore buffer 5 µL 
BSA (10mg/mL) 5 µL 
Purified PCR product 30 µL 
AscI enzyme (20U/mL) 1 µL 
NotI enzyme (20U/mL) 1 µL 
Total volume 50 µL 
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The different amounts of vectors were calculated using the following calculation: 
Length of insert (in kb)     x ng of vector = ng of insert needed for a 1:1 ratio 
Length of vector (in kb) 
This was done using the ligation calculation tool on: http://www.insilico.uni-
duesseldorf.de/Lig_Input.html 
Table 3.5 - Example ligation 
An example of the different ratio ligations is shown below with a 9895 bp insert and 
4000 bp vector: 
1:3 = 20 ng (1 µL) vector to 150 ng (6 µL) insert 
1:1 = 20 ng (1 µL) vector to 50 ng (2 µL) insert 
3:1 = 20 ng (1 µL) vector to 17 ng (1 µL) insert 
The components were added in an order that ensured that the ligase enzyme was the 
last to enter the microcentrifuge tube. The tube was pulse spun down in a centrifuge 
to collect all the reactants in the bottom and then put into a PCR machine at 16°C for 
16 h. After samples were removed from the PCR machine they could then be stored in 
the -20°C freezer ready for use in transformations into an E. coli cloning strain such as 
TOP10. 
3.2.12 Preparation of chemically competent cells 
The day before the competent cells were made, 100mM CaCl2.2H20 (147.02) (1.47g in 
100 mL), 100mM MgCl2.6H2O (201.31) (2.01g in 100 mL), 10 mL of sterilised 50% 
Reactant Volume used 
10 x Ligation Buffer 1 µL 
Ligase enzyme (1U/mL) 1 µL 
Purified PCR product 6 µL 
Digested pACYC vector  1 µL 
18.2 MΩ H2O 1 µL 
Total volume 10 µL 
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glycerol, 80 x 1.5 mL sterilised microcentrifuge tubes were all sterilised. A 10 mL 
culture of the chosen E. coli strain/ LB /antibiotic was also setup overnight. 
The next day, 1 mL LB was put aside for OD600 (zero) blank.  2 mL of the overnight 
culture was added to 200 mL LB/antibiotic in 500 mL flask and incubated for 1.5 hrs 
with OD600 readings being taken (every 15 mins) in a spectrophotometer. When the 
cells were at an OD600 of roughly 0.5 (not more than 1.0) the culture was put on ice for 
at least 10 mins with occasionally swirling. The 200 mL of cells were spun down in 4 
red topped 50 mL falcon tubes at 4500rpm for 10 mins at 4oC. The supernatants were 
discarded and the pellets were very gently resuspend in 20 mL 100mM MgCl2 each by 
swirling and then spun down again at 4500rpm for 10 mins at 4oC. The supernatant 
was again discarded and the first pellet (of 4) was very gently resuspend in 6 mL 
100mM CaCl2, by swirling and poured into the tube containing the second pellet 
(sterile conditions are essential). All pellets were resuspended in this manner until all 4 
pellets were resuspended in 6 mL and the combined pellet was then put on ice for 1.5 
hrs to become competent. 1.8 mL of sterile 50% glycerol was added to 6 mL cell 
“solution” and swirled very gently until the glycerol was mixed to homogeneity and 
cells were resuspended. 150 µL aliquots of the cells were taken and transferred into 
sterile, cooled (-20oC) 1.5 mL microcentrifuge tubes. The cells were then flash frozen or 
left in the -80oC to freeze. They were then stored at -80oC until needed. 
3.2.13 Transformation into chemically competent E. coli TOP10, DH5α 
and BL21 (DE3) 
The following protocol was used to transform ligated plasmids or control plasmid into 
competent E. coli cells. A 150 µL aliquot of competent cells was taken out of the -80°C 
freezer and stored on ice. A thawed ligation product or plasmid was then removed 
from the microcentrifuge tube and an aliquot was inserted into the correctly labelled 
tube containing the competent cells. The sample was left on ice for 30 min before 
being heat shocked at 42°C in a water bath for 90 s to allow the ligated vector or 
plasmid to be transformed into the cells through the disruption of the cell membrane. 
The cells were then put back onto ice for a few min before having 200 µL of LB added 
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to them and then stored at 37°C, 180 rpm for at least an hour to allow the cells to 
repair. Following the cells storage at 37°C, 180 rpm they were then plated out on LB 
agar plates containing the desired antibiotic (section 3.2.16) ensuring that strict aseptic 
technique was adhered to.  
Table 3.6 - Transformation into TOP10 
Reactant Volume used 
E. coli TOP10 150 µL 
Ligation product 10 µL 
LB 200 µL 
Total volume 360 µL 
3.2.14 - Preparation of electrocompetent cells 
Electrocompetent cells provide another method of transferring DNA into bacteria. The 
day before making electrocompetent cells, 100 mL of MQ water, 50 mL of 10% 
glycerol, 100 mL of LB and ~100 1.5 mL microcentrifuge tubes were sterilised. Water 
and 10% glycerol was stored at 4°C. An overnight culture of the desired E. 
coli/LB/antibiotics was put up. 
The next day, 1 mL of LB was put aside for an OD600 (zero) blank.  1 mL of the overnight 
culture was added to 100 mL of LB in a 250 mL flask and incubated at 37°C, 200 rpm 
(unless temperature sensitive plasmids were involved) for 1.5 hrs with OD600 readings 
then being taken every 15 mins in a spectrophotometer. When the OD600 reached 
roughly 0.5 (not more than 1.0) the culture was put on ice for at least 10 mins, with 
occasionally swirling. The 100 mL of cells were spun down cells in 2 red topped 50 mL 
falcon tubes at 4500rpm for 10 mins at 4oC. The supernatants were discarded and the 
pellets resuspended and combined in 25 mL of ice cold MQ. The centrifugation, 
discarding of supernatant and resuspension in 25 mL of ice cold MQ was repeated 
twice more. The cells were spun down at 4500rpm for 10 mins at 4oC and resuspend in 
2 mL of ice cold 10 % glycerol. The cells were the split into 150 µL aliquots in each 
sterile microcentrifuge tube. The cells were then ready for electroporation or storage 
at -80°C for later use. 
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3.2.15 - Electroporation into electrocompetent cells 
Electrocompetent cells were used throughout this thesis for recombination events as 
described in section 3.2.27. The following protocol details how this was done. 
150 µL aliquot of electrocompetent cells was taken and no more than 10% DNA was 
added to it, followed by mixing and incubation on ice for 30 mins. Cells were added to 
0.1 cm electroporation cuvettes and tapped to ensure removal of any bubbles. The 
cuvette containing the sample was then inserted into the electroporation holder 
attached to the Biorad gene pulser Xcell (Hercules, CA, USA). The pre-set E. coli 
protocol listed under bacteria was used with the following parameters; Exponential 
decay pulse type, pulse length – 25 ms, capacitance, 200 pF, for a 0.1 cm cuvette. 
Recommended sample volume is 20 µL but 150 µL was successfully used on numerous 
occasions. A time constant between 4.8 and 5.1 was preferable for successful 
transformations but this cannot be controlled. 
Following electroporation, 1 mL of LB media was immediately added to the 
electroporation cuvette. The cells were gently mixed in the LB solution then 
transferred to a sterile 1.5 mL microcentrifuge tube. Unless temperature sensitive, the 
cells were transferred to a 37 °C incubator, 200 rpm for 1.5 hrs and then plated onto 
selective antibiotic agar plates. 
3.2.16 Plating bacteria 
Prior to plating, LB agar plates were surface dried by placing open face down at 65 °C for 
10 min. A glass spreader was sterilised by immersion in 70 % (v/v) ethanol and the excess 
ethanol was removed by passing the spreader through a blue Bunsen flame. Once the 
spreader had cooled it could then be used to spread 50-200 mL of bacterial suspension 
evenly over the surface of the agar until the solution had adsorbed sufficiently into the 
agar. 
The plates were then stored at 37°C for 16 h to allow the cells to grow. 
The cultures that were present on the plates after they had been left in the incubator 
were regarded as containing the recombinant gene and were then grown in liquid 
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culture containing the desired antibiotic. If this was successful then the cells were 
ready to have minispin DNA extracted from them. 
3.2.17 Minispin plasmid DNA purification protocol 
The minispin DNA preparation technique provides a method for obtaining a very high 
purity plasmid DNA product. The procedure used for this was followed as detailed in 
the manufacturer’s manual. 
3.2.18 Maxiprep plasmid DNA purification protocol 
The Qiagen Maxiprep kit provides a method to harvest a much greater yield of high 
quality plasmid than a minispin column. This procedure requires a much larger volume 
of culture to harvest the plasmid. The copy number of the plasmid determines the 
volume of the main prep culture. A low copy number plasmid will require between 200 
and 500 mL of culture (ensure that media makes up a max of 2/5 of the available 
volume in flask) whereas a high copy number plasmid will require between 100 and 
200 mL of culture. The protocol is as detailed. 
10 mL overnight starter culture was grown up from a plate containing the desired 
plasmid. This was (unless temperature sensitive) kept at 37°C, 200 rpm for 16 hrs. A 1 
in 100 dilution of overnight culture into LB media was done. The volume used 
depended on the plasmid to be harvested. The culture was kept at 37°C (unless 
temperature sensitive), 200 rpm for 16 hrs. The culture was spun down at 6000 rpm, 
15 mins with the supernatant being discarded. The pellet was resuspended in 10 mL of 
buffer P1, containing lyseblue and RNase A. 10 mL of buffer P2 was then added and 
the sample was mixed by inverting 4-6 times. The sample was then left a room 
temperature for no longer than 5 mins. Due to the prior addition of lyseblue, the 
solution all turned blue. 10 mL of pre-chilled buffer P3 was then added and the 
solution was mixed by inversion again. The sample changed from blue to yellow (cell 
lysates) with white particulate matter (cellular debris, including cell membrane and 
proteins). Sample was then kept on ice for 20 mins. Sample was centrifuged at ≥20,000 
x g for 30 mins at 4°C. Supernatant was immediately transferred to a fresh container. 
Cell debris, pelleted at the bottom of old container was discarded. Centrifugation was 
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carried out on the sample again. ≥20,000 x g for 15 mins at 4°C. Supernatant was 
immediately removed and kept, with any remaining pellet discarded. A Qiagen-tip 500 
was equilibrated by applying 10 mL of buffer QBT to the top and the solution allowed 
to flow through by gravity. The retained supernatant was then added to the 
equilibrated column. Following binding of sample to the column, the flow through was 
discarded and the column was washed with 2 x 30 mL of buffer QC. The column was 
moved to a fresh container and the DNA was then eluted with 15 mL of buffer QF. DNA 
was precipitated by adding 10.5 mL of room temperature isopropanol to the eluted 
DNA. This was then mixed and centrifuged immediately at ≥15,000 x g for 30 mins at 
4°C. The solution was then carefully decanted, ensuring the pellet was not disturbed. 5 
mL of room temperature 70% ethanol was then added and the sample was centrifuged 
at ≥15,000 x g for 10 mins at 4°C. The solution was then decanted, ensuring the pellet 
was left undisturbed, any remaining supernatant was the aspirated and the sample 
was left to air dry for 10-15 mins. The DNA pellet was then resuspended in between 
250 and 400 µL of 1 x TAE and the sample was stored at -20°C for later use. 
3.2.19 DNA sequencing 
All sequence verification was carried out at the University of Sheffield Medical School 
core genomic facilities. Data files were sent back as SEQ (notepad readable) and ABI 
format chromatogram file (FinchTV compatible), providing the option to look through 
a FASTA type format of the data or view the chromatogram for manual identification. 
3.2.20 Protein extraction protocol 
Based on T7 extraction protocol (TB125 T7 Tag Affinity Purification Kit) using Wash 
Buffer 10x (1.5 M NaCl and 1 M Tris-HCl pH 8.0) – i.e. no EDTA for Metalloproteins; 1.5 
M NaCl, 1 M Tris-HCl, 10 mM EDTA, pH 8.0 for other proteins. 
Protein extraction solutions 
 120 mL 1X Wash Buffer (150 mM NaCl, 100 mM Tris-HCl, 1 mM EDTA, pH 8.0) 
used for non-metalloproteins 
 25 mL  1X Elution Buffer with biotin (150 mM NaCl, 100mM Tris-HCl, 1 mM 
EDTA, 2 mM D-biotin, pH 8.0) 
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Additional components required: 
o Ice 
o 0.45 micron membrane syringe-end filters 
o Glass beads, acid washed, 425-600 μm (G8772 Sigma Aldrich) 
Prepare reagents: 
10x Wash Buffer for metalloproteins - 1.5 M NaCl and 1 M Tris-HCl pH 8.0 (100 mL) 
Take 60 mL of ddH2O  
Add 8.766 g of Sodium Chloride (NaCl MW 58.44) 
Add 12.114 g Trizma (Tris(hydroxymethyl)aminomethane - C4H11NO3 MW 
121.14)  
Adjust pH to 8.0 with HCl 
Take up to 100 mL with ddH2O 
1x Wash Buffer for extracting insoluble proteins – 6 M Urea, 150 mM NaCl , 100 mM 
Tris-HCl, 1 mM EDTA, pH 8.0 (100 mL) 
Take 30 mL of ddH2O  
Add 36.036 g of Urea (mW 60.60) 
Add 0.8766 g of Sodium Chloride (NaCl mW 58.44) 
Add 1.2114 g Trizma (Tris(hydroxymethyl)aminomethane - C4H11NO3 mW 
121.14)  
Add 0.0292 g EDTA (mW 292.24) 
Adjust pH to 8.0 with HCl 
Take up to 100 mL with ddH2O 
1x Wash Buffer for Bind/Wash insoluble proteins – 2 M Urea, 150 mM NaCl , 100 mM 
Tris-HCl, 1 mM EDTA, pH 8.0 (100 mL) 
Take 30 mL of ddH2O  
Add 12.012 g of Urea (mW 60.60) 
Add 0.8766 g of Sodium Chloride (NaCl mW 58.44) 
Add 1.2114 g Trizma (Tris(hydroxymethyl)aminomethane - C4H11NO3 - mW 
121.14)  
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Add 0.0292 g EDTA (mW 292.24) 
Adjust pH to 8.0 with HCl 
Take up to 100 mL with ddH2O 
1x Elution Buffer for with biotin for insoluble proteins – 2 M Urea, 150 mM NaCl, 
100mM Tris-HCl, 1 mM EDTA, 2 mM D-biotin, pH 8.0 (100 mL) 
Take 30 mL of ddH2O  
Add 12.012 g of Urea (mW 60.60) 
Add 0.8766 g of Sodium Chloride (NaCl mW 58.44) 
Add 1.2114 g Trizma [Tris(hydroxymethyl)aminomethane - C4H11NO3 mW 
121.14]  
Add 0.0292 g EDTA (mW 292.24) 
Add 0.0490 g D-biotin (mW 244.3) 
Adjust pH to 8.0 with HCl 
Take up to 100 mL with ddH2O 
3.2.20.1 Cell Extract Preparation – Soluble Proteins: 
1. The extraction of metalloproteins was done (as must be) with 1 x wash buffer 
without EDTA with all other proteins suitable to be extracted with EDTA in 1 x 
wash buffer. Buffers were kept ice cold for cell resuspension. 
2. Cells were harvested by centrifugation at 2800 RPM for 10 mins. The supernatant 
was decanted and the cell pellet allowed to drain as completely as possible. Cells 
were resuspended in 1-15 mL of ice-cold wash buffer (volume as required), 
depending if metalloprotein or not (check step 1). 
3. Using 425-600 µM glass beads, the following steps were applied: 
a. The same weight of glass beads as to the volume of the cell pellet was 
added, i.e. 0.2 g for 0.2 mL. 
b. Sample was placed on a bead beater for 3x1 min, allowing for 5-10 sec 
rest between each 1 min to prevent overheating. 
c. Tubes were placed on ice for 5 mins to prevent overheating and step b 
was repeated again. 
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Tip: Check carefully for beads between the lid and the tube as this can cause 
leaks and result in sample loss. 
4. Lysate was centrifuged at 21,000 x g for 30 min at 4C to remove debris. Lysate 
was then stored at -20°C. 
5. If stored, lysate was centrifuged at 13,000 RPM for 5 min at 4°C, to remove 
aggregates that may have formed during storage. 
3.2.20.2 Cell Extract Preparation – Insoluble Proteins: 
This procedure was used for the extraction of insoluble proteins. This was done on cell 
samples following the extraction of soluble proteins. The addition of 6M urea to the 
bind/wash buffer aided in the solubilisation of proteins. This following protocol details 
extraction of proteins starting from cell harvesting: 
1. Cells were harvested by centrifugation at 2800 RPM for 10 mins. Supernatant 
was decanted and excess liquid removed by aspiration. Cell pellets were 
resuspended in 1-15 mL 1X Bind/Wash buffer that does not contain urea (volume 
as required). 
2. Samples were vortexed to resuspend the pellet followed by the use of glass 
beads to shear DNA: 
3. 425-600 µM glass beads were used with application of the following steps: 
a. The same weight of glass beads was added equal to the volume of the 
cell pellet, i.e. 0.2 g for 0.2 mL. 
b. Pellet was placed on a bead beater for 3x1 min, allowing for 5-10 sec rest 
between each 1 min to prevent overheating. 
c. Tubes were placed on ice for 5 mins to prevent overheating with step b 
being repeated again. 
4. Samples were centrifuged at 20,000×g for 15 mins to collect the inclusion bodies 
and cellular debris while leaving other proteins in solution. 
5. Supernatant was removed and the pellet was resuspended in same volume of 1X 
Bind/Wash buffer (without urea) used in step 1. Vortex was sometimes 
necessary to resuspend the pellet. Steps 3-5 were repeated. 
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6. Supernatant was removed from the final centrifugation and the pellet was 
resuspended in 1 mL of 1X Wash Buffer containing 6M urea. Sample was 
incubated on ice for 1 hour to completely dissolve the protein. Insoluble material 
was removed by centrifugation at 21,000 x g for 30 min at 4C and the 
supernatant harvested as the insoluble fraction. 
3.2.20.3 Protein extraction in specific relation to MFC iTRAQ 
The following describes the method used for the collection of cells and protein 
extraction used within the iTRAQ detailed in chapter 5. 
The electroactive biofilms in the MFCs were extracted into 40 mL phosphate buffered 
saline (PBS) and, taking into account the production of cells in the MFC effluent, their 
specific growth rate was calculated with methods as described in (211,212). The 
specific formula used was: 
µ (h-1) = production rate of cells in culture (cells h-1)/ biofilm population (total number 
of cells) 
The M1 supply-rate to planktonic continuous-culture in the chemostat was 
subsequently adjusted so that the growth rate of these cultures would match the 
calculated MFC biofilm growth rates, following which samples from the chemostat 
were also acquired (2x20 mL).  
From each phenotype, insoluble and soluble proteins were extracted from 2 biological 
replicates each before an iTRAQ-based quantitative proteomic analysis was carried 
out. The extraction of insoluble and soluble proteins followed two protocols (213,214), 
with some modifications as detailed elsewhere (215). Cells were resuspended with 43 
mM NaCl, 81 mM MgSO4, 27 mM KCl buffer or 1 M TEAB 
(triethyloammoniumbicarbonate; pH 8.5), 0.12% SDS buffer for the insoluble and 
soluble protein extraction, respectively. The former buffer used was devoid of 
detergents to achieve the isolation of the insoluble fraction (i.e. fraction not dissolved 
in high salt contents buffers used for extractions), whilst the latter buffer used both 
TEAB and SDS to achieve more denaturation of proteins as well as solubilisation of 
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membrane proteins. Protein extraction of both fractions was carried out using an ultra 
sonicator (Sonifier 450, Branson) 10 times (alternatively 30 s of sonication and 1 min 
on ice) at 80% duty cycle, followed by liquid nitrogen cracking and water bath 
sonication with ice for 15 min. Samples were then centrifuged at 2,000 x g for 5 min at 
4 °C to discard unbroken cells and debris, the supernatant collected was then 
centrifuged at 100,000 x g for 2 hrs or 21,000 x g for 30 min for insoluble and soluble 
fractions, respectively. Before the total protein concentration was determined from 
both fractions using the RC-DC Protein Quantification Assay (Bio-Rad, UK), soluble and 
peripheral membrane proteins were removed from the insoluble fraction by washing 
the pellet with ammonium carbonate (pH 11)(216) and the pellet resuspended in 1 M 
TEAB, 0.12% SDS buffer. 
3.2.21 Protein quantification assay – Bradford ultra 
For quantification of proteins a Bradford ultra (Expedeon, Harston, UK) assay was 
carried out. Bradford ultra provides an advantage over standard Bradford due to its 
tolerance of detergents (up to 1%).  
In order to be able to determine the concentration of a protein a standard curve must 
be made using a suitable protein standard, such as bovine serum albumin (BSA). The 
range of the standard curve will depend on the approximate concentration range the 
target protein lies. 
For high protein range, a dilution series between 0.1 mg/mL and 1.5 mg/mL was 
required. For a low protein range this may lie between 1 µg/mL and 25 µg/mL. The 
following methodology considers a high protein range. 
1. The test samples, standards (for the defined protein range) and blank (same 
buffer as protein samples are stored in but with no protein) were mixed with 
Bradford ultra reagent in a 1:15 ratio of sample to reagent. The cuvette based 
method made use of 100 µL of sample and 1.5 mL of reagent. All samples, 
standards and blanks were done in triplicate. 
2. Absorbance was read at 595 nm. 
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3. Sample readings were corrected against the blank, the standard curve plotted 
and the protein concentration read off protein samples against this. 
3.2.22 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS PAGE) 
SDS-polyacrylamide gels were cast between two glass plates that had been cleaned 
using 50% (v/v) ethanol. The dimensions of these plates were (10.1 x 7.2 and 10.1 x 8.2 
cm) with the larger plate having 0.75 mm spacer ridges attached to it. The two plates 
were clamped together, making sure that they were correctly positioned with both 
their bottoms flush. The components for the 12% (w/v) resolving gel were mixed 
together in a plastic universal and then pipetted between the two plates until the 
solution was approximately 2cm from the top of the smallest plate. To ensure that the 
resolving gel had a straight top edge, water was pipetted over the top of the gel until it 
began to overflow from the top. The gel was left like this for around 20 min to allow it 
to polymerise. After this period, the water was poured off, leaving a solid, straight 
topped resolving gel. To ensure that no water was left sitting on top of the gel, thin 
strips of blotting paper were dabbed lightly just above the top of the gel. The 
components of the stacking gel were mixed together in a small conical flask and then 
pipetted into on top of the resolving gel until the top of the small plate. A 10 – toothed 
comb was then immediately inserted into the gap between the plates and the gel was 
allowed to set for 20 min before the comb was removed. The wells of the gel were 
rinsed with distilled water to remove any gel debris. The gels were then removed from 
the clamps that were used to set the gels and moved into the electrophoresis module 
ensuring that the smaller plates were facing inwards to create a central reservoir. 
 
 
 
 
117 | P a g e  
 
Table 3.7 - Resolving gels 
Running buffer (1x) (Appendix) was poured into the tank up to the desired level, 
making sure that no bubbles were produced that could affect the running of the gel. 
The gels had 5 µL of broad range molecular weight marker (191, 97, 64, 51, 39, 28, 19 
and 14 kDa) added to one of the wells. The CFE samples that were frozen away were 
boiled again and the 25 µL sample was loaded onto the gel along with 25 µL of the 
solubilisation buffer samples. The gels were then run at a constant 200V for 40 min. 
3.2.23 Staining and transfer of SDS-PAGE 
Depending on the type of work being carried out, different stains were employed on 
SDS-PAGE gels: 
3.2.23.1 Instant Blue 
Once the gels had run for a sufficient amount of time, they were then carefully removed 
from the electrophoresis module and taken out from between the plates. The gels were 
Reactant Volume used 
40% (w/v) solution 37.5:1 acrylamide: bisacrylamide 3.0 mL 
Solution B (appendix section 7.2) 2.5 mL 
18.2 MW/cm H2O 4.5 mL 
10 % (w/v) ammonium persulphate 20 µL 
Tetramethylethylenediamine (TEMED) 10 µL 
Total volume 10.03 mL 
 
Table 3.8 - Stacking gels 
Reactant Volume used 
40% (w/v) solution 37.5:1 acrylamide: bisacrylamide 0.5 mL 
Solution C (appendix section 7.2) 1.0 mL 
18.2 MW/cm H2O 2.5 mL 
10 % (w/v) ammonium persulphate 30 µL 
Tetramethylethylenediamine (TEMED) 10 µL 
Total volume 4.04 mL 
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placed into plastic containers and had Instantblue (Expedeon, Harston, UK) stain poured 
over them until covered and then were left for 10 min. The stain was then poured off 
and the gels were washed in distilled water to remove any residual stain. Gels were then 
suitable for visualisation and further analysis if required. 
3.2.23.2 Silver stain 
Silver stain provides a more sensitive method of visualising proteins from SDS-PAGE 
gels. The added flexibility of choosing the period to halt the staining and the 
compatibility with mass spectrometry downstream makes the Pierce (Rockford, IL, 
USA) “sliver stain for mass spectrometry - 24600” a very appealing option. It is 
important that no metal utensils are used during this procedure. 
The following solutions were required and must be made up for this procedure. Any 
other solutions mentioned with the recipe not stated are supplied in the kit: 
Fixing solution 
60% distilled water, 30% ethanol, 10% acetic acid 
Stop solution 
95% distilled water, 5% acetic acid 
Ethanol wash 
90% distilled water, 10% ethanol 
The procedure for this stain was followed as detailed: 
1. The gel was washed in ultrapure water for 5 mins. The water was replaced and 
the gel was washed for another 5 mins. 
2. Water was poured off and 20 mL of fixing solution was added to the gel. Gel 
was incubated at room temperature for 15 mins. The solution was replaced and 
left for another 15 mins. 
3. The gel was washed with ethanol wash for 5 mins. The solution was replaced 
and the gel was washed for a further 5 mins. 
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4. The gel was washed in HPLC grade water for 5 mins. The solution was replaced 
and the gel was washed for a further 5 mins. 
5. Immediately prior to use, sensitiser working solution was prepared by mixing 1 
part silver stain sensitiser with 500 parts ultrapure water (50 µL sensitiser with 
25 mL distilled water). 
6. The gel was incubated in sensitiser working solution for exactly 1 min then 
wash with 2 changes of HPLC grade water for 1 min each. 
7. 1 part silver strain enhancer was mixed with 100 parts silver stain (250 µL 
enhancer with 25 mL stain) and immediately added to the gel following 
removal of HPLC water and incubated for 5 mins. 
8. Developer working solution was prepared by mixing 1 part silver stain enhancer 
with 100 parts silver stain developer (250 µL enhancer with 25 mL developer). 
Making sure not add to the gel at this point. 
9. The gel was quickly washed with two changes of HPLC grade water for 20 secs 
each. 
10. Developer working solution was immediately added and incubated until protein 
bands appear (2-3 mins). This was the optimal recommended time and 
background was noted to increase past this point although at times 
development has been extended up to 5 mins. Must be watched at all times. 
11. At the point where desired band intensity was reached, developer working 
solution was replaced with stop solution. Gel was washed briefly then replace 
with fresh stop solution and incubate for 10 mins. 
12. The gel was then ready for image analysis or further downstream processing. 
3.2.23.3 Western blot 
Western blots provide a very simple method for specifically detecting proteins within a 
sample. This antibody based method can target a defined region and help provide 
verification or absence of the protein of interest. Developments in the use of western 
blotting have allowed for increased simplicity in the technique, the Invitrogen iBlot 
system is an example of this. The following protocol was used for transferring the 
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protein from an SDS-PAGE gel to nitrocellulose paper and then performing a western 
blot following using this setup: 
Protein transfer to nitrocellulose paper 
1. The iBlot device was opened, the anode stack unsealed, making sure to keep it 
in its plastic tray. The anode stack was inserted, with the plastic tray touching 
the bottom, securely onto the iBlot device. 
2. Following the running of an SDS-PAGE gel, the plates were carefully “cracked” 
open and the gel placed on top of the anode stack making sure not to leave any 
bubbles. Any bubbles were removed using a plastic roller. 
3. Place pre-soaked filter paper over the top of the gel and use plastic roller to 
remove any bubbles. 
4. The cathode stack was unsealed, the plastic tray discarded and the gel coated 
side placed down on top of the filter paper. The roller was to ensure good 
contact. 
5. The disposable sponge was placed on top of the cathode stack with the metal 
contact facing upwards. 
6. The iBlot device was switched on. 
7. The lid of the iBlot was sealed, ensuring that the red light was shown. This 
denoted proper contact throughout the setup. 
8. The desired program was chosen (default of P3: 20V, 7 mins) and the red 
button pressed to start the transfer of the proteins to the nitrocellulose paper. 
9. Following the 7 min transfer time, the lid was opened, the sponge, cathode 
stack, filter paper and gel removed and discarded.  
10. The nitrocellulose paper was removed and transferred to a suitable container 
for blocking. 
11. The remaining anode stack was removed and the iBlot machine switched off if 
no longer needed.  
Blocking and detection of antibodies 
Materials required: 
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1 x Tris buffered saline with 0.1% Tween 20 (TBS/T)  
Blocking buffer – TBS/T with 5% skimmed milk powder 
1. The nitrocellulose paper obtained from the iBlot transfer was left in 20 mL 
blocking buffer for an hour at 4°C. 
2. Blocking buffer was poured away and replaced with fresh blocking buffer plus 
an appropriate dilution of a primary antibody (1:10,000 of blocking buffer to 
antibody is relatively standard). The sample was left overnight at 4°C. 
3. Blocking buffer was poured away and the sample was washed three times with 
TBS/T for 5 mins each. To ensure a clean sample the container was washed 
multiple times with TBS/T to help remove any remaining blocking buffer. 
4.  The membrane was blocked in blocking buffer with the recommended dilution 
of the secondary antibody for 1 hour at room temperature. 
5. Blocking buffer was poured away and the sample was washed three times with 
TBS/T for 5 mins each. To ensure a clean sample the container was washed 
with TBS/T to help remove any remaining blocking buffer. 
6. Abcam chemiluminescent reagent kit (ab79907 - Abcam, Cambridge, UK) was 
used to detect samples. 1 drop of oxidant reagent B was added to 1 mL of 
substrate reagent A and poured over the membrane immediately. 
7. The membrane was then be visualised on a gel doc using the chemiluminescent 
feature. 
3.2.24 Culture media 
The culturing of bacteria, unless otherwise stated was carried out using Lysogeny broth 
at 37 °C, 200 rpm. 
3.2.25 Cell growth 
As some of the cells that were to be tested in the MFC contained multiple plasmids 
and therefore required the use of different antibiotics simultaneously, a single culture 
was taken from a plate and inoculated into 100 mL of LB in a 250 mL conical flask 2 
days before it was required for testing. The culture was then incubated at 37°C and 
200 rpm for 16 hrs. 1 mL of this culture was then transferred to another 100 mL conical 
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flask of LB at 2 pm the day before it was required for testing and stored at 37°C and 
200 rpm until 10 am the next day.  
3.2.26 Induction 
Unless otherwise stated, inductions were carried out as follows: 
1. Single colony picked from plate and transferred into LB with appropriate 
antibiotics. Grown at 37°C and 200 rpm overnight. 
2. 1 mL of the culture was taken and transferred to 100 mL conical flask on LB 
along with the appropriate antibiotics. This was transferred to a shaking 
incubator at 37°C and 200 rpm for 1.5 hrs. 
3. OD 600 checked every 20 mins until an OD of 0.5 was reached. 
4. Protein expression was induced with 1 mM IPTG and cells were returned to 
37°C and 200 rpm overnight. 
3.2.27 Recombination 
Lambda red recombination was employed during this project for the modification of 
plasmids. The protocol used for this was adapted from Datsenko and Wanner (210). 
The use of the pKD based lambda red recombination system required growth at 30°C 
with induction of the recombination machinery through the use of arabinose. During 
this thesis, it was noted that the cells grew too slowly at 30°C to be able to effectively 
work with them on the same day as starting the culture. A culture was instead setup 
the night before needed for use and the cells induced with arabinose at that point: 
1. A single colony containing the recombination plasmid pKD46 was picked from a 
plate and transferred to 10 mL LB with 10 µg/mL ampicillin. 
2. This was grown at 30°C and 200 rpm overnight. 
3. 18 hrs before cells were needed, 10 µL of culture was taken and transferred to 
a fresh 10 mL LB culture with 10 µg/mL ampicillin and 5 mM arabinose. This 
was grown at 30°C and 200 rpm for 18 hrs. 
4. Cells were spun down at 4000 rpm for 10 mins at 4°C. 
5. The supernatant was discarded and the cell pellet gently resuspend in 1 mL of 
ice cold sterile distilled water. 
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6. Solution was spun down at 4000 rpm for 2 mins at 4°C. The water was then 
removed. 
7. Steps 5 and 6 were repeated twice more. 
8. The cell pellet was resuspended in 100 µL of sterile distilled water. 
9. 30 µL was removed and set aside as a control. 
10. 100 ng of purified PCR DNA was added to the remaining cells. 
11. Protocol detailed in 2.2.14 was followed for electroporation procedure. 
12. Outgrowth was done at 37°C as temperature sensitive pKD46 was no longer 
required. 
13. To increase efficiency, plating out was done on lower concentration resistance 
plates (typically 40% of normal concentration) as this boosted the number of 
colonies. 
14. Screen was carried out as required with PCR and sequencing verification. 
3.2.28 Transposon based insertion 
A method of chromosomal insertion fixed to a defined position in the chromosome 
compared to the much more versatile recombination method. This was adapted from 
McKenzie and Craig (217). This paper details the potential for this system to be able to 
insert sequences up to 14 kb in size and has function in multiple organisms. Other 
notable references - (218)(219). The methodology for chromosomal insertion using 
attenuation is detailed below: 
Note – pGRG36 is temperature sensitive and must be grown at 30°C to allow for 
plasmid replication 
1. The GOI was cloned into the MCS of pGRG36 making sure that the Tn7 flanking 
arms are left intact.  
2. The recombinant plasmid was transformed into the desired host strain for 
chromosomal insertion and colonies selected for on Ampicillin LB plates 
overnight at 30°C. 
3. Colonies were then grown in 10 mL of antibiotic free LB media at 200 rpm, 30°C 
for 18 hrs. 
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Note – the original paper (217) reports that no induction was required for the 
chromosomal insertion of the GOI due to leaky expression. pGRG36 is 
arabinose inducible to allow for increased expression if required. Repression 
of the transposase system can also be done using 0.1% glucose. 
4. Cells were plated out on antibiotic free LB agar plates and stored overnight at 
42°C for removal of the plasmid. 
5. Colonies were selected for detection of insertion using PCR with the following 
primers that flank the attTn7 site: 
FP: 5'GATGCTGGTGGCGAAGCTGT 
RP: 5'GATGACGGTTTGTCACATGGA 
6. Determination of the removal of the plasmid was then determined by 
Ampicillin sensitivity. 
3.2.29 Tandem affinity purification 
Tandem affinity purification provided a method of doubly purifying the desired target 
protein. This was done through the use of two affinity tags, in this case a SPA tag was 
used (3 x FLAG tag and a calmodulin binding peptide with a TEV protease site between 
the two tags). This technique allows for either very high purification of a target protein 
or can be adapted for use in protein interaction work. The original paper detailing this 
is by Zeghouf et al (220) and further application in E. coli (208). The SPA-tag was 
attached to the C-terminus of target proteins in this study with overlap PCR being used 
to achieve this (details of overlap PCR in section 3.2.6). The following describes the 
process of tandem affinity purification of a SPA-tagged protein for interaction work 
with for the expression of a SPA tagged OmcA protein in pACYCOmcA: 
The following reagents and solutions were required: 
Wash buffer 
Tris-buffered saline (TBS, Product No. 28360) containing 0.05% Tween-20 Detergent 
and 0.5M NaCl 
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AFC buffer 
30 mM Tris-HCl, 150 mM NaCl, 0.1% detergent, and 0.1-0.5 mM TCEP [tris (2-
carboxyethyl) phosphine-hydrochloric acid] 
TEV protease buffer 
~5 to 10μl (50 units) of TEV protease and 400 μL of 1X AFC buffer 
Calmodulin elution 1X stock buffer:  
10 mL of 1X calmodulin elution stock buffer containing 50 μL of 2 M Tris-HCl (pH 7.9), 1 
mL of 1 M ammonium hydrogen carbonate (NH 4 HCO 3 ), 150 μL of 0.2 M EGTA, 7 μL 
of 14 M β-mercaptoethanol, and 8.8 mL of sterile distilled water. 
1. Primers were designed for insertion of the SPA-tag by amplifying the desired 
region from pJL148 and attachment of the genetic sequence to the target 
protein sequence (OmcA). 
2. Sequence verified tagged plasmid was transformed into the desired expression 
strain (BL21 DE3) and plated onto selective antibiotic plate (Cm). 
3. A single colony was picked and grown in 10 mL LB media at the required 
temperature (37°C), with antibiotics (20 µg/mL Cm) and rotation (200 rpm) and 
grown overnight. 
4. 1 mL of overnight culture was taken and transferred to 100 mL of LB in a 250 
mL flask with fresh antibiotics. Grow at 200 rpm, 37°C for 18 hrs. 
5. Cell pellets were harvested by spinning down the culture at 4000 x g for 15 
mins at 4°C. 
6. The desired cell extract as produced as described in section 3.2.20. 
7. A 50 µL sample was taken and combined with 10 µg of antibody. The sample 
volume was adjusted to 500 μL with cell lysis buffer. This was rocked at room 
temp for 1-2 hrs. 
8. 25μL (0.25mg) of Pierce Protein A/G Magnetic Beads were placed into a 1.5mL 
micro centrifuge tube. 
9. 175μL of Wash Buffer was added to the beads and gently vortexed to mix. 
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10. The tube was placed into a magnetic stand to collect the beads against the side 
of the tube. The supernatant was removed and discarded. 
11. 1mL of Wash Buffer was added to the tube, inverted several times or gently 
vortexed to mix for 1 minute. The beads were collected with a magnetic stand. 
The supernatant was removed and discarded. 
12. The antigen sample/antibody mixture was added to a 1.5mL micro centrifuge 
tube containing pre-washed magnetic beads and incubated at room 
temperature for 1 hour with mixing. 
13. The beads were collected with a magnetic stand and the flow-through removed 
and saved for analysis. 
14. 500μL of Wash Buffer was added to the tube and gently mixed. The beads were 
collected and the supernatant discarded. Wash step was repeated twice. 
15. 500μL of purified water was added to the tube and gently mixed. The beads 
were collected on a magnetic stand and the supernatant discarded. 
16. Cleavage of the TEV protease site was then performed by adding ~5 to 10μl (50 
units) of TEV protease and 400 μL of 1X AFC buffer onto the column. The top of 
the column was closed with a cap. The column containing the beads were 
rotated gently overnight at 4 °C using a LabQuake shaker. 
17. Eluate was collected and transferred into a tube with 10 µg of Anti-CBP. 
18. Steps 2 to 9 were continued as before and the proteins eluted with 1 x 
calmodulin elution buffer. 
3.2.30   Immunoprecipitation  
The following protocol was provided for manual immunoprecipitation using Pierce A/G 
magnetic beads (88802 – Pierce, Rockford, IL, USA): 
Materials and solutions required: 
 
• 1.5mL micro centrifuge tubes 
• Wash Buffer: Tris-buffered saline (TBS, Product No. 28360) containing 0.05% Tween-
20 Detergent and 0.5M NaCl 
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• Low pH Elution Buffer: IgG Elution Buffer, pH 2.0 (Product No. 21028) or 0.1M 
glycine, pH 2.0 
• Alternative Elution Buffer: SDS-PAGE reducing sample buffer 
• Antibody for immunoprecipitation 
• Antigen Sample 
• Cell Lysis Buffer (used to adjust IP reaction volume) 
• Neutralisation Buffer: High-ionic strength alkaline buffer such as a 1M phosphate 
or 1M Tris; pH 7.5-9 
•Magnetic stand (e.g., MagnaBind Magnet for 6 ×1.5mL Micro centrifuge Tubes, 
Product No. 21359) 
 
Note:  This protocol provides a general guideline for immunoprecipitation but 
required optimisation for each application. 
 
1. The antigen sample was combined with 10μg of antibody. The reaction volume 
was adjusted to 500μL with the Cell Lysis Buffer.  The reaction was incubated 
for 1-2 hrs at room temperature or overnight at 4°C with mixing. 
2. 25μL (0.25mg) of Pierce Protein A/G Magnetic Beads were placed into a 1.5mL 
micro centrifuge tube. 
3. 175μL of Wash Buffer was added to the beads and gently vortexed to mix. 
4. The tube was placed into a magnetic stand to collect the beads against the side 
of the tube. The supernatant was removed and discarded. 
5. 1mL of Wash Buffer was added to the tube. The tube was inverted several 
times or gently vortexed to mix for 1 minute. The beads were collected with a 
magnetic stand. The supernatant was removed and discarded.  
6. The antigen sample/antibody mixture was added to a 1.5mL micro centrifuge 
tube containing prewashed magnetic beads and incubated at room 
temperature for 1 hour with mixing. 
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7. The beads were collected with a magnetic stand and the flow-through removed 
and saved for analysis. 
8. 500μL of Wash Buffer was added to the tube and gently mixed. The beads were 
collected and the supernatant discarded. The wash step was repeated twice. 
9. 500μL of purified water was added to the tube and gently mixed. The beads 
were collected on a magnetic stand and the supernatant discarded. 
10. Low-pH Elution: 100μL of Low-pH Elution Buffer was added to the tube. The 
tube was incubated at room temperature with mixing for 10 mins. The beads 
were magnetically separated and the supernatant containing target antigen 
saved. 
To neutralise the low pH, 15μL of Neutralisation Buffer was added for each 100μL of 
eluate.  
Alternative Elution: 100μL of SDS-PAGE reducing sample buffer was added to the tube 
and the samples heated to 96-100ºC in a heating block for 10 mins. The beads and 
were magnetically separated and the supernatant containing target antigen was saved. 
3.3 Proteomics techniques and mass spectrometric analysis 
3.3.1 In gel digest 
Following gel staining, further analysis of particular protein bands was at times carried 
out using mass spectrometry. The method used following coomassie or instant blue 
staining is detailed here: 
When using 1-D gels, reduce the size of gel pieces to 1-2 mm in each dimension with a 
clean scalpel.  Pieces that are too large will resulted in reduced peptide recovery. 
Pieces that are too small can be lost during pipetting steps. 
1) Stock Solution Preparation 
Reduction buffer  
10mM Dithiothreitol (DTT) solution 
 2.3145 mg  DTT = 0.0023 g 
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 1500 l 50 mM NH4HCO3 
Alkylation buffer: 
 55mM Iodoacetamide in 50mM NH4HCO3 
 15.26mg  Iodoacetamide = 0.0153 g 
 1500l 50 mM NH4HCO3 
Trypsin solution (The final concentration of the trypsin solution is 20g/ml.) (4°C?) 
 100l  1mM HCl 
 1 vial of trypsin 
Use necessary amount of trypsin reconstituted in HCl, as hereby indicated: 
Prepare 100 L of trypsin solution (5 digestions using 20 L of solution) by mixing: 
- 10 L reconstituted trypsin in HCl 
- 90 L 40mM ammonium bicarbonate in 9% acetonitrile solution 
Wash and De-stain Gel Pieces 
1. The gel was washed in 20 mL of water for 5 mins. 
2. The band of interest was carefully cut from SDS-PAGE gel using a scalpel or 
razor blade, taking care to include only the desired region. The gel piece was 
lifted out using clean flat nosed tweezers. 
3. The gel piece was placed in a siliconised Eppendorf tube or equivalent. A 
siliconised tube reduces binding of the peptides to the tube surface. 
4. The gel piece was covered with 200 µL of 200 mM ammonium bicarbonate with 
40% acetonitrile and incubated at 37oC for 30 mins. The solution was removed 
and discarded from the tube. 
5. Step 4 was repeated one more time. 
6. 100 µL of acetonitrile was added and incubated for 5 min until the gel pieces 
appeared shrunken and opaque. The gel particles were spun down the liquid 
was discarded.  
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7. The gel pieces were dried in a Speed Vac for approximately 15 to 30 mins. 
Reduction and alkylation. 
1. The gel pieces were swollen in 100 µL of reduction buffer and incubated for 30 
min at 56°C to reduce the proteins. 
2. The gel particles were spun down and the liquid discarded. The gel pieces were 
shrunk with 50 µL of acetonitrile. 
3. Acetonitrile was replaced with 100 µL of Alkylation buffer to block reactive 
cysteines. The sample was incubated for 20 min at room temperature in the 
dark. Iodoacetamide solution was then discarded. 
4. The gel particles were washed with 100 µL of 50mM NH4HCO3 for 10 min.  
5. 100 µL of acetonitrile was added and incubated for 5 min until the gel pieces 
shrank. The gel particles were spun down and the all the liquid discarded. 
6. Step 12 was repeated one more time. 
Enzymatic digestion 
1. The gel pieces were dried in a Speed Vac for approximately 15 to 30 mins. 
2. 20 µL (0.4 ug of trypsin – as an example) of the trypsin solution prepared for in-
gel digests was added to the gel sample. 
3. 50 µL of 40 mM ammonium bicarbonate in 9% acetonitrile solution was added 
to the gel sample. 
4. Made sure that the gel piece is at the bottom of the tube and covered with 
liquid. 
5. The gel piece was incubated overnight at 37oC. 
Peptide extraction 
1. After overnight incubation, the samples were spun down to collect all the 
water droplets condensed inside the lid of the microcentrifuge tube.  
2. All the liquid from the gel piece was removed, transferred and saved in a new, 
labelled tube. 
3. Peptides were extracted from the gel matrix by adding 10 to 15 µL of 25 mM 
NH4HCO3 (ammonium bicarbonate). Samples were vortexed briefly, incubated 
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at room temperature for 10 min, and the supernatant recovered after a brief 
spin. 
4.  1 to 2 times the volume of the gel particles worth of acetonitrile was added 
and left to incubate at 37°C for 15 min with agitation. The gel particles were 
spun down and the supernatant collected. 
5. 40 to 50 µL of 5% formic acid was added and then left for 15 min at 37°C with 
agitation. The gel particles were spun down and the supernatant collected. 
6. 1 to 2 times the volume of the gel particles worth of acetonitrile was added and 
the samples incubated at 37°C for 15 min with agitation. The gel particles were 
spun down and the supernatant recovered. 
7. All extracts were pooled and dried down in a vacuum centrifuge. Dry digests 
were stored in a freezer at –20°C until needed. 
8. Resuspension of the samples was carried out in 0.1% trifluoroacetic acid, 3% 
acetonitrile with the rest of the volume being HPLC grade water. 
3.3.2 Silver destain and in gel digest 
Silver stain in gel digest was carried out exactly the same except that a further initial 
destain protocol was required. This procedure was initially followed and then the 
protocol in 3.3.1 was continued in order to finish: 
1. The gel was washed in HPLC grade water for 10 mins. The water was replaced 
and the gel was washed for another 10 mins. 
2. The desired protein bands were excised and transferred to siliconised 
Eppendorf tubes. 
3. Destain solution was prepared by combining 74 µL of silver destain reagent A 
with 245 µL of silver destain reagent B and 4 mL of HPLC grade water. This is 
sufficient to treat 10 gel pieces and was must be used within the same day as 
being made up. 
4. 0.2 mL of the destain solution was added to the gel pieces, mixed gently and 
incubated at room temp for 15 mins. 
5. The destain solution was removed and replaced with fresh solution followed by 
incubation for a further 15 mins. 
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6. The destain solution was removed and gel pieces were washed three times 
with 0.2 mL of wash solution for 10 mins each time. 
7. The gel bands were then ready to follow the in gel digest protocol listed in 
3.3.1. 
3.3.3 In solution digestion 
Prior to labelling protein samples with iTRAQ for quantitative proteomics, it was 
necessary to determine the concentration of the protein within the sample. This was 
done using a Bradford Ultra assay as described in section 3.2.21. Running samples on 
an SDS-PAGE gel will also show if the samples have roughly the same amount of 
protein. It is highly advised to run an SDS-PAGE gel following digestion as this will give 
a good indication to if the proteins have been fully digested. The following protocol 
describes the digestion of 100 µg of protein sample from each phenotype. The 
protocol and required reagents are hereby listed: 
Required reagents: 
 Dithiothreitol (DTT – Sigma Aldrich, Dorset, UK) 
 Tris-(2-carboxymethyl phosphine) (TCEP – Sigma Aldrich, Dorset, UK) OR 
Iodoacetamide (IAA – Sigma Aldrich, Dorset, UK) 
 Sequencing grade modified Trypsin (Promega, Southampton, UK) 
 Sodium dodecyl sulphate (SDS – Sigma Aldrich, Dorset, UK) 
 Sodium deoxycholate (Sigma Aldrich, Dorset, UK) 
 
1. 20 µL of 0.5 M triethyloammoniumbicarbonate (TEAB) at pH 8.5 was added to 
100 µg of almost completely dry sample to give a protein concentration of ~ 5 
mg/ mL. 
2. 1 µL of 2% SDS was added and vortexed. 
3. 1 µL of 110 mM of TCEP was added to each sample and vortexed. 
4. Samples were incubated at 60°C for 1 hour. 
5. Samples were centrifuged to collect all solution. 
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6. 1 µL of freshly prepared 84 mM IAA was added followed by vortexing of the 
sample and centrifugation to collect the solution. 
7. Samples were incubated in a dark cupboard for 30 mins at room temperature. 
Wrapping tubes in foil is preferential to prevent exposure to light. 
8. Samples were vortexed and centrifuged. 
9. 1 mg/mL solution of trypsin using 1 mM HCL and 40 mM ammonium 
bicarbonate with 9% acetonitrile was prepared and 10 µL was added to each 
sample followed by vortexing and a spin down to collect sample. 
Note – For insoluble fractions, sodium deoxycholate (SDC) was added to a 
final concentration of 0.007% before tryptic digestion (1:10 w/w ratio) 
overnight. A combination of trypsin and chymotrypsin was then used at a 
1:10 (w/w) ratio of enzyme/protein for the second day. 
10. Samples were incubated at 48°C overnight (221). 
11. Samples were centrifuged to collect all sample. 
3.3.4 iTRAQ labelling 
The following is a description of iTRAQ labelling used following the in solution digest 
that was carried out as described in section 3.3.3. 
1. iTRAQ reagents were allowed to reach room temperature and 70 µL of ethanol 
was added to each tube, with the samples then vortexed and centrifuged. 
2. The contents of one of the iTRAQ reagent vials was transferred to one sample 
tube and vortexed to mix. 
3. The samples were then incubated at room temperature for 1 hour 
4. Before combining samples, a small aliquot of each sample was taken, the 
organic solvent removed and cleaned using a C18 Zip tip as described in section 
3.3.6 and analysed through LC-MS/MS to check for identification of correct m/z 
charge for each iTRAQ label 
5. The samples of each iTRAQ reagent labelled tube sample were combined in a 
fresh tube. 
6. Samples were be desalted (as necessary) before transfer to LC-MS/MS. Due to 
the  complex nature of the sample (global proteomic analysis) then 
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fractionation of samples through strong cation exchange (SCX) or hydrophilic 
interaction chromatography (HILIC) was needed as described in section 3.3.5. 
3.3.5 Strong Cation Exchange (SCX) 
After incubation at room temperature, labelled samples were combined before being 
dried in a vacuum concentrator. Off-line (to the LC-MS/MS) first dimensional 
fractionation of samples using SCX was performed on a BioLC HPLC system (Dionex, 
UK) prior to online second dimension RP (reverse phase) - LC MS/MS analysis. The SCX 
fractionation was carried out using a PolySULFOETHYL-A Column (PolyLC, USA) with a 5 
μm particle size, 10 cm length x 4.6 mm diameter and 200 Å pore size. The system was 
operated at flow rate of 0.4 mL/min with an injection volume of 70 μL. Transfer and 
elution of peptides was achieved using binary mobile phase buffers A and B (buffer A: 
10 mM KH2PO4 and 25% ACN at pH 3; buffer B: 10 mM KH2PO4, 25% ACN and 500 mM 
KCl, at pH 3). Separation was performed using a 60 min gradient, starting with 5 min at 
100% buffer A, followed by a linear ramp to 30% buffer B over 40 min, then 30% to 
100% B over 5 min, and finally holding at 100% A for 5 min. A UV detector UVD170U 
calibrated at 214 nm and Chromeleon Software (Dionex, Netherlands) were used to 
record the SCX chromatography. Labelled peptide fractions were collected every 
minute, and later dried in a vacuum concentrator.  
3.3.6 C18 cleanup columns 
In order to clean up peptide samples following digestion non complex samples were 
cleaned up using C18 zip tip columns. The protocol for this is hereby detailed: 
Samples are noted to have been dried using a vacuum concentrator 
Required solutions: 
Hydration solution: 
50:50, ACN: HPLC purity water, 0.1% TFA 
Wash solution: 
0.1% TFA in HPLC purity water 
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Peptide elution solution: 
60:40 ACN: HPLC purity water, 0.1% TFA 
Reconstitution buffer: 
5:95 of ACN to HPLC purity water plus 0.1% TFA 
1. Dried samples were resuspended in 13 µL of reconstitution buffer, vortexed 
and centrifuged. 
2. Sample pH was checked and adjusted to pH ≤ 3 with 10 % TFA. 
3. P10 pippetor was to 10 µL and a ZipTip was placed on the pipette. 
4. The tip was hydrated by aspirating 10 µL of hydration solution and discarding it. 
5. Step 4 was repeated. 
6. The tip was then washed by aspirating 10 µL of wash solution and discarding it. 
7. Step 6 was repeated. 
8. The peptide sample was then loaded onto the tip by repeated aspiration and 
expulsion back into the sample holding tube. This was done 5-6 times 
9. The sample was then washed by aspirating 10 µL of wash solution into the tip 
and then expelling to waste. 
10. Step 9 was repeated 5 times. 
11. Sample was eluted from the tip using 5 µL of peptide elution solution. 
3.3.7 Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 
3.3.7.1 – Standard identification of proteins 
Detection of proteins within a sample has been a desired technique within life sciences 
for a substantial period of time. Western blots provide a very simple solution to this 
issue although there is a limited amount of information generated from them. The 
development of mass spectrometry allows for analysis of the polypeptide chain to 
further confirm the identification of proteins instead of relying on a visual result. 
For the general detection of samples, LC-MS/MS analysis was typically carried out on 
either an HCT ultra PTM discovery electrospray ionisation (ESI)-Ion Trap MS/MS 
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(Bruker Daltonics, Coventry, UK) or a Bruker amaZon Ion-Trap MS/MS (Bruker) coupled 
with an Agilent Ultimate 3000 nano-flow HPLC (Dionex). Samples for these 
experiments were typically prepared as described in section 3.3.1. 
3.3.7.2 – Quantitative analysis of proteins 
For the quantitative analysis of proteins using iTRAQ, fractionation was carried out as 
described in section 3.2.5. Prior to tandem MS analysis, each fraction was first desalted 
using UltraMicroSpin Column (The Nest Group, Southborough, MA, USA) following the 
manufacturer’s protocol, detailed in section 3.2.6. 2D Liquid chromatography tandem 
mass spectrometry (LC MS/MS) of iTRAQ labelled samples was carried out on a 
QStarXL hybrid QToF system (AB-SCIEX, Foster City, USA) and a maXis hybrid UHR-
QToF system (Bruker Daltonics, Coventry, UK), both coupled to an Ultimate 3000 nano-
flow HPLC (Dionex). All iTRAQ-labelled samples were further desalted online using a 5 
mm x 300 μm ID LC-Packings C18 PepMap trap cartridge under 0.1% TFA and 3% ACN 
for 15 min, and eluted to a 15 cm, 75 μm ID LC-Packings C18 PepMap analytical column 
in 0.1% formic acid with an ACN gradient performed over a 90 min gradient (3-35% 
ACN). 
3.3.8 Multiple reaction monitoring (MRM) 
In order to be able to focus in on a specific protein or peptide within a sample a 
method called multiple or selective reaction monitoring is used. This is based upon a 
protocol described in Anderson and Hunter (222). To determine the peptides to search 
for they can either have been previously identified through the use of AutoMS or a 
theoretical digest can be done on the polypeptide chain of the protein to determine 
the resulting peptides. From this the mass over charge (m/z) of the peptide will be 
known providing the information required. In order to target a specific peptide from 
within a protein it must meet the following criteria: 
 Must be doubly or triply charged  
 Ideally not containing Methionine as this can be variably oxidised leading to 
fluctuations in the m/z of the peptide 
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 If containing Cysteine then this carboxymethylation must be considered 
following alkylation 
The MRM procedure was carried out on either an HCT ultra PTM discovery 
electrospray ionisation (ESI)-Ion Trap MS/MS (Bruker Daltonics, Coventry, UK) or a 
Bruker amaZon Ion-Trap MS/MS (Bruker) coupled with an Agilent Ultimate 3000 nano-
flow HPLC (Dionex). The HPLC aspect of the setup was carried out as specified in 3.3.7. 
In order to program the setup of the Bruker trapControl software had the mode 
changed to MRM The precursor m/z of the desired peptides was input into the 
precursor column. Isolation was selected with a width window of 2 m/z to ensure the 
desired ion was captured whilst providing room for low levels of instrument error. 
Essentially, the reaction selection was chosen to ensure that any ion isolated within 
the desired m/z window were then fragmented to determine their component ions. 
The MS was run in positive mode along with a target window of 200000 and an 
accusition time of 0.30 ms. 
3.3.9 Mass spectrometry analysis and data searching 
The protein identification and quantification processes were mainly carried out as 
described by Ow et al (223). Tandem MS data generated from QStarXL instrument 
were used to find peaks and converted to MGF format using the mascot.dll embedded 
script (V1.6) coupled with Analyst QS 1.1.1 (Applied Biosystems / AB-SCIEX). MGF data 
were interrogated (for identifications only) using an in-house cluster running the 
Phenyx algorithm (224) (binary version 2.6; Genebio, Geneva). Protein sequences for 
interrogation were obtained from the ftp site (ftp://ftp.ncbi.nih.gov/) of NCBI 
databases. Details on the identification parameters and target-decoy database 
strategies  for the identification are based on search criteria established elsewhere 
(225).  Only proteins satisfying a 1% global peptide false positive identifications or 
False Discovery Rate (FDR) (226) and observed with ≥ 2 peptides were considered for 
further quantitative analysis. The intensities of the iTRAQ reporters were automatically 
exported from all qualified (as above) spectra and were processed as described by 
Pham et al (213). 
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3.3.10 Analysis of iTRAQ quantification and statistical validation 
The analysis of iTRAQ ratio, statistical tests, and their distributive estimations were all 
performed as described by Pham et al (224).  Briefly, protein quantifications were 
obtained by computing the geometric means of the reporters’ intensities. A global 
median correction and isotopic impurity correction was subsequently applied to every 
reporter in order to compensate for experimental and systematic errors. A t-test 
comparison between the reporter ions’ intensities was carried out employing these 
corrected intensities. The distribution of the values was tested to see if it had a mean 
different from zero, and reported the p-values associated with the said distribution, 
based on a threshold (∝ = 5%) for significance. Since two replicates are available for 
each condition, a change is reported only if it is significant regardless of which replicate 
is chosen to perform the comparison. This was carried out for every protein. In the 
remainder of the thesis, proteomic probability scores are defined as -log10 (p) to 
measure significance, and only report quantitative results that are statistically 
significant, thus requiring a score > 1.3 [i.e. -log10 (∝)].  
3.4 MFC and Half Cell techniques 
3.4.1 MFC Setup  
3.4.1.1 UWE MFC setup 
The electrode material used within the MFC chambers was pure carbon fibre veil (PRF 
Composite Materials, Poole, U.K.) cut into 6 x 20 cm oblongs and folded in the middle 3 
times until they measured (H x W x D) 5 cm x 3.5 cm x 0.5 cm.  The surface area was 
calculated as 120 cm2 and the electrodes were then attached to Ni/Ti wire. The MFCs 
used are a two chamber set up as shown in Figure 1.2 that have a void volume of 15 
mL. The two chambers are separated by a proton exchange membrane (PEM) (VWR, 
Leicestershire, U.K.) that had been stored in 1% NaCl solution for at least 24 hrs before 
use in the fuel cell. 
The MFC had heated (25°C) and aerated tap water flowing through the cathode 
chamber overnight at a flow rate of 10 mL/min, before any culture was loaded into the 
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anode chamber. This flow rate was chosen as the highest rate that could be flowed 
through the cathode without any effect on the PEM and interference with the anode. 
The anode chamber had distilled water passing through overnight at the same flow 
rate. This was done to ensure that the fuel cell voltages were low and stable before the 
test began as to minimise errors. 
The anode chamber was completely emptied before the culture was loaded into the 
chamber and the anode run in batch mode. A sample of 15 mL of culture was 
measured out aseptically and then loaded into the chamber using a peristaltic pump 
set at a flow rate of 10 mL/min. After the cells were loaded, the MFC was connected to 
the computer through the use of an interface box, ADC-24 A-D converter computer 
interface (Pico Technology Ltd., Cambridgeshire, U.K.) left at open circuit (No load set 
on the device) for 4 hrs to allow the cells to stabilise. A polarisation curve was carried 
out to determine the maximum power density of the engineered strains by applying an 
external resistance which was decreased every 500 s. The initial starting resistance was 
111 kΩ, gradually decreasing to 1.11 kΩ over 16 steps. Data obtained was then 
analyzed using Microsoft Excel. 
3.4.1.2 Cambridge MFC setup 
A sample of 10 mL of dense cell cultures were diluted to a final OD600 of 1.0 with fresh 
LB, along with replenishing required antibiotics (20 µg mL-1 Cm, 100 µg mL-1 Amp) and 
0.5 mM IPTG. 200 µl of sample was injected into the anodic chamber of a microfludic-
scale microbial fuel cell with the cathode chamber facing upwards to allow full 
exposure to the air. The device was then connected to the computer through the use 
of an interface box, ADC-24 A-D converter computer interface (Pico Technology Ltd., 
Cambridgeshire, U.K.) and allowed to settle for 30 mins with no external resistance 
applied. A polarisation curve was carried out to determine the maximum power 
density of the engineered strains by applying an external resistance which was 
decreased every 500 s. The initial starting resistance was 111 kΩ, gradually decreasing 
to 1.11 kΩ over 16 steps. Data obtained was then analyzed using Microsoft Excel. 
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3.4.1.3 Bacterial culture and nutrient supply 
The following describes the procedure used for culturing bacteria for use within the 
iTRAQ study detailed in this study: 
Bacterial cell cultures were grown as described in previous work (212) and, as before, a 
high cell density of Shewanella oneidensis MR-1 was obtained with supplemented M1 
medium containing among other things the electron donor sodium lactate (Recipe 
detailed in appendix). Cultures of S. oneidensis were taken from a glycerol stock and 
sub-cultured onto an LB agar plate, overnight at 28°C. A single resulting colony was 
then transferred to 100 mL of M1 medium (227) containing 0.4% (w/v) sodium lactate 
as a single carbon source and allowed to grow for 16 h at 28°C, 180 rpm. A volume of 1 
mL from this dense culture (OD540nm = 0.250) was then used to inoculate 4 x 25 mL 
flasks of M1 for each of the different setups (2 for MFC inoculation and 2 for 
continuous culture in a chemostat). The cells were then transferred to their relevant 
containers, generating two different phenotypes: (i) electroactive anodic anaerobic 
biofilms inside the MFC; and (ii) chemostat planktonic microaerobic cells. A peristaltic 
pump was used to continuously supply anolyte (M1 medium) and catholyte (tap water) 
to the MFC chambers with the flow rate set to 62.5 ml.h-1 for each UWE fuel cell used.  
All MFC experiments were conducted at room temperature (23 ± 2 ºC). 
3.4.1.4 MFC design and operation for iTRAQ experiment 
The following MFC method  was adapted from those used in Ieropoulos et al. (76) as 
this experiment was done in collaboration with this group. 
The MFCs utilised for this experiment were a standard two-chamber type, separated 
by a 12 cm2 cation-exchange membrane (VWR, UK) and with 20 mL reactor volume per 
chamber (anode/cathode). These fuel cells were fabricated by 3D-printing in 
biocompatible polycarbonate (212). Each chamber contained a folded sheet of carbon 
fibre veil with a total surface of 270 cm2 each (212) (20m2 g−1; PRF Composite 
Materials, Dorset, UK) as the electrode and a resistance of 5 Ω m in the machine 
direction and 9 Ω m in the cross direction. The folded electrodes were pierced with a 
5cm long nickel–chrome wire coming out of one of the two top holes to provide the 
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connection points for the external circuit. The electrode conformation was such that 
270 cm2 surface area of carbon veil was ‘folded down’ to 5 cm2, in order to reduce the 
resistance of the material, and hence reduce the internal resistance of the fuel cell.  
3.4.2 Polarisation curves 
Polarisation curves were generated by connecting the MFC up to a decade resistance 
box (Farnell, U.K.) set at a starting resistance of 100 kΩ and decreasing in steps of 10 
kΩ down to 10 kΩ. The resistance was then decreased by 2 kΩ down to 2 kΩ and 
moved a single kΩ down to 1 kΩ. The final set of resistance changes were from 1 kΩ to 
200 Ω in 200 Ω decrements. The MFCs were left for at least 500 secs between each 
resistance change to allow to cell voltage to level out. The data was acquired in 
millivolts (mV) using an ADC-16 A-D converter computer interface (Pico technology 
Ltd., Cambridgeshire, U.K.). Recorded data was then analysed using Microsoft Excel. 
In order to be able to directly compare one strain to another, the maximum power 
density was calculated. This provided more information than the voltage output as it 
allows the resistance at which the greatest power is output is achieved to be 
determined. The point of external resistance at which this occurs is equal to the 
internal resistance of the MFC (Ieropoulos et al., 2008). In order calculate the power 
density achieved in the MFC, the current (I) firstly needed to be calculated using Ohm’s 
law, I=V/R, where V is the measured voltage and R is the known external resistance. 
Power was then calculated (W) by multiplying current by voltage, P=IxV. This then 
allowed the power density to be determined by dividing the power by the surface area 
of the electrode PDensity = P/SA. The power density is presented as mW/m2. 
However, it should be noted that although power density can be used to compare 
between MFC models, it is highly dependent on what the authors chose to consider as 
their "projected surface". Different interpretations of electrode surface area lead to 
orders-of-magnitude-differences in current density estimation (76,228) so the use of 
this parameter is not helpful to estimate if the bacterial cultures are limited in 
nutrients. 
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3.4.3 Half cell setup 
The use of a half cell provided an opportunity to test strains over a longer period of 
time that was not possible with the microfluidic Cambridge MFCs. The design and 
setup for these was adapted from Carmona-Martinez et al (229) and Pereira-Medrano 
et al (230). 
3.4.3.1 Strain testing in a sedimentary half cell using LB 
A 10 mL sample of a dense, uninduced culture of engineered E. coli cells was 
condensed down to an OD600 of 5. Within a flow hood, 1 mL of this sample was loaded 
into a sterile 250 mL Duran bottle of LB alongside the relevant antibiotics (20 µg mL-1 
Cm, 100 µg mL-1 Amp) and 0.5 mM IPTG. The final initial OD of the culture was 
therefore diluted to 0.2. A sterile carbon paper electrode (PRF Composite Materials, 
Poole, U.K.), woven with Ni/Ti wire, and a Ag/AgCl red rod reference electrode (Hach 
Lange, Salford, UK) were inserted into the 250 mL Duran bottle, ensuring the carbon 
electrode was flat against the bottom. The Ni/Ti wire was fed through a small hole of 
the lid and the end of the reference electrode came through a similar hole. Aquarium 
Silicone Sealant was used to seal any gaps left in the lid (Aquatics Online Ltd, Bridgend, 
UK) after it was tightly screwed. The completed half cell was then transferred to a 37°C 
water bath and connected up to the computer via an ADC-24 A-D converter computer 
interface (Pico technology Ltd., Cambridgeshire, U.K.). Readings were taken every min 
for 15 hours, with data being analyzed in Microsoft Excel.  
3.4.3.2 Strain testing in a sedimentary half cell using a minimal media 
The engineered strains were also tested over an 8 day period in order to determine the 
negative potential within a sparged minimal media with a defined carbon source. M9 
minimal media) was chosen with 0.4% sodium lactate as the sole carbon source (231). 
The media was filter sterilized using the Stericup system (Millipore, Watford, UK). 
Media was then sparged with Nitrogen gas for 15 mins within a flow hood, with a filter 
placed between the nitrogen source and the media. Following this, antibiotics (20 µg 
mL-1 Cm, 100 µg mL-1 Amp) were added alongside 0.5 mM IPTG. The cells were 
prepared as stated in section 3.4.3.1 and 1 mL of OD 5.0 culture was added to the 
media. The half cells were then sealed and placed in a water bath at 37°C and 
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connected to a picologger device (as in section 3.4.3.1) with readings being taken 
every minute for 8 days. 
3.4.4 Chronoamperometry 
A secondary testing method for the analysis of exoelectrogenic activity of the 
engineered and wild type strains was the use of a half cell with a poised potential of 
+0.2 V. The half cell was setup as follows: 
1. 100 mL of a dense, uninduced culture of engineered cells was condensed down 
to an OD600 of 5.  
2. Within a flow hood, 1 mL of this sample was loaded into a sterile 250 mL Duran 
bottle of LB alongside the relevant antibiotics (20 µg mL-1 Cm, 100 µg mL-1 
Amp).  
3. A sterile carbon paper electrode (PRF Composite Materials, Poole, U.K.), woven 
with Ni/Ti wire, platinum coated counter electrode poised at +0.2 V and a 
Ag/AgCl red rod reference electrode (Hach Lange, Salford, UK) were inserted, 
ensuring the carbon electrode was flat against the bottom. The Ni/Ti wire was 
fed through a small hole in the lid, the counter came through one of equal size 
and the end of the reference electrode came through a similar hole. 
4. The completed half cell was then transferred to a 37°C water bath and the 
potential was poised at +0.2 V using a Uniscan PG-581 portable potentiostat 
connected up to the computer. Readings were taken every min for 900 mins, 
with data being analysed in Microsoft Excel. 
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3.5 Plasmid and strain development 
Table 3.9 - Obtained vectors 
Plasmid Origin of Replication Promoter Antibiotic Coding Received from 
pKP1 pBR322/ColE1 T7 AmpR MtrA Prof. Richardson 
pEC86 p15A pTrc/pTetA CmR ccmABCDEFGH Prof Richardson 
pRGK333 pBR322/ColE1 bla AmpR ccmABCDEFGH IPTG inducible Prof. Kranz 
pOmcA p6K gamma tat AmpR OmcA Prof. Richardson 
pKD46 OriR101 Ara AmpR Bet, Gam, Exo Yale culture collection 
pKD13 R6K gamma n/a KanR FRT flanked Kan cassette Yale culture collection 
pKD32 R6K gamma n/a CmR FRT flanked Cm cassette Yale culture collection 
pCP20 repA101ts temperature sensitive bla AmpR/CmR Flippase Yale culture collection 
pGRG36 pSC101 temperature sensitive Ara AmpR TnsA-D Zdeno Levarski (Addgene) 
pJL148 pBR322/ColE1 n/a AmpR SPA-Tag Prof. Jeff Greenblatt 
pACYCDuet-1 p15A Lac T7 CmR Dual MCS Novagen 
pRSFDuet-1 pRSF Lac T7 KanR Dual MCS Novagen 
pUC19 pBR322/ColE1 n/a AmpR MCS NEB 
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Table 3.10 – Constructed vectors 
Plasmid Origin of Replication Promoter Antibiotic Coding 
pACYCOmcA p15A Lac T7 CmR OmcA 
pACYCMtrABO p15A Lac T7 CmR MtrA, B and OmcA 
pACYCMtrCAB p15A Lac T7 CmR MtrC, A and B 
pACYCMtrCABO p15A Lac T7 CmR MtrC, A, B and OmcA 
pACYCMR-1 p15A Lac T7 CmR MtrD, E, F, OmcA, MtrC, A and B 
pKD46Kan OriR101 Ara KanR Bet, Gam, Exo 
pUC19 Cm pBR322/ColE1 n/a CmR MCS 
pUC19Cm-Tn7 pBR322/ColE1 n/a CmR AttTn7 flanked MCS 
pACYCMtrOmcA-SPA-tag p15A Lac T7 CmR SPA tagged OmcA 
pACYCMtrABO-SPA-tag p15A Lac T7 CmR SPA tagged OmcA + MtrA, B  
pACYCMtrCAB-SPA-tag p15A Lac T7 CmR SPA tagged MtrB + MtrC and A 
pACYCMtrCABO-SPA-tag p15A Lac T7 CmR SPA tagged OmcA + MtrC, A and B 
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Table 3.11 – Tested strains 
Strain Genotype Plasmids Resistance Source 
E. coli MG1655 F- λ- ilvG- rfb-50 rph-1 None None Novagen 
E. coli BL21 E. coli B F- dcm ompT hsdS(rB- 
mB-) gal [malB+]K-12(λS) 
None None Novagen 
E. coli BL21 DE3 fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5 
None None Novage
n 
E. coli RGK103 (Delta 
ccm) 
F- λ- ilvG- rfb-50 rph-1 
∆ccmABCDEFGH 
Δ(ccmA-H) KanR Prof. Kranz 
E. coli MG1655 pEC86 F- λ- ilvG- rfb-50 rph-
1/ccmABCDEFGH 
pEC86 CmR Made in this project 
E. coli MG1655 MtrA F- λ- ilvG- rfb-50 rph-1/mtrA pKP1 AmpR Made in this project 
E. coli MG1655 
pRGK333 
F- λ- ilvG- rfb-50 rph-
1/ccmABCDEFGH 
pRGK333 AmpR Made in this project 
E. coli MG1655 pOmcA F- λ- ilvG- rfb-50 rph-1/omcA pOmcA AmpR Made in this project 
E. coli JM109 pEC86 
MtrA 
endA1 glnV44 thi-1 relA1 
gyrA96 recA1 mcrB+ Δ(lac-
proAB) e14- [F' traD36 
proAB+ lacIq lacZΔM15] 
hsdR17(rK-mK+) 
/ccmABCDEFGH mtrA 
pEC86, pKP1 CmR,     
AmpR 
Prof. Richardson 
E. coli K-12 pEC86 
pOmcA 
F- λ- ilvG- rfb-50 rph-
1/ccmABCDEFGH omcA 
pEC86, 
pOmcA 
CmR,     
AmpR 
Made in this project 
E. coli BL21 pEC86 
pOmcA 
E. coli B F- dcm ompT hsdS(rB- 
mB-) gal [malB+]K-12(λS)/ 
ccmABCDEFGH omcA 
pEC86, 
pOmcA 
CmR,     
AmpR 
Prof. Richardson 
E. coli BL21 DE3 pEC86 
pOmcA 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
omcA 
pEC86, 
pOmcA 
CmR,    
AmpR 
Made in this project 
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E. coli BL21 DE3                      
pRGK333 pACYCOmcA 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
omcA 
pRGK33, 
pACYCOmcA 
AmpR,    
CmR 
Made in this project 
E. coli BL21 DE3                 
pRGK333 
pACYCMtrABO 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
mtrAB omcA 
pRGK33, 
pACYCMtrA
BO 
AmpR,    
CmR 
Made in this project 
E. coli BL21 DE3 
pRGK333 
pACYCMtrCAB 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
mtrCAB 
pRGK33, 
pACYCMtrC
AB 
AmpR,    
CmR 
Made in this project 
E. coli BL21 DE3 
pRGK333 
pACYCMtrCABO 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
MtrCAB omcA 
pRGK33, 
pACYCMtrC
ABO 
AmpR,    
CmR 
Made in this project 
E. coli BL21 DE3 
pRGK333 pACYCMR-1 
fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5/ ccmABCDEFGH 
mtrCABDEF omcA 
pRGK33, 
pACYCMR-1 
AmpR,    
CmR 
Made in this project 
Shewanella oneidensis 
MR-1 
ATCC - MR-1 [CIP 106686] None AmpR Prof. Gralnik 
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3.6 SEM preparation and analysis 
Before samples could be analysed using SEM they firstly had to be prepared. For the 
analysis of anodic biofilms the following protocol was adhered to: 
The MFCs were disassembled and the carbon paper anode was removed and cut into 
1.25 by 2.5 cm pieces. The samples were completely covered in 3% glutaraldehyde and 
then stored in flat bottom containers in the fridge (4°C) overnight. The following day 
the solution was carefully discarded and the samples were submerged in cold 0.1 M 
PBS for 30 mins. This solution was discarded and the sample was again covered in 0.1 
M PBS and then left in the fridge until needed. 
A secondary fixation of the samples was then required, where they were covered in 2% 
Osmium tetroxide for 2 hrs at room temperature and then washed in 0.1 PBS as above. 
The samples were then dehydrated by using a graded series of ethanol: 
 75% ethanol for 15 mins 
 95% ethanol for 15 mins 
 X 2 100% ethanol for 15 mins 
 X 2 100% ethanol dried over anhydrous Copper sulphate for 15 mins 
All of these steps were carried out at room temperature. 
The samples were then stored in a 50/50 solution of HDMS and ethanol for 30 mins 
and were then moved to 100% HDMS. The samples were then dried in the fume hood. 
Infiltration of the sample was accomplished by placing the specimens in a 
50/50mixture of propylene oxide/araldite resin and left overnight at room 
temperature. 
The specimens were left in full strength araldite resin for 6-8 hrs at room temperature 
after which they were embedded in fresh araldite for 48-72 hrs at 60°C. 
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Araldite resin 
CY212 resin  10 mL 
DDSA hardener 10 mL 
BDMA accelerator   1 drop per 1mL of resin mixture 
The samples were thinly sliced thereby making them suitable for analysis using the 
SEM 
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Chapter	4	-	Introduction	of	an	
electrogenic	pathway	into	a	foreign	
organism	
This chapter was done in collaboration with Dr. Greg. J. S. Fowler, Dr. Ana. G. Pereira-
Medrano and was supervised by Prof. Phillip C. Wright 
4.1 - Introduction 
Interaction between living systems and man-made technologies provides the means to 
bridge the gap between the analogue and the digital world, presenting massive 
potential for biosensing, biocomputation and bioenergy. Energy within US wastewater 
is estimated to contain 9.3-fold that required to power its treatment (37). The 
potential for simultaneous degradation of organic compounds and energy generation 
employing diverse bacterial metabolism within an MFC is an attractive prospect. 
Transfer of electrons between most natural and artificial systems is only possible in the 
presence of lipid-soluble mediators that can permeate the insulating cell membrane. 
These mediators diffuse into the membrane and strip electrons from intracellular 
redox enzymes (232,233) in order to reduce an acceptor. They are, however, in general 
only artificial additions (with the exception of natural couplers such as nitrate/nitrite 
and sulphate/sulphide – which aren’t present in pure culture studies where minimal 
media is used), often introducing more problems than they solve, especially in 
wastewater treatment, due to high costs (233), need for replenishment (76) and 
cellular toxicity  (45). These problems all require solutions. 
A limited number of organisms are capable of transferring electrons to inorganic 
compounds. Most, notably DMRB, such as Shewanella species, are able to secrete such 
mediators (136), and although they are Shewanella’s main method of extracellular 
electron transfer (104), they are not essential for activity (136). The activity of natural 
DMRB (e.g. Shewanella and Geobacter) capable of reducing insoluble electron 
acceptors without the use of artificial mediators under anaerobic conditions is well-
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documented (69,234–236). The wide range of Shewanella studies carried out show a 
predicted model for electron transport from the cytoplasm to the outer membrane 
(OM) focusing on a highly conserved cluster of c-type cytochromes (85,108,237). These 
comprise CymA, a tetrahaem cytochrome that functions as a major hydroquinone 
dehydrogenase (238), accepting electrons from the intracellular menaquinone pool 
and transferring them through the inner membrane to the periplasmic decahaem 
MtrA (239). The electrons are then transported through to an OM complex of 
decahaem proteins formed by OmcA and MtrC, localised by the presence of the non-
haem β-barrel protein MtrB (112). Shewanella and Geobacter species can also utilise 
electrically conductive appendages in the form of nanowires for the reduction of 
insoluble terminal electron acceptors (127,240,241). For Geobacter, there is a well 
documented alignment of c-type cytochromes along these nanowires that allows for 
direct transfer to insoluble TEA (114,241). In Shewanella species, OmcA has been 
implicated in metal oxide reduction (103), even though, in other works, OmcA appears 
to be incapable of facilitating metal oxide reduction (242). The removal of either of the 
decahaem cytochromes OmcA and MtrC results in a vastly diminished electron transfer 
ability (103,109). It has been suggested that OmcA, for example, localises to the outer 
membrane when heterologously expressed in E. coli, but only in the presence of a type 
II secretion system (120). The requirement for the type II secretion system for the 
correct localisation of OmcA and MtrC is also seen in wild-type S. oneidensis with 
further observations also identifying these two proteins being present in the external 
medium (243). 
This chapter shows the development of a portable electron transporter harnessed 
from S. oneidensis MR-1 which allows for the introduction of an extracellular electron 
transfer ability into a non electrogenic strain. This synthetic electron transporter 
provides the genetic coding for a defined protein chain, allowing novel interaction 
between a strain incapable of extracellular electron transfer and a carbon electrode. 
To achieve this, different protein sets from the Mtr operon of S. oneidensis MR-1 were 
expressed in combination with overexpressed cytochrome maturation genes in E. coli. 
Escherichia coli was chosen for this project as it is the model prokaryotic organism for 
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synthetic biology techniques, with a vast number of studies documenting both 
heterologous expression of functional proteins and the introduction of foreign 
pathways  (172,244–247). This versatile organism was chosen not only for these 
reasons, but also because functional expression of S. oneidensis MR-1 c-type 
cytochromes in E. coli has been shown to be possible for reduction of Fe (III) 
(105,107,120,125), but this does not confer the ability to produce current as 
demonstrated by the DMRB Pelobacter carbinolicus (122).  
The highly conserved metal reduction genes within a large proportion of Shewanella 
species are MtrCAB and OmcA (108). These four proteins provide an electron transport 
pathway between the periplasm and insoluble extracellular terminal electron 
acceptors, all coded by genes located within a single operon on the genome. In order 
to channel electrons from the intracellular quinone pool to the periplasm, we relied on 
the E. coli host inner membrane electron donors as previously seen (105,107,125). The 
main hub of this activity was presumed to have originated from the E. coli orthologue 
of the S. oneidensis inner membrane tetrahaem cytochrome CymA, namely NapC 
(107). Some level of plasticity has been demonstrated within this network with 
residual iron reduction ability of MtrA in a ΔnapC mutant (125). The new construct 
relies on over-expression of cytochrome maturation genes and the type II secretion 
pathway found in B- type strains, both of which have been shown to be vital in 
previous experiments in which S. oneidensis outer membrane cytochromes were 
expressed (120,243). 
This chapter demonstrates the importance of a complete electron transport chain 
from periplasmic tetrahaem cytochrome to outer membrane and extracellular 
decahaem cytochrome, acting as a terminal reductase within an engineered E. coli, 
permitting interaction with a carbon anode. At the time of experimentation this was 
the first documented example, to my knowledge, of a redundant strain, devoid of 
artificial mediators, being engineered through the introduction of a synthetic electron 
transport conduit to generate current within a bioelectrochemical system (BES). The 
subsequent publication of the paper by Goldbeck et al (124) employed a genetically 
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identical system to the one shown here with an added synthetic biology aspect that is 
discussed towards the end of this chapter.   
In order to be able to determine the exoelectrogenic activity of strains, a BES was 
required. This chapter provides an insight into the many challenges of accurate, 
reproducible, high throughput testing of samples. A breakdown of the key points of 
each of the different BES tested is shown in Table 4.1. 
Table 4.1 - Key points describing each of the different BES setups 
4.2 University of West England (UWE) MFC 
4.2.1 – MFC testing and strain analysis 
The initial method of screening was through the use of a relatively large volume two 
chamber MFC with a 60 mL anode chamber volume and equal cathode chamber 
volume. This setup comprised a folded carbon veil anode and cathode (each with an 
area of 120 cm2) with a Ni-chrome wire woven through and a VWR proton exchange 
membrane (PEM) separating the two compartments. Further descriptions of this can 
MFC type (chapter 
section) 
Anode/Cathode 
volume 
Other notable mentions 
UWE two chamber 
MFC (Chapter 4.2) 
60 mL/60 mL  Oxygenated cathode H2O 
 Temperature kept at 25°C 
 Cathode water pumped 
through at 10 ml/min 
Cambridge MFC 
(Chapter 4.4) 
200 µL/200µL  Multiple channel 
 Small volume 
 Quicker setup 
Half cells (Chapter 4.6) 250 mL  Single cell 
 Poised anode potential 
(Chronoamperometry) 
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be found in methods section (3.4.1.1). A diagrammatic representation of this MFC can 
be seen in Figure 4.1.  
The main defining elements of this setup were the fact that the cathode solution was 
constantly replenished with fresh oxygenated distilled water in an attempt to increase 
the available oxygen and therefore capability for reduction to occur. The setup also 
had a relatively large volume with 60 mL of culture volume loaded into the anode 
chamber. This setup was left at open circuit potential for 1 hour to allow the large 
culture volume to settle and adapt to the environment. Once this was done, a 
polarisation curve was carried out as described in section 3.4.2. 
Figure 4.1 – Expanded view of the UWE MK1 MFC device 
The results that were obtained required a number of calculations before more useful 
information could be acquired. The results that were collected during a polarisation 
curve were the change in voltage as the external resistance was reduced. An example 
of this can be seen in the Figure 4.2. 
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Figure 4.2 – Example of the results obtained from a polarisation 
curve of S. oneidensis MR-1. Results shown are for 3 biological 
replicates within a single UWE MFC showing the ability of the 
apparatus to reproduce results. 
The example shown in Figure 4.2 is of the voltage values obtained from a triplicate 
analysis in a MFC of S. oneidensis MR-1 after applying a range of external loads (100kΩ-
200Ω). The power density is then calculated from these results as detailed in section 
3.4.2. Using the average of the results from the calculations the data was then plotted 
as a power density and cell voltage curves as shown in Figure 4.3. Figure 4.3 then 
allowed for the measurement of the resistance, in which the maximum power density 
was achieved. The point at which the greatest power density was achieved is equal to 
the internal resistance of the MFC. This is not just to do with the structural 
components of the cell, but also relates to the bacteria and their transfer mechanisms. 
The maximum power density achieved is a standard measure that is used to compare 
the power output achieved between different MFCs and strains. The analysis of the 
maximum power density achieved by two other strains (BL21 DE3 and BL21 DE3 
pOmcA) is shown in Figures 4.4 and 4.5. 
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Figure 4.3 – Power density and cell voltage curves plotted using 
the average of the results from three biological replicate of S. 
oneidensis MR-1 following polarisation curves within 3 UWE 
MFCs.  Results present show standard deviation from the median 
of the combined replicates. 
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Figure 4.4 - Power density and cell voltage curves plotted using 
the average of the results from three biological replicates of BL21 
DE3 following polarisation curves within 3 UWE MFCs.  Results 
present show standard deviation from the median of the 
combined replicates. 
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Figure 4.5 - Power density and cell voltage curves plotted using 
the average of the results from three biological replicates of BL21 
DE3 pEC86 pOmcA following polarisation curves within 3 UWE 
MFCs.  Results present show standard deviation from the median 
of the combined replicates. 
The comparison of the maximum power density values from a variety of different 
strains (detailed in Table 3.11) allowed for the production of a bar chart of the results 
obtained in the initial MFC setup. The results were however, variable, as shown in 
Figure 4.6. 
Figure 4.6 clearly shows a range of power outputs for the different strains that were 
tested in the MFC, with the highest power output being achieved by the naturally 
electrogenic DMRB S. oneidensis MR-1. All experiments were carried out in at least 
triplicate, often with many more. The median max power density from these runs is 
shown in Figure 4.6 with the standard deviation represented. In terms of the E. coli 
strains the lowest power output can be seen with the cytochrome maturation deficient 
strain Δccm (detailed in Table 3.11). There was a nearly 30% power increase with the 
use of the wild type E. coli strain  MG1655, which may be due to the native 
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cytochrome maturation genes allowing expression of the endogenous c-type 
cytochromes present, which in turn may have allowed for electron transport to the 
anode. The results for strain JM109 pEC86 MtrA showed a return to the minimal power 
output observed for the control strain delta ccm even though cytochrome maturation 
genes and a periplasmic c-type cytochrome from S. oneidensis MR-1 are over-
expressed in this strain. This could be explained by the observation that MtrA was 
thought to be a periplasmic protein in S. oneidensis and therefore MtrA may also be 
located solely in the periplasm even when over-expressed in E. coli; as a result it may 
not capable of transporting electrons outside of the cell. This correlates with the 
observation that heterologously expressed MtrA was unable to reduce insoluble Fe (III) 
as shown by Pitts et al (248), although it should be noted that the literature does not 
necessarily offer a direct correlation between electrogenesis and the ability to reduce 
Fe (III) (122). The expression of these additional proteins in this case may have caused 
an increased metabolic burden upon the cell and a further point of electron loss at 
MtrA as the electrons were not used for current production. The lack of power 
increase seen with K-12 pEC86 pOmcA could be explained by the cryptic nature of the 
type II secretion pathway in K-12, which prevents the expression of OmcA (249). The 
overexpression of cytochrome maturation genes and OmcA in BL21 DE3 produced an 
increased power output compared to wild type K-12. This appeared to show that the 
extracellular electron transfer ability demonstrated by Donald et al (249) where 
insoluble Fe (III) was reduced to Fe (II), did in fact also allow the engineered strain to 
transfer electrons to an anode.  
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Figure 4.6 – Comparison of the power outputs achieved by a 
variety of bacterial strains within the first MFC setup. Results 
shown are the averages with standard deviation, from at least 
three biological replicates carried out within UWE MFCs. High 
level of variance can be seen between an initial batch of 
experiments compared to a later set. 
4.2.2 Issues with UWE MFC 
Although all of the strain tests were carried out in triplicate it was decided that K-12 
should be retested. The variation in the obtained results being put into doubt as the 
power output produced this time was the highest yet achieved. This demonstrated a 
lack of reproducibility within the MFC setup being used. 
This was not the only problem that was seen in this setup, as the MFC was made out of 
very pliable yet brittle plastic. The constant de- and reconstruction of them caused 
large cracks to occur at a certain point around the cell. Attempts were made to seal 
the MFC with silicon sealant, as shown in Figure 4.7. This was however only a very 
short term solution as the MFC would leak the next time it was assembled and would 
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in some cases not last the whole length of an experiment before beginning to leak, 
which could have affected the results. 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 – UWE MFC setup showing signs of wear and tear. 
Arrows indicate the points of the MFC that were breaking and 
required patching up with silicon sealant shown. 
4.2.3 Alternative MFC options – Reading MFC 
Following all of these issues, it was decided that an alternative setup should be used, 
one that would not be as awkward to assemble and that would be more resistant to 
wear and tear. This new fuel cell (schematic shown in Figure 4.8) consisted of a 2 
chamber setup with internal volumes of 5 mL in the anode and cathode 
compartments.  The device was much easier to assemble (7 layers but only 4 screws), 
primarily composed of Perspex (which provided greater durability) and with a total 
device size of approximately 55mm x 55mm it had a smaller demand on space. The 
cathode chamber still relied on the reduction of oxygen within distilled water, which 
was pumped into the cathode chamber at a rate of 1 mL/min. Cultures to be tested 
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were loaded into the anode chamber using a syringe and due to the smaller volume, in 
comparison to the UWE MFC, were allowed to settle for 30 mins in an open circuit 
configuration. 
 
 
 
 
 
 
Figure 4.8 – A schematic for a smaller volume two chamber MFC – 
(Modified from Madden (250))  
The use of this MFC setup provided more reproducible results and allowed for the re-
testing of the most promising initial engineered strain, BL21 DE3 pEC86 pOmcA. The 
testing and comparison of this strain against standard BL21 DE3 and S. oneidensis MR-
1 produced the results seen in Figure 4.9.  
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Figure 4.9 – Comparison of the maximum power density of E. coli 
strains to S. oneidensis MR-1. Results shown are the average and 
standard deviation of at least three biological replicates carried 
out within the Reading MFC. The difference observed between 
BL21 DE3 and BL21 DE3 pEC86 pOmcA was significant (p-value = 
0.05) 
Tests for the E. coli strains were carried out 5 times to ensure that the results obtained 
were reproducible. Figure 4.9 shows a statistically significant increase in activity in 
BL21 DE3 following the addition of pEC86 and pOmcA as determined by an unpaired t-
test, p-value = 0.05. This was determined to be an increase of 29% from 0.017 mW/m2 
to 0.022 mW/m2. This is obviously still significantly lower than that demonstrated by 
the naturally electrogenic S. oneidensis MR-1. This organism does however have a fully 
developed method for extracellular electron transport whereas this E. coli strain only 
has the addition of a single c-type cytochrome from this pathway. The theory 
postulated at this point in the project was that the addition of further cytochromes 
may well aid in increasing the achievable power output. As there are at least 4 c-type 
cytochromes that have been shown to be important in the production of power in S. 
oneidensis MR-1, it seemed reasonable to assume that the further addition of these 
may increase the ability of E. coli to transport electrons to an anode. 
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4.2.4 Post UWE MFC experiments 
4.2.4.1 – Visual analysis of biofilm by SEM 
At this point in the project it was decided that the analysis of biofilm formation within 
the MFC setup being used should be attempted. An S. oneidensis MR-1 culture was 
allowed to develop within an MFC for 30 days at a fixed resistance of 20 kΩ (resistance 
at which max PD previously noted in device – Figure 4.3) within the UWE MFC setup. 
Although issues were noted with this setup, it provided a much larger overall anode 
area for colonisation by S. oneidensis MR-1 and was much better suited to long term 
analysis instead of high throughput testing.  The anode was then analysed using SEM 
as described in Section 3.6 
 
Figure 4.10 clearly shows intimate contact of the cells with the carbon anode and 
appears to show the early stages of biofilm development as seen by the somewhat 
fluffy appearance to the cells in Figure 4.10 A. This could be caused by the production 
of EPS to allow the biofilm to grow. The cells appear to be the correct length of approx 
2 µm which is easier to determine in Figure 4.10 B. 
 
Figure 4.10 – SEM image of S. oneidensis MR-1 anodic biofilm A) 
1600 x magnification B) 6000 x magnification 
B A 
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4.2.4.2 Construction of MR-1 electrogenic gene cluster plasmid 
Following on from the initial experiments, it was decided that in order to try and 
increase the power density achieved in the MFC using an engineered E. coli strain, a 
more complete exoelectrogenic pathway was required. Instead of relying on the 
overexpression of the single c-type cytochrome OmcA alongside overexpressed 
cytochrome maturation genes, a variety of options with regard to the “completeness” 
of the Mtr pathway were proposed. These consisted of individual plasmids containing 
the following options: 
 OmcA 
 MtrCAB 
 MtrCAB and OmcA 
 MtrDEF, OmcA and MtrCAB 
The following section gives a brief description into the considerations taken 
4.2.4.3 Bioinformatic analysis  
In order to determine if the construction of a plasmid containing the electrogenic gene 
cluster from S. oneidensis MR-1 was possible, a preliminary bioinformatic analysis of 
the genes and encoded proteins was carried out. Although only the restriction site 
analysis was required for the construction of the plasmid, the other tools provided 
valuable information about the expression and predicted localisation of the proteins. 
4.2.4.3.1 Signal peptides 
The results of the analysis of the amino acid sequence resulted in a signal peptide 
being predicted for every protein encoded within the gene cluster. An example of the 
results obtained from this analysis can be seen with the example of OmcA in Figure 
4.11 (Details obtained from analysis of all other proteins can be found in the 
appendix). 
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Figure 4.11 – Graphical output for the signal peptide prediction 
along the entire protein for OmcA from S. oneidensis MR-1. 
Analysis performed on SignalP 3.0 (251) 
The S score is predicted for every amino acid within the protein with a high score being 
indicative of its role within a signal peptide, whilst low scores suggest a lack of 
involvement. The C score is the position of the predicted cleavage site; this point is 
considered the end of the signal peptide. All subsequent amino acids are considered 
part of the mature protein. This prediction can sometimes be seen numerous times 
within a sequence as shown at residue 27 in Figure 4.11 along with the other predicted 
site at residue 32. There is however only one true cleavage site, which is determined 
through the use of the Y-score. This is a combination of the S and C scores that 
provides a better prediction. This is done by combining the position of a significant C-
score with a position where the slope of the S-score is steep. A prediction is also 
presented at the end of the results that indicates the probability of a signal peptide 
and also the position of the cleavage site. The higher the probability, the greater the 
chance of a signal peptide being present: 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
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Max cleavage site probability: 0.908 between pos. 32 and 33 
As all the proteins that were encoded within the cluster were predicted to be 
expressed in the periplasm or outer membrane in S. oneidensis MR-1 it is not 
unexpected that the proteins all have predicted signal peptides. 
4.2.4.3.2 Transmembrane helices 
The proteins were also analysed for the presence of transmembrane spanning regions. 
The results from this analysis predicted that only one of the proteins was believed to 
have a transmembrane spanning region. This protein was MtrA, which has been 
identified as a periplasmic protein within S. oneidensis MR-1, but also appears to cross 
between the membrane. Figure 4.12 presents the predicted transmembrane helices 
within MtrA (Details obtained from analysis of all other proteins can be found in the 
appendix). In this case there is a predicted membrane spanning region. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AA position 
Figure 4.12 – Predicted transmembrane helices within MtrA 
 
Sequence Length:                                              333 
Sequence Number of predicted TMHs:            1 
Sequence Exp number of AAs in TMHs:         20.26577 
Sequence Exp number, first 60 AAs:               20.26558 
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Sequence Total prob of N-in:                           0.75587 
Sequence POSSIBLE N-term signal sequence 
Sequence TMHMM2.0 inside                    1    11 
Sequence TMHMM2.0 TMhelix     12    34 
Sequence TMHMM2.0 outside     35   333 
The position of this region is predicted as being between amino acid residue 12 and 34, 
with the N-terminal of the protein residing in the cytoplasm and the remainder of the 
protein predicted to be outside the cytoplasm. 
4.2.4.3.3 Identification of restriction sites 
In order to be able to clone the desired gene cluster into a plasmid of choice the 
available restriction sites must be identified to show which restriction enzymes digest 
the sequence. This then allows for the choice of restriction sites to attach to the end of 
the sequence through the use of primers that will allow for it to be inserted into a 
plasmid. 
All of the gene clusters were searched through Webcutter 2.0 and NEBcutter 2.0. An 
example of the results obtained from this can be seen from the analysis of the entire 
gene cluster (MtrD, E, F, OmcA, MtrC, A and B) shown in Figure 4.13. 
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Figure 4.13 – Overview of some of the restriction sites seen within 
the MR-1 electrogenic gene cluster 
As the programs allow for a comprehensive search for restriction sites using all NEB 
restriction enzymes, the list of the sites acquired is vast. A more useful piece of 
information in this case was the identification of enzymes that do not cut the sequence 
and are also present within the multiple cloning sites (MCS) of pACYCDuet-1. 
The following endonucleases were selected but do not cut this sequence: 
AatII, AccBSI, AscI, AspI, AtsI, BsrBI, BstD102I, CciNI, Cfr9I, CpoI, CspI,  
DraII, EcoO109I, FseI, NotI, PacI, PmeI, PpuMI, PshAI, Psp5II, PspAI, PspALI,  
RsrII, SapI, SbfI, SexAI, SgfI, SgrAI, SmaI, SmiI, SrfI, Sse8387I, SwaI,  
Tth111I, XbaI, XmaI. 
From these results and the comparison to the MCS shown in Figure 4.14, the most 
suitable restriction sites to use were determined to be AscI and NotI.
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Figure 4.14 – Multiple cloning sites of pACYCDuet-1 
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4.2.4.3.4 Predicted protein molecular weight 
The predicted molecular weight and isoelectric point of each of the individual proteins 
within the gene cluster was calculated. The results can be seen in Table 4.2 
Table 4.2 – Predicted molecular weight and isoelectric point of 
MR-1 proteins 
Protein Molecular weight (kDa) Signal peptide (AA c.pos) 
OmcA 79 Yes (32,33) 
MtrA 36 Yes (33,34) 
MtrF 67 Yes (23,24) 
MtrD 33 Yes (15,16) 
MtrE 79 Yes (31,32) 
MtrC 71 Yes (21,22) 
MtrB 78 Yes (21,22) 
4.2.4.4 Agarose gel analysis of DNA fragments 
In order to be able to construct an efficient current producing organism using proteins 
from highly electrogenic strains, the interaction of the proteins with the E. coli native 
metabolic pathways needed to be established. As discussed in the literature review in 
chapter 1, the work conducted by Pitts et al (248) and Donald et al (249) showed that it 
was possible for this to occur through the use of OmcA and MtrA. These examples 
however only allowed for the reduction of Fe (III) and this does not directly confirm or 
prove the ability to produce current. Our results show that the introduction of OmcA 
from S. oneidensis MR-1 only produces a 29% increase in power output. The addition 
of further cytochromes may then allow for further increase in power output as the 
extracellular electron transport pathway becomes more developed.  
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The genomic DNA (gDNA) from S. oneidensis MR-1 was successfully prepared as shown 
in Figure 4.15. 
 
 
 
 
 
 
Figure 4.15 – S. oneidensis MR-1 genomic DNA – Lane 1 – 
Hyperladder I. Lane 2 and 3 – S. oneidensis MR-1 gDNA. 
As the gDNA was now assumed to have been obtained, several PCR reactions were 
setup in an attempt to amplify the desired gene fragments. All of the fragments were 
believed to have been successfully amplified on the first attempt as shown in Figure 
4.16. This can be seen in the production of clear bands of the correct size following the 
PCR reaction. These bands were all very bright and distinct from others present and 
therefore considered to have a high enough DNA concentration to be able to continue 
working with. 
 
 
 
 
 
 
S. oneidensis  
MR-1 gDNA 
3        2       1      Lane number 
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Figure 4.16 – S. oneidensis MR-1 PCR products – Lane 1 – 
Hyperladder I. Lane 2 – Undigested pACYCDuet-1. Lane 3 – MR-1 
gene fragment 1 (OmcA – MtrB – 7729 bp). Lane 4 – MR-1 gene 
fragment 2 (MtrF – MtrB – 9895 bp). Lane 5 – MR-1 gene fragment 
3 (MtrD – MtrB - 13002 bp). 
The digested plasmid of pACYCDuet-1 shown in Figure 4.17 produced 2 bands showing 
that the plasmid had not been fully digested. The enzymes used are not compatible 
under the use of any of the supplied New England Biolabs buffer but the digest was 
done using a multicore buffer, which should have allowed for the reaction to occur 
unaffected. 
 
  6       5      4        3        2      1           Lane number 
13002 bp 
Linearised  
pACYCDuet-1 
9895 bp 
7729 bp 
5273 bp 
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Figure 4.17- AscI and NotI digested pACYCDuet-1 – Lane 1 – 
Hyperladder I. Lane 2 – AscI and NotI digested pACYCDuet-1. 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 – Clone screening for pACYCMR-1 (MtrDEF,OmcA,MtrCAB) AscI 
and NotI digested. Lane 1 – Hyperladder, Lane 2 – Empty plasmid, Lane 3 – 
Empty plasmid, Lane 4 – Successful clone, Lane 5 – Unknown, Lane 6 – 
Empty plasmid, Lane 7 – Empty plasmid 
+10,000 bp (13002 bp target) 
~4,000 bp  
AscI and NotI digested 
pACYCDuet-1 
   2                      1                Lane Number 
1            2            3             4            5            6              7                Lane            
Number 
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4.2.5 Concluding remarks 
The results obtained from the initial MFC setup demonstrated for the first time the 
ability to introduce electrogenic activity into a foreign organism although not to a 
particularly substantial level. The first published demonstration of this activity was by 
Goldbeck et al (124). There were differences between the two approaches as Goldbeck 
et al chose to focus on a single Mtr system with MtrCAB and instead tune the 
expression of it through promoter modifications to alter transcript levels. The thoughts 
considered at the time of discovery was that activity may be able to be further 
developed through the use of additional cytochromes, synthetic biology techniques 
and metabolic engineering. The development of the plasmids using various gene 
fragments of the MR-1 electrogenic cluster was done to help determine the genes 
essential to power production and which ones present a metabolic burden.  
The limitations of the initial MFC were considered too great to carry on working with 
this type of device and so a new device was sought to combat the following 
limitations: 
 This MFC had a large anode area but only a very small area of it was actually in 
contact with the cells. The large culture volume and sedimentation of the cells 
meant that this was only at the bottom of the anode. The MFC was tilted to try and 
alleviate this issue but the fact that the anode was run in batch mode didn’t aid in 
the movement of bacteria within the chamber.  
 The device was a pretty large size and when testing was being attempted in 
triplicate on a daily basis this meant: 
o Setting up three large MFCs 
o Loading the cells 
o Settling for an hour 
o Doing a polarisation curve 
o Processing the data 
o Cracking open the MFCs 
o Cleaning the MFCs and having them ready for the next day 
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The relatively complex nature of the setup meant that this was not really feasible, 
especially if trying to attempt any other work simultaneously. 
 Managing to setup three MFCs was hugely time consuming and size of the 
equipment setup for this (including water tank, heater, oxygenator and MFCs) was 
very large, meaning that it would have been impossible for a single person to do 
any more replicates in one go. 
 On top of this, the setup was fairly delicate making it unsuited to continual 
assembly and disassembly. Doing this resulted in high levels of wear and tear, 
including ripping of PEM leading to leaking from the cathode to anode. This then 
had the knock on effect of altering the available volume to load into anode. 
Knowing all the limitations of the current device, the desired characteristics were also 
known. These were as follows: 
 A more durable setup, capable of withstanding repeated assembly and 
disassembly 
 A smaller scale system to allow for quicker setup, cleaning, less parts 
susceptible to damage 
 Multiplexing capabilities to allow for more rapid testing of strains 
 A high level of reproducibility 
The advantages of the smaller setup provided by the Reading MFC due to the smaller 
testing setup, reduced setup time and more durable material made it a much better 
testing setup than the first MFC. This was however, still not considered to meet the 
testing criteria (especially with regards to the high throughput aspect) for the project 
and so other options were sought. 
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4.3 University of Cambridge MFC  
4.3.1 MFC testing and strain analysis 
With the information in hand about the desired MFC, a search of other groups with 
suitable devices was carried out.  
The strains that were tested in chapter 4.2 were sent to a lab in the University of 
Cambridge for testing in a small volume, dual chamber, multiple channel MFC. 
Results are presented in Figure 4.19: 
Figure 4.19 – Current generation in a Cambridge, low volume, 
multiple- independent channel MFC. Results shown are averages 
with standard deviation from at least three biological replicates 
carried out within the University of Cambridge MFC. Differences 
between BL21 DE3 and BL21 DE3 pEC86 pOmcA were statistically 
significant (p-value=0.0001) 
178 | P a g e  
 
The Cambridge MFC was built and transferred to Sheffield. This MFC setup utilised a 
much lower volume than the UWE MFC, permitted much quicker assembly and had 
multiple channels. All of these advantages made this a much simpler device to work 
with although the low chamber volumes (200 µL) brought challenges with it as well. 
The device was very delicate and needed to be handled very carefully, ensuring proper 
alignment of all components. The chamber volume was so low that the chamber 
vessels had to be loaded with a syringe, this is itself is not an issue but it meant that air 
pockets could form in the chamber that could not be removed easily and sometimes 
required the device to be opened and cleaned out to ensure no gaps. 
 
Figure 4.20 – Schematic diagrams and photographs of the Cambridge 
microfluidic microbial fuel cell (µMFC). (A) Schematic representation of the 
microfluidic microbial fuel cell (µMFC). (B-D) Photographs of the µMFC.  
The initial assessment that had to be carried out once the MFC was delivered and built 
was to replicate the results obtained in Cambridge apart from K12 pEC86 pMtrA. This 
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was due to the fact that this single c-type cytochrome was shown not to be capable of 
insoluble metal reduction or generating current in previous experiments. The results 
from the in house test are shown in Figure 4.21. 
 
 
Figure 4.21- Initial in house replication of Cambridge results in 
Cambridge multichannel MFC. Results shown are averages with 
standard deviation from at least three biological replicates carried 
out within the University of Cambridge MFC. Differences between 
BL21 DE3 and BL21 DE3 pEC85 pOmcA were shown to not be 
statistically significant. 
Although this result was carried out using power density instead of current density, the 
level of difference between empty media (LB), E. coli BL21 DE3 and the engineered 
strain is nowhere near where it is shown in the results obtained from Cambridge. The 
reasons behind this are uncertain. The biological setup was exactly the same as that 
used in Cambridge, but the results could not be repeated in Sheffield. 
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4.3.2 Expression of S. oneidensis MR-1 cytochromes in E. coli.  
To introduce electrogenic activity into the host E. coli strain, a variety of plasmids were 
created in which cytochrome gene expression was under the regulation of a T7lac 
promoter as described previously. 
The plasmids pACYCOmcA (OmcA), pRSFOmcA-MtrCAB (OmcA-MtrCAB), pACYCMtrDEF 
(MtrDEF) and pACYCMR-1 (MtrDEF, OmcA, MtrCAB) were created and tested. The use 
of an additional IPTG inducible plasmid, pRGK333 (Figure 4.22) containing cytochrome 
maturation genes (ccmABCDEFGH, denoted ccm), was required in combination with 
the recombinant S. oneidensis cytochromes, due to the lack of expression of the 
equivalent maturation genes within E. coli under aerobic growth conditions (252). The 
need for anaerobic conditions was to ensure prevention of the use of oxygen, as the 
terminal electron acceptor, as this has a preferential redox potential over the anode. 
Although the anode is considered an anaerobic or more likely a microaerobic 
environment, which is conducive to the expression of the native E. coli ccm genes, the 
inducible basing of the gene set allowed for more controlled induction. This meant 
that in theory there would be no variation between the amount of ccm expression 
seen in each strain and replicate, which may not have been the case if it was based on 
how anoxic the anode was. 
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Figure 4.22 - (A) Two of the plasmids used in this chapter;  pRGK333, an 
IPTG inducible E. coli cytochrome maturation protein over-expression 
plasmid (Feissner et al. 2006) and the Shewanella cytochrome expression 
plasmid pACYCMtrCAB-OmcA(B) Heterologously-synthesised decahaem 
cytochromes (MtrA-C and OmcA from Shewanella oneidensis MR-1) 
potentially involved in the transfer of electrons for the novel E. coli strains. 
(C refers to cytoplasm, P to periplasm, and ES to extracellular space). 
To test the hypothesis that the more engineered strain, with a larger number of 
cytochromes would generate more current, the expression of the target protein was 
firstly attempted.  In order to determine successful expression of the desired 
cytochromes, the cells needed to be tested for the presence of the proteins. The 
chosen methodology for this was the purification of the proteins from the cells 
followed by SDS-PAGE and in gel digestion (full methods detailed in chapter 3). Table 
4.3 shows the identification of the expressed proteins within their relevant strains.  
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Table 4.3 – Analysis of engineered E. coli strains with the portable electron 
transporter assembly. The proteins identified are from the Mtr operon of S. 
oneidensis MR-1 through the use of Auto MS(n) and/or HPLC-ESI-pSRM 
(pseudo-selective reaction monitoring – see text) MS/MS, after resolving 
protein extractions via 1D SDS-PAGE. A Phenyx AC score of at least 5.0 was 
considered an unambiguous identification. Brackets indicate the number of 
unique peptides from the total number identified.  
 
The following peptides were identified from OmcA:  
OmcA  
Identified peptides: 
SNVVTGIALGR VTYSADATQR GYQWQAYINAK 
GFALSNSK FTNATVDAGK GGYGVEDVVATPCSTDTR 
TFTIDSTNSNLK FGIAQLTPVK EFISDPSAYTK 
 
These peptides map onto the target protein as follows: 
>gi|24347602|gb|AAN54832.1|AE015622_1 decahaem cytochrome c [Shewanella 
oneidensis MR-1] 
MMKRFNFNTATKAMLGAGLLSLLLTGCGGSDGKDGEDGKPGVVGVNINSTSTLKAKFTNATV
DAGKVTVNFTLENANGVAVLGLTKDHDLRFGIAQLTPVKEKVGETEADRGYQWQAYINAKKE
PGTVPSGVDNLNPSTQFQANVESANKCDTCLVDHGDGSYSYTYQVNVANVTEPVKVTYSADA
Mtr plasmid within E. 
coli strain 
Expressed 
proteins 
Fraction 
identified 
Phenyx AC 
score 
Coverage 
% 
Number of 
peptides 
pACYCOmcA OmcA Soluble 23.77 5 6 (3) 
  OmcA Insoluble 23.26 5 8 (3) 
  OmcA Insoluble 14.47 3 3 (2) 
pACYCOmcA-MtrCAB MtrC Insoluble 13.75 3 3 (2) 
  MtrA Soluble 5.77 4 1 (1) 
  MtrA Insoluble 7.36 3 2 (1) 
  MtrB Soluble 11.23 4 2 (2) 
  MtrB Insoluble 8.37 1 3 (1) 
 OmcA Soluble 12.45 3 3 (2) 
 OmcA Insoluble 10.69 3 3 (2) 
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TQRATMELELPQLAANAHFDWQPSTGKTEGIQTRNVVSIQACYTCHQPESLALHGGRRIDIEN
CASCHTATSGDPESGNSIEFTYMIHAIHKGGERHTFDATGAQVPAPYKIIGYGGKVIDYGKVHYP
QKPAADCAACHVEGAGAPANADLFKADLSNQACIGCHTEKPSAHHSSTDCMACHNATKPYG
GTGSAAKRHGDVMKAYNDSLGYKAKFSNIGIKNNALTFDVQILDNKDQPIGKEFISDPSAYTKS
SIYFSWGIDKDYPAYTAGSRYSDRGFALSNSKVSTYNEATKTFTIDSTNSNLKLPADLTGMNVEL
YAGVATCFNKGGYGVEDVVATPCSTDTRYAYIQDQPFRFKWNGTDTNSAAEKRRAIIDTAKCS
GCHNKEIVHYDNGVNCQACHTPDKGLKTDNTYPGTKVPTSFAWKAHESEGHYLKYAGVQSGT
VLKTDCATCHTADKSNVVTGIALGRSPERAWLYGDIKNNGAVIWVSSDAGACLSCHQKYLSDA
AKSHIETNGGILNGTSAADVQTRASESCATCHTPSQLMEAHGN 
The numerous peptides detected in OmcA, MtrA, B and C provided the proof for the 
presence of these proteins in the strains they were extracted from.  Apart from MtrC in 
the strain BL21 DE3 pRGK333 pACYCOmcA-MtrCAB, all the other Shewanella proteins 
were identified both in the soluble and insoluble fractions. This could suggest that the 
proteins were being incorrectly localised with a certain percentage appearing in the 
cytoplasm instead of the membrane. This does not mean that any proteins in the 
cytoplasm would be correctly folded or functional due to the sec signal sequence on 
the Mtr proteins, which transports unfolded proteins to the periplasm and also the 
requirement of the ccm machinery to insert the haem groups. The identification of 
these proteins in unexpected cellular fractions could have been due to the lack of 
specificity yielded by the protein extraction method used. Ultracentrifugation would 
most likely provide a better division of subcellular compartments. 
4.3.3 Current generation from E. coli expressing S. oneidensis c-type 
cytochromes within a microfluidic MFC.  
A microfludic-scale MFC (MFC) (shown in Figure 4.20) was chosen due to its many 
advantages: easy assembly, high power density per unit area, and utility for high 
throughput analysis of a wide number of strains (253). The main disadvantage of the 
MFC is that long-term growth is infeasible. In order to determine whether the E. coli 
strains expressing S. oneidensis cytochromes could produce current, the bacterial 
strains were each tested by carrying out a polarisation curve within the MFC. A longer 
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term analysis was carried out using a sedimentary fuel cell in which the negative redox 
potential generated by the bacterial culture was measured over 15 h (900 min) (as 
detailed in methods chapter section 3.4.3). Following proteomic analysis of the strains 
and initial MFC test using the microfluidic Cambridge MFCs was carried out in 
Sheffield. The results of this are shown in Figure 4.23 with the values of the empty 
media subtracted (-10mW/m2) in Figure 4.24 to make it determine the difference in 
power density between the engineered strains and the most basic control.  
Figure 4.23 – Max power density obtained from a variety of different strains 
and standards within the Cambridge MFC at Sheffield. Results shown are 
averages with standard deviation from at least three biological replicates 
carried out within the University of Cambridge MFC. Only the result 
between the highest maximum power density strains (BL21 DE3 pRGK333 
pRSF-OmcA-MtrCAB) and the control (BL21 DE3 pRGK333 pACYCDuet-1) 
generated a statistically significant P-value (0.0085). 
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Figure 4.24 – Max power density obtained from a variety of different strains 
and standards within Cambridge MFC with LB result subtracted. Results 
shown are averages with standard deviation from at least three biological 
replicates carried out within the University of Cambridge MFC. The 
difference between BL21 DE3 pRGK333 pRSFOmcA-MtrCAB and BL21 DE3 
pRGK333 pACYCDuet-1 considered to be statistically significant (p-value = 
0.01). The difference between BL21 DE3 pRGK333 pACYCOmcA and BL21 D3 
pRGK333 pACYCDuet-1 was also deemed to be significant (p-value=0.02) 
The results shown in Figure 4.24 demonstrated that although all the engineered strains 
appeared to generate a greater power density than the other controls (BL21 DE3 and 
BL21 DE3 pRGK333 pACYCDuet-1) this was not to a significant level (unpaired t-test 
compared to BL21 DE3 pRGK333 pACYCDuet-1 – (pEC86 OmcA, p-value = 0.29), 
(pRGK333 pACYCMtrDEF, p-value = 0.76), (pRGK333 pACYCMR-1, p-value = 0.13)) 
within this MFC. It was decided at this point that only BL21 DE3 pRGK333 pACYCOmcA 
and BL21 DE3 pRGK333 pRSFOmcA-MtrCAB should continue to be tested as both of 
these were considered significant when compared to BL21 DE3 pRGK333 pACYCDuet-1 
(pRGK333 pACYCOmcA, p-value = 0.02.) and (pRGK333 pRSFOmcA-MtrCAB, p-value = 
0.01). 
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All cultures were diluted to an OD600 of 1.0. They were then replenished with a 
carbon source (in the form of 5 mM sodium lactate); fresh antibiotics and IPTG (0.5 
mM) were added before being loaded into the anode chamber of the µMFC. A 
polarisation curve was generated by varying the load applied to all the channels of the 
MFC (full methods in Chapter section 3.4.2). Each strain had 6 replicates carried out 
simultaneously within the different channels of the MFC. As shown in Figure 4.25, the 
engineered strain containing pRSFOmcA-MtrCAB was capable of generating power 
within the µMFC, with a power output of 17 mW/m-2. This strain had a power output 
6.4 mW m-2 higher than the control bearing the empty parent plasmid pACYCDuet-1 in 
combination with the overexpressed cytochrome maturation genes in pRGK333. The 
strain bearing pRSFOmcA-MtrCAB also produced a power output 5 mW m-2 higher 
than pACYCOmcA alongside the ccm genes. This demonstrates the ability of a “more 
complete” extracellular electron pathway to allow for the greater power generation. 
The functional interaction between a more complete electrogenic pathway in the form 
of OmcA-MtrCAB appeared to be key in allowing E. coli to produce current more 
efficiently. The initial results within the Cambridge MFC did however demonstrate that 
this is a balance and that there can potentially be too many cytochromes leading to 
redundancy in the system and metabolic burden. The length of the transcript in 
pACYCMR-1, which contained MtrDEF-OmcA-MtrCAB, may have been too long to 
provide an adequate level of the desired protein. The lack of activity of MtrD, E and F 
within E. coli suggested that although these proteins are highly similar to MtrC, A and 
B, they do not appear to be able to provide the same power generation capability. It is 
hard to determine why this is without further analysis. The native electron donator 
NapC may not be able to interact with MtrD to the same extent as it does with MtrA. 
Admittedly there was no OmcA or a suitable alternative in this strain, which may have 
also impacted on the results.  
Previous studies on Fe (III) reduction by E. coli strains revealed that expression of MtrC, 
A, and B cytochromes in E. coli results in an engineered strain that can reduce metal 
ions and solid metal oxides 8× and 4× faster, respectively, than its parental strain (125). 
Before the work presented in this chapter and that demonstrated by Goldbeck et al 
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(124), it was unclear whether cytochrome-containing E. coli strains would produce 
current in an MFC, especially given the observation that for Pelobacter carbinolicus, 
the capacity for Fe (III) oxide reduction does not necessarily demonstrate an ability to 
transfer electrons to fuel cell anodes (122). It is also not clear how similar (a) 
cytochromes in situ in S. oneidensis, with or without the presence of other 
cytochromes, (b) isolated cytochromes tested in vitro, and (c) cytochromes expressed 
in E. coli, are to each other and whether it is possible to draw generic functional 
conclusions.  Gram negative bacteria are known to respond to stress conditions by 
shedding membrane vesicles (254) and in the case of an OmcA-only E. coli strain it has 
been shown that these vesicles only carry OmcA molecules (120). Analysis of both the 
OmcA-only and OmcA-MtrCAB cluster bacterial samples showed OmcA was always 
present in the supernatant. It is possible that vesicle-bound OmcA proteins are 
involved in electron transport maybe via bound flavins (255), and that the vesicles act 
as some sort of transport system to the anode surface.  
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Figure 4.25 - Maximum power density (mW/m2) attained within the 
microfluidic microbial fuel cell (µMFC) (blue data - left axis). Half cell results 
are presented as the negative potential obtained at 900 mins against the 
counter electrode (purple data - right axis) (1) Growth medium only - LB + 
lactate + 0.5mM IPTG (µMFC=11.8 mW/m2 +/- 0.8 mW/m2). (2) E. coli 
expressing the plasmids pRGK333 and pACYCDuet-1(µMFC =10.7 mW/m2 
+/- 1.1 mW/m2) (Half cell = 107.4 mV +/- 2.0 mV), (3) pRGK333 and 
pACYCOmcA (µMFC = 12.0 mW/m2 +/- 2.5 mW/m2) (Half cell = 105.7 mV +/- 
1.8 mV) (4) pRGK333 and pRSFOmcA-MtrCAB (µMFC = 17.0 mW/m2+/- 0.6 
mW/m2) (Half cell =115.8 mV +/- 0.8 mV) and (5) pRGK333 and 
pACYCMtrABC-OmcA (Half cell = 117.9 mV +/-  0 mV). T 
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4.3.4 Negative potential within a sedimentary half cell 
To verify the results and test the capability of the electrogenic strains within different 
devices, we employed a sedimentary half cell (Figure 4.26). This provided an 
opportunity for a longer term analysis in which the carbon (working) electrode was 
placed in the base of the sedimentary half cell to allow the transfer of current from 
planktonic cells, sedimented bacteria and/or from bacterial biofilms. In combination 
with an Ag/AgCl red rod reference electrode, the negative potential from the reduction 
of the working electrode was calculated. The results clearly show a more negative 
potential in strains expressing S. oneidensis c-type cytochromes following a 15h growth 
period within the sedimentary half cell (Figure 4.27). Both the pACYC and pRSF 
derivatives of OmcA-MtrCAB gave a higher electrogenic potential than an empty 
plasmid (pACYCDuet-1).  
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Figure 4.26 - Schematic diagram and photographs of the sedimentary half 
cell (HC). The circular anodes are arranged at the base of the cell to allow 
potentially electrogenic bacteria to form a layer or a biofilm. A) Schematic 
of half cell setup B) Photograph of E. coli BL21 DE3 in HC C) Photograph of S. 
oneidensis MR-1 in HC (D) Photograph of engineered E. coli strain pRGK333 
pACYCOmcA. 
The engineered strains pACYCOmcA and pACYCOmcA-MtrCAB were also compared 
over an 8 day period within sedimentary half cells containing sparged M9 minimal 
media. The results (Figure 4.25) presented a difference (unpaired t-test, p-value = 
0.001) in the potential observed between pACYCOmcA-MtrCAB and pACYCOmcA with 
average readings of -207 mV and -176 mV respectively. This further demonstrates the 
ability of the engineered strain to interact with a working electrode over a substantial 
period of time within nitrogen sparged, minimal media with a defined carbon source. It 
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should be noted that the half cell tests were done to provide extra validation of the 
setup with the potential to be used as a screen but MFC’s are still required to provide 
more detailed information about the strains such as power density. 
 
 
 
 
 
 
 
 
 
Figure 4.27 Results from an 8-day half cell run in minimal media 
with three biological replicates of each. Average negative 
potential is shown (-mV) along with standard deviation. The result 
were shown to be statistically significant (p-value=0.001) 
4.4 Discussion and Conclusions 
The results presented in this chapter show that transfer of electrogenic activity into an 
organism not naturally capable of such an ability, is possible. The use of OmcA, MtrC, A 
and B proteins from S. oneidensis MR-1 alongside overexpressed cytochrome 
maturation genes proved to be the more successful method to do this within this in 
this case. The aforementioned Goldbeck paper (124), although utilising largely the 
same genetic elements (MtrCAB from S. oneidensis MR-1) as those used in this 
chapter, took a different, synthetic biology approach to the experiment. Goldbeck et al 
(124) made use of a promoter library which provided an opportunity to focus on the 
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greatest cellular balance between overexpressed recombinant protein and a healthy, 
functional cell, capable of generating ~30-fold greater maximal current per cfu than 
the cytochrome maturation gene only control strain.  
This chapter demonstrates the challenges faced by synthetic biologists. The 
molecular/synthetic biology community have moved past the point of recombinant 
expression of single non-native proteins and ventured into non-native recombinant 
pathways. It is to be expected that significant challenges would be faced in this quest, 
especially when the overexpression of relatively large pathways is attempted 
simultaneously. Complexity was added due to the fact that all the proteins chosen to 
work with were membrane proteins, many with multiple haem groups. The option for 
codon optimisation of the pathways for enhanced expression was limited due to the 
large financial investment in producing constructs of such considerable size that may 
well not provide any greater yield. The BioBrick style approach towards the challenge 
that Goldbeck et al (124) took in regard to the promoter variation was an efficient way 
of adapting towards the challenges of the project. An interesting conclusion from this 
study was the importance of minimal perturbation to cellular morphology when 
transferring electrons extracellularly. The choice of basing the Mtr system with the 
Duet-1 series of plasmids from Novagen provided downstream flexibility in the fact 
that these plasmids have two multiple cloning sites. In the event of further genes being 
identified that could enhance the power density, these would have then been inserted 
and attempted. This did however put the genes under the control of the notoriously 
active T7 viral promoter. This promoter is designed for maximum expression of the 
target protein (typically a single target protein) (256,257) with yields of that protein 
reaching up to 50% of total cell protein (258,259).  
The challenges faced in the synthetic biology aspects of the project were paired with 
equal challenges with testing apparatus. Although microbial fuel cells have seen 
considerable development over the past 10 years, they are still far from a “plug and 
play” device. A great deal of electrochemistry knowledge is required in order to make 
sense of the results obtained and even more in order to be able to troubleshoot. The 
193 | P a g e  
 
demands of the project in terms of the high throughput approach to determining the 
genetic variants that lead to an increase in power generation due to the heavy 
industrial basis of the project caused issues with the initial MFC setup.  
With all said the aforementioned challenges, the expression of two large plasmid 
systems coding for two separate membrane localised pathways within E. coli did 
demonstrate a change in the electrogenic activity between engineered strains and wild 
type E. coli across multiple testing devices. The increase in power generation noted 
between wild type and the highest output engineered strain was approximately 60%. 
This was 64% of the S. oneidensis value (which produced an average power density of 
26.8 mW/m2) and showed that there was still room for improvement in order to be 
able to reach the levels seen in the native organism. It must be noted that the result 
generated from the Shewanella will be skewed from the expected values from S. 
oneidensis MR-1 due to the aerobic growth of the MR-1 culture and replacement of 
the media before use in the MFC. Aerobic growth would have prevented full 
expression of the c-type cytochromes normally utilised within an anaerobic 
environment and the replacement of the media would have removed any flavins. 
These flavins are Shewanella’s dominant method of extracellular electron transfer 
(104) and their removal would drastically decrease any power reading obtained.  
Limited proteomic work had been carried out between S. oneidensis MR-1 under 
different environmental conditions, especially with regard to the proteomic changes 
noted when adapted to survival within an MFC was carried out. With this in mind an 
investigation into a comparison between the proteomic profiles of Shewanella under 
standard lab conditions and Shewanella within a MFC. The results obtained from this 
study were intended to be used to identify heavily upregulated proteins and pathways 
within Shewanella that could then be used for further genetic engineering in E. coli. As 
the reason behind the low increase in power generation was unknown, pairing 
additional genetic components with the already established Mtr pathway may then 
yield a greater power output. The reasoning behind this being that there may be other 
components present in Shewanella that allow it to generate higher current, which 
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could be detected using quantitative proteomics. Issues relating to the substantially 
different regulatory mechanisms in Shewanella compared to E. coli (260) would have 
to be carefully considered. Details of this proteomic analysis can be found in chapter 5. 
As stated previously, the reason behind the low power output was complex. Further 
thought as to the cause of this issue was that it could have been due to the high level 
of metabolic burden imposed upon the cells. The current setup was 2 large plasmids, 
with one carrying native E. coli genes, in the form of cytochrome maturation genes, 
(11,250 bp) and the other consisting of varieties of the Mtr pathway (up to 16,994 for 
pACYCMR-1). A method to move away from this was considered, with further analysis 
as to the thought process of why this should occur, and is detailed in chapter 6. 
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Chapter	5	-	Quantitative	proteomic	
analysis	of	Shewanella	oneidensis	MR-
1	within	an	MFC	compared	to	
microaerobic	chemostatic	growth	
This chapter was done in collaboration with Dr. Greg. J. S. Fowler, Dr. Ana. G. Pereira-
Medrano, Dr. Trong Khoa Pham, Dr Pablo Ledezma, Dr Ioannis A. Ieropoulos and was 
supervised by Prof. Phillip C. Wright 
5.1 Introduction 
As detailed in chapter 2, the use of model organisms such as Shewanella within BESs is 
well documented (96,261–264) and various bacterial biochemical pathways have been 
proposed to explain the mechanisms through which MFCs are capable of producing 
electricity (265,266). Direct electron transfer to an MFC anode has been widely studied 
in dissimilatory metal reducing bacteria such as Shewanella oneidensis MR-1 (the 
bacterium used in this chapter) and Geobacter sulfurreducens. Several reviews discuss 
the putative mechanisms of direct transfer, typically involving at least a series of 
periplasmic and outer membrane complexes in these species (266–268). Primary 
bacterial metabolites, such as sulphur species (269), and iron oxides  have also been 
found to conduct electrons to electrodes (270) respectively, whilst electron shuttles 
have been shown to be produced by some organisms as secondary metabolites, such 
as flavins by S. oneidensis MR-1 and Shewanella sp. MR-4 (104,136) and phenazines by 
Pseudomonas aeruginosa KRP1 (271). The use of “omics” studies has previously 
demonstrated their ability to not only provide an understanding of the shift of the 
metabolism of an organism towards a situation, but also towards forward engineering 
(272). 
A number of transcriptomic and proteomic studies have been carried out on S. 
oneidensis, including the effect of chromate challenge (273,274), the role of the fur 
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regulon (275,276) and investigations into the membrane and biofilm composition 
(277–280). Most recently, a transcriptional analysis of S. oneidensis with an electrode 
compared to Fe (III) citrate or oxygen as terminal electron acceptor, has been 
published (281). Although advances have been made in understanding anodic electron 
transfer mechanisms by the terminal cytochromes of exoelectrogenic bacteria 
(102,282), related non-cytochrome outer membrane biochemical mechanisms used by 
electricity-producing organisms are still poorly understood. The current understanding 
of fundamental mechanisms is largely due to extensive bioelectrochemical and 
biophysical studies, genomics and some proteomics studies. The subcellular proteome 
of S. oneidensis MR-1 has been qualitatively mapped using LC-MS/MS (277), but 
quantitative proteomics has yet to play a major role in the characterisation of the 
extracellular electron transfer pathways (215). Recent work has shown the first 
demonstration of control and measurement of speciﬁc growth rates in MFCs and the 
maximum speciﬁc growth rate for S. oneidensis bioﬁlms, and that operation at 
maximum speciﬁc growth rate returns maximum electrical power output (212).  
In this chapter, quantitative proteomics techniques have been employed to 
understand more about the S. oneidensis electrogenic behaviour when operating 
under relevant current inducing conditions at the anode in an MFC. The results from 
chapter 4 revealed that a greater knowledge of the mechanisms of exoelectrogenic 
activity was required and thus, by developing a greater understanding of the protein 
profile of a DMRB within an MFC compared to microaerobic growth, it may be possible 
to apply this knowledge to the enhancement of the engineered E. coli strain. Whilst a 
quantitative proteomic analysis of the engineered E. coli strain BL21 DE3 pRGK333 
pRSFMtrOmcA-CAB may have provided information as to where bottlenecks lie within 
the metabolism of the organism, this was not considered the highest priority. The 
reasoning behind this was that S. oneidensis MR-1 is a well studied organism, 
especially in regards to extracellular electron transport but no quantitative proteomics 
had been carried out at this point. This presented an opportunity to conduct highly 
informative research for the DMRB and MFC community. Although engineered E. coli 
was producing a statistically significant amount of power when compared to BL21 DE3 
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and the control strain BL21 DE3 pRGK333 pACYCDuet-1, it was not considered 
sufficient to deem this the most useful experiment at this point in time. Instead a more 
targeted analysis of the interacting partners of the recombinant Mtr pathway within E. 
coli was considered (as detailed in chapter 6). Quantitative proteomics of engineered 
E. coli was still considered for later research following analysis of S. oneidensis, with 
the potential for any information obtained from the proteomic analysis of MR-1 to be 
applied to further increase power generation in E. coli. The basing of the Mtr pathway 
on the chromosome of BL21 DE3 (discussed in chapter 6) was done with the aim of 
reducing the metabolic burden and increasing electrogenic activity. This would then be 
a more stable basing of the genetic material, where less cellular energy was being 
diverted to plasmid maintenance, which could otherwise create a proteomic skew. A 
proteomic analysis of a further engineered E. coli was deemed to be the most valuable 
after these two key developments. 
 iTRAQ (and other prominently applied silent isotope incorporation techniques) 
remains one of the most robust and easy-to-use techniques to be applied in 
quantitative proteomics (283). Previous work in an MFC indicates that even in a 
Shewanella oneidensis MR-1 mutant that has had OmcA and MtrC knocked out, the 
bacterium still produces approximately one seventh of the current of WT S. oneidensis, 
and has approximately one third of the ability to reduce iron (III) species to iron (II) 
species. (109). This evidence is not wholly by the literature as at least one study 
identifies the Mtr pathway as being essential (284). This suggests that these decahaem 
proteins may not be the only route for electrons producing current at an MFC anode. 
Following this information, iTRAQ proteomics was carried out for the first time to try 
and understand more about the non-cytochrome S. oneidensis MR-1 electrogenic 
behaviour, when operating under relevant current inducing conditions at the anode of 
an MFC. Full details of the materials and methods used in this chapter can be found in 
chapter 3.  
Before discussing the results obtained from this iTRAQ experiment it should be noted 
that iTRAQ analysis can under-estimate the degree of fold change (283,285,286). This 
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results from technical issues, mainly due to the so called mixed MS/MS, which results 
when two or more precursor (nearly isobaric) ions with similar mass/charge and 
retention time during HPLC, prior to MS analysis', are selected for fragmentation. The 
net result is augmented iTRAQ reporter intensities with compression of the ratio for 
selected peptides and thus underestimation (283,287,288). Whilst the fold change may 
be underestimated, the direction of change i.e. up or down regulated, is correct (289).  
5.2 Results and discussion 
5.2.1 Bacterial growth within the UWE MFC and protein extraction 
The first step towards making a comparison of the cellular proteins produced from 
anode-associated cells in an MFC, with those produced in planktonic conditions was to 
grow cells of S. oneidensis MR-1 both in an MFC set up and in flasks. Accordingly a pre-
culture of S. oneidensis, grown microaerobically in LB, was used to inoculate replicate 
cultures in lactate minimal medium (see materials and methods section 3.4.1.1 for 
details). These cultures were grown either microaerobically in flasks or anaerobically in 
MFCs, such that all cultures reached the late exponential growth phase.  
Following the initial 3 week growth period where a stable biofilm was allowed to 
develop, the MFCs then had a load applied to them with the resulting power output 
shown in Figure 5.1. The power outputs stabilised until the point in which the flow rate 
of the growth medium within the MFCs was increased. This happened after 10,000 
mins, which led to an increase in power seen in Figure 5.1. The increase in flow rate 
allowed for a greater circulation of nutrients, which in turn allowed higher metabolic 
activity and movement of endogenous mediators through the media. All these 
elements combined yielded a near instantaneous 4 fold power increase from an 
average of 15 µW to 60 µW. 
At the end of the appropriate growth period, S. oneidensis MR-1 cells were harvested 
from the liquid phase of the microaerobic growth vessels and from the electrode 
biofilm of the MFCs. A comparison of protein abundances in cells that use oxygen as a 
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terminal electron acceptor (aerobic cells) versus cells, which can use the carbon anode 
as an electron acceptor (anode bound cells) was then carried out. 
Figure 5.1 The production of electrons in the form of power output (in µW) 
versus time (in min) recorded from Shewanella oneidensis MR-1 attached to 
the anodes of microbial fuel cells (MFC) (data generated from 2 MFCs). 
Following the initial 3 week growth period (before time = 0 mins) where a 
stable biofilm was allowed to develop, the MFCs then had a load applied to 
them, with the resulting power output shown in the figure. After 10,000 
mins the flow rate of the medium in the MFCs cells was increased, which led 
to a near instantaneous 3 fold power increase from an average of 15 µW to 
57 µW. The increase in flow rate allowed for a greater circulation of 
nutrients, which in turn allowed higher metabolic activity and movement of 
endogenous mediators through the media. 
5.2.2 Data mining: identification and quantification of differential 
protein abundance 
The method used to quantify the differential abundance of bacterial proteins in the 
MFCs compared to bacteria grown in flasks was iTRAQ, as it has major advantages over 
traditional gel-based quantitative approaches, not least in reproducibility, since it 
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produces a relative quantification for each identified peptide (225). This section 
describes the quantitation methods used, the number of proteins detected by iTRAQ, 
and the distribution of proteins between soluble and insoluble fractions, prior to 
analysis of which proteins were significantly associated with growth on the anode. 
The relative quantification of proteins from the anaerobic cells taken from the MFC 
anode versus microaerobically grown cells was carried out using iTRAQ labels. These 
iTRAQ sets were used to carry out different analyses to include the soluble and 
insoluble sub-proteomes for each phenotype (Table 5.1). As described in materials and 
methods section 3.3.9, MS/MS data interpretation was performed using Phenyx 
peptide identification, and a quantitative data analysis algorithm using in-house 
developed Mathematica scripts. 
Table 5.1. - Summary of iTRAQ experiments  
iTRAQ experiment 
number and 
descriptiona 
Type of sub-
proteome, 
g per sample, 
iTRAQ kit used 
Phenotype 1 – 
Labels of biological 
replicates for 
microaerobic 
planktonic S. 
oneidensis cellsb 
Phenotype 2 – 
Labels of biological 
replicates for MFC 
anodic S. oneidensis 
cellsc 
Biological 
comparison by pair 
iTRAQ 1  
Microaerobic 
planktonic S. 
oneidensis MR-1 vs 
anaerobic anodic S. 
oneidensis MR-1 
 
Soluble proteins 
100 g 
4 iTRAQ labels 
 
Aerobic –115, 116 
 
Anodic – 119, 121 
 
119:115, 121:115, 
and 
119:116, 121:116 
iTRAQ 2  
Microaerobic 
planktonic S. 
oneidensis MR-1 vs 
 
Insoluble proteins 
100 g 
 
Aerobic – 115, 116 
 
Anodic – 119, 121 
 
119:115, 121:115, 
and 
119:116, 121:116 
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anaerobic anodic S. 
oneidensis MR-1 
4 iTRAQ labels 
 
a. Two biological replicates were used for each phenotype. Biological comparisons for 
each pair were carried out as indicated, and determination of differential expression 
was evaluated via t-tests, as described in methods section 3.3.10, MS and MS/MS level 
measurements for QStarXL instrument Survey scans were acquired from 350 to 1,800 
m/z, and MS/MS scans from 65 to 1,800 m/z. The spectrometer sequentially 
conducted MS/MS on the precursor ions (+2 and +3 charge state) detected in the full 
scan. MS profile data was acquired using Analyst QS 2.0 (Applied Biosystems ABI). 
Profile data was stored in wiff format. 
b. Phenotype 1 are microaerobic planktonic cells culture.  
c. Phenotype 2 are all anaerobic anodic biofilm cells cultured from the MFC. 
Using Phenyx and a robust in-house statistical approach, 2090 and 2727 peptide 
spectral matches (PSM) were detected from the anaerobic MFC vs microaerobic cells. 
(iTRAQ 1 for soluble sub-proteome and iTRAQ 2 for the insoluble, respectively). 
 Combined datasets from the soluble and insoluble sub-proteomes of MFC cells vs 
microaerobic planktonic cells comparison (iTRAQs 1 and 2, respectively) identified a 
total of 170 unique proteins, of which 92 are common to both sub-proteomes, whilst 
42 and 36 were only identified in the insoluble and soluble sub-proteomes, 
respectively. The predicted protein functions for the identified proteins are shown in 
Figure 5.2, whilst a schematic showing the subcellular localisation of some of the 
quantified proteins is shown in Figure 5.3. There were 8 and 11 predicted membrane 
proteins (including cytoplasmic membrane, outer membrane and periplasmic proteins) 
identified in insoluble and soluble fractions, respectively, whilst 3 regulated membrane 
proteins were common to iTRAQs 1 and 2 (Details in Appendix). A high proportion of 
predicted regulated cytoplasmic proteins were found in the insoluble fractions (62% of 
regulated proteins), many of which were ribosomal proteins (cytoplasmic proteins) 
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possibly due to the attachment of these (nominally cytoplasmic) proteins to the 
membrane via nascent polypeptide chains (214,290). It is clear that separate 
measurement of the insoluble and soluble sub-proteomes increased the total number 
of identified and quantified membrane and cytoplasmic proteins.   
Figure 5.2 Analysis from iTRAQ data of the functions of the identified 
proteins from Shewanella oneidensis MR-1 in the microbial fuel cell under 
fast perfusion (62.5 mL.h-1) conditions. Combined datasets from the soluble 
and insoluble sub-proteomes of anaerobic HC vs microaerobic planktonic 
cells comparison (iTRAQs 1 and 2, respectively) identified a total 
of 170 unique proteins, of which 92 are common to both sub-proteomes, 
whilst 42 and 36 were only identified in the insoluble and soluble sub-
proteomes, respectively. 
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Figure 5.3 A schematic diagram showing the subcellular locations of selected 
membrane protein “hits” from the iTRAQ and 2D-LC MS/MS experiments. 
Membrane proteins are represented as RasMol drawings made using PDB 
coordinates generated using from the relevant protein sequence by the 
I_TASSER software suite (291). Structures in grey represent an iTRAQ result 
from either only one unique peptide (Q8EB8 and Q8EIM3) or from a peptide 
unique to a class of proteins rather than one protein within that class 
(methyl-accepting chemotaxis proteins) (see Table 5.2). OM= outer 
membrane, IM= inner membrane PG = peptidoglycan layer/cell wall. An 
upward arrow indicates a protein that is overall more abundant in anodic 
electron-producing Shewanella oneidensis MR-1 than the planktonic 
equivalent. Red arrows represent results from the “insoluble” fraction whilst 
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blue arrows represent results from the “soluble” fraction. Figure developed 
by Dr Greg Fowler. 
5.2.3 The TolC efflux pump (Q8EAJ8/SO_3904) 
The iTRAQ results indicate that TolC (Q8EAJ8/SO_3904) protein is statistically 
increased in abundance, in the insoluble fraction prepared from S. oneidensis cells, 
producing electricity at an anode than in planktonic cells (Table 5.2). It has been noted 
previously that the TolC-dependent efflux system of MR-1 is required for protection 
against toxic levels of redox active compounds (292), and it has been suggested that 
this may provide direct evidence linking efﬂux pumps with the reduction of insoluble 
electron acceptors (106). TolC proteins can form part of a type 1 secretion system or 
be part of an efflux pump complex, creating a continuous, solvent-accessible conduit 
(293): structurally, TolC itself is a channel over 14 nm long that spans both the outer 
membrane and periplasmic space (see, for example, the Protein Data Bank (PDB) 
archive rcsb.com). The periplasmic or proximal end of the tunnel is sealed by sets of 
coiled helices. In E. coli, TolC is involved in the export of enterobactin, which, once it 
has bound iron to become ferric enterobactin, is imported by the cell (294). TolC may 
form part of the putative type I secretion from G. sulfurreducens, another electrogenic 
bacterium, whose function may include exporting some outer membrane proteins 
which are important in cell–anode interactions (295). These observations, combined 
with the iTRAQ results seen in this chapter, suggest that TolC may also have an indirect 
role in the transfer of electrons to an anode. 
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Table 5.2 Selected iTRAQ abundance trends for Shewanella oneidensis MR-1 
membrane proteins in cells at the anode of an anaerobic MFC (compared to 
those from a microaerobic planktonic culture) 
Uniprot 
Name_SHEON 
NCBI 
identification 
iTRAQ distinct peptide 
hits 
Soluble 
fraction 
abundancea. 
Insoluble 
fraction 
abundancea. 
Subcellular 
locationb. 
p-
valuec. 
Outer membrane proteins 
Q8EAJ8 
(SO_3904) 
AE015823_1 
TolC TIVDVLNR 
ALNVLDTNR  
- Increase OM 7.58e-
4 
Q8EFY5 
(SO_1829)  
AE015626_10 
TPR LYADLLLQEK 
QAVEADILGGTDHAATLR 
LAQLMAQK 
MLGNFYAEK 
YSEAIPVLEK 
- Increase 
 
OM 1.36e-
2 
 
Q8EHD1 
(SO_1295) 
AE015573_9 
Lpp AAAMDAQAEAK 
AAAMDAQAEAKR 
RANDRLDNVASR 
ANDRLDNVASR 
LDNVASR 
VDQLSADVSSLK 
- Decrease OM 1.31e-
11 
Q8EBH3 
(SO_3545) 
AE015790_7 
OMP GATLGLVGVWPLGNR 
RIEAIVTTTEK 
VTSNGYGITKPLVAGNSK 
- Decrease OM 1.18e-
3 
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VDSVGCTLYENVK 
Outer membrane TonB receptors 
Q8EIM3 
(SO_0815) 
AE015526_2 
BtuB VDEHLVVIGR (unique) d. Increase - OM 1.44e-
3 
 
Q8ED60 
(SO_2907) 
AE015729_7 
ArgR-reg TonBR YEALDNLVLR 
VVFAGYK 
ITDELEWFGQAIVMR 
TFDGLAFDAK 
GNPACEDTQYLR 
Decrease - OM 2.63e-
3 
Q8EEF5 
(SO_2427) 
AE015683_8 
ArgR-reg TonBR IYNQDTDTWR 
LTGEFALR 
MNDVGPR 
VIDANGNWVK 
TIYGGVTVK 
QDMETASPVTVIDAAAIK 
TLVLIDGR 
TLVLIDGRR 
Decrease Decrease OM 1.40e-
11 
1.73e-
2 
Q8EEB8 
(SO_2469) 
AE015688_6 
TonBR TLVLIDGR (unique) d. Decrease - OM 2.74e-
5 
TonB2 system  
Q8EFY6 
(SO_1828) 
TonB2 IEPQYPIAAAR 
DGDATPIVR 
Decrease Decrease - 6.90e-
4 
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AE015626_9 FTINELGGVEDVEVIQAEPK 1.38e-
2 
Q8EFY7 
(SO_1827)  
AE015626_8 
ExbD2 NGIIMMENR (unique) d. 
 
Decrease - IM 7.18 e-
3 
Q8EFY9 
(SO_1825) 
AE015626_6 
TtpC2 EQEFQAER 
ETPALEAR 
FIADLGAR 
TIDQLLQQVK 
VGAYNLTAEGK 
GVLLNIYTNK 
TAQGDLGEMFGVVK 
GEAGDFAGK 
GKDLNQAFLDNER 
SITQILEEQSAGIIAAHAEK 
NVDKPGNNALGR 
DKFIADLGAR 
FQGSVTAIDGSVK 
Decrease Decrease IM 4.96e-
9 
3.51e-
10 
Q8EFZ0 
(SO_1824) 
AE015626_5 
DUF3450 LILDAYSIER 
LLNTAEVTLAEK 
VALYAQSLDQK 
QGVVPLMFK 
GWDKLEDSYLR 
EVLVDFFNLGR 
Decrease Decrease - 2.82e-
11 
3.72e-
6 
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MVESLEQFVQLDLPFNSEVR 
TGWMYNPQTK 
LLNTAEVTLAEK 
QGALDLFALPIPAAETAQ 
SMDAIQNDINGVDKLR 
Methyl-accepting chemotaxis proteins  
24  possible 
 S. oneidensis 
Methyl-
accepting 
chemotaxis 
proteins * 
Methyl-
accepting 
chemotaxis 
proteins 
(MACP) 
GFAVVADEVR * Increase Increase IM 8.66e-
10 
1.11e-
16 
 
 
a. "Increase" represents a greater abundance for that protein in anodic S. oneidensis.  
b. Tang et al., 2007 Profiling the Membrane Proteome (278) and InterPro, OM = outer 
membrane, IM = inner membrane. 
c. The p-values are included (see appendix for more details) to give an indication of 
statistical significance. 
d. Peptides labelled “unique” are only found in that particular protein in the S. 
oneidensis proteome, and since these results only represent one peptide in an iTRAQ 
run, they are included merely because they appear suggestive rather than because 
they provide conclusive proof.  
* Peptide GFAVVADEVR is found in 24 different S. oneidensis methyl-accepting 
chemotaxis proteins (MACP) and the iTRAQ data is included not as definitive data but 
merely as a possible clue to what may be different between anodic and planktonic 
cells. Q8EA56, Q8ECT0, Q8E837, Q8EBE2, Q8EJ84, Q8E939, Q8EC62, Q8EI62, Q8EGZ8, 
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Q8EEX1, Q8EFA2, Q8EHS3, Q8EHE5, Q8EB90, Q8EAL2, Q8E928, Q8E8M8, Q8E8U9, 
Q8EHZ8, Q8EBU5, Q8EF69, Q8EAQ8, Q8EH45, Q8EJG7 
5.2.4 The TonB2 system 
The iTRAQ results indicate that TonB2 (Q8EFY6/SO_1828), ExbD2 (Q8EFY7/SO_1827), 
TtpC2 - the (Q8EFY9/SO_1825/AE015626_6) TonB2 complex-associated transport 
protein and DUF3450 (Q8EFZ0/SO_1824) are statistically less abundant in anaerobic 
cells from the MFC anode than in microaerobic planktonic S. oneidensis MR-1 cells 
(Table 5.2). The genes coding for the TonB2 system of S. oneidensis all lie on the same 
operon (AE015626_5/AAN54876.1 - AE15626_9/AAN54880.1, 1917616-1921206) as 
shown in Figure 5.4.   
 
Figure 5.4 - TonB2 system genes located within the S. oneidensis 
MR-1 genome. SO numbers equate as follows; SO1829=DUF3450, 
SO1825=TtpC2, exbB2 = SO1826, exbD2=SO1827, TonB2=SO1828  
The TonB family of proteins are generally thought to be required, amongst other things 
for the energy dependent active transport of iron bound substrates across the outer 
membrane of gram-negative bacteria (296–301). 
In order to highlight the functions of the TonB2 and related systems in S. oneidensis, it 
was thought useful to compare them with those of the gram negative 
gammaproteobacteria Vibrio (which although not defined as a DMRB, has multiple 
decahaem c-type cytochromes. There are examples of other similar uncharacterised 
proteins within other Shewanella species but the high sequence homology and level of 
investigation into this protein in Vibrio made it a suitable choice for comparison. 
Further reasons will become clearer throughout the chapter). This parallels a similar 
S. oneidensis TonB2 system 
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comparison between the TonB2 systems of V. anguillarum and Escherichia coli (302). A 
number of bacteria, including the Vibrio bacteria (V. anguillarum, V. vulnificus and V. 
cholerae) and S. oneidensis, contain a second TonB system termed the TrpC2-TonB2 
system and in this way differ from, for example, E. coli, which only contains the single 
TonB1 system. The TtpC2-TonB2 system has shown uptake specificity to certain iron-
bound substrates in both V. anguillarum and V. cholerae [(301) and, unlike the TonB1 
system, the TtpC2-TonB2 system consists of four proteins: TonB2, ExbD2, ExbB2, and 
TtpC. TtpC2 and TonB2 are required for the uptake of endogenously produced ferric-
siderophores (300). In Vibrio anguillarum the TonB2 protein, the protein most 
comparable to S. oneidensis TonB2, is essential for the uptake of the indigenous 
siderophore anguibactin (302). Siderophores are naturally secreted iron carriers with a 
high specificity and affinity towards ferric iron (303,304). Gram-negative bacteria take 
up ferric-siderophore complexes via TonB outer membrane receptors, by energy-
transducing TonB systems. Further bioinformatic examination of TonB2 and TtpC2 
(Discussed further at the end of this section) suggests similarities with Vibrio TonB2 
systems, which are associated with endogenously produced ferric-siderophores, 
exogenous siderophore aerobactin and anguibactin transport, for example.  
DUF3450 (Q8EFZ0/ SO_1824) (shown in Figure 5.4) is one of a family of functionally 
uncharacterised proteins that are found in bacteria and eukaryotes. DUF3450 
(PF11932) is a protein family of unknown function with 253 members from 168 
bacterial species including many of the Shewanella and Vibrio Gammaproteobacteria, 
and is represented in this chapter by Q8EFZ0 from S. oneidensis (see, for example, 
http:/pfam.sanger.ac.uk/family/DUF3450). It has already been noted in this chapter 
that DUF3450 lies on the same operon as the TonB2 system and therefore it has been 
posited that it is involved with the TonB2 system (300). DUF3450 (Q8EFZ0) is described 
as a “TonB2 energy transduction system periplasmic component” in its entry in the 
NCBI database (http:/www.ncbi.nlm.nih.gov/protein/NP_717432) and this study gives 
some new quantitative experimental evidence that DUF3450 is connected with the 
TonB2 system as the abundance for this protein seems to mirror that of the TonB2 and 
ExbD2, namely, being less abundant in anodic than planktonic S. oneidensis cells. This 
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is the first known example of a potential role for DUF3450, with a potential role in the 
TonB2 system. 
5.2.5 The Shewanella oneidensis MR-1 TonB2 system 
A BLAST comparison (discussed later in the chapter) indicates that the loop 3 in the V. 
anguillarum TonB2 associated with anguibactin transport (302) aligns well (70% 
identity) with a similar region in the S. oneidensis TonB2; 
F7YJ70_VIBA7: 179 WKYQPQIVDGKAIEQPGQTV 198 
Q8EFY6_SHEON: 177 WKYKPKIVDGKPLKQPGMTV 196 
The TonB2 system in both V. anguillarum and V. cholerae shows uptake specificity to 
certain endogenously produced ferric-siderophores, TtpC2 and TonB being required 
for their uptake (300,301). TtpC2 is essential for the uptake of endogenous 
siderophores. Examples include the pathogenic bacterium V. vulnificus vulnibactin and 
a hydroxamate compound, an exogenous siderophore aerobactin (300) as well as 
enterobactin, vibriobactin and hemin in V. cholerae, vulnibactin in V. vulnificus and 
likely, vibrioferrin in V. parahaemolyticus and V. alginolyticus (305). 
In S. oneidensis an affinity labelling study has co-localised TtpC2, ExbB2 and ExbD2 to 
the inner membrane (278), whilst in a recent study TtpC2 was found to be co-purified 
with the decahaem cytochrome MtrC (306). Furthermore according to a BLASTN 
search and the KEGG Ortholog Clusters databases, the C-terminus (amino acids 325-
425) of TtcP2 is orthologous to ExbB, whilst BLASTP of this section of TtcP2 against a 
Vibrio database most closely resembles TolR (57-61%) (Q8DDW2 _VIBVU, Q7MPW4 
_VIBVY, Q7MDW7_VIBVY, F7YJ67_VIBA7). TolR is anchored to the inner membrane by 
a single transmembrane (TM) segment, extends into the periplasm and is homologous 
to ExbD. The TM domains of TolQ and TolR present structural and functional 
homologies, not only to ExbB and ExbD of the TonB system, but also with MotA and 
MotB of the flagellar motor (307). In E. coli, for example, TolQ is involved in the TonB-
independent uptake of group A channel-forming colicins. The MotA/TolQ/ExbB proton 
channel family groups together integral membrane proteins that appear to be involved 
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in translocation of proteins across the outer membrane, and TtpC2 may be fulfilling an 
analogous role in the S. oneidensis TonB2 system. 
For DUF3450 (Q8EFZ0/SO1824) a BLAST search against the protein databases shows 
that it has sequential similarities to a type of protein described as a “TonB system 
biopolymer transport component” particularly in the Vibrio bacteria (alignment not 
shown). The results from some online protein modelling programs (www.expasy.ch) 
such as TMpred, HMMTOP, TMHMM, SOSUI and SAPS indicate that DUF3450 is a 
soluble protein with high alpha helical content, no transmembrane spanning regions, 
and no hydrophobic or charged patches. Coiled-coil prediction software COILS 
indicated a high probability of a coiled-coil region between approximately Arg101 and 
Tyr130. Annotated coiled coil motifs are not especially common in the proteome of S. 
oneidensis and the handful that are there, belong to either chemotaxis related proteins 
or proteins that bind zinc ions (see for example in the Uniprot database S. oneidensis 
proteins Q8EF63, Q8EEQ2, Q8EC93, Q8EDR9, Q8EFG8, Q8EIG5, Q8EFV4, Q8EE83).  
Moreover, it is worth noting that the DUF3450 protein (Q8EFZ0/SO_1824) featured in 
this study (coded by the same operon as the TonB2 proteins) uniquely lacks an 
approximately 16 amino-acid N-terminal sequence that is found in other DUF3450 
proteins from both the Shewanellaceae family and from the Vibrio bacteria; an 
example is MSKVSNRTKIATALVGVLALASSNLVVADPLTDVQKADS from the DUF3450 
protein (A6WLT1_SHEB8) of Shewanella baltica (strain OS185). 
5.2.6 TPR (tetratricopeptide repeat) protein Q8EFY5/SO1829 
(AE015626_10) 
The STRING annotation for TPR (http:/string-db.org) indicates a “co-occurrence” and a 
“neighbourhood” quality but not a “gene fusion” for TPR with the TonB2 system, 
Q8EFY6 (SO1828) - Q8EFZ0 (SO_1824) (Table 5.2), as well as with two other TPR 
domain-containing proteins (Q8EIS8/SO_0757, Q8EGP6/SO_1552), and a hypothetical 
protein (Q8EKN7/SO_0055), which when compared to the general proteome with 
BLASTP also shows similarity to TPR domain-containing proteins. However, sequence 
comparison of TPR with the three other putative TPR domain-containing proteins using 
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BLASTP shows that they have little in common and this seemed to be mirrored in the 
iTRAQ study results. The STRING entry also indicates a similar connection for TPR to a 
fimbrial biogenesis protein (Q8EC30/SO_3314) and an NlpI lipoprotein 
(Q8EHL0/SO_1210).  Since this family of proteins (TPR) is of unknown function, it was 
thought sensible to look at whether structural data could be modelled. Examination of 
the protein sequence and modelling using the I-TASSER software suite (291) shows, in 
Figure 5.5 that Q8EFY5/SO_1829 TPR has an unusually high number of charged 
residues (106 R,K,D,E out of 415, shown in red and blue) with a number of hydrophobic 
alpha-helical regions (shown in green in Figure 5.5). 
Figure 5.5 - Modelling 
of the Shewanella 
oneidensis MR-1 
protein of unknown 
function  
Q8EFY5/SO_1829 TPR 
using the I-TASSER 
software suite (308) 
shows that this outer 
membrane protein has 
an unusual 
combination of a high 
number of charged 
residues (106 R,K,D,E 
out of 415, shown in 
red and blue) with a 
number of hydrophobic alpha-helical regions (shown in green). These 
observations suggest that Q8EFY5/SO_1829 TPR could form part of an 
amphiphilic membrane spanning protein, possibly lined with positive 
arginine and lysine residues. This may explain its up-regulation/increased 
abundance during electron transfer to an anode (Table 5.2). 
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In direct contrast to the other putative members of the TonB2 gene cluster, the iTRAQ 
results indicate that the TPR protein (Q8EFY5/SO_1829) is statistically increased in 
abundance in the insoluble fraction in S. oneidensis cells that are at an anode 
producing electricity compared to planktonic cells that are not (Table 5.2). This type of 
TPR protein seems, judging from BLAST searches (Discussed previously in this chapter), 
to be mainly found in Gammaproteobacteria, especially the Vibrio and Shewanellaceae 
families. In the most recently updated version of the S. oneidensis proteome, the TPR 
protein is described as a putative Zn-dependent protease associated with a TonB2 
energy transduction system and containing a tetratricopeptide repeat (TPR) domain.  
This TPR protein, which is "geographically" near to the TonB2 gene cluster on the S. 
oneidensis genome, appears not to be co-transcribed or co-regulated with the other 
putative TonB2 operon members (discussed previously in this chapter).  It has been 
confirmed that TPR is an outer membrane-located protein (278), (Table 5.1), unlike the 
other component proteins of the TonB2 system. These observations suggest that 
Q8EFY5/SO_1829 TPR could form an amphiphilic membrane spanning protein, possibly 
lined with positive arginine and lysine residues (Figure 5.5) and thereby may explain its 
up-regulation/increased abundance during electron transfer to an anode. 
5.2.7 The TonB-receptors, iTRAQ data and bioinformatics 
Two TonB-receptors were observed by iTRAQ to be more abundant in planktonic than 
anodic S. oneidensis; (namely Q8ED60/SO_2907) and Q8EEF5/SO_2427) (Table 5.2). An 
NCBI BLAST comparison of the TonB-like proteins coded by the various operons in 
Vibrio vulnificus (strain CMCP6) with the S. oneidensis proteome was carried out to see 
if more light could be shed on these S. oneidensis TonB receptors (Table 5.3).  As would 
have probably been expected, the TonB1 of S. oneidensis most resembles the TonB1 
system in V. vulnificus, namely Q8D3S3-Q8D3S7. The TonB2 system of S. oneidensis 
resembles both the TonB2 and TonB3 system in V. vulnificus, namely Q8D705-Q8D710 
and Q8DDV8-Q8DDW3.  With respect to the potentially associated TonB receptors, the 
V. vulnificus TonB3 system also has associated with it a protein Q8DDW4 (VV1_0842) 
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(described as a TonB-dependent receptor or an outer membrane receptor for 
ferrienterochelin and colicins). Despite the fact that this gene coding for Q8DDW4 - 
according to the operon predictor from the UCSC Genome Browser 
(http:/microbes.ucsc.edu, vibrVuln_CMCP6_1) - may not be on the same operon in the 
genome of V. vulnificus as those for Q8DDV8-Q8DDW3, nonetheless lies in the same 5’ 
to 3’ orientation close to the operon. Interestingly, a BLAST study showed that three of 
the TonB proteins that showed up in the iTRAQ study were the closest (if not very 
good) fits to the aforementioned V. vulnificus Q8DDW4 from the S. oneidensis 
proteome, namely, Q8EEB8/SO_1822 (28%), Q8ED60/SO_2907 (28%) and 
Q8EEF5/SO_2427 (24%) (Table 5.3). Two nearby proteins in the S. oneidensis 
proteome, a TonB receptor-like protein Q8EFY2/ SO_1822 (Table 5.3) and a putative 
outer membrane porin, Q8EFZ3_SHEON/ SO_1821 are not predicted to lie in the same 
operon as the S. oneidensis TonB2 protein genes. (The area of genome once attributed 
to Q8EFZ1_SHEON/ SO_1823 is probably not a coding region as this has been removed 
from the latest genome annotation.) Given that from the BLAST search it is not 
possible to narrow down which TonB receptor is interacting with the S. oneidensis 
TonB2 system, the question remained as to whether any further light be shed by the 
iTRAQ results. As discussed previously, the TonB2 system proteins are in general 
statistically more abundant in the planktonic cells compared to the anodic S. 
oneidensis cells (Table 5.2). The TonB receptor that most closely fits this 
downregulation trend is Q8EEF5/S0_2427, which is described in the NCBI database as 
an ArgR-regulated TonB-dependent receptor and if this is indeed the role played by 
this protein, then the results suggest that, in the absence of an electron-accepting 
electrode, a siderophore transport mechanism is brought more into play by S. 
oneidensis. It also suggests that the TonB2 system in S. oneidensis can play a similar 
physiological role to the TonB3 system in V. vulnificus. For the other two TonB 
receptors, BtuB (Q8EIM3/SO_0815) and Q8EEB8 (SO_2469), only one peptide was 
observed by iTRAQ for BtuB (Q8EIM3/SO_0815) namely VDEHLVVIGR (although it was 
identified 39 times), and this was found to be more abundant in anodic than 
planktonic cells (Table 5.2). Similarly, only one peptide (identified 13 times) was 
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observed by iTRAQ for TonB-receptor Q8EEB8 (SO_2469), namely TLVLIDGR, and this 
was observed to be less abundant in anodic than planktonic cells.  
Table 5.3 - BLAST comparison of the proteins coded by the TonB 
systems operon from Shewanella oneidensis MR-1 with similar 
operons from Vibrio bacteria. 
(a) BLAST comparison of the proteins coded by the TonB2 system operon from 
Shewanella oneidensis MR-1 with similar operons from other gammaproteobacteria. 
Shewanella 
oneidensis 
UniProt 
submitted 
name  
Protein Vibrio 
vulnificus 
(CMCP6) 
Vibrio 
cholerae 
(M66-2) 
Vibrio  
anguillarum 
(ATCC 
68554/775) 
Shewanella 
baltica 
(OS155) 
Ferrimonas 
balearica 
(DSM 
9799) 
 
Pseudoaltero-
monas atlantica 
(T6c) 
Q8EFY5 TPR  Q8DDV8, 
(24%*) 
Q8D710, 
(23%) 
C3LMM2, 
(26%) 
F7YJ71, 
(28%) 
A3D344, 
(83%) 
E1SW90, 
(46%) 
Q15RJ5, (63%) 
Q8EFY6 TonB2 Q8DDV9, 
(29%) 
Q8D709, 
(25%) 
C3LMM3, 
(35%) 
F7YJ70, 
(33%) 
A3D343, 
(77%) 
E1SW89, 
(57%) 
Q15RJ4, (48%) 
Q8EFY7 ExbD2 Q8DDW0, 
(51%) 
Q8D708, 
(48%) 
C3LMM4, 
(49%) 
F7YJ69, 
(50%) 
A3D342, 
(94%) 
E1SW88, 
(76%) 
Q15RJ3, (54%) 
Q8EFY8 ExbB2 Q8D707, 
(51%) 
Q8DDW1, 
(44%) 
C3LMM5, 
(53%) 
F7YJ68, 
(54%) 
A3D341, 
(88%) 
E1SW87, 
(69%) 
Q15RJ2, (70%) 
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Q8EFY9 TtpC2 Q8DDW2, 
(40%) 
Q8D706, 
(33%) 
C3LMM6, 
(36%) 
F7YJ67, 
(34%) 
A3D340, 
(83%) 
E1SW86, 
(51%) 
Q15RJ1, (46%) 
Q8EFZ0 DUF3450 Q8DDW3, 
(38%) 
Q8D705, 
(29%) 
C3LMM7, 
(36%) 
F7YJ66, 
(29%) 
 
A3D339, 
(93%) 
E1SW85, 
(51%) 
Q15RJ0, (47%) 
 
*Identity to S. oneidensis 
(b) BLAST comparison of the TonB-like system operons from Vibrio vulnificus (strain 
CMCP6) with proteins coded by various operons in Shewanella oneidensis MR-1  
V. vulnificus 
TonB1 * 
Q8D3S3   
VV2_1614 
TonB 
Q8D3S4  
VV2_1613 
ExbB 
Q8D3S5  
VV2_1612 
ExbD1 
Q8D3S6  
VV2_1611 
Periplasmic 
hemin-binding 
protein 
HutB 
Q8D3S7  
VV2_1610  
Hemin ABC 
transporter, 
permease 
protein 
HutC 
Q8D3S8  
VV2_1609  
Hemin import 
ATP-binding 
protein 
HmuV/HutD 
Nearest 
BLAST 
identity in S. 
oneidensis 
Q8EB64  
SO_3670 
TonB1, 
38% 
Q8EB63  
SO_3671 
ExbB1, 
37% 
Q8EB62  
SO_3672 
ExbD1, 
42% 
Q8EB61 
SO_3673 
 Hemin ABC 
transporter 
HmuT,  
43% 
Q8EB60  
SO_3674 
Hemin ABC 
transporter, 
permease 
protein  
44% 
Q8EB59 
HMUV_SHEON 
SO_3675 
Hemin import 
ATP-binding 
protein HmuV 
48% 
 
 
V. vulnificus 
TonB2 * 
Q8D710   
VV2_0359 
TPR domain 
protein, 
putative 
Q8D709 
VV2_0360 
Periplasmic 
protein 
Q8D708  
VV2_0361 
ExbD/TolR 
Q8D707 
VV2_0362 
 ExbB 
Q8D706  
VV2_0363 
MotA/TolQ/ExbB 
“TtpC2” 
Q8D705 
VV2_0364 
TonB system 
biopolymer 
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component of 
TonB system 
TonB 
(tonB2) 
transport 
component 
DUF3450 
Nearest 
BLAST 
identity in S. 
oneidensis  
Q8EFY5  
SO1829 
TPR, 25% 
Q8EFY6 
SO1828 
 TonB2, 33% 
Q8EFY7 
SO1827 
ExbD2, 
48% 
Q8EFY8  
SO1826 
ExbB2, 
51% 
Q8EFY9  
SO1825 
 TtpC2, 35% 
Q8EFZ0  
SO1824 
DUF3450, 29% 
 
 
V. 
vulnificus 
TonB3 * 
Q8DDV8  
VV1_0848 
TPR 
Q8DDV9 
VV1_0847 
 TonB 
Q8DDW0 
VV1_0846 
ExbD/TolR 
Q8DDW1 
VV1_0845 
ExbB 
Q8DDW2 
VV1_0844 
TolR 
“TtpC3” 
Q8DDW3 
VV1_0843  
TonB 
system 
biopolymer 
transport 
component 
DUF3450 
** Q8DDW4  
VV1_0842 
TonB-dependent 
receptor; Outer 
membrane 
receptor for 
ferrienterochelin 
and colicins 
Nearest 
BLAST 
identity in 
S. 
oneidensis  
Q8EFY5  
SO1829 
TPR, 24% 
Q8EFY6 
SO1828 
 TonB2, 
45% 
Q8EFY7 
SO1827 
 ExbD2, 
51% 
Q8EFY8  
SO1826 
ExbB2, 
37% 
Q8EFY9  
SO1825 
TtpC2, 
41% 
Q8EFZ0  
SO1824 
DUF3450, 
38% 
Q8EFZ2 
SO_1822, 24% 
Q8EEB8 
SO_1822, 28% 
Q8ED60 
SO_2907, 28% 
Q8EEF5 
SO_2427, 24% 
 
* The nomenclature for the TonB systems of V. vulnificus is taken from Kustusch et al., 
2012 [34]. 
** according to the operon predictor from the UCSC Genome Browser 
(http://microbes.ucsc.edu, vibrVuln_CMCP6_1) the gene coding for Q8DDW4 may not 
be on the same operon in the genome of  Vibrio vulnificus CMCP6 as those for 
Q8DDV8-Q8DDW3, despite being in the same 5’ to 3’ orientation. 
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5.2.8 Outer membrane porin (OMP) Q8EBH3/SO_3545 and Lpp murein 
lipoprotein (Q8EHD1/SO_1295) 
The iTRAQ results indicate that outer membrane porin (OMP) Q8EBH3/SO_3545 
protein is statistically increased in abundance in the insoluble fraction prepared from 
planktonic S. oneidensis cells compared to anaerobic cells producing electricity at an 
anode (Table 5.2). This OMP belongs to the "Outer membrane protein, OmpA/MotB, 
C-terminal (IPR006665)" family. In contrast, various authors have determined that 
OmpA is overexpressed in E. coli biofilms compared to planktonic cells in different 
oxidation states (164,309).The reason for the up-regulation of OmpA in biofilms is not 
yet fully known, but it could be that it facilitates the transport of extracellular 
polymeric substances (EPS) formed during biofilm maturation (164).  
PAL_ECOLI  IVYFDLDKYDIRSDFAQMLDAHANFLRSNPSYKVTVEGHADERGTPEYNI 119 
PAL_SHIFL  IVYFDLDKYDIRSDFAQMLDAHANFLRSNPSYKVTVEGHADERGTPEYNI 119 
Q8EBH3     SIQFANDSAVVKKEYYKDIERLANYMNKNPEFTVEIAGHASNVGKPEYNM 300 
                : *  *.  ::.:: : ::  **::..**.:.* : ***.: *.****: 
PAL_ECOLI  SLGERRANAVKMYLQGK-GVSADQISIVSYGKEKPAVLGHDEAAYSKNRR 168 
PAL_SHIFL  SLGERRANAVKMYLQGK-GVSADQISIVSYGKEKPAVLGHDEAAYSKNRR 168 
Q8EBH3     VLSDKRADAVAKILVEKYGISQSRVTSNGYGITKPLVAGNSKEAHAANRR 350 
                *.::**:**   *  * *:* .:::  .**  ** * *:.: *:: *** 
Figure 5.6 - CLUSTALW2 alignment of the c-terminus of OMP (Q8EBH3) with 
the peptidoglycan(PG)-associated lipoproteins of Escherichia coli (strain 
K12) PAL_ECOLI and Shigella flexneri PAL_SHIFL indicates that they share 
similar peptidoglycan binding motifs (cd07185: OmpA_C-like conserved 
domain, NCBI, shown underlined 
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These OmpA_C-like conserved domains have been shown to non-covalently interact 
with peptidoglycan layer (PG). Furthermore, a role for OM-peptidoglycan links in 
vesiculation has been suggested since deleting or truncating OmpA, an abundant 
protein linking the OM and PG, results in increased vesiculation in E. coli, Salmonella, 
and Vibrio cholerae (310,311).The abundance of OMP seems to correlate with that of 
Lpp murein lipoprotein (Q8EHD1/SO_1295), which may be more than a coincidence. 
The iTRAQ results show that Lpp murein lipoprotein (Q8EHD1/SO1295, Braun's 
lipoprotein) is statistically decreased in abundance in the insoluble fraction of S. 
oneidensis cells producing electricity at an anode compared to planktonic S. oneidensis 
cells (Table 5.2). Lpp is one of the most abundant proteins in E. coli (312) and therefore 
may be equally abundant in S. oneidensis; recent studies have shown that Lpp can span 
the OM despite the lack of an obvious transmembrane segment (313). Lpp can occupy 
two separate and distinct subcellular locations: the “free” state is thought to be an 
integral outer membrane protein whose C-terminus is exposed on the cell surface (i.e. 
mostly in the outer membrane “insoluble” environment), whilst the “bound” form of 
the protein is tethered to the outer membrane (OM) by its N-terminal lipid moiety and 
covalently attached to the PG by its C-terminal lysine residue (i.e. mostly in the 
periplasmic “soluble” environment). The iTRAQ results show a statistically significant 
drop in abundance in the insoluble fraction in anodic cells that could suggest that the 
Lpp is in its “bound” form within planktonic S. oneidensis. Since "bound" Lpp is 
associated with a reduction in outer membrane vesicle (OMV) formation (254), 
perhaps OMV's do not form an important part of the mechanism of cell-anode 
electron transfer. Similarly since "bound" Lpp forms a tether which helps maintain the 
structural integrity of the cell (313),  it maybe is found in less abundance at anode cells 
to allow the relaxation of a particular cell shape; for example, a more elongated cell 
shape can lead to increased current densities (314). 
5.2.9 The OmcA and MtrA-F decahaem cytochrome system 
Previous work in an MFC indicates that even in a Shewanella oneidensis MR-1 mutant 
that has had OmcA and MtrC knocked out, the bacterium still produces about 
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approximately one seventh of the current of WT S. oneidensis, and has approximately 
one third of the ability to reduce iron (III) species to iron (II) species (109). Another 
study carried out by Coursolle et al (315) further states the impact on S. oneidensis 
mutants that are deficient in Mtr proteins with an even greater reduction in activity 
noted from a double OmcA/MtrC knockout. A large body of evidence points towards 
the importance of the Mtr pathway and the interaction with soluble mediators (315) in 
the form of FMN following processing by UshA (316) and bfe (104). Up to 75% of the 
extracellular electron transfer capabilities of S. oneidensis are believed to be from the 
interaction of mediators with the Mtr pathway, whilst the other portion is likely largely 
due to direct contact. The results from chapter 4, with the overexpression of OmcA, 
MtrC, A and B leads towards the conclusion that direct contact is capable of generating 
current without the presence of mediators. This does not however mean that these 
decahaem proteins are the only important proteins allowing for this power generation 
to occur. A number of membrane proteins associated with electron transfer, most 
notably MtrC/OmcB and OmcA from the decahaem cytochromes electron transport 
system did not show up on the list of proteins found in the present iTRAQ work; 
comparison with the literature suggests that for some "-omics" studies the abundance 
of these S. oneidensis decahaem cytochrome proteins is not high enough (Table 5.4).  
Briefly, in previous studies, cytochromes were not detected in the collection of 
proteins identified using proteomic or transcriptomic techniques, and other proteomic 
studies using 2-D gel electrophoresis have also failed to identify these proteins (Table 
5.4). 
Table 5.4 - Summary of "-omics" literature related to the OmcA and MtrA-F 
decahaem cytochromes of Shewanella oneidensis 
Paper "Challenge" Which -omic, 
i.e. 
italics= proteins 
OmcA or 
MtrA-F 
detected? 
fold change/ 
difference 
Growth conditions 
Beliaev 
2002 
(317) 
Different 
terminal 
global mRNA 
patterns 
OmcA 
MtrA 
MtrB 
2-5 
1.8-5 
1.4-4.7 
For anaerobic 
growth, 
anaerobically 
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electron 
acceptors 
No MtrC prepared LB broth 
supplemented with 
sodium lactate (20 
mM) as an electron 
donor and the 
following electron 
acceptors: 20 mM 
sodium fumarate, 10 
mM ferric citrate, or 
5 mM sodium 
nitrate. 
Beliaev 
2002 (318) 
etrA (fur) 
mutant 
global mRNA 
patterns 
No - Myers and Myers 
1993 (319), defined 
minimal medium 
supplemented with 
15 mM lactate and 
vitamin-free 
Casamino acids. 24 
mM fumarate was 
added to the 
medium as the 
electron acceptor. 
Beliaev 
2005 (106) 
Metal ions, 
different 
terminal 
electron 
acceptors 
global mRNA 
patterns 
MtrCAB 
operon, 
No OmcA 
2- to 8- fold 
decrease in 
mRNA levels 
under metal-
reducing 
conditions 
Anaerobic minimal 
medium containing 
15 mM sodium 
fumarate and 20 
mM sodium lactate. 
Brown 
2006 (273) 
Chromate 
stress 
Transcriptomics  
Table IV 
 
Proteomics 
Table VII 
omcA 
mtrA 
mtrC 
OmcA 
MtrA 
MtrB 
MtrC 
1.2-8 
1-6 
1-5 
53.5/26.7=2 
From "9" to 
"0" 
48.5/25.7=1.8 
55.1/25=2.2 
Both transcriptomic 
and proteomic 
analyses and was 
propagated in Luria-
Bertani (LB)1 
medium (pH 7.2) at 
30 °C under aerobic 
conditions 
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Cao 2011 
(280) 
? loosely 
versus 
tightly 
bound EPS 
Used number of 
peptides as 
measure of 
protein 
abundance? 
OmcA 
MtrB 
MtrC 
No MtrA 
No change 
2.9 
8.2 
Modified M1 
medium containing 
3.00 mM PIPES, 7.50 
mM NaOH, 28.04 
mM NH4Cl, 1.34 mM 
KCl, 4.35 mM 
NaH2PO4 and 
0.70mM CaCl2 
supplemented with 
trace amounts of 
minerals, vitamins 
and amino acids 
under anaerobic 
conditions 
Chourey 
2006 (320) 
Chromate 
stress 
RNA isolation, 
microarray  
No - LB medium 
containing either 0 
or 0.3 mM 
potassium chromate 
Cruz-Garcia 
2011 (321) 
Grown on 
lactate and 
nitrate 
relative to 
the wild 
type 
Total RNA 
global 
expression, 
microarray 
OmcA 
MtrA 
MtrB 
MtrC 
0.3 
0.25 
0.22 
0.3 
Anaerobically in 3 
mM KNO3 in HEPES 
medium with 20 mM 
sodium pyruvate as 
the electron donor 
and dimethyl 
sulfoxide (DMSO; 1 
mM), fumarate (10 
mM) or nitrate (2 
mM) as electron 
acceptors. 
De Vriendt 
2005 (322) 
Sessile and 
planktonic 
Darkness of 2D 
gel spots 
No - Silicone tubing 
containing LB 
medium 
De Windt 
2006 (323) 
aggA 
mutant 
Total RNA 
global 
expression, 
microarray 
MtrB 
No OmcA, 
MtrA, MtrC 
1.6-4.3 
 
 
0.185/0.08=2.3 
Test tubes 
containing 10 ml LB 
medium and 
propagated using 
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Darkness of 2D 
gel spots 
increasing 
concentrations of 
rifampicin 
Elias 2008 
(324)  
Controlled 
batch or 
continuous 
culture in 
bioreactors 
versus 
shake flasks 
Darkness of 2D 
gel spots 
OmcA 
MtrA 
MtrB 
MtrC 
1.9 
5.5 
2.0 
2.1 
Aerobically in 
defined medium  
(Elias et al. 2005), 18 
mM lactate, PIPES 
concentration 3-30 
mM 
Fang 2006 
(325)  
Transitioned 
from 
aerobic to 
suboxic 
conditions 
Differential 
quantitative 
analysis using 
the AMT tag 
OmcA 
MtrA 
MtrC 
4.3-7.1 
No and 5.5 
3.7-4.5 
Suppl. Table 3 
Defined medium - 
0.907 g/liter PIPES, 
0.3 g/liter NaOH, 1.5 
g/liter NH4Cl, 0.1 
g/liter KCl, 0.6 g/liter 
NaH2PO4, 0.213 
g/liter Na2SO4, and 
16.85 g/liter DL-
lactate as well as 
vitamins, minerals, 
and amino acids. 
The cultures used 
O2 as the terminal 
electron acceptor. 
Gao 2006 
(326) 
Cold shock RNA isolation, 
microarray  
No - LB medium, aerobic 
Gao 2008 
(279) 
arcA 
deletion, 
aeorbic 
versus 
anaerobic  
RNA isolation, 
microarray, RT-
PCR 
OmcA 
MtrC 
No MtrB, 
MtrA 
0.35-1.08 
0.43-1.17 
 
Suppl. Table 
M1 defined medium 
containing 0.02% 
(w/v) of vitamin- 
free Casamino Acids 
and 15 mM lactate 
under aerobic or 
anaerobic 
Gödeke 
2012 (327) 
Surface-
associated 
growth 
RNA isolation, 
microarray, RT-
PCR 
MtrB 
MtrC 
-1.24 
-1.08 
LM medium [72] 
without antibiotics 
containing 0.5 mM 
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between 15 
and 60 
minutes 
after 
attachment 
No OmcA, 
MtrA 
log2 fold 
change 
Suppl. Table 
lactate. FeCl2 and 
FeCl3 were used at a 
concentration of 20–
100 mM. 
Leaphart 
2006 (328) 
Acidic and 
Alkaline pH 
Transcriptome 
microarray 
analysis, RT-
PCR 
MtrA, 
MtrC 
 
No OmcA, 
MtrB 
pH10/pH7 0.44 
pH7/pH10 2.26 
pH10/pH7 0.57 
pH7/pH10 1.73 
 
Suppl. Table 
Specialised minimal 
medium, aerobically 
Liang 2012 
(329) 
Pellicle cells 
relative to 
planktonic 
cells 
Transcriptome 
microarray 
experiments 
No - LB in beakers 
Liu 2005 
(330) 
Elevated 
salt 
conditions 
Transcriptome 
microarray 
experiments 
No - MR2A medium 
containing different 
amounts of NaCl 
Mclean 
2008 (331) 
O2-limited 
versus  
aerobic 
aggregated 
cells 
Transcriptome 
microarray 
experiments 
MtrD 
MtrE 
MtrF 
No MtrCAB, 
OmcA 
3.32 
2.39 
3.32 
log2 fold 
change 
30°C in tryptic soy 
broth (TSB, pH 7.4) 
or M1 minimal 
medium (pH 7.0) 
that contained 3 
mM PIPES, 2.8 mM 
NH4Cl, 0.4 mM 
NaH2PO4, 3 mM 
NaCl, 0.1 mM KCl, 1 
mM Na2SeO4, 10 
mM L-arginine 
hydrochloride, 13 
mM L-glutamate, 19 
mM L-serine and 10 
ml each of 10¥ 
Wolfe’s vitamin and 
10¥ mineral 
solutions, plus 6-30 
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mM D, L-sodium 
lactate. 
Rosenbaum 
2012 (281) 
Anode 
versus iron 
salts oxygen 
Transcriptome 
microarray 
analysis, RT-
PCR 
MtrB 
MtrA 
MtrC 
OmcA 
2.96 
2.16 
1.93 
3.27 
The medium for all 
experiments was 
prepared according 
to Myers and 
Nealson and was 
modified by adding 
1.27 mM K2HPO4, 
0.73 mM KH2PO4, 
125 mM NaCl, 5 mM 
HEPES, 0.5 g/L yeast 
extract, 0.5 g/L 
tryptone, and 5 g/L 
sodium ß- 
glycerophosphate 
(no addition of 
amino acids as in the 
original medium 
recipe). The pH was 
adjusted to 7.2. 
After autoclaving, 
sodium L-lactate was 
added to final 
concentrations of 20 
mM. In iron 
respiration 
experiments 50 mM 
iron(III) citrate as the 
electron acceptor. 
Ruebush 
2006 (332) 
Soluble and 
Insoluble 
Iron Forms, 
Aerobic and 
Anaerobic 
Conditions 
Darkness of 2D 
gel spots, 
Western blots 
OmcA 
MtrC/OmcB 
MtrB 
MtrA 
CymA 
Various, not all 
detected in all 
conditions, 
already 
discussed in 
paper. 
Defined minimal 
medium as per 
Myers and Nealson 
with the following 
modifications: 30 
mM D,L-lactate, 4 
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mM sodium 
phosphate, and 10 
mM HEPES (pH 7.4) 
with 50 mM ferric 
citrate or 25 mM 
fumarate in 4-liter 
flasks under N2 at 
30°C. 
Thompson 
2007 (333) 
Chromate 
stress 
Label free 
quantitation, 
LC-MS/MS 
analysis. 
MtrB 
 
 
OmcA 
 
 
OmcB/MtrC 
 
 
No MtrA 
1mM downreg 
0.5mM 
downreg 
0.3mM 
downreg 
1M downreg 
0.5mM No 
0.3mM No 
1M downreg 
0.5mM No 
0.3mM No 
LB plus potassium 
chromate 
Vanrobaeys 
2003 (334) 
Growth on 
fumarate 
compared 
to growth 
on Fe2O3 
Darkness of 2D 
gel spots 
No - Anaerobically 
prepared LB broth 
supplemented with 
lactic acid (20 mM) 
as an electron donor 
and either one of 
the electron 
acceptors 20 mM 
sodium fumarate or 
1.6 g/L ferric oxide 
(Fe2O3) 
Wan 2004 
(275) 
Fur mutant, 
aeorbic 
versus 
anaerobic 
with 20 mM 
fumurate 
Transcriptome 
microarray 
analysis, RT-
PCR 
OmcA 
MtrC 
MtrB 
MtrA 
5.9- and 4.8-
fold 
5.3- and 4-fold 
No 
4.5- and 2.7-
fold 
LB medium in the 
presence of 20 mM 
lactate at 30°C 
under aerobic or 
anaerobic (with 20 
mM fumurate as the 
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electron acceptor) 
conditions. 
Wang 2010 
(335) 
Grown with 
azo 
compound 
or Fe (III) 
citrate 
Darkness of 2D 
gel spots 
No - In anaerobic 
cultivation, strain 
S12 grew in defined 
medium (pH7.4) as 
described by Hong 
et al. (2007) with 
minor modifications: 
10 mM succinate, 12 
mM formate, 5.7 
mM Na2HPO4, 3.3 
mM KH2PO4, 18.0 
mM NH4Cl, 1.01 mM 
MgSO4, L- cysteine 
(20 mg/L), 1% 
vitamin solution, 
and mineral solution 
 
The only study similar to the present work, is one in which the transcriptome of S. 
oneidensis producing current at an electrode, was compared to the transcriptome of S. 
oneidensis using Fe (III) citrate or oxygen as a terminal electron acceptor (336). In that 
work, genes for OmcA, MtrA, MtrB and MtrC were shown to be upregulated at an 
electrode compared to those using Fe (III) citrate (which is membrane permeable) or 
oxygen as an electron acceptor. However this does not provide any information as to 
the likely final abundance of protein that might be expected in a proteomic study. This 
is often due to the lack of 1:1 correlation between mRNA levels and protein levels 
(337,338). The number of OmcA molecules per bacterial cell is about 2000-2500 (339), 
a number probably similar to that for the TonB1 system proteins (ExbB1 = 2463+/- 522 
in E. coli (340)), but neither - despite their apparent abundance - gave peptides that 
were identified using this particular mass spectrometry technique. 
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5.3 Conclusions 
In the present work, iTRAQ techniques were used to investigate changes in the soluble 
and insoluble sub-proteomes of a functioning exoelectrogen. We identified 75 
differentially expressed proteins in the Gammaproteobacterium Shewanella oneidensis 
MR-1 during anaerobic growth on an insoluble electrode in a microbial fuel cell. For S. 
oneidensis under these conditions whilst producing current at an electrode, the efflux 
protein channel TolC (Q8EAJ8/SO_3904) and the putative amphiphilic channel-forming 
Q8EFY5 (SO_1829) tetratricopeptide repeat (TPR) protein, are more abundant than in 
equivalent microaerobic planktonic cells. Under the same circumstances, systems 
involved with iron respiration such as the TonB2 system and TonB receptors are less 
abundant, suggesting that this is a competing system for energy transfer that is taken 
“off line”.  Proteins that interact with the peptidoglycan layer and that may have a role 
in overall cell shape or the formation of outer membrane vesicles such as Q8EBH3 
(SO_3545) outer membrane porin (OMP) and Lpp murein lipoprotein 
(Q8EHD1/SO_1295) are more abundant in planktonic microaerobic S. oneidensis cells 
than anodic electrogenic cells, and future work may be able to tell what these 
potential changes in cell morphology, if they are present, signify. 
This chapter illustrates that different mechanisms may come into play for transfer of 
electrons to an anode by S. oneidensis depending on the degree of oxygenation of the 
growth medium. For example in an anaerobic study, such as the transcriptomic study 
by Rosenbaum and co-workers (336), not only are the mRNA levels for the MtrCAB-
OmcA decahaem cytochrome system upregulated in electrogenic anodic respiration S. 
oneidensis (versus Fe(III) respiration), but also the TonB2 system (SO1824-1928) and 
the putative TonB receptors Q8EEF5/SO_2427 and Q8ED60/SO_2907. This seems to be 
in contrast to the present study, where some of the same proteins are less abundant in 
anaerobic anodic cells. This again points towards the lack of correlation between 
mRNA levels and protein quantification as a possible explanation for this. There is the 
need to consider that the relative abundance of mRNA and protein for each of these 
differentially regulated elements is incredibly dependent upon the exact circumstances 
under which the comparison is being carried out.  It makes it very difficult to draw 
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comparisons between the mRNA and proteomic level studies discussed and can only 
be considered suggestive of differences at this point in time. 
With respect to electron transport mechanisms that can operate in the absence of a 
high abundance of the S. oneidensis decahaem cytochromes, a recent study by Bücking 
and co-workers  (341) demonstrated a membrane cytochrome-independent electron 
transport chain (MtrA-minus  and MtrB-minus) to ferric iron, manganese oxides, and 
humic acid analogues, operating in S. oneidensis. Qian  and co-workers have proposed 
an outer membrane cytochrome-independent iron chelate uptake mechanism 
catalyzed by TonB receptor Q8ED60 (SO_2907), with subsequent periplasmic ferric 
iron reduction (342). Bücking et al (341) note that these results would certainly 
challenge the assumption that Fe (III) citrate can be used as a model substance to 
study extracellular respiration. 
This chapter provides the first demonstration of quantitative proteomics carried out 
on Shewanella oneidensis MR-1 within an MFC, delivering an insight into the regulation 
of pathways under these conditions compared to microaerobic growth. The 
identification of upregulated targets within the anode bound cells in the MFC, points 
towards a target that needs further validation to determine if it has any role in activity. 
Although the analysis did not identify any obvious targets to transfer into an 
engineered E. coli strain, the validation of the activity of these proteins within 
Shewanella may more clearly demonstrate their activity. This work may however be 
better suited towards forward engineering Shewanella to enable it to better survive 
and produce current in the environment within the MFC. Further analysis of 
engineered E. coli strains through either interaction work, or global proteomic analysis, 
may be paired with this Shewanella analysis in order to direct future work. 
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Chapter	6	–	Chromosomal	insertion	
of	an	electrogenic	pathway	and	
Interaction	studies	of	plasmid	based	
electrogenic	system		
This work was carried out with initial assistance from Dr Graham Stafford with the 
supervision of Professor Phil Wright 
6.0 Introduction 
This chapter is broken down into two distinct sections detailing chromosomal insertion 
work carried out at the start of the chapter in section 6.1 and interaction work carried 
out in section 6.2. 
6.1 Chromosomal insertion of an electrogenic pathway 
6.1.1 Introduction 
Following on from the demonstration in chapter 4 that current generation is possible 
using plasmid based expression of an extracellular electron transfer pathway, the 
decision then had to be made as to what steps could be taken to further increase 
output.  
 Would this be a case of metabolic engineering and pathway tuning to 
streamline the transfer of energy?  
 Inserting further genetic elements?  
 Or reducing the metabolic burden on the system?  
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It was decided that the path to follow that would yield the greatest “bang for our 
buck” was most to remove reliance on the dual plasmid based system.  
Chromosomal insertion was considered over the other options due the fact that as 
chapter 4 discussed, the use of a non-native Mtr pathway was based within a 4 kb 
pACYCDuet-1 plasmid. The overall size of this plasmid for the different constructs 
varied from 6 to 17 kb and this was only considering the Mtr pathway. A further 
plasmid was also required for the IPTG inducible overexpression of the cytochrome 
maturation genes in the form of the 12 kb plasmid, pRGK333. Metabolic burden due to 
plasmid based expression is well documented (343–348) with physiological effects 
noted including up to 18% of total cell protein being required for antibiotic resistance 
(343) and 26% decrease in growth rates between plasmid and non plasmid systems 
(345). Increasing the metabolic burden can also decrease the chance of plasmid 
retention (344) which, when a system is being used for long term analysis, is of even 
greater concern. 
If a purely metabolic engineering pathway had been chosen, then this would have 
meant either manipulation of the host organism genome or overexpression of a 
(metabolic) bottleneck. Both of these would firstly require a study (potentially 
quantitative proteomics) into how the wild type host cells (or empty plasmid bearing 
cells) compared to the engineered (plasmid bearing) strain, which is a significant piece 
of work in itself. If the genome modification option was chosen, then this presents 
further challenges compared to standard cloning. If a more standard cloning option 
was chosen, then the option is either to base an upregulated gene on a new plasmid 
(making a highly undesirable 3 plasmid system) or add to the already very large 
plasmids (difficult due to cloning limitations with such a large plasmid).  
Due to the aforementioned stated reasons, it was decided that basing the S. oneidensis 
MR-1 Mtr genes and overexpressed cytochrome maturation genes on the 
chromosome was the most logical choice. Once this system was chromosomally based, 
it would yield the following potential outcomes: 
1. Greater power output than a plasmid based system 
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2. No change in power output compared to the plasmid based system 
3. Decrease in power output compared to the plasmid based system 
Result number 1 presents the obvious advantage that a greater power output is 
achieved from the system being chromosomally based and therefore showing the 
impact of plasmid maintenance. It provides opportunities to base other potentially 
useful genes on plasmids. 
Result number 2, where the power output is the same would mean that although 
there is no increase in power output, the cells are still now plasmid free. Although this 
may not have removed any metabolic burden, it frees up space for new plasmids that 
may allow for power increases that could not easily be done with the current 2 plasmid 
system. 
Result number 3 is the worst circumstance, but as long as the cells are still alive, then 
there is no real reason why the cells would be producing less power. It could be due to 
reduced transcript levels due to a single DNA copy of the genes being based on the 
genome compared to multiple plasmid copies. This would not be a failure of the 
chromosomal insertion, but would instead be a question of rebalancing the overall 
transcript levels generated by the genome based system through promoter tuning. If 
the transcript strength was determined to be the same as that seen in the plasmid 
based system (through a comparison by q-PCR), then theoretically there is no reason 
why the system should not generate the same power output as the plasmid based 
system. Once this has been done the cell system still has at least the advantages of 
result number 2. 
This thesis was based on an attempt to generate electricity through the use of an 
organism that was previously incapable or at the very most, poorly capable of this 
ability.  Following demonstration of this through a plasmid based system, maximising 
electrical output was the ultimate aim of this chapter through the reduction in the 
metabolic burden of the cells. 
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6.1.2 Experimental thought process 
The details presented here are specific to this chapter and necessary to explain the 
various iterations that were worked through, as the process went on in order to try 
and attain a functional chromosomal insertion method. 
6.1.2.1 Chosen organism 
As discussed in chapter 4, the choice of the host cell for the introduction of a non-
native extracellular electron transport pathway for interaction with an electrode was 
based on a variety of reasons. E. coli was the chosen species due to its well 
documented history as a model organism for genetic engineering (349–351) and also 
due to previous research that had been conducted showing that heterologous 
expression of Shewanella c-type cytochromes allowed for the reduction of soluble and 
insoluble iron (248,249).  During the course of these studies it was discovered that in 
order to be able to express the membrane based c-type cytochromes, a type II 
secretion system was required (249).  
Due to the use of a T7 based expression system, the BL21 variant, BL21 (DE3) was 
chosen as this has the prophage DE3. This provides a chromosomally based, stable 
integration of T7 RNA polymerase under the control of the lacUV5 promoter, allowing 
for production of transcript of T7 regulated genes following induction by IPTG (258).  
6.1.2.2 Chromosomal insertion techniques 
Choice of genetic manipulation 
There is a variety of different methods that can be used to insert genetic fragments 
into a chromosome of a desired organism, all with varying degrees of success, size 
limitations and localisation options. A selection of these is shown in Table 6.1. 
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Table 6.1 – Comparison of a variety of chromosomal insertion 
methods 
Chromosomal 
insertion method 
Recombination Attenuation 
transposition 
Mosaic (random) 
transposition 
Success rate Up to 90 % (352) 79% average (up to 
97%) (217) 
50% (353) Up to 
90% (354) 
Insertion size limits 10 kb  
demonstrated 
(352) 
7 kb demonstrated 
and ~14 kb 
theoretical (217) 
10 kb 
demonstrated 
(353) 
Localisation 
options 
Site specific 
recombination, 
theoretically at any 
point 
Targets highly 
conserved specific 
region (attTn7) – 
immediately 
downstream (3’ 
end) of glmS gene 
Random 
integration into 
the genome 
Highly cited 
example system 
Datsenko and 
Wanner’s Lambda 
red recombination 
– pKD46 based 
system (210) 
Tn7 - pGRG36 
based system (217) 
Mini Tn5 – pUJ 
based system (354) 
 
A more detailed analysis of two of the methods described in Table 6.1 is carried out in 
sections 6.1.2.2.1 to 6.1.5 with descriptions of the pros and cons of different methods, 
leading to their eventual use within this chapter. 
6.1.2.2.1 Lambda red recombination 
This is a homologous recombination technique whereby PCR primers can be designed 
to provide the homology that permits “one-step” gene knockouts and if designed 
properly, can be tailored for “three-step” gene insertion. This method, although not 
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initially discovered, was highly popularised by Datsenko and Wanner in 2000 (210) 
with the paper being cited over 6000 times as of 2014.  
The protocol can be used for either site specific deletion of a gene, gene cluster or with 
a little more work, the insertion of a gene or gene cluster.  Due to the flexibility of the 
system, a researcher feeling bold enough can even manage a simultaneous deletion of 
a genetic element and replacement within the same experiment. Recombination can 
occur with as little as 35 bp homology on either side of the desired site of modification 
(355,356) and has been used as the sole method to create a library collection of single 
knockout E. coli K-12 variants (357).  
 
The system is strongly based around solid work with PCR with this being especially true 
for insertion work. Full description of the exact methods can be found in the materials 
and methods section 3.2.7 – this discussion point is being used to confer the simplicity 
(or not so as is shown to be the case) of the techniques to get either method to work. 
 
This site specific system makes use of the yeast homologous recombination machinery 
neatly packaged away within a set of plasmids as shown in Table 6.2 below 
Table 6.2 – Details of Datsenko and Wanner lambda red 
recombination plasmids 
Plasmid name Genetic elements 
contained 
Role in the process 
pKD46 Beta, Gam, Exo (355) Arabinose inducible 
recombination machinery.  
 Gam - protein to 
prevent degradation of 
linear DNA.  
 Exo – 5’ to 3’ dsDNA 
lambda exonuclease. 
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 Beta-  protein to aid in 
insertion of linear DNA 
(355) 
pKD3, pKD4, pKD13, 
pKD32 
Flippase recognition target 
(FRT) flanked resistance 
cassette. Kan for pKD3 and 
pKD13 and Cm res for 
pKD4 and pKD32 
For insertion of FRT 
flanked, removable 
selection marker 
pCP20 FLP recombinase (358) Allows removal of FRT 
flanked resistance cassette 
 
For deletions to occur, the following steps must be followed (illustrated in Figure 6.1): 
 
1. A set of primers need to be designed that will amplify the desired FRT flanked 
resistance cassette (either Cm or Kan) with 5’ regions that are homologous for 
the region flanking the desired deletion point. These can be designed to be 
base sensitive to allow for very precise deletion (and insertion of selection 
marker) of DNA regions.  
2. Once the resistance cassette has been amplified with the flanking regions for 
the desired deletion target, the strain in which the deletion is to occur needs to 
be transformed with the temperature sensitive plasmid pKD46. This plasmid 
contains the recombination machinery, Bet, Gam and Exo. Gam inhibits the 
host RecBCD exonuclease V (359) so that Bet and Exo can gain access to DNA 
ends to promote recombination. This plasmid is selected for by ampicillin and 
then induced in a fresh culture with 1 mM arabinose to express the plasmid 
proteins to allow for recombination.  Purified dsDNA of the FRT flanked 
resistance cassette is then electroporated into a washed, desalted aliquot of 
the induced pKD46 containing target cells. Outgrowth is done in suitable media 
such as LB and cells are then plated out on selective plates, dependant on the 
choice of FRT flanked resistance cassette. Colonies that grow on the selective 
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plate are deemed to be positive but are the deletion event can be confirmed in 
a variety of ways including western blots against a control to see if the target 
protein is no longer present. An example of the layout can be seen in Figure 
6.1. 
 
Step 1. PCR amplify FRT flanked resistance cassette  
 
 
 
Step 2. Transform strain expressing λ Red recombinase  
 
 
 
Step 3. Select antibiotic resistant transformants 
 
 
 
Step 4. Eliminate resistance cassette using FLP recombinase 
 
 
 
Figure 6.1 - 4-step procedure for site specific gene knockout using 
lambda red recombination. Modified from Datsenko and Wanner 
(210) 
In order for an insertion event to occur, two additional PCR steps are required at the 
beginning which can be considered a step 1 and step 1.5 in relation to Figure 6.1. The 
gene(s) to be inserted need to be amplified and fused to the antibiotic resistance 
cassette. For the duration of this explanation it will be assumed that the resistance 
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cassette is to be attached upstream of the genes of interest. In practice, the 
localisation of the resistance cassette in regard to the gene(s) of interest doesn’t 
matter. 
1. The first step for the insertion event involves modification of the primer design 
whereby the first chromosomally homologous region (H1) at the 5’ of primer 1 
remains the same but primer 2, shown at the 3’ end in step 1 in Figure 6.1 
retains priming site P2 but H2 changes from being homologous to the region of 
chromosomal insert to being a flanking region homologous to a flanking region 
of the gene of interest (H3). 
2. The gene of interest then has primers that are designed for it amplification but 
also have homologous ends that permit fusion to the resistance cassette at the 
5’ and are homologous to the desired region of insert at the 3’. 
3. Once both these targets have been amplified the two PCR fragments must then 
be fused together which is done through the use of PCR overlap. This is 
typically done by adding in the two PCR products as the templates, relying on 
H2 and H3’s complementarity to each other for the fusing of the two regions. 
P1 and P4 are then used to amplify the completed construct which then results 
in a product with internal homologies linked but still with terminal flanking 
regions that are homologous to the chromosome. 
4. A strain expressing the lambda red recombinase system based on pKD46 is 
electroporated with the fused linear DNA from step 3. Outgrowth and selective 
plating of the cells is then done. 
5. Cells demonstrating antibiotic resistance to the inserted cassette are deemed 
to be successful insertions but further verification is done by PCR, sequencing 
or western blots. 
6. The resistance cassette is then removed through the use of a curing plasmid 
named pCP20 that expresses a Flippase for recognition and removal of the FRT 
flanked cassette. 
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Step 1. PCR amplify FRT flanked resistance cassette  
 
 
Step 2. PCR amplify gene of interest  
 
 
Step 3. Overlap PCR  
 
 
Step 4. Electroporate overlap DNA into strain expressing λ Red 
recombinase 
 
Step 5. Select antibiotic resistant transformants 
Step 6. Eliminate resistance cassette using FLP expression plasmid 
 
 
Figure 6.2 - Example of the steps needed in order to be able to insert 
a genetic element into a genome using lambda red recombination 
 
H3 
H2 
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6.1.2.2.2 Transposon based insertion 
An alternative to the lambda red recombination method for chromosomal insertion is 
transposon based insertion. Whereas recombination is a highly flexible technique in 
terms of the site of modification and the type of modification (deletion, base swapping 
or insertion), a transposon based method is purely focussed on insertion and is 
localised towards a single site. The chosen method for further investigation is Tn7 
based attenuation with a basis around a paper from McKenzie and Craig (217) with 
details of the plasmid used shown in Table 6.3. 
Table 6.3 Details of Tn7 attenuation chromosomal insertion 
plasmid 
Plasmid name Genetic elements 
contained 
Role in the process 
pGRG36 TnsA,B,C and D (217,360)  TnsA - works together 
with TnsB to form a 
transposase – 
recognising, breaking 
and joining transposon 
 TnsB – member of 
retroviral integrase 
family – works with 
TnsA to form 
transposase 
 TnsC – double stranded 
DNA binding protein 
and regulator. 
Required for activity of 
TnsAB complex 
 TnsD – Target selection 
protein 
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This system makes use of a single 12kb plasmid (pGRG36) whereby the GOI is inserted 
into the MCS which is flanked by two Tn7 recognition arms. Once in there, the plasmid 
is then transferred into the desired host strain, induced with arabinose and plated out 
on selection free media. This in theory turns chromosomal insertion into a cloning 
experiment followed by a transformation and induction. The plasmid contains 
numbers transposase proteins that are required for identification, regulation, DNA 
cleavage and insertion (as detailed in table 5.3). A full description of the methods used 
can be found in chapter 3.2.28. 
This system has been used for the insertion of a variety of different genetic elements 
with sizes up to 7.1 kb being demonstrated for insertion and a theoretical size limit of 
14 kb (217) making it a viable option for the insertion of potentially the entire Mtr 
operon (MtrD, E, F, OmcA, MtrC, A and B) if required. 
Once the GOI is cloned into pGRG36, the same plasmid can be taken to a wide variety 
of different strains, not just E. coli but other gram negative species, due to the highly 
conserved nature of the Tn7 recognition sequence (361–364).  
6.1.2.3 Method overview 
Following an overview of the available methods a final table stating the clear 
advantage and disadvantages of each can be seen in Table 6.4.  
Table 6.4 - Comparison of the two chromosomal insertion methods 
Method of 
insertion 
Advantage Disadvantage 
Lambda red 
recombination 
 Site specific insertion 
 Resistance selection marker 
 Multiple insertion/deletion 
events can be done in one strain 
 Linear dsDNA 
 Overlap PCR to join 
resistance cassette and 
GOI 
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 Must be optimised and 
repeated for every 
experiment 
 Multiple plasmids needed 
 Limited transfer to 
organisms outside of E. 
coli 
Transposon  Single plasmid system 
 Standard cloning into MCS of 
plasmid before insertion 
 Allows for large quantity of DNA 
to be made 
 Attenuation site is highly 
conserved within many 
prokaryotic species 
 Allows for chromosomal insert 
into many strains (other than E. 
coli due to highly conserved 
AttTn7 region) using same 
plasmid 
 Single insertion into 
strain. Once the site is 
used then you can’t use it 
again 
 No selection marker 
 Large plasmid (12kb) 
made larger with insert. 
 Very low copy number 
 Very limited MCS 
 
The advantages of the lambda red recombination system make it a very appealing 
method for insertion although the number of steps involved, the complications in 
designs and multiple plasmid systems mean that you need to be very comfortable in 
your molecular biology skills before attempting. The attenuation system, although 
slightly limited, provides the opportunity for a standard cloning experiment to turn 
into a chromosomally based system – although at a fixed location. 
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6.1.3 Results and Discussion 
6.1.3.1 Lambda red recombination for upregulation of native cytochrome 
maturation genes 
In an attempt to move away from the large dual plasmid system detailed in chapter 4, 
the overexpressed cytochrome maturation genes found on pRGK333, which are native 
to E. coli, but not under aerobic conditions, were to be chromosomally upregulated. 
This meant that instead of having to try and insert all the genes present on the large 
plasmid, the genes that were already present were to be tuned to more appropriately 
fit the task at hand. This required a much smaller insertion than the chromosomal 
basing of the full Mtr pathway and presented a good test of the lambda red 
recombination system. 
The options for this were a high level constitutive based expression system for 
continual protein expression of these genes using the promoter for the native hupA 
gene (365–368) and also a tuneable or at least an inducible system using the arabinose 
promoter (369). These promoters were then to be inserted upstream of the respective 
Ccm genes and an option to include the further upstream genes NapB and NapC was 
included due to their alleged roles in donating electrons to a recombinant Mtr 
pathway within E. coli. 
In order to do this, the respective promoters needed to be amplified with ends 
permitting attachment to the FRT flanked resistance cassette. The initial amplification 
of the HupA promoter for use with Ccm A-H and for NapB, C and CcmA-H is shown in 
Figure 6.3. 
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Figure 6.3 - Amplification of the HupA promoter for constitutive 
expression of CcmA-H and NapB, C, CcmA-H 
 
Figure 6.4 - Amplification of the arabinose promoter for inducible 
expression of CcmA-H and NapB, C, CcmA-H 
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The results show clear bands of the desired size for the amplified HupA and arabinose 
promoter, which could then be used to attach to the FRT flanked resistance cassette. 
Each of the amplified DNA sequences had a complementary DNA region to the 
element that it was to be attached to. 
 
Figure 6.5 - Successful amplification of FRT flanked Kan cassette 
for attachment to respective promoter systems 
Now that both the FRT flanked cassette and promoter systems had been amplified, the 
procedure to attach the two separate genetic sections needed to be carried out. The 
results of this overlap are shown in Figure 6.6. 
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Figure 6.6 - Overlap PCR joining promoter regions to FRT flanked 
Kan cassette 
Figure 6.6 shows the attempted overlap of the sections that resulted in low level 
amplification of bands around 1.5 kb. This was done using the same protocol to 
amplify the promoter section and the resistance cassette separately but used a longer 
extension time and appeared not to have worked. The protocol for the initial 
amplifications were optimised to provide the best possible yields as shown in Figure 
6.7. 
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Figure 6.7 - Optimised PCR protocol for amplification of promoters 
and FRT Kan 
Following the optimised amplification of the initial DNA elements, there was now a 
greater concentration of each of the components and potentially a greater chance of 
the overlap procedure working. The results of the overlap are shown in Figure 6.8. 
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Figure 6.8 - Overlap PCR joining defined promoters to FRT flanked 
resistance cassette 
The results show that the bands appear to be the correct size at 1.6 kb but are very 
faint even before full purification to remove other bands. The bands post purification 
are shown in Figure 6.9. 
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Figure 6.9 - Gel purified joined promoter and FRT flanked 
resistance cassette  
An electroporation into BL21 DE3 expressing the recombinase machinery (pKD46) was 
done using 10 µL of each of these samples in 100 µL aliquots of electrocompetent cells, 
but no positive colonies appeared on any of the plates. The procedure needed to be 
optimised further in order to be able to get a quantity that could be used for a 
successful insertion. 
Balancing the molar ratios of the different DNA elements was attempted in order to try 
and aid the overlap procedure. This meant that instead of using equal volumes of the 
promoter and Kan cassette, the size and concentration of the different components 
was taken into account to provide a better balance of each. The results of this are 
shown in Figure 6.10. 
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Figure 6.10 - Increased concentration of promoter joined to FRT 
flanked cassette using molar ratio technique 
The modification of the procedure appeared to produce a greater yield in the final 
DNA product when compared to Figure 6.8. A large, unwanted band was still amplified 
at roughly 500 bp. Due to the high level of unwanted DNA bands, the product still had 
to be purified before it could be used for recombination. The post purification 
concentrations of the samples are shown in Figure 6.11. 
Figure 6.11 - Gel purified promoter, Kan cassette and combined 
samples 
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The purified samples were still of a very low concentration that again did not yield any 
colonies when electroporated into cells expressing recombination machinery. As the 
concentration of the overlap PCR product could not be increased, the obtained final 
product was then used as a template to allow for amplification of this using a simple 
PCR technique. The results of this are shown in Figure 6.12. 
 
Figure 6.12 - Attempted amplification of the final overlapped PCR 
and Kan cassette using the product from Figure 6.11 as a template 
The results from this attempted amplification show that the yield is roughly the same 
as was previously acquired with multiple bands also being amplified as well. As the use 
of the template instead of the two separate fractions appeared not to make a 
difference, an adaptation of the old method was instead attempted. This one made 
use of a high temperature initial denaturation. A variety of conditions were attempted 
with the high denaturation and 1:1 molar ratio of different DNA elements kept as a 
constant. The results of this setup are shown in Figure 6.13. 
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Figure 6.13 - Overlap PCR for combination of promoter with Kan 
cassette using modified protocol 
The results of this experiment provided very similar results to those seen before with 
little, if any increase in the desired final PCR product. Due to the large number of 
attempts at this method, with little no real sign of improvement, alternative methods 
were sought. This is discussed further at the end of this section. 
6.1.3.2 Lambda red recombination for chromosomal insertion of Mtr genes 
This was attempted simultaneously with the chromosomal upregulation of the 
cytochrome maturation genes.  
In order to try and ensure good production of transcript, it was decided that the Mtr 
cluster should be inserted near the origin of replication on the BL21 (DE3) genome. It 
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also had to be done at a point that wouldn’t interfere with any genes or operons. In 
order to do this, the genome of BL21 (DE3) was viewed on Xbase 
(http://www.xbase.ac.uk/) starting from the origin of replication. The genes closest to 
the origin were then reviewed in order to try and identify operons. Immediately 
downstream of the origin of replication is thrL, thrA, thrB and thrC which is then 
followed by yaaX (shown in Figure 6.14). This appears to show a 4 gene cluster at the 
start of the genome which is then followed by an unconnected yaaX gene. It was 
decided that the cluster could be inserted at this point. 
 
Figure 6.14 – Genome view of yaaX location near the origin of 
replication in the BL21 (DE3) genome 
In order to make sure that the insert would not interfere with the yaaX including any 
regulatory elements, this had to be inserted sufficiently upstream of the yaaX start 
codon.  
The primers were designed to have 40% of the primer available for amplification of the 
GOI with 60% homologous to the region the insertion was to occur (upstream of yaaX). 
Amplification of the various Mtr gene sets were divided up as follows: 
 OmcA 
 MtrA, B and OmcA (MtrABO) 
 MtrC, A and B (MtrCAB) 
 MtrC, A, B and OmcA (MtrCABO) 
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In order to ensure proper regulation of the inserted genes, the same regulation system 
utilised within the plasmid system (lac inducible T7 promoter) was chosen to be 
amplified. Due to the high level of activity exhibited by the T7 RNA polymerase, it was 
essential that a T7 terminator was placed downstream of the GOI. Due to the fact that 
all Mtr clusters were cloned into MCS1 of pACYCDuet-1 and the same upstream and 
downstream elements of the plasmid were required from each plasmid, only a single 
set of primers was required to amplify all the different Mtr fractions. The primers were 
however modified to such an extent that correct binding to the Mtr sequence was not 
guaranteed due to the fact that a large percentage of the primer was not homologous 
to the target sequence. This however proved not to be an issue as can be seen with 
the amplification of the gene sets in Figure 6.15. 
 
 
Figure 6.15 - Amplification of Mtr gene fragments with flanking 
ends overlap with FRT flanked Kan cassette 
Following this successful amplification, the FRT flanked Kan cassette from pKD13 was 
the amplified as shown in Figure 6.16. 
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Figure 6.16 - Amplification of FRT flanked Kan cassette to be 
overlapped with Mtr fractions 
Now that both the Mtr fraction and FRT flanked resistance cassette had been 
amplified, these two individual elements needed to be combined into a single dsDNA 
element to allow for site directed insert into the genome of BL21 (DE3).  In order to 
ease the explanation of this, the reader is directed towards Figure 6.2 for further 
details. The two PCR products were added together into a single reaction along with 
primers for the 5’ and 3’ end of the eventual full sequence. The overlap of the two 
DNA sections together was in theory to be done through the homologous region in the 
middle of the two sections. Due to the multiple DNA binding events that were 
occurring within a sample, it was difficult to predict the best conditions for proper 
overlap to occur and so a range of temperatures were attempted. The result from this 
can be seen in Figure 6.17. 
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Figure 6.17 - Attempted overlap PCR for attachment of Mtr 
fragment to FRT flanked Kan cassette 
The results above show that the PCR overlap didn’t work across the range of 
temperatures chosen. 
The results of these experiments demonstrated the difficulties of joining different DNA 
elements together in order to form single linear dsDNA fragments for insertion into the 
chromosome. This may have been down to issues with the length of the primers being 
used in the amplification of the Mtr gene cluster, FRT flanked resistance cassette and 
the promoter regions. The overlapping region between the two constructs may have 
been too small to allow for effective joining of the sections, but as there are no defined 
laws for this it is hard to properly estimate the correct amount of overlap. In order to 
get the overlap to work, the primers used could have been modified to increase the 
efficiency of the overlap but this would have led to very large primers and potentially 
increased the chance of secondary structures and unspecific binding. Even with new 
primers, the protocol would have to be essentially started from scratch, with the 
potential need for optimisation of all the amplification procedures that may well have 
yielded the same result. In the knowledge of the challenges accompanied by this 
method, alternatives were sought. 
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As the PCR required to amplify the Mtr fractions had already been demonstrated to 
work very successfully and the overlap was proving so troublesome, alternatives were 
looked for. A method that turned the issue into more of a cloning based one, 
compared to a complex overlap procedure was found with attenuation. This setup 
relied upon the cloning of the GOI into the MCS of the attenuation plasmid pGRG36 as 
detailed by McKenzie and Craig (217). This system was limited however by the fact that 
it was directed towards a specific region within the genome also meaning that further 
insertions, although not impossible, were supposedly done at a much lower (60-fold 
lower) efficiency using this system (219). 
6.1.3.3 Tn7 based transposition 
For the insertion of the Mtr gene elements into the genome using a Tn7 based system 
the genes needed to be cloned into the MCS of pGRG36 and then transformed into a 
desired host. Due to the limited MCS present in pGRG36 and the large size of the Mtr 
gene cluster (and resulting restriction sites naturally present within it), only the SmaI 
one site was suitable for insertion of the clusters. In order to try and ease the cloning 
of this blunt ended element it was decided that 5’phosphorylated primers should be 
utilised in order to try and increase the efficiency of the ligations. Using these primers 
would mean that any DNA amplified with these primers would by default have a 5’ 
phosphate group that would be readily available for ligation instead of having to add 
this group through the use of a kinase or an equally complicated method. 
Due to the fact that the PCR primers for the amplification of the Mtr fragments could 
be made directly homologous to the cloned Mtr constructs, no issues were expected 
with the amplification. This proved to be right as shown in Figure 6.18. 
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Figure 6.18 - Amplification of the Mtr fractions with 5’ 
phosphorylated primers 
The results show clear amplification of the desired fragments.  The samples then 
needed to be prepared for ligation as shown below. 
 
Figure 6.19 - Pre-ligation concentrations of Mtr fractions and 
pGRG36 
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Following ligation and successful transformation, the colonies were screened through 
the preparation of maxipreps and sending for DNA sequencing. For cloning purposes, 
DH5alpha library cloning efficiency was used as this has a EndA1 mutation resulting in 
decreased nuclease activity (370) making it a good choice for this procedure. The 
resulting miniprep DNA is shown in Figure 6.20. 
 
Figure 6.20 - Colony screening of pGRG36 clones following 
miniprep 
The DNA sequencing for these constructs came back as a failure. At first it was 
presumed to have been a poor batch of sequencing as all of the pGRG36 insert screens 
failed. Other samples that had been sent up at the same time had however worked 
perfectly. The low yield of DNA shown in Figure 6.20 could have been the cause of lack 
of sequencing data and so a PCR amplification screen of the constructs was attempted 
as described by McKenzie and Craig (217). The results of this are shown in Figure 6.21. 
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Figure 6.21 - PCR screen of miniprep DNA following inconclusive 
sequencing results 
Using primers to amplify either side of the attenuation flanking arms, it provides a 
clear distinction between samples with an insert in the MCS of pGRG36 and those 
without. From immediately upstream of the Tn7 right arm to immediately downstream 
of the Tn7 left arm with no insert provides a product of 526 bp. The insertion of any 
genes within the MCS using the blunt end SmaI site would therefore yield the size of 
the gene (s) plus this 526 bp. As can be seen in Figure 6.21, all the screened colonies 
have inserts at the undesired size of 526 bp. 
The issues with pGRG36 included a limited MCS, blunt end cloning, very low copy 
number of plasmid and very large sized plasmid that may have been a cause of why 
the ligations weren’t working. Subsequently, it was decided that a work around for 
some of these issues should be attempted. A sensible and quick alternative was 
considered to be moving the attenuation recognition arms into a small, high copy 
number plasmid. Cloning into this alongside the larger pGRG36 (that still contained all 
the recombination machinery) in theory had the potential to help ease cloning issues. 
The chosen plasmid was pUC19 due to the fact that it was highly available, a very small 
plasmid, moderate sized MCS and was high copy number.  
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Figure 6.22 - pUC19 concentration analysis 
A limiting factor with pUC19 was the fact that it carries Amp resistance which couldn’t 
be used in parallel with pGRG36 as this also carried Amp resistance. In order to be able 
to change the resistance of pUC19, a recombination event was chosen as the simplest 
solution due to the ease of a single PCR and transformation allowing for simultaneous 
removal of the Amp cassette and replacement with the Cm cassette. The result of this 
can be seen in Figure 6.23. 
Figure 6.23 - pUC19 with Cm cassette inserted through 
recombination 
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In order to insert the attenuation recognition arms required for chromosomal 
insertion, the desired element from pGRG36 was simply amplified using PCR with the 
addition of restriction sites at the end that were compatible for insertion into the MCS 
of pUC19 (now with Cm). The insertion of the attenuation recognition sequence also 
included the MCS from pGRG36 including the previously used SmaI site. Results for this 
can be seen in Figure 6.24. 
Figure 6.24 - Doubly digested pUC19Cm-Tn7 clones 
Following the successful construction of pUC19Cm-Tn7, Mtr insertions into this 
plasmid were attempted as shown in Figure 6.25. 
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Figure 6.25 - PCR screen of insertions into pUC19Cm-Tn7  
The insertion into pUC19Cm-Tn7 yielded no positive clones. The reasons for this are 
hard to determine and allow for speculation: 
 It could potentially be due to a much larger range of concentrations for 
ligations are required to increase the chances. 1:10 ratio of plasmid to insert is 
touted as the recommended setup for blunt ended cloning although this is 
likely to be highly case dependent. 
 The chosen batch of competent cells were not competent enough leading to 
decreased efficiency and propagation of unsuccessfully ligated plasmids. 
 The plasmid had not been properly desphosphorylated and ended up re-
circularising instead of allowing for insertion of the Mtr fractions. 
 The concentration of the Mtr fragments could have been too low and a larger 
concentration, especially per volume may be required. 
 Accidental induction of the plasmid through the activation of the arabinose 
inducible promoter when using rich media could have potentially caused 
chromosomal insertion into the cloning strain but 0.4% glucose was added to 
prevent this occurring. 
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 The whole experiment relies largely on the guarantee that 5’ phosphates are 
present and tightly bound to the primers. If this is not the case then it is 
impossible for the blunt ended cloning to occur. 
6.1.4 Conclusions 
The attempts to transfer the previously cloned S. oneidensis MR-1 Mtr genes onto the 
chromosome of BL21 DE3 using two significantly different methods have been shown 
to be significantly harder than expected. 
The many advantages of the lambda red recombination method were heavily 
outweighed by the difficulty in trying to get large DNA fragments to overlap. The 
technique is remarkably straight forward for deletions and for switching resistance 
cassettes but outside of this, the technical challenges increase greatly. From later 
discussions with externally based colleagues, overlaps have had to extend to hundreds 
of base pairs in length in order to be able to overlap the desired elements. This may be 
the case but is a costly and further time consuming option. The benefits later offered 
by the attenuation method became increasingly appealing as time went on. 
The transition to the attenuation method meant that a simple cloning experiment 
could potentially yield an easy method to insert the genes on the BL21 chromosome. 
This however also turned out to be a challenge due, potentially to the very large 
plasmid size, large insert size and low efficiencies of blunt end cloning. The 
development of a small plasmid for this system was believed to help this situation 
although from the limited experiments done with it, it still did not work. Given time 
and new 5’phosphorylated primers, this small plasmid system may well work and has 
the potential to be very useful in other projects, due to the ability to insert genetic 
material in other gram negative bacteria, such as S. oneidensis. 
Genetic manipulation is rarely, if ever documented within B-type E. coli strains which 
seems highly unusual due to the positive capabilities of these strains for protein 
expression. This however may be purely coincidental. In this particular case a BL21 
(DE3) strain was chosen due to the fact that as stated in chapter 3, the strain 
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possessed a functional type II secretion system but, it was also capable of high level, 
inducible protein expression. 
The levels of efficiencies stated in papers for either gene knockouts or chromosomal 
insertions seem infeasibly high. There are a number of possible options for this. Either 
the inserts they were dealing with were particularly small which is largely, but not 
always seen to be the case (as seen in (352)), they were very selective with the 
information they provided (i.e. it worked very well for certain setups but was either 
untested or the data was not shown for other attempts) or there was incredibly bad 
luck/technique applied during molecular biology experiments. This high level of 
efficiency seems especially dubious for insertions carried out without a selection 
pressure. It is conceptually understandable to expect to see a relatively high level of 
successful mutants, when a selection pressure is applied, as the vast majority of 
unsuccessful transformants would die. Having no selection marker, as presented in the 
Tn7 attenuation method, was very appealing due to the lack of extra resistance 
advantage post-insertion. The ability of a molecular biology procedure to not only 
produce successful mutants, but perform this so successfully that on average 79% of 
colonies on the resulting selection free plate having insertions appears higher than 
expected. 
Science continues to move at an incredible rate with new technologies being 
developed on a near daily basis. Genome manipulation tools are no exception to this 
as other genome editing tools are appearing all the time. Recent tools that have come 
onto the scene include TAL (transcription activator-like) effector nucleases, zinc finger 
nucleases, with the latest technique being CRISPR/Cas (clustered regularly interspaced 
short palindromic repeats) RNA modification. All of these techniques are showing 
remarkable promise but are designed for genome modification (deletions, mutations) 
and post transcriptional regulation instead of gene insertion (371–373). For the field of 
chromosomal insertion, there has been very limited progress in terms of technology, 
which for something that the literature considers to be able to remove metabolic 
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burden, therefore providing more streamlined cell lines, leading to greater yields and 
industry profits, seems unusual. 
A recent paper demonstrating promise in this area has come from Enyeart et al (374) 
with a highly flexible plasmid system capable of insertions, deletions and inversions. 
The system has shown the capability of inserting a 12-kb insert, simultaneous deletions 
up to 120 kb and inversions up to 1.2 Mb. The system is also capable of working within 
Shewanella oneidensis, which provides an added incentive to work with a system that 
is also functional in multiple organisms of interest. This is due to the use of the cre-
recombinase system that is supposedly suitable for universal organism genome 
tailoring use (375) in combination with mobile group II introns.  
Another recent paper of interest is a claimed single step recombination demonstrated 
by St-Pierre et al (376). This paper combines steps from a technique known as 
conditional replication, integration, excision and retrieval (CRIM) to reduce the total 
time taken for an integration. This system makes use of a highly efficient integrase 
from phage 186 and selection through the toxic ccdB gene. The GOI still has to be 
cloned into the MCS of the plasmid, but post ligation is transformed directly into the 
desired host strain.  
 
 
 
 
 
 
268 | P a g e  
 
6.2 Interaction studies of plasmid based electrogenic system 
6.2.1 Introduction 
In order to try and improve the efficiency of the plasmid based electrogenic system, 
the way in which it was able to work as a heterologously expressed system needed to 
be established. In order for current to be generated from the system, the Mtr pathway 
from S. oneidensis MR-1 had to have been functionally interacting with the host 
metabolism to some extent. Work prior to this thesis has also demonstrated functional 
interaction of Mtr proteins within E. coli (105,107,120,125). A proposed mechanism of 
electron transfer is from the quinone pool to NapC, a tetrahaem cytochrome 
homologous to CymA in S. oneidensis to MtrA to MtrC, through the beta barrel sheath 
protein MtrB. This was however shown not to be the only method by which electrons 
can travel through this recombinant pathway as Jensen et al deleted NapC from E. coli 
and still demonstrated current generation although at a reduced rate (125). This 
suggests that either a portion of the overexpressed recombinant cytochromes within 
E. coli are incorrectly localised and somehow obtaining electrons from intracellular 
mechanisms or other electron donors to MtrA present.  
In an attempt to try and determine interacting partners of the recombinant Mtr 
proteins, to help gain a better understanding of the system and potentially increase 
efficiency, an interaction study was decided to be carried out. 
Before attempting this, it was necessary to determine the best approach. The following 
analysis of the experimental techniques for interaction work has since been published 
as part of an article in IUBMB life (377). 
6.2.2 Experimental techniques for protein-protein interactions 
(PPIs) 
This section broadly considers and discusses the major approaches used to determine 
PPIs: (i) Yeast two hybrid (Y2H), (ii) Tandem affinity purification (TAP-tag), (iii) 
Proximity ligation assay (PLA) and (iv) Chemical cross-linking. 
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6.2.2.1 Yeast two hybrid screening (Y2H) 
The first publications for the use of a yeast two hybrid (Y2H) system provided 
information about the interaction of a single protein with its specific partners (378), 
whilst simultaneously yielding the cloned interacting partner (379). This technique has 
seen noteworthy success over the past decade, allowing for some of the most complex 
and complete interactomics studies to be carried out (380,381). 
The technique makes use of two sub-units of a protein (GAL4) which, when combined 
provide a transcriptional activator for the expression of beta-galactosidase (378). The 
first step involves cloning the protein of interest into a plasmid that fuses the DNA 
binding domain of GAL4. A second plasmid codes the activating domain of GAL4, which 
is fused to either pre-selected proteins of interest or protein sequences encoded by a 
library of genomic DNA fragments (379). Only when two interacting proteins come into 
contact, following their heterologous expression does the complete GAL4 protein 
occur, subsequently leading to expression of beta galactosidase. This therefore permits 
detection of interacting proteins to occur through the use of a galactose selection 
system such as X-gal. In order for the system to function, the assay has to be carried 
out in a system where the screenable gene has been inactivated or does not natively 
exist. This is to ensure that a positive result is only noted when the two subunits of the 
fusion protein come into contact. 
Although initially designed for function with yeast, the system has been modified for 
use within E. coli (382,383) permitting a greater ease of use without the need for yeast 
growth facilities. A more complete list of the Y2H variations can be found elsewhere 
(384). 
Two hybrid studies have been shown to be the method of choice for many of the 
ambitious, high profile interaction studies involving Saccharomyces cerevisiae 
(385,386), a Drosophila melanogaster map (387) and even the human protein 
interactome (388). This is mainly due to the simplicity of the technique, the ability to 
scale up and the vast amount of information that is retrieved. For all the benefits of 
the technique, two hybrid screening does however suffer from a variety of flaws:  
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 The system was designed to study binary interactions, whereby only a single 
protein is ever seen interacting with another at any point in time. 
 A large number of false positives are found, with reports of up to 70% noted 
previously (389). 
 If the system is plasmid based then the proteins may be overexpressed which 
can lead to inaccurate interaction (390). 
 The fusion portion of the protein has the potential to interfere with the 
function of the protein and could theoretically prevent proteins from 
interacting. 
 The protein may not function in the correct manner if expressed in a 
recombinant host. 
 
 
 
 
 
 
 
 
Figure 6.26 - An example of a yeast two hybrid (Y2H) setup. 
Modified from Causier (384) 
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6.2.2.2 Tandem Affinity Purification (TAP-tag) 
Tandem affinity purification tag (TAP-tag) has seen significant use since it was first 
published over a decade ago (391,392). The method makes use of 2 simultaneous 
affinity tags expressed at either the C- or N- terminus of the desired protein. This 
technique initially relied on dimeric protein A followed by a tobacco etch virus (TEV) 
protease cleavage site and then calmodulin binding peptide (CBP) (Figure 6.27 
provides an illustration). The technique is very open to modification and many 
different combinations of tandem tags have been developed since (393), allowing it to 
be tailored specifically to the protein interactions wanting to be studied. The method is 
similar to that seen in protein co-immunoprecipitation (Co-IP), although this method 
requires the use of a greater number of antibodies to target each specific protein. 
The DNA sequence for the protein tags is inserted up- or downstream of the DNA 
sequence for the protein of interest to allow for native expression of the tagged target. 
This will allow for the most representative interaction with surrounding proteins, 
thereby limiting false positives that may otherwise occur due to overexpression. 
Following cellular disruption, the protein sample is loaded into a column containing 
either magnetic or agarose beads coated with anti protein A antibodies. The column is 
washed to remove contaminating proteins whilst still retaining interacting ones and 
the target protein. The protein A tag is cleaved from the antibody through the use of 
TEV protease and the protein of interest is eluted onto a calmodulin column where the 
secondary tag binds. The sample is washed again to remove any residual contaminants 
and then the proteins are eluted using ethylene glycol tetraacetic acid (EGTA). Samples 
are run through 1D SDS-PAGE gels against a protein sample from the wild type 
organism to allow for visualisation of proteins of interest. Bands present only in the 
positive sample are removed from the gel, enzymatically digested, typically with 
Trypsin, before being loaded onto a mass spectrometer for identification of the 
proteins. 
The technique is relatively simple, requiring the chromosomal tagging (ideally) of 
proteins of interest but afterwards making use of the same antibody and column 
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components. Only one antibody is required unless a western blot of the target protein 
is desired following tandem purification. A large number of proteins can be 
successfully tagged and detected in the mass spec with reports of 86% successful 
tagging - confirmed by western blot, and 65% successful identification through mass 
spectrometry (394). A single tagged protein is able to pull down multiple interacting 
protein (391). The method has been used in large scale interactome studies in yeast 
(395) but has been shown to be susceptible to a high level false positives with one 
group reporting using the same method on the same samples but carried out by 
different researchers yielding less than 30% of the same interactions (396). It is highly 
recommended that any protein interactions 
that are detected should be confirmed 
through re-tagging the detected interaction 
protein to verify the detection of the initial 
target. 
 
 
 
 
 
 
 
 
Figure 6.27 - An example of Tandem affinity purification tag (TAP-
tag) setup. Modified from Rigaut et al (392) 
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6.2.2.3 Proximity ligation assay (PLA) 
Proximity ligation assay (PLA), commercially known as Duolink is a novel technology for 
determining protein interactions in their native state (397) (Example illustrated in 
Figure 6.28).This allows for direct visualisation of the proteins within whole fixed cells 
or tissue sections, thereby preventing any erroneous data from cell lysis, cross 
contamination or imperfect subcellular fractionation. The system doesn't suffer from 
bias due to overexpression or functional modification of the proteins from the addition 
of an affinity tag. 
The technique makes use of two primary antibodies, ideally from different organisms 
that are used against the target proteins. These are subsequently targeted by species 
specific secondary antibodies containing DNA linkers. When closer than 30 nm 
(depending on oligonucleotide length) (397) to an opposing oligonucleotide sequence 
on the opposite secondary antibody, the DNA is linked and ligated using a connector 
oligo and ligase. This creates a circular DNA sequence between the two adjacent 
antibodies. Using rolling circle amplification, the circular DNA sequence is amplified up 
to 1000 times (397,398). Addition of fluorescently labelled detector oligos permits the 
binding of multiple reporter molecules for a single event, thereby allowing low level 
interactions to be identified. Results are analysed and quantified using microscopy and 
Duolink software.  
PLA is an incredibly powerful technique that allows for studies to be done on weak and 
transient interactions. Amplification of the signal is done by RCA so low levels of 
protein interaction can be detected. The major flaw in this method is that it can only 
be done when there is knowledge of the proteins to be targeted. It can provide useful 
information on interactions but no previously unknown targets will be detected. It is 
therefore incapable of doing large scale interaction studies or complete interactomics. 
The technique is highly suited to being used as a confirmatory measure of the 
interaction between proteins seen in any of the previously mentioned methods where 
false positives are much higher. 
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Figure 6.28 - An example of a proximity 
ligation assay (PLA) setup. Modified from 
Soderberg et al (397) 
6.2.2.4 Chemical cross-linking 
The use of chemical cross-linking allows for covalent clustering 
of nearby proteins through the use of a synthetic linker with 
the initial use of this technology being nearly 40 years ago 
(399). There are a wide variety of cross-linkers, allowing the 
technique to be used in a number of ways. A standard method 
is the introduction of the cross-linker molecule following the 
growth of the cell sample but before lysis. The cross-linker 
permeates the cell in order to link proteins and capture them 
in the configuration in which they act natively. The cross-linker 
will in this case be designed to have ends that are reactive to 
specific functional groups such as primary amines. Following 
lysis, the cross-linked proteins are purified and either detected 
using western blots or enzymatically digested and loaded onto a mass spectrometer 
(illustrated in Figure 6.29). 
The development of photo-cross-linking has provided a method for rapid connection of 
cellular proteins that ensures linkers are distributed throughout the cells. The method 
makes use of inert photoactivatable amino acids, such as photo-methionine and 
photo-leucine (400), in the growth media which are then incorporated into mature 
proteins without affecting function. Application of ultraviolet light activates the 
molecules resulting in covalent cross-linking and allows for subsequent analysis as 
mentioned above. 
Recent developments have seen a rise in the use of cross-linking coupled with mass 
spectrometry (401,402) permitting the identification of protein complexes. The linker 
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can be chosen to be of a specific length to determine provide information about 
distances between complexes, state the location of the cross-link and aid in structural 
understanding of multiprotein complexes (401). 
The technique has many different available options that permit a wide range in the 
speed of processing and the quality of data that can be obtained. The linking of 
proteins in vivo increases the chances of detecting weakly interacting and transient 
partners (403). 
 
 
 
 
 
 
 
 
 
Figure 6.29 - An example of a chemical cross-linking setup. 
Modified from Sinz (403) 
A large challenge in modern interactomics studies is the identification of interactions 
between metalloproteins.  These proteins perform vital roles within cellular survival, 
with involvement in energy metabolism (404) and signal transduction (405). Roughly 
30% of proteins within sequenced genomes predicted to contain a metal ion (406,407). 
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Determining the interacting partners of a particular metalloprotein, as with other 
proteins, can depend on the physiological function of the target. Interactions can 
range from stable complexes to incredibly transient interactions in the microsecond 
range (408) often seen with redox proteins (409). The use of coupled techniques such 
as in vivo cross-linking and subsequent tandem affinity purification helps to identify 
specific partners whilst also managing to remove decoys due to the dual purification 
(406). For a more detailed insight into interactions of metalloproteins, the reader is 
advised to view the following papers (406,408,409). 
6.2.2.5 Closing statements - PPI Methods 
A key component for the development of interactomics data is the use of mass 
spectrometers (410–412). The development in this field has made a dramatic impact 
on all aspects of the life sciences with interactomics being no-exception. Mass 
spectrometers allow for a far greater wealth of information to be obtained compared 
to western blots. De novo sequencing (413,414) structural analysis (415) and 
identification of interacting residues (401) are all possible. 
There are many variations of methods that can be applied to attempt to achieve 
the best results from an interactomics study. If the identification of a large number of 
interactions is required, then use of Y2H or TAP-tagging is highly suited. However, 
these experiments are susceptible to high degrees of false positives that must be 
validated. Smaller scale studies involving the interaction between weakly interacting 
proteins and low abundance proteins are better suited to methods such as PLA or 
chemical cross-linking. Techniques are liable to bias, certain methods may determine 
the type of interaction that is found (396). The methods detailed above are not 
mutually exclusive, with examples of two being used in combination to provide greater 
detection methods (416).  
With all this information in mind, it was decided that a directed approach towards to 
proteins of interest was needed which ruled out the use of a simple full cross-link 
although this still held potential. The system had to be able to work with a single 
known protein but not know any of the interacting species, meaning that PLA was 
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ruled out. This left the main choices between a Y2H and a TAP-tag study open for 
choice. The fact that TAP-tag allowed a defined tag to be integrated into the same 
plasmid based system currently used for previous electrogenic studies was particularly 
appealing. This meant that the cells could be used in a functioning current generation 
experiment and the desired protein then extracted to reveal the interacting partners. 
Due to the interest in metalloproteins and the recombinant nature of the system a 
combination of a simple cross-link of 1% formaldehyde (as previously demonstrated 
for the identification of MtrCAB, OmcA, CctA and CymA (237)) paired with tandem 
affinity purification was decided as the best option to attempt. 
6.2.3 Experimental thought process 
6.2.3.1 Reasoning for TAP-tag 
Once the decision was made to use a combination of cross-linking and tandem affinity 
purification, the decision about which tandem affinity purification technique needed to 
be made. The initial TAP-tag setup, as described above, made use of a sequence of 
dimeric protein A, a TEV protease cleavage site and a CBP. This is quite a large protein 
sequence that adds around 20 kD onto the end of a protein sequence (and also confers 
to a large genetic element that needs to be attached). When trying to carry out an 
interaction study, the sequence of the target protein wants to be as close to the 
original as possible to avoid modifying the structure and disrupting normal 
interactions. The length of an affinity tag is a major consideration when carrying out 
single protein studies for the very same reason. As described above, it is the idea of 
tandem affinity purification, rather than the actual protein components that make it a 
useful technique. There have been many modifications of the TAP-tag setup so the 
criteria for choosing one had to be set as one that: 
 Had a smaller tag than the TAP-tag, preferably under 10 kD 
 Had been tested significantly 
 Used common components 
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A match for all three of these was found in the form of the SPA-tag from the lab of Jack 
Greenblatt. This tag comprised of a CBP, TEV protease cleavage site and 3 x FLAG tag 
making the total tag size less than 8 kD (417). It had previously been used to carry out 
a highly cited interactomics study on E. coli (394) and as stated above, made use of a 
FLAG tag instead of protein A, which in a microbiology lab, is a lot more common. 
6.2.3.2 Choice of genetic manipulation 
For the SPA-tag to be able to function, it needed to be attached to the protein of 
interest. In order to do this, the 201 bp SPA-tag would need to be attached to the 
protein of interest. Due to the large size of the Mtr gene cluster and the compatible 
restriction sites available in pACYCDuet-1, the GOI’s couldn’t be cloned into the 
standard MCS and then have the SPA-tag inserted in frame with the current setup. 
Using a standard cloning method, the plasmid would need to be modified to add 
additional cloning sites, the inserted Mtr fraction would also have to be modified to 
allow for in frame insertion of the SPA-tag and the SPA-tag would need to have 
multiple restriction sites added. It was decided that the modifications to do the 
insertion this way would be overly laborious and that other options may provide a 
simpler solution. 
The first method to be considered was Gibson assembly. This is a relatively new 
molecular/synthetic biology technique developed to help enable the generation of the 
first synthetic genome (100,418). It uses the homology of DNA elements to allow them 
to be joined together through the use of a T5’ exonuclease, DNA polymerase and a 
ligase. The plan for this to be used was for the Mtr fraction to be amplified with a 
forward primer that was homologous to the start of the Mtr gene (s) whilst also being 
a reverse complement to the insertion point in the MCS of pACYCDuet-1. The plan for 
this was as follows: 
1. Amplification of the SPA-tag from pJL148 using the specific primers making sure 
to leave the 3’ of the specific Mtr sequence on the 5’ of the amplified SPA-tag. 
2. The next step had two options: 
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a. Amplify the Mtr region of interest using specific primers and use this 
product alongside PCR product from step 1 and amplify. 
b. Use the product from step 1 alongside gDNA from S. oneidensis MR-
1/pACYC plasmid containing insert to try and simultaneously amplify 
Mtr fragment and combine with the SPA-tag. 
3. The final product would then contain both the Mtr section of interest and the 
SPA-tag. This would then need to be inserted into AscI and NotI digested 
pACYCDuet-1.  
The second method that was considered for this was lambda red recombination. As 
this was being used in the chromosomal insertion work that was being carried out 
simultaneously, it seemed sensible to use the same setup to try and insert a sequence 
into different plasmids. The plan for this setup was essentially the same as the design 
for a gene knockout as shown in Figure 6.2. Instead of amplifying an FRT flanked 
resistance cassette with homologous arms to the region wanting to be deleted, the 
SPA tag was to be amplified with arms allowing for insertion at the end of the chosen 
Mtr gene. This would need to be designed carefully to be base perfect, ensuring in 
frame DNA insertion whilst simultaneously removing the final stop codon of the 
chosen Mtr protein.  
For modification of the chosen Mtr plasmid the amplified SPA tag with homologous 
regions to the Mtr gene would merely need to be transformed into a cloning strain 
harbouring the desired Mtr plasmid and an induced pKD46. This, in theory would allow 
this to be a very quick procedure. 
In order to have another option for the insertion of the SPA-tag, another simple 
modification method was considered. PCR overlap allows for simple modifications to 
be made within a plasmid sequence whilst simultaneously removing any of the original 
template plasmid (209). The full method for how to carry this out is detailed in 
methods section 3.2.6. A brief diagrammatic example of how this procedure was used 
is shown in Figure 6.30. 
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1. Amplify SPA-tag from pJL148 with 5’ region on FP (D1) complementary to the 3’ 
region of target gene and the 5’ of the RP (D2) designed to region downstream 
of the GOI. 
 
 
2. Combine amplified fragment from step 1 with desired template. Product from 
step 1 acts as FP and RP for second PCR reaction  
 
 
 
 
 
 
3. Add DpnI to digest original dam methylated template DNA leaving only nicked, 
recombinant unmethylated plasmid 
 
 
 
 
 
4. Transform recombinant plasmid into cloning strain such as DH5alpha to ligate 
nicked plasmid and allow for further replication 
5. Extract plasmid and express in desired strain 
Figure 6.30 - Diagrammatic representation of PCR-overlap method 
used to insert SPA-tag into Mtr plasmids 
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Using these two methods to try and simultaneously insert the SPA-tag had the 
advantage that the same primer sets could be used for both techniques. 
6.2.4 Results and Discussion 
6.2.4.1 Gibson assembly 
The initial Gibson assembly PCR involved the amplification of the SPA-tag with 
modified primers that allowed for further combination of the genetic sequence with 
the desired Mtr region for further cloning into pACYCDuet-1. The initial amplification 
for this was tested with a wide range of annealing temperatures to try and determine 
the best option. The results are shown in Figure 6.31. 
 
Figure 6.31 - Initial amplification of the SPA-tag using primers for 
Gibson assembly.  
The gel shows a very poor amplification of the SPA-tag, at the size indicated by the 
arrow on the gel picture with the apparent banding beneath the indicated bands likely 
being unused dNTPs. This was across a wide range of annealing temperatures, making 
use of both primary and secondary annealing temperatures for some of the samples to 
account for the addition of extra nucleotides to the template. The poor amplification 
was most likely due to poor primer binding to the template, although this is unlikely to 
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have been caused from unspecific binding of the added homologous region as this 
would be expected to create a larger number of unspecific bands. 
Due to the poor amplification of the SPA-tag using this technique, alternatives that had 
been designed for use in parallel were tested as described. 
6.2.4.2 Lambda red recombination 
Amplification of the SPA-tag using primers suitable for lambda red recombination was 
attempted with the results shown in Figure 6.32. 
 
Figure 6.32 - Amplification of the SPA-tag for use in lambda red 
recombination 
Figure 6.32 shows a much higher concentration of SPA-tag was obtained from this PCR 
compared to that used for the Gibson assembly PCR. 
This sample was then gel purified ready for recombination with the resulting samples 
shown in Figure 6.33. 
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Figure 6.33 - Gel purified SPA-tag, ready for recombination into 
pACYCMtr plasmid 
This purified sample was then ready for use within a strain expressing the lambda red 
recombination machinery (pKD46) and also containing the chosen pACYCMtr plasmid. 
The results of the subsequently plated out cells and colony screen are shown in Figure 
6.34. 
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Figure 6.34 - Colony screening of potentially SPA-tagged 
pACYCMtr plasmids 
Figure 6.34 shows that there is plasmid DNA present in all of the screened samples 
which were then sent on for sequencing. Unfortunately the samples came back 
showing that the plasmid was the original pACYCMtr template instead of samples that 
had been modified with the SPA-tag. 
Although the amplification of the SPA-tag with homologous regions was successful, the 
following integration into the Mtr plasmid proved troublesome. This was potentially 
down to the fact that no further selection marker was added for the insertion of the 
SPA tag thereby preventing any additional requirement for the DNA sequence to be 
inserted. As another resistance cassette addition would have modified the current 
engineered cell setup, it was decided that a different method of modification should 
be attempted. 
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6.2.4.3 PCR overlap 
Following the successful amplification of the SPA-tag for the lambda red recombination 
based insertion, it was known that the SPA tag amplified fine. As mentioned above, the 
primers used for lambda red recombination were also suitable for PCR overlap based 
insertion. The initial amplification of the SPA-tag cassette is shown in Figure 6.35. 
 
 
 
 
 
 
 
 
Figure 6.35 - SPA-tag amplification 
Once this DNA fragment had been successfully amplified and purified it could then be 
used as essentially a forward and reverse primer for insertion into the chosen Mtr 
plasmid. The recombinant, amplified plasmid was then distinguished from the original 
pACYCMtr template, through the selective digestion of the original pACYCMtr plasmid 
with DpnI as shown in Figure 6.30. 
Following transformation of the DpnI treated PCR mixture, the sample was 
transformed into DH5α and the resulting colonies screened for successful insertion. 
The results of this are shown in Figure 6.36. 
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Figure 6.36 - SPA-tag screen. Identification of desired 300 bp band 
in all but one of the samples 
Following on from the positive identification of bands of the correct size being 
amplified from all but one of the screened samples, a test SPA-tag pull down was 
attempted to trial the methodology before putting on a longer, current generating test 
run for full analysis. The full methodology for how this was carried out is detailed in 
methods section 3.2.29. The protein samples were added to protein A/G beads 
containing an anti-FLAG antibody. This allowed for the samples to be bound and 
permitted further release of the samples following TEV protease cleavage. The bead 
bound samples were washed with the released proteins being stored and loaded on 
the left hand side of Figure 6.37. The TEV protease was allowed to cleave the protease 
site overnight and the samples were then carried forward onto the next step. The 
beads with the remaining FLAG tag were kept, and the standard elution protocol for 
removal of bound sample was followed. This was then loaded onto a gel as shown in 
Figure 6.37. 
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Figure 6.37 - Silver stained BL21 DE3 test samples following FLAG-
tag pull down. Left hand side is the protein removed following the 
wash. Right hand side is remaining elution from beads following 
TEV protease cleavage of bound sample 
Figure 6.37 shows proteins washed from the protein beads on the left hand side 
showing an expectedly high number of proteins due to the removal of the vast 
majority of the proteome. The right hand side of Figure 6.37 shows single bands at a 
weight of around 35 kD across all the samples. This is unusual as the only sample that 
should be eluted at this point is the 3xFLAG tag that was still bound to the protein A/G 
beads. This has a weight of 2.7 kD which is not visible on the gel.  
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Following TEV protease cleavage the removed samples were then taken on for a 
second stage of purification using CBP. The samples were again washed, with the 
removed protein removed from the second wash stored and then loaded on the left 
hand side of the gel shown in Figure 6.38. The sample containing the CBP tagged 
protein and interacting partners was then eluted from the protein A/G beads and the 
sample loaded onto the right hand side of the gel shown in Figure 6.38. 
Figure 6.38 - Silver stained BL21 DE3 test samples following CBP 
pull down. Left hand side is the protein removed following the 
wash. Right hand side is the final elution of the CBP tagged 
proteins from the protein A/G beads 
The results clearly show a reduced amount of contaminating proteins washed off from 
the beads following the second affinity binding using CBP after FLAG on the left hand 
side of the gel. The right hand side of the gel shows dark bands of eluted protein in all 
of the samples at sizes of around 30 kD and another smaller band at roughly 15 kD. 
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This is of concern due to the fact that the OmcA-SPA-tagged protein in BL21 DE3 
pRGK333 pACYCOmcA shows exactly the same interacting partner as the other MtrB-
SPA-tagged samples in BL21 DE3 pRGK333 pACYCMtrABO, CAB or CABO. This is 
however still possible. Of more concern is the fact that OmcA and MtrB are roughly 80 
kD in size and yet there are no bands at this size. Of even greater concern again is the 
fact that the OmcA, ABO, CAB and CABO samples all yield exactly the same result as 
the control sample containing just BL21 DE3. 
This seems extraordinary. It is not unusual for a single affinity purification step to co-
purify host proteins along with the target protein (419,420) and potentially even 
outcompete the target protein if the tag happens to be folded within the protein. This 
is somewhat unlikely to occur with a FLAG tag due to the high specificity of the 
purification, especially compared to a His-tag (421). The chances of competing host 
proteins interfering with a single affinity can be considered a possibility, but for this to 
occur with a second high affinity tag following TEV protease cleavage and removal of 
protein but no elution, seems highly improbable. The fact that the same bands 
appeared in all of the samples presents a few possibilities: 
 A native E. coli BL21 DE3 protein has both FLAG and CBP affinity with a TEV 
protease site between – highly unlikely to find BL21 DE3 only protein that has 
this highly engineered sequence present within it.  
 Native BL21 DE3 proteins that have limited affinity for FLAG tag to prevent 
removal following a gentle wash but were eluted during TEV protease step due 
to buffer. This protein complex may then have had very high specificity for CBP, 
potentially outcompeting the low levels of recombinantly expressed, tagged 
Mtr protein. 
 The samples were mixed up so that an engineered strain containing a 
recombinant, tagged Mtr protein was also loaded as a control – Unlikely due to 
the fact that if this were the case then the band for the protein would be seen 
at the correct size for the tagged protein (roughly 80 kD for OmcA/MtrB plus 3 
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kD for CBP) and any interacting partners. None of the samples show bands of 
the desired size. 
 The protocol did not work – unlikely as the samples went through two stages of 
high affinity purification and still yielded high concentration bands at the end. 
The wash steps clearly worked as demonstrated with the near full proteome 
identified in Figure 6.37. The FLAG tag elution showed that the minimal 
proteins were still bound to the beads post TEV protease cleavage. The CBP 
wash loaded onto the gel shown in Figure 6.38 shows a potentially 
unexpectedly high level of proteins washed off, but this was of a vastly reduced 
complexity compared to the first step. The final eluted proteins from the CBP 
beads were tightly bound. The wash step may not have been harsh enough to 
remove all contaminating proteins, but it had to be kept relatively mild in order 
to retain the potential interacting partner proteins. 
 The tagged Mtr proteins could have been digested to the extent that a tagged 
portion of the protein still bound to the beads but once run on a gel and 
stained, appeared the wrong size. This is unlikely due to the fact that all the 
samples have exactly the same size bands meaning that MtrB would have to 
have been digested/degraded to exactly the same size as OmcA. This also does 
not explain the presence of bands in the control sample. There is a chance that 
the equal digestion idea and incorrectly labelled samples have both occurred 
but this seems highly unlikely. 
 The DNA sequence for the sample was incorrect. Although the band had come 
out the correct size from the diagnostic PCR, due to timescales, the test SPA-tag 
experiment was started as the sequencing was run. Before the sequencing data 
came back, a further SPA-tag PCR screen was run along with full controls 
including pJL148 (where the SPA-tag was originally amplified from) as a positive 
and the parent pACYCMtr plasmids (Duet-1, ABO, CAB and CABO) for negative 
controls. The results of this are shown in Figure 6.39. 
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Figure 6.39 - SPA-tag screen with controls. Identification of band 
at the same size as desired in both positive and multiple negative 
controls 
The gel in Figure 6.39 clearly shows that although there were bands of the correct size 
present in all but one of the tested SPA tag samples, there were also bands present 
within the negative controls.  
6.2.5 Conclusions 
The current plan was perhaps overly optimistic in scope, whilst also being overly eager 
to adopt new technologies that had not been thoroughly scrutinised such as Gibson 
assembly. The development of this technique (418) and the subsequently widely 
publicised use to create the greatest molecular/synthetic biology achievement to date 
with the generation of the first fully synthetic genome (100) and the more recent 
artificial yeast chromosome (422), made it appear an obvious choice for joining DNA 
sequences. Help in designing experiments using this technique has come from the vast 
increase in the number of computer tools available to help in the design and 
theoretical troubleshooting of cloning such as enhancements in SnapGene, release of 
Benchling and DNA 2.0’s gene designer technology to name a few.  
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The attempted use of lambda red recombination without the use of an added selection 
marker appeared to prevent this insertion from occurring. Due to the design of the 
experiments, the same primers were able to be used for the PCR overlap technique. 
Understanding the correct process to undergo when carrying out a new technique 
always takes time and there have been a number of lessons learned during this. 
6.3 Chapter conclusions 
This chapter summarises the attempts to try and insert multiple genetic fragments 
onto the chromosome of a B-type E. coli strain and attempts to determine the 
interacting partners of a plasmid based Mtr system. The developments in the 
chromosomal insertion work, provide options to continue attempts with the 
development of the pUC19Cm-Tn7 plasmid. The insertion of the SPA-tag onto the Mtr 
based plasmids presented a greater challenge than expected, but the issues as with 
the methodology, has been demonstrated to be feasible, and further troubleshooting 
of the PCR overlap method are expected to yield useful information into interacting 
partners. The challenges posed by the overlap of DNA elements were a constant 
theme throughout the chapter and are an experiment to avoid if at all possible. 
Development of tools that prevent the use of these types of experiments are 
recommended. 
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Chapter	7	–	Final	Conclusions	and	
Future	Directions	
At the closing point of this thesis, it presents an opportunity to consider the work that 
has been carried out during this endeavour. A variety of microbiology, molecular 
biology, proteomic and bioelectrochemistry techniques have been employed, in order 
to try and gain a greater understanding of the underlying mechanisms that allow for 
exoelectrogenic activity and options for engineering its improvement. The complexity 
of genetic systems means that they are usually far beyond a “plug and play” type 
analogy often espoused by the synthetic biology BioBrick community. 
7.1 Microbial fuel cell evaluation 
Something that became apparent throughout chapter 4 of this thesis was the 
difficulties and technical issues associated with microbial fuel cells, especially with 
regard to high-throughput strain evaluation. There is a huge variety of MFCs and BESs 
detailed in the literature but no single, commercially available, defined device(s) that 
are used as standards. Due to the complex nature of the interactions occurring within 
an MFC, especially with the level of exoelectrogenic activity change observed in this 
study for the E. coli strains, the device needs to be highly sensitive, reliable and 
reproducible, whilst still maintaining high-throughput capabilities.  
7.2 Transferring electrogenic capabilities 
A real focus of the thesis at the point of inception was to determine if the functional 
transfer of exoelectrogenic activity into a foreign organism was possible, the ultimate 
aim being to engineer a step change in current beyond wild-type behaviour. As the 
results from chapter 3 show, the transfer of a section of the Mtr proteins from S. 
oneidensis MR-1 into E. coli BL21 DE3 show this to be possible, although with a change 
(ca. 60%) in the observable power output.  
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As for the chosen methods for the transfer of electrogenic activity, these were 
scientifically sound from the literature available at the time (105,120). The continued 
research carried out into the mechanisms of extracellular electron transfer during the 
course of this thesis has led to the discovery that a great deal of the electrogenic 
activity seen in Shewanella is due to mediators (104,136,284,316,423). This is not to 
say that electrogenic activity is not possible without the use of mediators, and is far 
from limited to them through the broad range of organisms contained within the 
classification of DMRB, as discussed in chapter 1.  The most clear cut example of this is 
the fact that the highly studied Geobacter genus not making use of mediators for 
extracellular electron transfer (104,424).  
Whether the continuation of engineering E. coli is the best route to further pursue for 
the creation of a highly tuned electrogenic organism is up for debate. This project was 
executed as a synthetic biology challenge to attempt the integration of a (‘useful’) 
functional pathway within a MFC. The use of a mixed consortium during this or even in 
the future is out of the remit of this approach due to the incredibly high complexity of 
microbial communities. As to whether E. coli should be used as the chosen organism 
for further manipulation, this is again questionable. The use of a tried and tested 
DMRB such as Shewanella or Geobacter provides advantages and although they are 
not specifically evolved for life within an MFC, further directed evolution has been 
shown to be possible (114). Genetic manipulation of strains such as Shewanella and 
Geobacter could yield large improvements in current generation through metabolic 
engineering and overexpression of desired pathways. E. coli is not naturally evolved for 
survival within the anode chamber of an MFC and cannot, at this stage, even with the 
introduction of the Mtr pathway create a considerable amount of current. There are 
however significant advantages of using E. coli over other organisms. It is still the most 
widely (genetically) studied micro-organism with an extensive list of models, mutants 
and studies having been carried out on it. It should be considered an incredible 
achievement that any increase in power density was noted following the introduction 
of the Mtr pathway, as this shows the integration of a highly complex system with the 
host metabolism. Now that this has been shown, the possibilities for 
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further/completely different components from a variety of organisms can be 
introduced and screened for activity. The results from E. coli in chapter 4 then showed 
that more fundamental studies of electron transport in both E. coli and Shewanella 
oneidensis MR-1 were required, which was the thinking behind the two proteomics 
driven chapters, 5 and 6.  
7.3 Quantitative proteomics of Shewanella 
This study, detailed in chapter 5 was done to try and determine the proteomic changes 
within Shewanella oneidensis MR-1, when generating current within an MFC compared 
to aerobically grown cells. Although a large amount of work has been carried out on 
deciphering the exact proteins involved in electron transfer within Shewanella, there 
was very little done at a global proteomic level. Understanding how Shewanella adapts 
to survival within the anode had the potential to provide insight into how an 
engineered E. coli strain could be modified to increase power generation. An iTRAQ 
analysis into the proteomic shift in the highest power producing E. coli strain BL21 DE3 
pRGK333 pRSFOmcA-MtrCAB was decided against a targeted interaction study, within 
this strain, as detailed in chapter 6. At the point of this study, a great deal of work had 
been conducted on the Mtr pathway and it had already been chosen for insertion into 
E. coli. The identification of the TolC as a potential component in the transfer of 
electrons extracellularly requires further testing in order to be verified as discussed in 
further work. This information was then carried forward for analysis with the 
interaction work in the Mtr gene expressing E. coli detailed in chapter 6. 
7.4 Chromosomal insertion of the Mtr pathway 
The issues of metabolic burden noted due to plasmid based systems detailed in the 
literature (343,345,347,425–427) needed to be addressed. This was due to the high 
level of metabolic burden placed upon the E. coli cells bearing the plasmids for the 
overexpression of the cytochrome maturation genes and the Mtr pathway. In order to 
remove the burden or at least determine if it was an issue, a method of basing the 
system on the genome of E. coli was needed. Though a variety of different methods 
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were attempted and new plasmids were developed, neither the overexpression of the 
native cytochrome maturation genes nor the chromosomal insertion of the Mtr genes 
was achieved in the time period. Table 6.4 in chapter 6 provides a concise overview of 
the pros and cons of the different genome manipulation tools that were evaluated. 
This evaluation had to be done as there is no kit based insertion system available that 
could be ordered and allow for guaranteed insertion. Analysis of the literature did not 
provide a defined, single tool that can be used in every situation for the basing of the 
different elements. There are significant challenges that must be overcome in order to 
integrate genetic material onto the chromosome of an organism. Choosing a 
commercial option such as paying for a company like Genebridges 
(http://www.genebridges.com) to carry out this insertion would not only be expensive 
but through discussion with the company, it appears they have experienced limitations 
with the insertion of genes in B-type strains. Plasmids were developed to aid in the 
chromosomal basing of genetic elements both in a fixed location and also at a chosen 
site. 
7.5 Interaction of the Mtr pathway with the native E. coli host 
machinery 
The transfer of electrogenic activity into E. coli (chapter 4) showed that it was possible 
for the electrogenic capability to be transferred although, this research, along with 
work in the same area from the group of Ajo-Franklin (124,125) does not indicate 
exactly how this is possible. In order to try and increase the level of power generated 
by the engineered strain, it was important to understand the partners that this 
recombinant system was interacting with. The use of a “SPA-tag” for tandem affinity 
purification of the genetically tagged proteins was attempted for identification of 
these. The exact localisation of the proteins within the engineered strain is not 
properly identified and due to the delicate nature of overexpressing recombinant 
proteins, it is highly unlikely that the system is arranged exactly as detailed in 
Shewanella. A portion of the complex decahaem cytochromes may well be in the 
correct orientation and ratio, to allow for correct extracellular electron transfer, but 
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there may well also be a large portion of charged recombinant cytochromes that are 
present within the media that are able to interact with the anode. There are 
indications of the methods that the host E. coli is able to interact with the Mtr pathway 
as shown by Jensen et al (125). The main hub of electron donation within Shewanella 
to the Mtr pathway is the tetrahaem c-type cytochrome CymA. This is very clearly 
demonstrated through a near complete knockout of current density of a knockout 
strain shown by Bretschger et al (109). The E. coli CymA homolog, NapC, was therefore 
posited to be a highly important in the transfer of electrons to the recombinant Mtr 
pathway (105,107). This theory was put to the test by Jensen et al where a NapC 
knockout within BL21 (DE3) was created and tested, in combination with and without 
cytochrome maturation genes and separately MtrA. This demonstrated that the cells 
were still able to reduce membrane soluble Fe (III) citrate without the presence of 
NapC. The ability of E. coli to provide a greater level of electron donation to the outer 
membrane than Shewanella, seems unlikely due to the high level of extracellular 
electron donation noted in the latter but not the former. It may well be due to the 
mislocalisation of overexpressed MtrA proteins. The use of subcellular fractionation 
could help to determine where recombinant proteins are being localised, but this 
technique is far from perfect. There can be “bleeding” from different cellular 
compartments leading to false positives. The use of the TAP-tag system described in 
chapter 6 allows for the discovery of interacting partners within the cell. The need for 
reciprocal tagging allows for the removal of false positives. The attempts to complete 
this within the time frame of this thesis were not successful as the use of the PCR 
overlap appeared to provide false positives. The SPA-tag setup used within this chapter 
has already been tested and a methodology for insertion created, making continuation 
of this work feasible. 
7.6 Future work 
7.6.1 Chromosomal insertion 
Although developments were made in the generation of alternative chromosomal 
insertion plasmids that potentially allow for the bypassing of certain issues, the lack of 
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a complete insertion into the chromosome of a desired organism means that this is the 
future work that needs to be tackled.  
As a limiting factor in the use of lambda red recombination is the overlap of the FRT 
flanked resistance cassette and the GOI. As shown in Figure 6.2 the resistance cassette 
has to be amplified from either pKD13 or pKD32 whereas the GOI is amplified 
separately (Step 1 in Figure 6.2). The 2 amplified genetic elements must then be 
connected to each other through a PCR reaction (step 3 in Figure 6.2). This means that 
they must have an overlapping section that is homologous (H2 complementary to H3), 
so that when the dsDNA is denatured, the two sections are complementary and have 
the potential to bind to each other and allow for amplification of the other element. 
There is a delicate balance when designing primers to ensure that the region of the 
primer specific to amplifying the first target e.g. GOI has enough of the primer that is 
specific to amplifying that target so that unspecific binding does not occur. It must, at 
the same time, have enough of a flanking region that is complementary to the DNA it is 
to be connected to e.g. an FRT flanked cassette. The larger the GOI is, the harder this 
can be as the primers will need to increase in size to be able to provide specific PCR of 
each of the reactions. This also becomes increasingly expensive, the PCR reactions less 
likely to work and the melting temperature of the primers continues to increase – all 
leading to the reactions being less likely to succeed.  
In order to combat these challenges a plasmid could be designed that contains the 
pKD13 or pKD32 FRT flanked resistance cassettes (or newly designed flanked 
resistance cassettes) in a plasmid that contains an MCS next to (upstream or 
downstream) it. This means that the GOI could then be cloned into the plasmid and 
relatively simple primers could be designed, one to amplify from the resistance 
cassette end and another from the GOI end. This would only need ends that are 
homologous to the region where the insert is needed and would then create a linear 
dsDNA template needed for transformation into a strain bearing an induced pKD46 
variant plasmid. This would therefore remove, what could be considered a major 
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limitation, of the current Datsenko and Wanner plasmid setup for chromosomal 
insertions. 
In terms of the attenuation plasmid setup, the pUC19Cm-Tn7 plasmid still has the 
potential to be a very useful plasmid for fixed site insertion of genetic elements 
alongside pGRG36. This is still a two plasmid setup but presents an opportunity to 
clone the GOI into a very small plasmid for later insertion. The fact that Tn7 systems 
can be used within such a wide range of organisms makes it very appealing option that 
is still worth consideration for future work. 
There are still a wide variety of opportunities that could be used to attempt to 
overexpress the cytochrome maturation genes and localise the heterologous Mtr 
pathway onto the chromosome to determine if metabolic burden is having an effect 
on the power output of the cells.  
7.6.2 Interaction of the Mtr system with native E. coli proteins 
In order to gain an understanding of how the Mtr pathway allows for current 
production within E. coli, either a new interaction method needs to be used, or a 
continuation of the SPA-tag work needs to be done. As the SPA-tag methodology has 
been established and trialled, albeit unsuccessfully so far, it still has the potential to be 
the quickest method and to deliver useful information. This is due to the fact that in 
theory, only two PCR reactions are required to insert the SPA-tag into desired plasmid. 
In order to carry on with the SPA-tag experiments, the following things would need to 
be considered: 
 Order fresh primers, amplify SPA tag and send for sequencing 
 Use PCR overlap protocol for insertion of SPA-tag – send transformants for 
sequencing 
 Test run of the SPA-tag protocol 
 If unusual banding is discovered, gel bands should be cut, digested and run on 
the MS for analysis 
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o If native BL21 proteins are detected then the sequence can be identified 
and a further investigation into how these proteins are being purified 
following TAP-tag can be made. 
o If the proteins are found to be digested/degraded Mtr proteins then this 
may suggest that either a higher concentration or a different protein 
inhibitor complex is needed. 
 Once the issues with the test procedure have been resolved, then the testing of 
the strains in triplicate within a poised potential half cell can begin, with the 
cells ready for SPA-tag purification and MS analysis. 
Analysis of the samples should provide details of the interacting partners of the Mtr 
proteins, which apart from helping to settle the debate about the proteins that donate 
electrons to this pathway within E. coli, they could also potentially provide the 
opportunity for upregulation of native machinery and remove bottlenecks. This work 
will then need to be carried out in Shewanella in order to visualise the difference 
between the interacting partners. 
7.6.3 Post iTRAQ analysis and future potential 
Following the quantitative proteomic analysis of S. oneidensis MR-1, the most logical 
way to test if any of the theories put forward in the thesis are true is through the 
creation of mutants such as ΔTolC. There is however, the potential for this to have a 
significantly detrimental effect on the strain, potentially preventing expulsion of toxins 
from the cell. Testing of this mutant would permit determination of the function of 
these proteins within the context of power generation within an MFC and provide 
valuable information for the MFC and Shewanella community. iTRAQ still holds a lot of 
potential in its ability to help decipher metabolic bottlenecks and aid in forward 
engineering (272), when used in tandem with bioinformatic techniques such as flux 
balance analysis. The use of this technique on the plasmid based or preferentially the 
chromosomally based electrogenic E. coli, could help to illustrate ways in which 
current density could be increased. The use of the information generated within this 
iTRAQ study may also be used to help further engineer a more adapted, current 
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generation strain. The issues with the lack of identification of the Mtr proteins within 
the Shewanella iTRAQ samples, could potentially be due to the low abundance of the 
proteins within the samples. The detection of these could be attempted through the 
use of targeted protein analysis in the form of MRMs. 
7.6.4 Future electrogenic targets 
Analysis of the literature throughout this thesis has provided ideas of future targets for 
integration into engineered E. coli.  This begs the question as to whether there is 
potential for the use of Geobacter cytochromes within E. coli.  This has never been 
demonstrated before and the ability of the Geobacter system to be able to integrate 
and functionally link with the E. coli system is questionable. This is based upon the 
assumption that Shewanella proteins are more likely to be able to interact with E. coli 
host proteins, due to the fact that they are both Gammaproteobacteria and therefore 
share a closer evolutionary ancestor than Geobacter which is a Deltaproteobacterium.  
Now that the Mtr system has been established within E. coli, it presents an opportunity 
for mediator based electron transfer. The UshA (316) and bfe (104) proteins that are 
touted as having a huge role within Shewanella, could potentially be carried across to 
E. coli to allow for greater power densities. 
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Closing statement 
Throughout this thesis there has been an attempt to further the understanding the 
mechanisms and transferability of extracellular electron transfer in regard to current 
generation. Cloning of varying components of the Mtr pathway from S. oneidensis into 
E. coli demonstrated, not only that electrogenic activity can be transferred but that this 
can lead to 64% of S. oneidensis power output being generated.  
Proteomic analysis of S. oneidensis under aerobic growth compared to cells grown 
within an MFC demonstrated the potentially important influence of proteins outside of 
the Mtr pathway.  
The attempted chromosomal basing of the Mtr pathway onto the E. coli genome, 
although unsuccessful at this point has led to a greater understanding of methods that 
should not be employed. There are also numerous other molecular biology techniques 
and options detailed that may allow for this to be successful.  
Determining the interacting partners of the recombinant Mtr pathway within E. coli 
presented an opportunity to elucidate an important part of the puzzle as to how 
recombinant electrogenicity functions. The continuation of this work may well yield 
the answer to this question. 
The aims set out at the beginning of this thesis were achieved, through the engineering 
paradigm, with the transfer of electrogenic activity into an organism that was 
previously incapable of such activity. Proteomic analysis and attempts at chromosomal 
insertion of relevant genetic elements and their interaction with the native machinery 
present further challenges to go forward with. The demonstration of transferrable 
electrogenic activity most importantly showing the fact that this was possible now 
presents the opportunity to further increase the electrogenic activity of this 
recombinant system. 
From the results obtained during the course of this thesis and the developments seen 
in the field over the course of this study, it is clear that electrogenic activity can be 
transferred through the use of the Mtr pathway from S. oneidensis MR-1. The 
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developments carried out by Goldbeck et al (124) showed that optimisation of 
promoter sequences, allowed for a balance of Mtr proteins produced and current 
generation whilst still yielding “healthy looking” cells. The results obtained from the 
transfer of activity into E. coli still yield relatively low levels when compared to those 
demonstrated by S. oneidensis MR-1 (661 W m-3) (428) and mixed culture MFCs (3320 
W m-3) (429). In order for engineered organisms to become a feasible option within 
BES’s this issue must be addressed. One way in which this may be possible to achieve is 
through the further enhancement of a well characterised organism such as E. coli. 
Transferring the initial Mtr pathway to the chromosome and upregulation of the native 
cytochrome maturation genes would present the option for use of other plasmid 
based elements. The identification and removal of unnecessary competing pathways 
(e.g. potentially the nitrate reductase pathway) could theoretically allow for more 
electrons to be transferred to the anode. 
All the work carried out with the transfer of this activity is however, carried out within 
the Gammaproteobacteria, (the same as S. oneidensis MR-1) E. coli. These organisms 
have important proteins that are closely related to each other in the form of the inner 
membrane anchored tetrahaem c-type cytochromes NapC (E. coli) and CymA (S. 
oneidensis). Both of these are involved with interaction with the quinone pool and 
then transfer of electrons into the periplasm. The ability to transfer electrogenic 
activity in to an organism that isn’t as closely related would surely be a much greater 
challenge.  
Due to the high desirable ability of BES’s to degrade waste organic material and 
convert it directly to electricity (or hydrogen) this is likely how the system will be used 
if carried on to industrial level use. In this circumstance there will be a large range of 
organisms that will be transferred into the system alongside the feedstock. Any single 
strain of bacteria is, unless high modified, to be outcompeted by a mixture of naturally 
occurring microorganisms. The future of the microorganisms used within BES’s may 
well lie with use of synthetic mixed cultures. This may either mean determining the 
ideal mixed culture for the conditions required or generating a collection of genetically 
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modified metabolically diverse organisms that are able to form a cohesive mutualistic 
relationship within the anode. Not all organisms need be DMRB or genetically modified 
to have electrogenic activity but they would as a whole need to be able to degrade all 
waste organic material whilst eventually transferring electrons (potentially through the 
transfer of by products to each other)  to the anode with a high coulombic efficiency. 
Considering the challenges that have been encountered during the course of this thesis 
the main differences I would want to make would be with the MFCs and BESs in 
general. It is these devices that have caused the most trouble throughout. I considered 
the project to be a strongly interdisciplinary study that could likely have benefitted 
from collaboration with a research group specialising in the technically challenging 
domain of MFCs. 
As for what I consider the next direct steps that hold the most promise in regards to 
the continuation of this work, I think the experiments attempted within Chapter 6 
(chromosomal insertion and interaction of Mtr components) have potential to yield 
interesting and useful information. Understanding what proteins the Mtr pathway is 
interacting with in the periplasmic space may provide opportunities for metabolic 
engineering and a greater understanding of how this recombinant pathway is working. 
As discussed previously, the basing of the Mtr pathway chromosomally provides an 
opportunity to free up space for plasmid based elements that may be able to enhance 
current generation. In order for the system to be able to achieve the levels seen within 
Shewanella there may be other components that need to be expressed. The use of a 
genetic library screen and a high throughput screening method may help to identify 
relevant targets. 
As for the long term future of MFCs, I have a strong belief in their abilities as a 
renewable energy technology although I find it incredibly unlikely that they will ever be 
a sole source of power for a large community. I do think that given the energy and 
waste challenges we face from a growing and developing global population I think they 
stand a good chance of being able to provide an economically viable venture. They 
have gathered considerable media attention recently, especially with real world 
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application like that done by Dr Ioannis Ieropoulos and colleagues at UWE with the use 
of urine as a feedstock. There are still considerable challenges that must be overcome 
with the engineering of the devices and being able to generate a large scale system 
that can be integrated alongside the current infrastructure. They also face strong 
competition from other waste to energy technologies such as anaerobic digesters. 
I’ve had some ups and downs throughout the course of my studies with this project 
but I’d like to think I’ve come out as a more knowledgeable person with an added 
appreciation for renewable technology and the important role that science plays in our 
lives. 
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Chapter	8:	Appendix	
8.1 – Plasmids 
8.1.1 – Cytochrome maturation genes 
pRGK333 
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8.1.2 – Mtr plasmids 
pACYCDuet-1 
 
pACYCOmcA 
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pACYCMtrABO 
 
pACYCMtrCAB 
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pACYCMtrCABO 
 
pACYCMR-1 
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8.1.3 Recombination plasmids: 
pKD46 
 
 
 
 
 
 
 
 
 
 
pKD13 
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8.1.4 Transposon plasmids:  
 
pGRG36 
 
 
 
 
 
 
 
 
 
 
 
pUC19 
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pUC19 Cm  
 
 
 
 
 
 
 
 
 
 
 
pUC19Cm-Tn7 
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Bioelectrochemical system pictures 
University of West England (UWE) MFC – MK1 
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Bioinformatics for Chapter 4 
MS results: 
MtrA 
Identified peptides: 
FAEGNYSPK 
GGNEPMITFGK 
QKADMNK 
 
These peptides map onto the target protein as follows: 
>gi|24347597|gb|AAN54830.1|AE015621_8 decahaem cytochrome c MtrA 
[Shewanella oneidensis MR-1] 
MKNCLKMKNLLPALTITMAMSAVMALVVTPNAYASKWDEKMTPEQVEATLDKKFAEGNYSPK
GADSCLMCHKKSEKVMDLFKGVHGAIDSSKSPMAGLQCEACHGPLGQHNKGGNEPMITFGKQ
STLSADKQNSVCMSCHQDDKRMSWNGGHHDNADVACASCHQVHVAKDPVLSKNTEMEVCTS
CHTKQKADMNKRSSHPLKWAQMTCSDCHNPHGSMTDSDLNKPSVNDTCYSCHAEKRGPKLW
EHAPVTENCVTCHNPHGSVNDGMLKTRAPQLCQQCHASDGHASNAYLGNTGLGSNVGDNAFT
GGRSCLNCHSQVHGSNHPSGKLLQR 
 
MtrB 
Identified peptides: 
VDLLGMNLK 
YANQLNTDAVDAK 
 
This peptide maps onto the target protein as follows: 
>gi|24347596|gb|AAN54829.1|AE015621_7 outer membrane protein precursor MtrB 
[Shewanella oneidensis MR-1] 
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MKFKLNLITLALLANTGLAVAADGYGLANANTEKVKLSAWSCKGCVVETGTSGTVGVGVGYNSEE
DIRSANAFGTSNEVAGKFDADLNFKGEKGYRASVDAYQLGMDGGRLDVNAGKQGQYNVNVNY
RQIATYDSNSALSPYAGIGGNNLTLPDNWITAGSSNQMPLLMDSLNALELSLKRERTGLGFEYQGE
SLWSTYVNYMREEKTGLKQASGSFFNQSMMLAEPVDYTTDTIEAGVKLKGDRWFTALSYNGSIFK
NEYNQLDFENAFNPTFGAQTQGTMALDPDNQSHTVSLMGQYNDGSNALSGRILTGQMSQDQA
LVTDNYRYANQLNTDAVDAKVDLLGMNLKVVSKVSNDLRLTGSYDYYDRDNNTQVEEWTQISI
NNVNGKVAYNTPYDNRTQRFKVAADYRITRDIKLDGGYDFKRDQRDYQDRETTDENTVWARLR
VNSFDTWDMWVKGSYGNRDGSQYQASEWTSSETNSLLRKYNLADRDRTQVEARITHSPLESLTI
DVGARYALDDYTDTVIGLTESKDTSYDANISYMITADLLATAFYNYQTIESEQAGSSNYSTPTWTGF
IEDQVDVVGAGISYNNLLENKLRLGLDYTYSNSDSNTQVRQGITGDYGDYFAKVHNINLYAQYQAT
EKLALRFDYKIENYKDNDAANDIAVDGIWNVVGFGSNSHDYTAQMLMLSMSYKL 
 
MtrC 
Identified peptides: 
ADLAFATLSGK 
VFNAQLTQR 
ETLESFGAVVDGTK 
GALNTAAAADK 
FDAFDSNK 
These peptides map onto the target protein as follows: 
 
>gi|24347598|gb|AAN54831.1|AE015621_9 decahaem cytochrome c [Shewanella 
oneidensis MR-1] 
MMNAQKSKIALLLAASAVTMALTGCGGSDGNNGNDGSDGGEPAGSIQTLNLDITKVSYENGA
PMVTVFATNEADMPVIGLANLEIKKALQLIPEGATGPGNSANWQGLGSSKSYVDNKNGSYTFK
FDAFDSNKVFNAQLTQRFNVVSAAGKLADGTTVPVAEMVEDFDGQGNAPQYTKNIVSHEVC
ASCHVEGEKIYHQATEVETCISCHTQEFADGRGKPHVAFSHLIHNVHNANKAWGKDNKIPTVA
QNIVQDNCQVCHVESDMLTEAKNWSRIPTMEVCSSCHVDIDFAAGKGHSQQLDNSNCIACH
NSDWTAELHTAKTTATKNLINQYGIETTSTINTETKAATISVQVVDANGTAVDLKTILPKVQRLEII
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TNVGPNNATLGYSGKDSIFAIKNGALDPKATINDAGKLVYTTTKDLKLGQNGADSDTAFSFVG
WSMCSSEGKFVDCADPAFDGVDVTKYTGMKADLAFATLSGKAPSTRHVDSVNMTACANCHT
AEFEIHKGKQHAGFVMTEQLSHTQDANGKAIVGLDACVTCHTPDGTYSFANRGALELKLHKKH
VEDAYGLIGGNCASCHSDFNLESFKKKGALNTAAAADKTGLYSTPITATCTTCHTVGSQYMVHT
KETLESFGAVVDGTKDDATSAAQSETCFYCHTPTVADHTKVKM 
 
MtrD 
No identified peptides 
>gi|410519705|gb|AAN54835.2| extracellular respiratory system periplasmic 
decahaem cytochrome c component MtrD [Shewanella oneidensis MR-1] 
MDMDIGLKFNSITQIMLTLMLSILSLSTLATPWDDKSSEEVVATLDKKFAEGKYSAKGADTCLMCH
KKSAVVMAIFDGVHGNPNIKDSPMADLQCEACHGPLGNHNKGGKEPMITFGQNSPVPAQKQN
SVCMSCHNDDQRIAWKGNHHDNADIPCSSCHQVHVAKDPISDKANEVAICTQCHSQQKADMH
KRSSHPLQWQQMVCSDCHNPHGSLNDASLKQMTVNENCYSCHAEKRGPKLWEHAPVTDNCA
NCHNPHGSVNESMLISKPPQLCQQCHASDGHSSNAYFGNQTNAFTSGNSCMNCHGQVHGSNH
PSGKLLQR 
MtrE 
Identified peptide: 
DSDQAGSNR 
 
>gi|24347604|gb|AAN54834.1| extracellular respiratory system outer membrane 
component MtrE [Shewanella oneidensis MR-1] 
MQIVNISTPKVCFSLTLLAWTMSGVLNTAHAEGYEIQKANRSGVKNEAWSCKQCQPQTGRQGN
VSATLAHNDGDDSRFGNRTGIDKDGLVGAIGADMKYKAESGYQTSLMADKLGFDTGSAKLSTGQ
LGHYQINLGYKGLANYQYNQLKSPYIAENDKMLLPDNWVAGATTQSMPLLQSSLAEQDLSLKRD
RFNLGGYYAGHISSTNRYKASINYQHENRSGAKKTSANILTNSVMLAQPIDDSTDEIDARIYFGGIG
WQAGINSQISQYKNDHQALLWQSAYTPTFGAAYYGQNAVEPDNKAYRIAAEASGGQNGHNVL
MHAGISQMSQDEAFLPATINGPAPTLPADNLDGQVDILEMLLKYSGRITQDLSIQANYHYQDKDN
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KTTQLDFPQVVTDSVYQGTAQNSLYDKRSNKLELKGKYRLTPSAYAEAGYSLDANDYSALDRQSV
DESGVFAKLSYRYSPSWSTWLKGEALTRDGSEYDPVSTTQSPSNPWLRKSYLADRKRQKVTLHTD
YQSDIGLSVGASLHNVDDDYNHTSVGLTHVSYLGYDVSAQYLIADNLSLNAYLNQDWRDSDQAG
SNRFSTPDWYSTAEEKSTLIGTGVVYQNLLDNHLDLGLDYSYSDGQSDTEVTYGITSPYGDYYNRK
HNINAYAKYKLADSMSLRFDWLFEKYQDASWQNQNTTWDTIPNVLSFGDISRDYNAHYLGLTLSY
QM 
 
MtrF 
No identified peptides 
>gi|24347603|gb|AAN54833.1| extracellular respiratory system surface decahaem 
cytochrome c component MtrF [Shewanella oneidensis MR-1] 
MNKFASFTTQYSLMLLIATLLSACGGSDGDDGSPGEPGKPPAMTISSLNISVDKVAISDGIAQVDY
QVSNQENQAVVGIPSATFIAAQLLPQGATGAGNSSEWQHFTSETCAASCPGTFVDHKNGHYSYR
FSATFNGMNGVTFLSDATQRLVIKIGGDALADGTVLPITNQHYDWQSSGNMLAYTRNLVSIDTCN
SCHSNLAFHGGRYNQVETCVTCHNSKKVSNAADIFPQMIHSKHLTGFPQSISNCQTCHADNPDLA
DRQNWYRVPTMEACGACHTQINFPAGQGHPAQTDNSNCVACHNADWTANVHSNAAQTSAL
AQFNASISSASMDANGTITVAVSLTNPTTGTAYADSADKLKFISDLRIYANWGTSFDYSSRSARSIRL
PESTPIAGSNGTYSYNISGLTVPAGTESDRGGLAIQGRVCAKDSVLVDCSTELAEVLVIKSSHSYFNM
SALTTTGRREVISNAKCASCHGDQQLNIHGARNDLAGQCQLCHNPNMLADATATNPSMTSFDFK
QLIHGLHSSQFAGFEDLNYPGNIGNCAQCHINDSTGISTVALPLNAAVQPLALNNGTFTSPIAAVCS
NCHSSDATQNHMRQQGAVFAGTKADATAGTETCAFCHGQGTVADVLKVHPIN 
 
TMHMM 
OmcA 
Sequence Length: 735 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 1.9354 
# Sequence Exp number, first 60 AAs:  1.92918 
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# Sequence Total prob of N-in:        0.09716 
Sequence TMHMM2.0 outside      1   735 
 
MtrA 
Sequence Length: 333 
# Sequence Number of predicted TMHs:  1 
# Sequence Exp number of AAs in TMHs: 20.26577 
# Sequence Exp number, first 60 AAs:  20.26558 
# Sequence Total prob of N-in:        0.75587 
# Sequence POSSIBLE N-term signal sequence 
Sequence TMHMM2.0 inside      1    11 
Sequence TMHMM2.0 TMhelix     12    34 
Sequence TMHMM2.0 outside     35   333 
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MtrF 
Sequence Length: 639 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 0.69532 
# Sequence Exp number, first 60 AAs:  0.65633 
# Sequence Total prob of N-in:        0.03427 
Sequence TMHMM2.0 outside      1   639 
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MtrD 
Sequence Length: 306 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 0.00018 
# Sequence Exp number, first 60 AAs:  0.00018 
# Sequence Total prob of N-in:        0.00321 
Sequence TMHMM2.0 outside      1   306 
 
MtrB 
Sequence Length: 697 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 7.1145 
# Sequence Exp number, first 60 AAs:  7.10972 
# Sequence Total prob of N-in:        0.32241 
Sequence TMHMM2.0 outside      1   697 
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MtrE 
Sequence Length: 712 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 2.021 
# Sequence Exp number, first 60 AAs:  2.01926 
# Sequence Total prob of N-in:        0.09838 
Sequence TMHMM2.0 outside      1   712 
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MtrC 
Sequence Length: 671 
# Sequence Number of predicted TMHs:  0 
# Sequence Exp number of AAs in TMHs: 2.93629 
# Sequence Exp number, first 60 AAs:  2.92742 
# Sequence Total prob of N-in:        0.15213 
Sequence TMHMM2.0 outside      1   671 
 
 
Signal Peptide 
OmcA 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
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Max cleavage site probability: 0.908 between pos. 32 and 33 
 
MtrA 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
Max cleavage site probability: 0.506 between pos. 25 and 26 
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MtrF 
Prediction: Signal peptide 
Signal peptide probability: 0.998 
Max cleavage site probability: 0.949 between pos. 29 and 30 
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MtrD 
Prediction: Signal peptide 
Signal peptide probability: 0.681 
Max cleavage site probability: 0.674 between pos. 15 and 16 
 
MtrE 
Prediction: Signal peptide 
Signal peptide probability: 0.996 
Max cleavage site probability: 0.952 between pos. 31 and 32 
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MtrC 
Prediction: Signal peptide 
Signal peptide probability: 0.999 
Max cleavage site probability: 0.420 between pos. 30 and 31 
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MtrB 
Prediction: Signal peptide 
Signal peptide probability: 1.000 
Max cleavage site probability: 0.977 between pos. 21 and 22 
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Chapter 5 – regulated proteins from iTRAQ 1 and 2 
iTRAQ 1 - Aerobic Planktonic vs  Semi-Anaerobic Anodic Biofilm 
cells - Soluble sub-proteome       
UniProt 
ident. gi Number Name 
# 
pe
pt
id
es 
119/1
15 
(log 
differ
ence) 
119/1
16 
(log 
differ
ence) 
121/1
15 
(log 
differ
ence) 
121/1
16 
(log 
differ
ence) 
119
/11
5 
(p-
valu
e) 
119
/11
6 
(p-
valu
e) 
121
/11
5 
(p-
valu
e) 
121
/11
6 
(p-
valu
e) 
Fold change 
(Anode 
associated 
cells/aerobic 
planktonic) 
P-value 
(Anode 
associated 
cells/aerobi
c 
planktonic) 
Q8EK77 
(RL1_SH
EON)  
SO0221 
gi|243456
24|gb|AA
N53306.1|
AE015471
_11 
AE015471_11 
ribosomal protein L1 26 
-
0.392
41 
-
0.941
95 
-
0.321
51 
-
0.871
05 
0.01
580
8 
4.6E
-06 
0.03
217
7 
1.32
E-05 -1.88086 0.00042 
Q8EK74 
(RPOB_S
HEON) 
SO0224 
gi|243456
31|gb|AA
N53309.1|
AE015472
_1 
AE015472_1 DNA-
directed RNA 
polymerase, beta 
subunit  11 
0.877
683 
0.933
698 
0.874
364 
0.930
379 
1.06
E-05 
1.49
E-05 
0.00
010
4 
5.38
E-05 2.469537 3.07E-05 
Q8EK73 
(RPOC_S
HEON) 
SO0225  
gi|243456
32|gb|AA
N53310.1|
AE015472
_2 
AE015472_2 DNA-
directed RNA 
polymerase, beta' 
subunit  47 
0.495
379 
0.579
96 
0.446
223 
0.530
804 
0.00
037 
3.51
E-05 
0.00
022
6 
6.89
E-06 1.670448 6.71E-05 
Q8EK65 
(RL2_SH
EON) 
SO0234 
gi|243456
45|gb|AA
N53319.1|
AE015473_6 
ribosomal protein L2 17 
0.938
404 
1.107
135 
0.698
667 
0.867
397 
3.06
E-05 
5.41
E-06 
4.61
E-07 
4.29
E-08 2.466748 1.34E-06 
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AE015473
_6 
Q8EK62 
(RL16_S
HEON) 
SO0238 
gi|243456
49|gb|AA
N53323.1|
AE015473
_10 
AE015473_10 
ribosomal protein L16 5 
0.516
184 
0.989
637 
0.618
082 
1.091
535 
0.00
523
6 
0.00
072
9 
0.01
012
4 
0.00
036
9 2.234147 0.001943 
Q8EK58 
(RL24_S
HEON)S
O0242 
gi|243456
53|gb|AA
N53327.1|
AE015473
_14 
AE015473_14 
ribosomal protein L24 14 
-
0.518
43 
-
1.025
67 
-
0.581
48 
-
1.088
72 
0.04
950
4 
0.00
642
3 
0.02
052
4 
0.00
316 -2.23351 0.011983 
Q8EK57 
(RL5_SH
EON) 
SO0243 
gi|243456
54|gb|AA
N53328.1|
AE015473
_15 
AE015473_15 
ribosomal protein L5 55 
-
0.646
04 
-
0.749
27 
-
0.819
84 
-
0.923
07 
6.61
E-11 
5.22
E-14 
3.46
E-11 
2.86
E-13 -2.19143 2.42E-12 
Q8EIM3 
(Q8EIM3
_SHEON) 
SO0815 
gi|243463
70|gb|AA
N53891.1|
AE015526
_2 
AE015526_2 TonB-
dependent receptor 
C-terminal domain 
protein 7 
0.531
59 
0.750
497 
0.496
669 
0.715
575 
0.01
036
1 
0.00
092
7 
0.00
046
2 
0.00
098
9 1.8656 0.001447 
Q8EHS3 
(Q8EHS3
_SHEON) 
SO1144 
gi|243467
93|gb|AA
N54214.1|
AE015558
_8 
AE015558_8 methyl-
accepting chemotaxis 
protein  27 
0.881
679 
1.049
178 
0.378
562 
0.546
06 
2.04
E-13 
1.38
E-14 
0.00
049
4 
4.05
E-07 2.041877 8.66E-10 
Q8EHM2 
(Q8EHM
2_SHEO
gi|243468
61|gb|AA
N54267.1|
AE015563_7 cell 
division protein FtsH 3 
0.851
71 
0.707
735 
0.847
712 
0.703
737 
0.03
605
4 
0.01
032
8 
0.01
162
9 
0.00
300
2 2.176511 0.010678 
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N) 
SO1197  
AE015563
_7 
Q8EGV9 
(Q8EGV9
_SHEON) 
SO1482 
gi|243472
32|gb|AA
N54543.1|
AE015593
_2 
AE015593_2 TonB-
dependent receptor, 
putative 4 
-
0.664
29 
-
0.432
25 
-
0.680
13 
-
0.448
09 
0.01
287
6 
0.03
239
6 
0.01
446
9 
0.03
419
9 -1.74402 0.021315 
Q8EFZ0 
(Q8EFZ0
_SHEON) 
SO1824 
gi|243476
58|gb|AA
N54876.1|
AE015626
_5 
AE015626_5 
conserved 
hypothetical protein 
20
6 
-
0.476
97 
-
0.425
33 
-
0.452
07 
-
0.400
43 
1.78
E-12 
1.76
E-10 
5.17
E-12 
3.94
E-10 -1.55069 2.83E-11 
Q8EFY9 
(Q8EFY9
_SHEON) 
SO1825 
gi|243476
59|gb|AA
N54877.1|
AE015626
_6 
AE015626_6 
MotA/TolQ/ExbB 
proton channel family 
protein [Shewanella 
oneidensis MR-1] 88 
-
0.483
88 
-
0.529
31 
-
0.486
41 
-
0.531
84 
1.18
E-08 
6.73
E-10 
8.78
E-08 
8.69
E-10 -1.66173 4.97E-09 
Q8EFY7 
(Q8EFY7
_SHEON) 
SO1827 
gi|243476
61|gb|AA
N54879.1|
AE015626
_8 
AE015626_8 TonB 
system transport 
protein ExbD2 
[Shewanella 
oneidensis MR-1] 3 
-
0.760
23 
-
0.765
48 
-
0.705
63 
-
0.710
89 
0.01
292
5 
0.00
766
8 
0.00
302
6 
0.00
888
6 -2.08664 0.007185 
Q8EFY6 
(Q8EFY6
_SHEON) 
SO1828 
gi|243476
62|gb|AA
N54880.1|
AE015626
_9 
AE015626_9 TonB2 
protein [Shewanella 
oneidensis MR-1] 9 
-
1.049
33 
-
1.124
82 
-
1.140
69 
-
1.216
18 
0.00
206
6 
0.00
150
6 
0.00
034
5 
0.00
021
1 -3.1042 0.00069 
Q8EFP4 
(Q8EFP4
gi|243477
90|gb|AA
N54977.1|
AE015636_1 citrate 
synthase [Shewanella 
oneidensis MR-1] 6 
-
0.573
17 
-
1.127
05 
-
0.287
03 
-
0.840
91 
0.00
079
3 
4.41
E-05 
0.04
513 
0.00
134
1 -2.02798 0.001206 
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_SHEON) 
SO1926 
AE015636
_1 
Q8EEF5 
(Q8EEF5
_SHEON) 
SO2427 
gi|243484
20|gb|AA
N55461.1|
AE015683
_8 
AE015683_8 TonB-
dependent receptor, 
putative [Shewanella 
oneidensis MR-1] 43 
-
0.729
82 
-
0.719
6 
-
0.796
91 
-
0.786
7 
3.42
E-11 
9.86
E-12 
3.02
E-11 
3.81
E-12 -2.13455 1.4E-11 
Q8EEB8 
(Q8EEB8
_SHEON) 
SO2469 
gi|243484
76|gb|AA
N55500.1|
AE015688
_6 
AE015688_6 
conserved 
hypothetical protein 
[Shewanella 
oneidensis MR-1] 14 
-
0.767
55 
-
0.770
81 
-
0.966
19 
-
0.969
45 
0.00
028
9 
0.00
019
1 
4.75
E-06 
2.16
E-06 -2.38333 2.74E-05 
Q8ED60 
(Q8ED60
_SHEON) 
SO2907 
gi|243490
09|gb|AA
N55923.1|
AE015729
_7 
AE015729_7 TonB-
dependent receptor 
domain protein 
[Shewanella 
oneidensis MR-1] 13 
-
0.947
72 
-
0.711
98 
-
0.938
74 
-
0.703 
0.00
066
6 
0.00
395
4 
0.00
190
7 
0.00
960
7 -2.2827 0.002635 
Q8EBN8 
(GLYA_S
HEON) 
SO3471 
gi|243497
03|gb|AA
N56464.1|
AE015783
_7 
AE015783_7 serine 
hydroxymethyltransfe
rase [Shewanella 
oneidensis MR-1] 8 
-
0.813
37 
-
0.563
04 
-
0.542
01 
-
0.291
68 
0.00
028
4 
0.00
265
4 
5.55
E-05 
0.00
406
7 -1.73763 0.000643 
Q8EBE6 
(CLPB_S
HEON) 
SO3577 
gi|243498
35|gb|AA
N56566.1|
AE015794
_4 
AE015794_4 clpB 
protein [Shewanella 
oneidensis MR-1] 4 
2.677
645 
2.519
805 
1.942
581 
1.784
742 
0.00
047
8 
1.37
E-05 
0.00
124
8 
0.00
018
4 9.310971 0.000197 
Q8EB65 
(Q8EB65
gi|243499
44|gb|AA
N56654.1|
AE015801_12 heme 
transport protein 17 
-
0.408
52 
-
0.266
58 
-
0.449
77 
-
0.307
83 
0.00
963
6 
0.04
785
3 
0.00
842
5 
0.03
603
8 -1.43072 0.019344 
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_SHEON) 
SO3669 
AE015801
_12 
[Shewanella 
oneidensis MR-1] 
Q8EAH2 
(RS6_SH
EON) 
SO3930 
gi|243502
59|gb|AA
N56905.1|
AE015825
_4 
AE015825_4 
ribosomal protein S6 
[Shewanella 
oneidensis MR-1] 13 
0.664
783 
0.499
885 
0.781
645 
0.616
747 
4.35
E-05 
0.01
390
7 
0.00
038
2 
0.01
412
8 1.897932 0.001344 
Q8EAG0 
(Q8EAG0
_SHEON) 
SO3942 
gi|243502
74|gb|AA
N56917.1|
AE015826
_2 
AE015826_2 serine 
protease, 
HtrA/DegQ/DegS 
family [Shewanella 
oneidensis MR-1] 18 
0.599
505 
0.767
732 
0.614
649 
0.782
876 
0.00
070
9 
0.00
010
8 
0.00
168
7 
0.00
022
6 1.99609 0.000414 
Q8E8C0 
(ATPB_S
HEON) 
SO4747 
gi|243512
79|gb|AA
N57706.1|
AE015907
_4 
AE015907_4 ATP 
synthase F1, beta 
subunit [Shewanella 
oneidensis MR-1] 47 
1.223
955 
1.189
632 
1.042
367 
1.008
044 
3.62
E-16 
2.69
E-15 
2.5E
-13 
1.23
E-13 3.052618 1.32E-14 
Q8E8B6 
(ATPF_S
HEON) 
SO4751 
gi|243512
83|gb|AA
N57710.1|
AE015907
_8 
AE015907_8 ATP 
synthase F0, B subunit 
[Shewanella 
oneidensis MR-1] 3 
-
0.748
63 
-
0.804
94 
-
1.184
62 
-
1.240
92 
0.02
911
9 
0.02
320
5 
0.00
098
9 
0.00
080
1 -2.70412 0.004809 
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iTRAQ 2 - Aerobic Planktonic vs Semi-Anaerobic Anodic Biofilm 
cells - insoluble sub-proteome 
 gi Number Name 
# 
pe
pt
id
es 
119/1
15 
(log 
differ
ence) 
119/1
16 
(log 
differ
ence) 
121/1
15 
(log 
differ
ence) 
121/1
16 
(log 
differ
ence) 
119
/11
5 
(p-
valu
e) 
119
/11
6 
(p-
valu
e) 
121
/11
5 
(p-
valu
e) 
121
/11
6 
(p-
valu
e) 
Fold change 
(Anode 
associated 
cells/aerobic 
planktonic) 
P-value 
(Anode 
associated 
cells/aerobi
c 
planktonic) 
Q8EK81 
(EFTU1_
SHEON) 
SO0217 
gi|243456
20|gb|AA
N53302.1|
AE015471
_7 
AE015471_7 
translation elongation 
factor Tu [Shewanella 
oneidensis MR-1] 
34
7 
-
0.312
54 
-
0.145
25 
-
0.434
72 
-
0.267
42 
4.09
E-13 
0.00
040
1 
6.19
E-24 
8.27
E-11 -1.3364 5.38E-13 
Q8EK76 
(RL10_S
HEON) 
SO0222 
gi|243456
25|gb|AA
N53307.1|
AE015471
_12 
AE015471_12 
ribosomal protein L10 
[Shewanella 
oneidensis MR-1] 27 
-
0.584
95 
-
0.577
42 
-
0.353
71 
-
0.346
19 
0.00
218
1 
0.00
170
6 
0.03
862
1 
0.04
751
6 -1.59291 0.009091 
Q8EK74 
(RPOB_S
HEON) 
SO0224 
gi|243456
31|gb|AA
N53309.1|
AE015472
_1 
AE015472_1 DNA-
directed RNA 
polymerase, beta 
subunit [Shewanella 
oneidensis MR-1] 43 
0.545
155 
0.505
266 
0.507
134 
0.467
245 
5.86
E-09 
5.24
E-08 
1.92
E-08 
2.57
E-07 1.658975 3.51E-08 
Q8EK73 
(RPOC_S
HEON) 
SO0225 
gi|243456
32|gb|AA
N53310.1|
AE015472
_2 
AE015472_2 DNA-
directed RNA 
polymerase, beta' 
subunit [Shewanella 
oneidensis MR-1] 54 
0.513
397 
0.627
565 
0.314
363 
0.428
53 
1.95
E-09 
1.08
E-10 
2.68
E-05 
6.32
E-07 1.601537 4.35E-08 
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P59166 
(RS12_S
HEON) 
SO0226 
gi|243456
33|gb|AA
N53311.1|
AE015472
_3 
AE015472_3 
ribosomal protein S12 
[Shewanella 
oneidensis MR-1] 7 
-
0.404
4 
-
0.346
98 
-
0.609
19 
-
0.551
76 
0.02
410
9 
0.04
106
6 
0.00
498
1 
0.00
952
6 -1.61298 0.014723 
Q8EK65 
(RL2_SH
EON) 
SO0234 
gi|243456
45|gb|AA
N53319.1|
AE015473
_6 
AE015473_6 
ribosomal protein L2 
[Shewanella 
oneidensis MR-1] 30 
0.369
058 
0.503
319 
0.468
274 
0.602
535 
5.62
E-06 
3.93
E-08 
3.26
E-05 
9.64
E-08 1.62547 9.13E-07 
Q8EK57 
(RL5_SH
EON) 
SO0243 
gi|243456
54|gb|AA
N53328.1|
AE015473
_15 
AE015473_15 
ribosomal protein L5 
[Shewanella 
oneidensis MR-1] 88 
-
0.582
72 
-
0.554
22 
-
0.730
35 
-
0.701
85 
1.32
E-13 
1.11
E-11 
6.56
E-12 
2.64
E-11 -1.90082 3.99E-12 
P59124 
(RS5_SH
EON) 
SO0248 
gi|243456
59|gb|AA
N53333.1|
AE015473
_20 
AE015473_20 
ribosomal protein S5 
[Shewanella 
oneidensis MR-1] 60 
-
0.421
63 
-
0.314
08 
-
0.572
19 
-
0.464
65 
6.92
E-07 
1.42
E-05 
1.34
E-09 
4.65
E-07 -1.55759 2.8E-07 
P59131 
(RS4_SH
EON) 
SO0255 
gi|243456
70|gb|AA
N53340.1|
AE015474
_3 
AE015474_3 
ribosomal protein S4 
[Shewanella 
oneidensis MR-1] 17 
-
0.448
59 
-
0.492
25 
-
0.434
08 
-
0.477
74 
0.01
469
7 
0.00
789
2 
0.00
828
2 
0.00
492
2 -1.5891 0.008292 
Q8EIJ7 
(EFG2_S
HEON) 
SO0842 
gi|243464
08|gb|AA
N53918.1|
AE015529
_2 
AE015529_2 
translation elongation 
factor G [Shewanella 
oneidensis MR-1] 47 
-
0.702
83 
-
0.493
2 
-
0.685
35 
-
0.475
73 
2.49
E-10 
2.31
E-07 
3.41
E-08 
8.54
E-06 -1.80268 6.4E-08 
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Q8EHS3 
(Q8EHS3
_SHEON) 
SO1144 
gi|243467
93|gb|AA
N54214.1|
AE015558
_8 
AE015558_8 methyl-
accepting chemotaxis 
protein [Shewanella 
oneidensis MR-1] 30 
0.886
152 
0.877
048 
0.931
3 
0.922
196 
1.43
E-17 
7.54
E-15 
4.15
E-16 
3.46
E-18 2.469891 1.12E-16 
Q8EHL1 
(PNP_SH
EON) 
SO1209 
gi|243468
79|gb|AA
N54278.1|
AE015565
_1 
AE015565_1 
polyribonucleotide 
nucleotidyltransferase 
[Shewanella 
oneidensis MR-1] 9 
0.680
209 
0.467
01 
0.664
506 
0.451
307 
0.01
413
7 
0.00
626
7 
0.01
821
8 
0.01
632
2 1.760781 0.01274 
Q8EHD1 
(Q8EHD
1_SHEO
N) 
SO1295 
gi|243469
90|gb|AA
N54362.1|
AE015573
_9 
AE015573_9 major 
outer membrane 
lipoprotein, putative 
[Shewanella 
oneidensis MR-1] 75 
-
0.917
04 
-
0.818
3 
-
0.825
09 
-
0.726
35 
2.97
E-13 
6.55
E-13 
2.12
E-10 
7.35
E-10 -2.27435 1.32E-11 
Q8EGV9 
(Q8EGV9
_SHEON) 
SO1482 
gi|243472
32|gb|AA
N54543.1|
AE015593
_2 
AE015593_2 TonB-
dependent receptor, 
putative [Shewanella 
oneidensis MR-1] 7 
0.811
4 
0.852
664 
0.660
667 
0.701
931 
0.00
781
1 
0.00
926
8 
0.03
949
4 
0.04
002
5 2.131158 0.018392 
Q8EGH5 
(RS2_SH
EON) 
SO1629 
gi|243474
18|gb|AA
N54684.1|
AE015609
_3 
AE015609_3 
ribosomal protein S2 
[Shewanella 
oneidensis MR-1] 5 
0.507
834 
0.594
903 
0.384
601 
0.471
671 
0.01
201 
0.00
256
2 
0.03
065
4 
0.02
606
8 1.631912 0.012522 
Q8EG20 
(TIG_SH
EON) 
S)1793 
gi|243476
19|gb|AA
N54846.1|
AE015623
_8 
AE015623_8 trigger 
factor [Shewanella 
oneidensis MR-1] 6 
-
0.727
8 
-
0.717
77 
-
0.818
71 
-
0.808
69 
0.02
324
5 
0.02
383
1 
0.01
185
7 
0.01
106
3 -2.15597 0.016418 
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Q8EFZ0 
(Q8EFZ0
_SHEON) 
SO1824 
gi|243476
58|gb|AA
N54876.1|
AE015626
_5 
AE015626_5 
conserved 
hypothetical protein 
[Shewanella 
oneidensis MR-1] 19 
-
0.980
92 
-
0.923
76 
-
1.067
4 
-
1.010
25 
5.47
E-07 
3.1E
-06 
4.42
E-06 
2.56
E-05 -2.7063 3.72E-06 
Q8EFY9 
(Q8EFY9
_SHEON) 
SO1825 
gi|243476
59|gb|AA
N54877.1|
AE015626
_6 
AE015626_6 
MotA/TolQ/ExbB 
proton channel family 
protein [Shewanella 
oneidensis MR-1] 
10
6 
-
0.326
28 
-
0.517
41 
-
0.341
16 
-
0.532
28 
1.71
E-07 
2.64
E-14 
2.94
E-06 
1.14
E-12 -1.53616 3.51E-10 
Q8EFY6 
(Q8EFY6
_SHEON) 
SO1828 
gi|243476
62|gb|AA
N54880.1|
AE015626
_9 
AE015626_9 TonB2 
protein [Shewanella 
oneidensis MR-1] 7 
-
0.536
47 
-
0.623
94 
-
0.627
28 
-
0.714
75 
0.04
093
8 
0.01
988
4 
0.01
080
1 
0.00
423
5 -1.86939 0.013891 
Q8EFY5 
(Q8EFY5
_SHEON) 
SO1829 
gi|243476
63|gb|AA
N54881.1|
AE015626
_10 
AE015626_10 TPR 
domain protein 
[Shewanella 
oneidensis MR-1] 5 
0.466
007 
0.405
748 
0.426
822 
0.366
563 
0.00
437
5 
0.00
733
8 
0.02
417
4 
0.04
419
1 1.516318 0.013609 
Q8EEF5 
(Q8EEF5
_SHEON) 
SO2427 
gi|243484
20|gb|AA
N55461.1|
AE015683
_8 
AE015683_8 TonB-
dependent receptor, 
putative [Shewanella 
oneidensis MR-1] 10 
-
0.337
55 
-
0.386
33 
-
0.459
32 
-
0.508
1 
0.02
788
2 
0.00
901
4 
0.03
009
2 
0.01
198
6 -1.52626 0.017352 
Q8ED64 
(Q8ED64
_SHEON) 
SO2903 
gi|243490
05|gb|AA
N55919.1|
AE015729
_3 
AE015729_3 cysteine 
synthase A 
[Shewanella 
oneidensis MR-1] 49 
-
0.650
46 
-
0.621
66 
-
0.570
09 
-
0.541
29 
2.35
E-06 
4.36
E-06 
5.6E
-05 
5.96
E-05 -1.81462 1.36E-05 
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Q8EBH9 
(RS20_S
HEON) 
SO3537 
gi|243497
84|gb|AA
N56528.1|
AE015789
_15 
AE015789_15 
ribosomal protein S20 
[Shewanella 
oneidensis MR-1] 18 
0.511
237 
0.928
064 
0.852
405 
1.269
232 
0.00
108
6 
2.18
E-06 
0.00
013
4 
8.75
E-08 2.435701 1.29E-05 
Q8EBH3 
(Q8EBH3
_SHEON) 
SO3545 
gi|243497
95|gb|AA
N56536.1|
AE015790
_7 
AE015790_7 OmpA 
family protein 
[Shewanella 
oneidensis MR-1] 33 
-
0.452
22 
-
0.468
52 
-
0.435
61 
-
0.451
91 
0.00
106
7 
0.00
07 
0.00
189
2 
0.00
141
4 -1.57156 0.001189 
Q8EB65 
(Q8EB65
_SHEON) 
SO3669 
gi|243499
44|gb|AA
N56654.1|
AE015801
_12 
AE015801_12 heme 
transport protein 
[Shewanella 
oneidensis MR-1] 11 
0.603
97 
0.578
88 
0.467
277 
0.442
187 
0.00
117
1 
0.00
124 
0.00
830
6 
0.00
697
1 1.687214 0.003028 
Q8EAJ8 
(Q8EAJ8
_SHEON) 
SO3904 
gi|243502
26|gb|AA
N56879.1|
AE015823
_1 
AE015823_1 outer 
membrane protein 
TolC [Shewanella 
oneidensis MR-1] 6 
1.079
354 
1.165
6 
0.761
545 
0.847
791 
0.00
056
2 
0.00
067
6 
0.00
221
5 
0.00
039
3 2.621044 0.000758 
Q8EAG3 
(RS9_SH
EON) 
SO3939 
gi|243502
68|gb|AA
N56914.1|
AE015825
_13 
AE015825_13 
ribosomal protein S9 
[Shewanella 
oneidensis MR-1] 15 
-
0.768
14 
-
0.746
67 
-
0.430
22 
-
0.408
75 
4.7E
-06 
7.61
E-06 
0.00
194
7 
0.00
372
8 -1.80119 0.000127 
Q8EAG0 
(Q8EAG0
_SHEON) 
SO3942 
gi|243502
74|gb|AA
N56917.1|
AE015826
_2 
AE015826_2 serine 
protease, 
HtrA/DegQ/DegS 
family [Shewanella 
oneidensis MR-1] 14 
0.743
34 
0.832
601 
0.782
237 
0.871
498 
0.00
032
4 
0.00
022
1 
9.27
E-06 
0.00
010
2 2.242114 9.06E-05 
374 | P a g e  
 
Q8E8C0 
(ATPB_S
HEON) 
SO4747 
gi|243512
79|gb|AA
N57706.1|
AE015907
_4 
AE015907_4 ATP 
synthase F1, beta 
subunit [Shewanella 
oneidensis MR-1] 85 
0.997
501 
1.002
962 
0.975
493 
0.980
954 
1.34
E-31 
1.06
E-28 
3.14
E-30 
1.54
E-26 2.689157 2.88E-29 
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Media 
M1 minimal media 
M1 media for Shewanella oneidensis MR-1 
 
The M1 media prepared had the following variations: 
- 18 mM Lactate 
- 50 mM PIPES 
- 100 mM sodium chloride (NaCl) 
 
(a) Vitamin Supplement 100x  
 
0.01 g   Pyridoxine hydrochloride 
0.005 g  Thiamine-HCl 
0.005 g  Riboflavin 
0.005 g  Nicotinic acid 
0.005 g  Calcium D-(+)-pantothenate 
0.005 g  p-Aminobenzoic acid 
0.005 g  Thioctic acid 
0.002 g  Biotin 
0.002 g  Folic Acid 
0.0001 g  Vitamin B12 
1000ml Water 
 
Filter sterilize with 0.22 um pore diameter filter. 
(b) Mineral Supplement 100x based on Wolfe’s Vitamin Solution (pH 7.0) 
1. Add 1.5 g nitrilotriacetic acid to approximately 500 ml of water and adjust to pH 
7.0 with sodium hydroxide (NaOH) to dissolve. 
2. Add the following: 
3.0 g  MgSO4-7H2O 
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0.5 g  MnSO4-H2O 
1.0 g  NaCl 
0.1 g   FeSO4-7H2O 
0.1 g   CoCl2-6H2O 
0.1 g    CaCl2-2H2O 
0.13 g   ZnCl2 
0.01 g   CuSO4-5H2O 
0.01 g   AlK(SO4)2-12H2O 
0.01 g   H3BO3 
0.025 g  Na2MoO4-2H2O 
0.024 g  NiCl2-6H2O 
0.025 g  Na2WO4-2H2O 
1000ml Water 
 
3. Filter sterilize with 0.22 um pore diameter filter. 
 
(c) Amino Acid Supplement 100x (pH 7.0) 
1. Dissolve (or add appropriate concentrations solutions) for the following into 
900ml of distilled water: 
2.0 g  L-glutamic acid 
2.0 g  L-arginine 
2.0 g   DL-Serine  
2. Adjust to pH 7.0 with sodium hydroxide (NaOH) 
3. Make up to 1000ml water 
4. Filter sterilize with 0.22 um pore diameter filter. 
 
(d) PIPES buffer 1 L pH 7.0 
 
1. Dissolve for the following into 700ml of distilled water: 
15.12 g   PIPES 
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0.3 g  sodium hydroxide (NaOH) 
2. Adjust to pH 7.0 with sodium hydroxide (NaOH) 
3. Make up to 1000ml water 
4. Filter sterilize with 0.22 um pore diameter filter. 
 
M1 MINIMAL MEDIA 
1. Dissolve (or add appropriate concentrations solutions) for the following into 
700ml of distilled water: 
15.12 g   PIPES buffer (see above) 
0.3 g  NaOH 
1.5 g   NH4Cl 
0.1 g   KCl 
0.6 g  NaH2PO4.H2O 
5.844 g   NaCl 
2. Adjust to pH 7.0 with sodium hydroxide (NaOH) 
3. Add the following solutions: 
9.0 mL  sodium lactate 2M pH7.0 
10.0 mL  mineral supplement  (see above) 
10.0 mL  vitamin supplement  (see above) 
10.0 mL  amino acid supplement  (see above) 
4. Make up to 1000ml water 
5. Filter sterilize with 0.22 um pore diameter filter. 
 
